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i6 Medicine and the military 
Life in the armed forces offers some physicians 
a chance to serve both country and patients. 
By Jill Max 
ON THE COVER ArmyColonei 
Lionel M. Nelson came out of retire¬ 
ment to serve as brigade flight 
surgeon with Task Force 449 at Camp 
Stryker in Baghdad. “The need for 
flight surgeons with experience 
is significant,” he said. "The Army 
asked, and I volunteered.” 
The high cost of a medical education 
With the cost of medical school topping $250,000, 
becoming a doctor means going into debt. 
By Sonya Collins 
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2 Letters 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or fewer) and 
news items to Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length, style, and content. 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
0 
Online: Yale Netcasts 
Additional content for articles 
in this issue of Yale Medicine 
is available online at iTunesU, 
or by pointing your browser 
to yalemedicine.yale.edu. 
Reactions to women 
in medicine 
In her excellent essay on women 
in medicine in the Autumn 
2010 issue of Yale Medicine 
[“Improving the lot of women 
in medicine’’], Jill Max seems to 
lament that "Even in pediatrics 
or psychiatry, where women 
have accounted for half the field 
for more than 25 years, they have 
accounted for only about 10 per¬ 
cent of department chairs during 
the past decade." I read that 
to imply that everyone in aca¬ 
demic medicine should strive to 
become a chair regardless of his 
or her primary interests or skills. 
More than rarely, it has 
seemed to me that some fac¬ 
ulty members advance beyond 
their original interests—and 
sometimes even their merits 
as an outstanding clinician or 
researcher—into running a 
department. That leads to a 
Rake’s Progress, as I like to call 
it, of going on to become a 
dean or worse. It may be unfair 
to gripe that women have not 
in larger numbers chosen the 
administrative route: they may 
have preferred the one-on-one 
of caring for patients. I am sure 
the satisfactions of patient care 
outlast those of any administra¬ 
tor, given the usually abbrevi¬ 
ated term of the latter. 
Howard M. Spiro, m.d. 
Professor Emeritus of Medicine 
New Haven, Conn. 
I was frankly astounded. I 
finished the nicely balanced 
article "Improving the lot of 
women in medicine” in the 
Autumn 2010 issue, impressed 
by the persistence of this issue 
of undervaluing women in 
medicine. How can we have 
discussed it for so long and still 
be baffled for a solution? Then 
I went on to read the following 
article, "When medicine meets 
the business world,” which 
features four photographs of 
business/medicine leaders. All 
four are men! Could not one 
photo be found of the success¬ 
ful female leaders mentioned in 
the article? Maybe I should not 
feel so baffled. As Pogo (Walt 
Kelly) said, “We have met the 
enemy and he is us.” 
Joseph Connors, m.d. ’75 
Vancouver, B.C. 
Remembering Tom Forbes 
when I returned to New Haven 
for the 45th reunion of the 
Medical School Class of 1965, my 
classmates immediately began 
entertaining each other with 
stories about Thomas Forbes, 
PH.D., our kind and gentlemanly 
associate dean who strove to 
avoid any stress in his encoun¬ 
ters with young people by 
preceding any possibly contrary 
comment with a nervous little 
cough. So many of us had so 
many kind things to say about 
him that it was easy for me to 
pitch in with my short tale: 
It was the winter of i960 
when I came to New Haven to 
be interviewed for the next 
medical class. A motherly secre¬ 
tary ushered me into the hand¬ 
some office of Dr. Forbes, who 
immediately put me at my ease 
with his kind smile, two-handed 
handshake, and comfortable 
slouching in his leather chair. 
We chatted amiably about this 
and that until finally he asked, 
“Uh, Mr. Barchilon, can you 
think of anybody at Yale that 
you particularly admire?” 
"Cole Porter!” I answered 
immediately. 
Tom Forbes leaned back and 
paused a moment. "Ahem, uh, 
Mr. Barchilon, I meant from the 
medical school.” He paused again 
a moment, then leaned forward 
with a smile. “But come to think 
of it, he’s my favorite, too.” 
That pretty well clinched 
Yale for me, especially after the 
adrenaline-rush interviews I 
had had at Columbia and Johns 
Hopkins. I felt comfortable 
at Yale and have always been 
proud to have learned the art of 
medicine there. 
John Barchilon, m.d. '6s 
Thousand Oaks, Calif. 
A “phantom” in the 
Class of ’72 
I was pleased to read in Yale 
Medicine that Donald Berwick, 
M.D., was the Commencement 
speaker last year. The article 
reminded me that Don was 
considered a phantom member 
of our Class of 1972. Apparently 
he enrolled at Yale but belat¬ 
edly decided to attend Harvard 
Medical School. For whatever 
reason, this news apparently 
did not prevent him from hav¬ 
ing a place at a cadaver or from 
having a designated place and 
materials in every laboratory 
and small-group session. To 
my recollection, this practice 
continued well into our second 
year. The joke was that with the 
Yale system as it was, he could 
earn an m.d. from both Yale and 
Harvard. It is fitting that Don 
finally did make it down to the 
Yale medical campus. 
Philip L. Cohen, m.d. ’12 
Philadelphia, Pa. 
starting point 
lA snapshot of the School of Medicine 
Since I started working at Yale Medicine in 1998, no issue of the magazine has generated the 
response of that to our Winter 2011 Bicentennial issue. Since we mailed this issue in mid- 
January, alumni, faculty, staff and colleagues at our peer schools have been sending their 
congratulations on the photo essay, “A Week in the Life.” 
“The breadth of the life at ysm shown in these photos is terrific—I learned a great 
deal about the mysteries down the halls I don’t walk—and in the hall in which I work every 
,day. It really made me proud to be part of the medical campus,” wrote Laura Crawford, a pro¬ 
gram administrator who coordinates international travel for residents and students. 
“Had I not graduated in 1948, I would have immediately applied to Yale med school,” 
■wrote Albert A. Fisk, m.d. ’48. 
From H. Steven Moffic, m.d. ’71, “Your special issue of A Week in the Life’ helped me 
to appreciate the current life of Yale School of Medicine, movingly going from a custodian to 
:our dean, from high-tech surgery to after-hours music, covering so many aspects of the sys- 
jtem of Yale medicine.” 
Once again I must extend thanks to a great team of photographers—Julie Brown, 
iTerry Dagradi, Robert Lisak, Michael Marsland, Frank Poole, and Stephanie Zollshan—and 
jto our designer, Jenn Stockwell, as well as everyone in our publications office who supports 
lour efforts. 
' John Curtis 
Editor 
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4 chronicle news from cedar street 
A shorter workday 
for interns 
New work rules for first-year residents 
put limits on their hours but raise 
concerns about training. 
As of July I, medical interns around the 
country will be required to work fewer 
hours per day but with more supervi¬ 
sion. and will be forbidden to moonlight 
within their hospital or elsewhere. Those 
changes, mandated by the Accreditation 
Council for Graduate Medical Education 
(acgme) in September last year, are 
drawing a mixture of praise and concern 
from the Yale medical community. 
The most controversial change 
involves duty hours. Currently 
residents may work no more than 
80 hours per week and no more than 
24 hours continuously (plus up to six 
additional hours for transfer of patient 
care). The new rules will put interns— 
first-year residents—into a separate 
category. They can still work up to 80 
hours but their shifts must end after 
16 hours with no extra time for trans¬ 
fer of care. Interns at Yale are already 
barred from moonlighting. 
Rosemarie L. Fisher, m.d., hs ’75, 
professor of medicine and pediatrics, 
and associate dean of graduate medical 
education, sat on the 16-person acgme 
task force that devised the new rules. 
“I’m getting things thrown at me,” she 
said, “like ‘Why did you do this?’ ” 
The answer, she said, is based on 
the intersection of two factors: the 
interns’ minimal level of training and 
growing evidence of problems caused 
by sleep deprivation. Sleep depriva¬ 
tion among interns has been linked to 
errors in patient care and medication 
administration, as well as to car acci¬ 
dents after long shifts. Extreme fatigue 
also hinders the ability to learn. “All of 
us on this task force believe we need 
graduated responsibility for patient 
care,” said Fisher, “and to do that we 
need to have the least trained, least 
competent people get more time off 
initially to learn and to get enough 
sleep so they’re not impaired.” 
Others aren’t so sure. Peter 
Herbert, m.d. ’67, chief of staff and 
senior vice president for medical 
affairs at Yale-New Haven Hospital 
(ynhh), said, “My major concern is 
that this may diminish the quality of 
the interns’ education and put them 
a little farther behind at the end of a 
year. Their perception of the overall 
course of illness obviously changes 
when they see less of it.” Moreover, 
Herbert said, they are not considered 
the key decision makers at any time 
of day—that role is for attendings and 
senior residents. “We’ll do our best to 
ensure that their education is as com¬ 
plete as possible, but there’s no substi¬ 
tute for being in the hospital.” 
Resident Erin Vaughn, center, goes over medi¬ 
cal records with first-year residents Anne 
Cowell and Natasha Shapiro as they prepare 
to hand off patients. 
Jason Ackerman, m.d., one of Yale’s : 
current 170 interns, questions the ; 
notion that cutting interns’ hours will i 
prevent mistakes. “If the reasoning is 
that you make poor decisions after so 
many hours of not sleeping,” he said, 
“it makes more sense to cap the hours 
of the senior resident, who ultimately 
makes the decisions and needs to be 
more rested and alert than the intern.” 
But like Fisher, Ackerman believes I 
that experience can make a difference 
when fighting fatigue. When facing i 
a medical situation, interns must go i 
through a mental checklist—a task I 
more difficult when exhausted but sec; 
ond nature with experience. He also j 
agrees that more rest could improve 
learning. “At the end of a 30-hour call 
shift, it really is hard to absorb any¬ 
thing, no matter what the lecture or 
teaching point is.” 
STOP AND SHOP COMES DOWNTOWN 
j Another concern is that as interns 
work fewer hours, there will be more 
patient handoffs. “We know handoffs 
between team members always increase 
error rates,” said Asghar Rastegar, m.d., 
professor of medicine. 
That’s where another new rule 
comes in. As of July i, a supervising 
physician must now be physically pres¬ 
ent or immediately available within 
I the hospital to help ensure safe hand¬ 
offs and patient care by interns. Fisher 
believes that this close supervision I will also enhance the interns’ educa¬ 
tion. Herbert notes that Yale-New 
Haven already has intricate protocols 
and electronic systems for hand¬ 
offs, established in response to rule 
changes mandated in 2003. 
Although the interns’ reduced 
'hours must be filled by other person¬ 
nel, Herbert doesn’t foresee a big 
increase in spending—again because 
of Yale’s response to the 2003 rules, 
iwhich included expanding Yale-New 
Haven’s Hospitalist Service by bring¬ 
ing in dozens of physicians, physician 
assistants, and nurse practitioners. 
Other changes in response to the 
rules are in the planning stages, accord¬ 
ing to Herbert, Fisher, and Rastegar. 
I “The interns are understandably 
1 anxious,” said Rastegar, “partly because 
the devil you know is better than the 
one you don’t. But I think things will 
settle down. And the bottom line is that 
we are not going to negotiate on the 
mission and our goals.” 
—Steve Kemper 
Child Study Center celebrates 100 
years of mental health research 
As the School of Medicine’s bicentennial 
year draws to a close, Yale’s Child Study 
Center (esc) celebrates a milestone of 
its own. A series of four symposia marks 
the centennial of an institution that 
has grown from a single room in the 
New Haven Dispensary into a leader in 
multidisciplinary research on children’s 
mental health. 
One of the School of Medicine’s 
28 departments, the esc evolved and 
matured together with the field of devel¬ 
opmental psychology—which was still 
young at the turn of the 20th century. 
The founder of psychoanalysis, Sigmund 
Freud, did not publish his major work on 
developmental psychology—Three Essays 
on the Theory of Sexuality—until 1905. 
Freud’s ideas did, however, infiu- 
ence G. Stanley Hall, the first president 
of Clark University and an early propo¬ 
nent of developmental psychology. One 
of Hall’s students, Arnold L. Gesell, 
PH.D., a native of Wisconsin, received 
In a single room in the New Haven Dispensary, 
Arnold Gesell launched in 1911 the Clinic of 
Child Development, which would become the 
Yale Child Study Center. 
More than a year after New Haven’s only 
downtown supermarket closed, the Stop and 
Shop Supermarket Company has announced 
plans to fill the space on Whalley Avenue 
with a new store this spring. The store will 
replace a Shaw’s supermarket that closed in 
March 2010. 
The loss of Shaw’s created a “food des¬ 
ert” downtown, depriving residents of the 
Whalley Avenue area and Yale students of 
a full-service supermarket. The new store 
comes after efforts by Yale, the city of New 
Haven, and the Greater Dwight Community 
Investment Corporation—owner of the 
site—to fill the space. The store is expected 
to generate about 130 full- and part-time 
Jobs. It will include seafood, deli, and floral 
departments; a cheese shop and bakery; 
ethnic specialty items; and an in-store branch 
of People’s United Bank. 
—John Curtis 
BIODESIGN INSTITUTE LAUNCHED 
By early next year, research scientists in 
Building B-24 on the West Campus may be 
working on nanomachines that function 
inside living cells, developing materials for tis¬ 
sue engineering, or creating dna nanorobots 
to carry out programmed tasks. 
In January university officials announced 
the creation of the Biodesign Institute, where 
biologists, engineers, and researchers in 
other disciplines will explore the ways in which 
living and material systems operate at the 
nanoscale. James E. Rothman, ph.d., the Fergus 
F. Wallace Professor of Biomedical Sciences 
and chair of the Department of Cell Biology, 
has been named director of the new institute. 
T. Kyle Vanderlick, ph.d., dean of the School of 
Engineering and Applied Science, will serve as 
deputy director. 
"Engineers design systems from first 
principles, and do so on ever-smaller scales,” 
said Rothman. “Biologists are reverse engi¬ 
neers, and seek to deduce the design that 
nature provides. There is a profound inter¬ 
section between these oppositely oriented 
views that enriches both.” 
—J.C. 
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6 chronicle news from cedar 
one of the first two doctorates con¬ 
ferred in developmental psychology in 
the United States from Clark in 1906. 
Gesell became an assistant professor in 
Yale’s new Department of Education in 
1911. On his arrival, Gesell persuaded 
the medical school’s dean, George 
Blumer, m.d. 1891, to provide a room in 
the dispensary for the study of retarded 
children. While working part time, 
Gesell then enrolled in the School of 
Medicine and received his m.d. in 1915, 
four years after he’d opened his clinic 
in the dispensary. 
Gesell’s work influenced not only the 
department he founded—then called 
the Yale Glinic of Ghild Development— 
but also the burgeoning field of child 
psychology as well as pediatrics. He was 
among the first to attempt a quantitative 
study of children’s maturation, observ¬ 
ing and measuring the responses of 
infants and children to different stimuli. 
A pioneer in the use of motion pictures 
and one-way mirrors, he filmed about 
12,000 children to record and study 
their behavioral patterns. Mental devel¬ 
opment, he concluded, occurs in an 
identifiable sequence of stages similar to 
those associated with physical develop¬ 
ment. Some of Gesell’s data were inte¬ 
grated into schedules used to calculate 
the Gesell Developmental Quotient—for 
a time a widely used measure of young 
children’s intelligence. One of his most 
prominent students was Benjamin 
Spock, MED ’29, whose ideas about child 
care influenced generations of parents. 
Although some of Gesell’s views have 
fallen out of favor, he exerted a strong 
influence on American psychology in 
general as well as on childrearing prac¬ 
tices. Gesell retired from the University 
in 1948 and died in 1961. 
The first of four symposia was held 
on January ii and focused on infant 
mental health and development, with 
talks by the esc faculty as well as by 
Helen Egger, m.d. ’91, assistant profes¬ 
sor of psychiatry and behavioral sciences 
at Duke University School of Medicine. 
Subsequent symposia will honor Gesell’s 
successors as esc directors: Milton J.E. 
STREET 
Senn, m.d., Donald J. Cohen, m.d. ’66, 
and Albert f. Solnit, m.d., hs ’52. 
CSC chair Ered R. Volkmar, m.d., 
smiled brightly when asked about the 
center’s future. “We’ve got a big push 
for anxiety programs,” he said, adding 
that a recent donation will fund three 
new professorships. Anxiety disorders, 
he said, affect about 20 percent of the 
population and often lead to or are asso¬ 
ciated with such problems as depression 
and mood disorders. 
Expansion is also occurring in the 
area of autism spectrum disorders 
(asds). “Eor the first time, we have kids 
with [asds] going to college on a regular 
basis, which is great,” said Volkmar. 
“But they need some special help, and so 
we’re trying to think about ways we can 
meet that need.” Although psychologists 
have made great strides in their ability to 
diagnose and intervene in children with 
ASDS, Volkmar noted that adolescents 
and young adults with these disorders 
still need support as they complete their 
education and enter mainstream society. 
Another point of pride for Volkmar 
is the csc’s Albert J. Solnit Integrated 
Training Program, a highly selective and 
innovative six-year program begun in 
July 2004. The program, which admits 
only two trainees per year, combines the 
traditional internship, residency, and fel¬ 
lowship years and prepares trainees for 
board examinations in both adult and 
child psychiatry. 
An innovative program from its start 
in 1911, Yale’s esc is still the leader in 
the field. Volkmar credits the depart¬ 
ment’s collaborative model—at least 
in part—for its success. “Some of the 
things here we take for granted,” he 
said, noting that the center’s scientists 
work in a range of fields, from neurobi¬ 
ology of developmental disorders to stem 
cells to MRi. “Because there’s so much 
going on,” he said, “it means there’s 
more potential for cross-disciplinary 
work,” which is critical to the successes 
he is aiming for. 
—Charles Gershman 
A federal grant moves plans 
to link med school with 
downtown a step forward 
Nearly half a century ago, the area 
between the Yale School of Medicine 
and downtown New Haven was the 
bustling Oak Street neighborhood, full 
of homes and small businesses. That 
space is presently occupied by Route 34, 
a busy highway that carries tens of 
thousands of speeding cars each day. 
In an ambitious project known as 
Downtown Crossing, the city is plan¬ 
ning to convert Route 34 back to a street 
grid that will reunite the School of 
Medicine with the rest of the university 
and downtown New Haven. Developer 
Carter Winstanley has already commit¬ 
ted to developing a $140 million office 
and lab building at 100 College Street. 
The proposed eight-story building will 
occupy what is now thousands of square 
feet of empty air above the connector 
between 300 George Street—another 
Winstanley building—and the School 
of Public Health. Like 300 George 
Street, which houses a number of medi¬ 
cal school programs and offices, the 
new building is slated to accommodate 
some of New Haven’s burgeoning bio¬ 
tech enterprises and could also provide 
much-needed space for the medical 
campus. “We have an infinite number 
of ideas for growing our programs and 
we need space to accommodate them,” 
said Dean Robert J. Alpern, m.d.. 
Ensign Professor of Medicine. 
Downtown Crossing came a step 
closer to reality in October when the city 
received a $16 million grant from the 
U.S. Department of Transportation to 
begin Phase i, covering the eastern half 
of the connector from Union Avenue to 
A rendering (below) shows the Route 34 corridor 
after the first phase of Downtown Crossing. A 
proposed eight-story building would add thou¬ 
sands of square feet of new office and lab space. 
At left, the connector and the Air Rights Garage. 
RNA HELPS GENES DETERMINE TRAITS 
A Yale study suggests that genes are not 
the sole determinants of an organism’s 
characteristics. The team reported in Nature 
Genetics on December 26, 2010, that a type 
of regulatory rna works with a common 
protein, Hspgo, to protect organisms from 
harmful genetic variations—without the 
help of genes. 
About a decade ago, scientists found that 
flies lacking Hspgo often had abnormalities. 
Hspgo seemed to protect against harmful 
genetic variations, but the researchers sus¬ 
pected that it doesn’t act alone. They found 
that a small non-coding rna called Piwi- 
interacting rna acts with Hspgo and another 
organizing protein called Hop to prevent both 
the emergence of new genetic variants and 
the activation of existing variants. 
“This study shows that we still have a lot 
to learn about the most basic principles of 
gene regulation,’’ said senior author Haifan Lin, 
PH.D., director of the Yale Stem Cell Center. 
—John Curtis 
College Street. The grant will allow the 
city to reclaim ii acres of land that will 
be used for new institutional, retail, 
residential, and commercial space— 
creating 2,000 immediate construction 
jobs and 960 permanent jobs, according 
to the mayor’s office. Phase i will also 
reconnect the medical school campus 
with downtown New Haven. 
“The medical school campus is 
very active during the day as a place 
to work but it’s not active as a place 
to live,” said Alpern. “We’d like one 
continuum as you walk from Chapel 
Street toward the medical school.” 
Returning the area to its urban 
origins will alleviate some of its traffic 
dangers—two pedestrians, including a 
Yale medical student, have been killed 
in recent years—and provide much- 
needed growing space for the medical 
campus and New Haven businesses. 
“This project allows us to knit the 
two principal job platforms of the city 
together,” said Mayor John DeStefano 
Jr. “It addresses a near-term demand for 
real estate and allows us to significantly 
increase the size of the central business 
district, which will have benefits for 
collateral economic growth as well.” 
The federal grant will be supple¬ 
mented by $8 million from the state 
and $7 million from the city to cover 
the $31 million estimated cost of the 
first phase of the project. The second 
phase—to develop the western half of 
the connector from Orchard Street to 
Ella Grasso Boulevard—is still in the 
preliminary planning stage. 
—Jill Max 
THE BRAIN’S MOLECULAR GLUE 
The human brain has about 90 billion 
neurons, interconnected through junctions 
called synapses. Our brains form synapses 
to organize new knowledge and memories; 
malfunctioning synapses, on the other 
hand, are linked to such disorders as mental 
retardation and Alzheimer disease. 
Yale scientists reported in the Journal 
Neuron in December that a molecule called 
synaptic cell adhesion molecule 1 (SyncAM i) 
is essential for both synapse formation and 
maintenance. When the SyncAM i gene was 
activated in mice, more synaptic connections 
were formed. Mice without the molecule 
produced fewer synapses. So far, so good. 
The team’s next finding, however, was 
not so clear-cut. Mice with high levels of 
SyncAM ^ failed at spatial learning, while 
mice lacking SynCAM 1 learned better. Too 
much of a good thing? 
“It appears that SyncAM 1 ties synapses 
together; some of this molecule is needed to 
promote contact, but too much glues down the 
synapse and inhibits its function,’’ said senior 
author Thomas Biederer, ph.d., associate profes¬ 
sor of molecular biophysics and biochemistry. 
—J.C. 
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8 Books & ideas 
The dark side of motherhood 
A psychiatrist explores mothers’ ambivalence over their 
needs and their children’s. 
Poetry, paintings, and corporate America have long idealized 
the love of a mother for her child, from Kipling’s “Mother o’ 
Mine" to Mary Cassatt’s portraits and soft-focus Mother’s 
Day cards. Psychiatrist Barbara Almond, m.d. ’63, has writ¬ 
ten a new book about another aspect of motherhood: moth¬ 
ers’ feelings of anger and resentment. 
Maternal ambivalence is both 
universal and inevitable, says 
Almond, a psychoanalyst, train¬ 
ing analyst, and instructor emeri¬ 
tus in psychiatry at Stanford. 
In her book The Monster Within: 
The Hidden Side of Motherhood, 
Almond explores “the conflicts 
between the child’s and the 
mother’s needs, both legitimate.” 
Complicating these conflicts is 
the fear that accompanies love. 
“What we love can disappoint us. 
What we love, we can also lose,” 
Almond writes. “That mothers have mixed feelings about 
their children should come as no surprise to anybody, but it 
is amazing how much of a taboo the negative side of ambiv¬ 
alence carries in our culture.” 
Almond draws on stories from clinical practice and 
fiction to investigate the dark side—from a woman’s com¬ 
monplace fear that she will love her child insufficiently to 
extremes that include a mother’s murder of a daughter in 
Toni Morrison’s novel Beloved and Andrea Yates’s real-life 
drowning of her five children. 
Almond contends that facing ambivalence, which she 
views as a mixture of loving and hateful feelings, can be con¬ 
structive, “when it leads the mother to think creatively about 
her difficulties mothering and how they can be managed.” 
Some publishers—and some reviewers—found Almond’s 
book too disturbing. On the contrary, she says, “I’m offering 
this as a comfort to mothers. They don’t have to drive them¬ 
selves so hard.” 
—Cathy Shufro 
The Monster Within 
Barbara Almond, m.d. ’63 
y, ll.iUHhaHUlBlfcl 
OCULAR INFLAMMATORY 
DISEASE AND UVEITIS 
MANUAL 
How We Age: A Doctor’s Journey 
into the Heart of Crowing Old 
by Marc E. Agronin, m.d. '91 (Da 
Capo Press) The author, a special¬ 
ist in geriatric psychiatry, recounts 
his experiences counseling the 
residents of the Miami Jewish 
Home and Hospital, and describes 
how his work has transformed 
his view of aging. This book illus¬ 
trates that aging is more than an 
inevitable decline—that old age 
can also be a period of vitality, 
wisdom, and creativity. 
After the Diagnosis: 
Transcending Chronic Illness 
by Julian Seifter, m.d., hs '78, 
with Betsy Seifter, ph.d. (Simon 
and Schuster) Julian Seifter had 
to learn to accept himself as a per¬ 
son with a lifelong illness when 
he was diagnosed with type ^ 
diabetes at the start of his intern 
year. In an account that is part 
memoir, part self-help book, the 
author speaks as both physician 
and patient, offering strategies 
helpful in managing chronic chal¬ 
lenges on a day-to-day basis in 
order to maintain a positive and 
productive attitude toward life. 
Envy Theory: Perspectives on 
the Psychology of Envy 
by Frank ). Ninivaggi, m.d.. 
FW ’77, assistant clinical professor 
in the Child Study Center and of 
psychiatry (Rowman & Littlefield) 
The author offers a theory of envy 
as the nucleus of information 
processing. He explores various 
concepts related to envy as the 
root of mental disorders and 
treatment resistance as well as 
the possibility of turning envy 
into a tool for healthy maturation. 
He also advances principles and 
guidelines for pragmatic applica¬ 
tions of his theory in psychothera¬ 
pies and psychoeducation. 
Ocular Inflammatory 
Disease and Uveitis Manual: 
Diagnosis and Treatment 
by John J. Huang, m.d., clinical 
instructor in medicine; and 
Paul A. Gaudio, m.d., assistant 
clinical professor of ophthalmol 
ogy and visual science (Lippin- 
cott Williams & Wilkins) This 
clinical manual is designed for 
quick reference; it features 
color photographs along with 
bulleted how-to instructions for 
workup and treatment of each 
disorder. The book is organized 
into anterior, intermediate, 
and posterior eye disease, with 
separate sections for inflamma¬ 
tion and infections of the cornea 
and sclera. 
The Roots of the Recovery 
Movement in Psychiatry: 
Lessons Learned 
by Larry Davidson, ph.d., profes¬ 
sor of psychiatry; Jaak Rakfeldt, 
PH.D., assistant clinical professor 
of psychiatry; and John Strauss, 
M.D. ’59, professor emeritus of 
psychiatry (Wiley) The authors 
highlight the limitations of 
such previous efforts to reform 
and transform mental health 
practice as the deinstitutional¬ 
ization movement begun in the 
1950s, in the hope that the field 
will not repeat these mistakes. 
The book incorporates lessons 
about recovery gained from 
such related fields as psychol¬ 
ogy, sociology, social welfare, 
philosophy, political economic 
theory, and civil rights. 
Probiotics: A Clinical Guide 
by Martin H. Floch, m.d., clinical 
professor of medicine; and Adam 
S. Kim, M.D. (Slack) This guide 
presents current and evidence- 
based recommendations for 
primary care providers and 
on campus 9 
I 
gastroenterologists in the use 
of probiotics to treat specific 
diseases and disorders. It includes 
a review of the science underlying 
probiotics and probiotic products. 
Handbook of Brain 
Microcircuits, ist ed. 
edited by Gordon Shepherd, 
M.D., D.PHiL., professor of neuro¬ 
biology; and Sten Grillner, m.d. 
(Oxford University Press) This 
handbook covers over 40 re¬ 
gions of the vertebrate and 
invertebrate nervous system to 
provide a guide to key circuits 
within the neurosciences. Each 
chapter is organized around wir¬ 
ing diagrams of the key circuits. 
The book includes a compre¬ 
hensive presentation of a new 
concept of brain microcircuits as 
the major organizing principle of 
the nervous system. 
Visualizing Psychology, 2nd ed. 
by Siri Carpenter, ph.d. ’00; and 
Karen Huffman, m.d. (Wiley) 
This book integrates updated 
photographs, illustrations, and 
graphics to elucidate complex 
iconcepts in psychology. The goal 
is to help students understand 
the world around them and 
interpret what they see in a 
imeaningful and accurate way. 
jExamples illustrate the uses of 
ipsychology in the workplace and 
Ipersonal relationships. 
Gastrointestinal Malignancies: 
An Issue of Emerging Cancer 
Therapeutics 
edited by Wasif Saif, m.d., 
M.B.B.S., associate professor of 
medicine (medical oncology) 
(Demos Medical Publishing) 
This text provides a review of 
current and emerging therapies 
for this group of malignancies, 
including common colorectal 
cancers, rare gastrointestinal 
stroma malignancies, and 
esophageal cancer. The chapters 
discuss current screening 
tools for colon cancers as well 
as assessment of predictive 
markers in the management of 
colon cancer. The volume also 
describes the state-of-the-art 
use of cytotoxic chemotherapy 
and the incorporation of newer 
biological therapies. 
Seeing Patients: Unconscious 
Bias in Health Care 
by Augustus A. White III, m.d., 
HS ’66 (Harvard University Press) 
In a book that is part autobiogra¬ 
phy, the author argues that the 
best means to improve health 
care is for medical schools to train 
physicians who are not only scien¬ 
tifically adept but also culturally 
competent. White cites studies 
showing that physicians and hos¬ 
pital staff on the whole dispense 
lower-quality care to minority 
patients. Females, both white and 
nonwhite, homosexuals, and the 
elderly are also treated differently 
from middie-class white men. 
Poorer quality of care results in 
measurably higher mortality 
rates among these vulnerable 
subpopulations. 
The descriptions above are based 
on information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e- 
mail to cheryl.violante@yale.edu 
Changing the language 
of medicine 
"From the moment we learn to 
speak the language of medicine,” 
said Pauline Chen, m.d., hs ’98, 
“we are taught to express our¬ 
selves in the passive voice." 
And that, said Chen, author 
of Final Exam: A Surgeon's 
Reflections on Mortality, has 
implications for patient care. 
Such phrases as “the patient 
presented ... sustained a gunshot 
wound ... pronounced dead ...” 
turn patients into passive recipi¬ 
ents of treatment rather than 
human beings actively involved 
in their care, said Chen, who gave 
the John P. McGovern Lecture for 
the Program for the Humanities 
in Medicine in January. 
“The language we use in 
talking about our patients, the 
mother tongue of medicine, 
the passive voice, does little 
to foster the kind of support 
and communication integral to 
compassionate care. It obliges 
us to objectify the very people 
we seek to care for. And it pro¬ 
vides an invisible but powerful 
hurdle to true patient-centered 
care,” she said. “The greatest of 
doctors are those who bypass 
the passive language they have 
inherited and replace it with the 
active comfort, true healing, 
and hope of compassionate, 
patient-centered care.” 
—John Curtis 
Mapping pathways in 
the human brain 
The human brain has 86 billion 
neurons, connected by 150 tril¬ 
lion synapses that exchange 
signals through 100,000 miles 
of wiring. Since the 1980s David 
C. Van Essen, ph.d., chair and 
Edison Professor of Neurobiology 
at the Washington University 
School of Medicine in St. Louis, 
has been trying to map those 
pathways. "The brain medi¬ 
ates perceptions, actions, and 
memories,” he told the audience 
at a Neurobiology Seminar in 
January. "It does that through 
the specificity of its wiring.” 
Van Essen and colleagues 
at the University of Minnesota 
and seven other institutions are 
part of the Human Connectome 
Project, which will use noninva- 
sive neuroimaging techniques 
to map brain circuits in 1,200 
healthy adults (twins and their 
non-twin siblings). The project 
recently received a five-year 
$30 million grant from the nih. 
Their research will yield 
valuable information about the 
brain’s workings, and may lead to 
future projects to study psychi¬ 
atric and neurological disorders. 
But Van Essen acknowledged 
that given the complexity of 
neural circuitry, the effort poses 
an “ambitious and exciting” chal¬ 
lenge. “We can anticipate major 
discoveries and insights, but we 
aren’t going to get a complete 
connectome, macroscopic or 
microscopic, in the near foresee¬ 
able future,” he said, “so we need 
to manage our expectations.” 
—f.C. 
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capsule 
Vernon Lippard served three 
terms as dean, steering the 
medical school through growth 
in its physical plant and an 
explosion in research funding. 
By Kerry Falvey 
The medical schooPs first full-time dean 
Until the middle of the 20th century, 
the School of Medicine’s department 
chairs were expected to serve as deans, 
juggling their decanal responsibilities 
in addition to their other work. When 
Dean C.N.H. Long, m.d., stepped 
down in 1952, the deanship became 
a full-time position, and the Yale 
Corporation hired Vernon W. Lippard, 
M.D. ’29, who had served as dean of 
two other medical schools. 
Lippard applied to the School of 
Medicine in 1925, after only three 
years at Yale College. Four years later 
he left the school with an m.d. cum 
laude. He had been a student edi¬ 
tor of the Yale Journal of Biology and 
Medicine, which began publication 
during his last year of medical school. 
After a period in private practice as a 
pediatrician, Lippard became an assis¬ 
tant dean of Columbia University’s 
College of Physicians and Surgeons in 
1939. During World War II he served 
in the U.S. Army with the 9th General 
Hospital in the Pacific Theater of 
Operations, returning to Columbia 
in 1945. In 1946 he became dean of 
Louisiana State University School of 
Medicine. Yale hired him away from 
the University of Virginia School of 
Medicine, where he had been serving 
as dean since 1949. 
At Yale, Lippard quickly focused on a 
number of challenges—a deteriorating 
physical plant, an ill-defined relationship 
with Grace-New Haven Hospital, defi¬ 
ciencies in the clinical departments, an 
undernourished Department of Public 
Health, and a need for increased finan¬ 
cial support for operations. 
Lippard’s tenure happily coincided 
with an explosion in federal funding 
for biomedical research. The dean also 
possessed a knack for fundraising. 
In 1953, he secured a grant to build a 
new dormitory—Edward S. Harkness 
Memorial Hall was completed in 
1955—and funding for the Mary S. 
Harkness Memorial Auditorium, the 
first large-capacity space at the medi- | 
cal school, with 449 seats. The dean 
n 
BELOW LEFT As the first full-time dean, Vemon 
Lippard oversaw a period of growth at the School 
of Medicine. During his tenure, which began in 
1952, a new dormitory and public health school 
were built and the medical school formalized its 
partnership with Yale-New Haven Hospital. 
An aerial view of the medical campus from the 
1950s, as the School of Medicine was about to 
see an explosion of growth in its physical plant. 
oversaw an addition to Sterling Hall 
of Medicine; he also renovated or built 
new laboratory space for the depart¬ 
ments of pharmacology, epidemiology, 
internal medicine, pediatrics, and 
radiology. The Department of Public 
Health celebrated its 50th anniversary 
in 1965 with a new home, the nine- 
story Laboratory of Epidemiology and 
Public Health. The Connecticut Mental 
Health Center, a cooperative endeavor 
between Yale and the state, opened 
in 1966. With the exception of Dean 
Milton C. Winternitz, m.d., no previous 
dean had embarked on such extensive 
expansion of the physical plant. 
Committed to building Yale’s clini¬ 
cal departments, Lippard increased 
the full-time faculty from about 
195 members in 1952 to 520 in 1967 
with an additional 560 part-time 
appointments. Many departments 
were reorganized, including the 
new Department of Epidemiology 
and Public Health, which combined 
public health with the Section of 
Epidemiology and Preventive Medicine 
under one chair in 1961. Federal grant 
money pouring into the School of 
Medicine at this time to fund research 
helped spur this huge growth. The 
school’s annual operating budget grew 
from nearly $3 million in 1952 to over 
$16 million in 1967; the endowment 
doubled as well. 
Lippard streamlined management 
of the medical school by centralizing 
authority within the dean’s office. He 
hired two half-time assistant deans: 
Thomas R. Forbes, ph.d., as assistant 
dean for student affairs and chair of 
admissions; and Lippard’s former col¬ 
league from the University of Virginia, 
Arthur Ebbert Jr., m.d., as assistant dean 
of postgraduate medical education. 
Lippard steered the medical school 
through another agreement with the 
hospital, creating the Yale-New Haven 
Medical Center in 1965. The agreement 
gave Yale more say in administering the 
hospital and changed the institution’s 
name to Yale-New Haven Hospital. 
Lippard maintained a high pro¬ 
file working on medical issues at the 
national level. After serving as presi¬ 
dent of the American Association of 
Medical Colleges in 1954-55, he was 
a member of the Surgeon General’s 
Consultant Committee on Medical 
Education, which published a report 
in 1959 on the growing shortage of 
physicians in the United States. As a 
member of the National Committee on 
Health Services for the Aged, Lippard 
was involved in the early development 
of the Medicare program. When he left 
the School of Medicine in 1967 after 
three terms as dean, he was appointed 
assistant for medical development to 
the president and fellows of the Yale 
Corporation. He died in 1985. 
This article has been adapted from Medicine at 
Yale: The First 200 Years, a book by Kerry Falvey 
celebrating the bicentennial of the Yale School 
of Medicine. 

The high cost of a 
medical education 
With the cost of medical school topping $250,000, becoming 
3 doctor means going into debt. 
3y Sonya Collins 
llustration by Joanna Szachowska-Tarkowska 
in the summer of 1957, Warren D. Widmann, m.d. ’61, 
HS ’67, earned his first year’s tuition for the School of 
Medicine by waiting tables at a hotel on the New Jersey 
shore. And he had money left over. 
j “I think when I started medical school, it was either 
$650 or $850 a year,” Widmann says. Unable to work sum¬ 
mers after his first year, Widmann relied on his wife’s sal¬ 
ary as a schoolteacher and some help from his parents—a 
ligh school administrator and a school secretary—and he 
finished medical school debt-free. “Now,” says Widmann, 
‘hardly anybody in the middle class can afford to go to 
medical school without accumulating debt.” 
Since Widmann’s day, medical school tuition has 
risen on a much steeper curve than wages and the cost 
af living. When “Adam” (students’ identities have been 
shielded in this article), the son of two schoolteachers, 
started medical school in 2008, Yale’s tuition was $42,350 
per year. Students were advised to budget an additional 
$25,000 per year for books, equipment, travel to rotations, 
medical expenses, licensing exams, and living expenses. 
Adam’s parents were expected to contribute about $8,000 a 
year, and scholarships and loans would cover the rest. 
Recent changes to financial aid policies have relieved 
some of the pressure on middle-class families, but students 
still struggle and the medical school would like to do more. 
“People save their whole lives to send their kids to col¬ 
lege, but they haven’t been saving to send them to medical 
school. That’s a reason there’s so much debt among medi¬ 
cal students,” says Dean Robert J. Alpern, m.d.. Ensign 
Professor of Medicine. “The only way to address debt is to 
increase the scholarship endowment. I don’t see tuition 
going down. Our only hope is that we can get the endow¬ 
ment to rise faster than tuition rises.” 
The basics of financial aid 
Yale is not the most expensive medical school in the coun¬ 
try. During the 2009-2010 academic year, tuition at Tufts 
($50,320), for example, exceeded Yale’s $43,850. Nor is Yale’s 
tuition far above the national average for private medical 
schools—$39,233 in 2009. 
How do students come up with the money? The 
School of Medicine has a “need-blind” admission policy 
and a “need-based” financial aid policy—once accepted, a 
student’s financial needs are fully met through loans and 
scholarships. But first, students must borrow what’s known 
as the “unit loan,” currently $22,700 per year. 
Before 2008, if the parents’ total income topped 
$45,000, they were expected to help pay for their child’s medi¬ 
cal school education. Parental assets apart from income are 
also considered in determining students’ need. (The Financial 
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Aid Office uses a formula that considers some 142 variables.) 
“We determine a parent contribution,” says Laura Ment, m.d., 
associate dean for admissions and financial aid, and professor 
of pediatrics and neurology, “but parents don’t always contrib¬ 
ute, so students borrow to cover their parents’ contribution.” 
In 2008, thanks to the infusion of $1.1 million from 
the Yale endowment, the income threshold for parental contri¬ 
butions increased to $100,000. Since then, a sliding scale for 
parents whose incomes fall between $100,000 and $140,000 
has been introduced. “These changes benefit almost 90 per¬ 
cent of the students who receive aid,” says Ment. 
The need-based financial aid policy allows students from 
lower- to lower-middle-class backgrounds to graduate with debt 
left goes into Michelle’s checking account each September 
and January. “I’ve never had accessible money before, so it 
almost feels like a luxury to me even though I’m budget¬ 
ing,” she says. 
Michelle shares a one-bedroom apartment, cooks at 
home, walks everywhere, and wears hand-me-downs. The 
money usually runs out shortly before the next disburse¬ 
ment is due. “I don’t know what I would do if I had to buy 
clothes, or if I didn’t share a bedroom, or if I had to spend 
any money.” 
“Emma White,” who entered medical school in the 
same boat as Michelle, borrowing the unit loan and receiv¬ 
ing the rest from scholarships, scrimps as well. “I never 
“Not many students will go into primary care just to have 
their debts forgiven; they go into primary care because 
they love the field and having their debt repaid is a bonus 
on top of that.” 
—Adam 
that rivals the lowest medical school averages in the country. 
(In 2008, the average debt of U.S. medical school graduates 
ranged from $79,872 at the University of Hawaii to $194,548 
at Creighton University.) In 2010 Yale medical students gradu¬ 
ated with an average debt of about $127,000, including debt 
incurred prior to medical school. “By selecting students based 
on their merits, without regard to their financial circum¬ 
stances, and by providing financial aid sufficient to enable all 
accepted students to attend the school without hardship, we 
have been able to enroll outstanding and exceptionally diverse 
classes year after year,” says Ment. 
Making ends meet 
Whatever their financial status, many medical students 
struggle with finances during their student days. Before 
medical school, “Michelle” had never had health insur¬ 
ance. Her father is unemployed and her mother has never 
worked, so she borrows only the unit loan. After tuition 
and any other monies owed to Yale are subtracted, what’s 
buy clothes,” White says, recalling a resident who teased 
her about the bleach spot on her pants. “It’s a tight budget. 
You don’t have a lot of extra spending money.” She grows 
her own vegetables and accepts gifts of tomatoes from a 
neighbor’s garden as well. By going to the same Cedar Street 
lunch cart every day, she gets her meal for half price and 
sometimes takes home leftovers. “You do feel like you’re a 
little old for this when all of your friends from college are 
now making six figures,” she says. 
To get free yoga classes during her first two years of 
medical school, “Lynn” would show up at 5:30 a.m., take a j 
90-minute class, wait for the others to leave, then clean the 
bathrooms and the studio. She also subsists on a backyard j 
garden and supplements her harvest with weekly deliveries I 
from a farm share program. I 
One student, whose father is a hospitalist and whose 
mother doesn’t work, said that he can’t expect much help 
because he has six siblings. “My parents have had to help 
them all,” says the student, who asked to be identified as 
j'Mike.” “I’m not going to receive any money from them.” He 
sorrowed $50,000 for his undergraduate education and will 
idd $240,000 to those loans by the time he finishes medical 
ichool. At $290,000, his debt will be more than double the 
iverage debt of a recent graduate of the School of Medicine. 
Disbursements arrive in January and September, and 
budgeting can be a challenge. “Right now I’m living on my 
:redit card,” says Mike, who admits that he could budget 
5etter. “A number of us all run out by the middle of June. 
\s soon as September comes. I’m going to pay off all my 
:redit card bills. And the cycle will start all over again.” 
Ment and Gerber advise students on ways to live within 
iheir means. “We show students where they need to cut cor¬ 
ners—whether it’s finding a roommate, eating at home, or 
going to Costco and buying in bulk,” Ment says. “I think the 
?ast majority of our students understand these strategies.” 
living with debt 
Despite significant student debt, loan forgiveness programs 
ike those of the National Institutes of Health (nih) and the 
National Health Service Corps (nhsc) attract relatively few 
students. These programs offer full or partial loan repayment 
d physicians who conduct research for nonprofit organizations 
ir practice primary care in underserved areas. Although the 
Jnited States has produced roughly 20,000 doctors per year 
or the past 10 years, in 2009 only 3,391 physicians who had 
earned their m.d.s in the previous decade applied to the nih’s 
oan forgiveness program. For nhsc, the number of annual 
ipplicants dropped from 963 in 2003 to 355 in 2008. 
Michelle, who came to medical school to be a psychia- 
;rist, says she would go into a loan forgiveness program only 
f its stipulations fit her career plans. Nor is Mike, who plans 
:o pursue an ear, nose, and throat specialty, willing to alter 
lis career plans over his nearly $300,000 of debt. As Adam 
rointed out, “Not many students will go into primary care 
ust to have their debts forgiven; they go into primary care 
because they love the field and having their debt repaid is a 
)onus on top of that.” 
Many students—those with debt levels ranging from 
relatively low to quite high—take their indebtedness in 
stride. “Jonathan” is leaning toward pediatrics or medicine 
Dut does not intend to apply to a loan forgiveness program. 
Te feels that many of his peers are not interested in the pro¬ 
grams because they “are not that fearful of their debt.” 
Some students, however, feel profoundly burdened by 
their debt and the emotional toll does not necessarily cor¬ 
relate with the number of dollars borrowed. “It gives me a 
knot in my stomach every day,” says White, who borrowed 
only the unit loan for her first two years. “You don’t know 
what lies down the road and if you’ll be able to pay it off” 
Debt and career choices 
Although it would seem that debt would drive young doctors 
into high-reward specialties, studies on the issue have only 
confounded researchers. A December 2008 report by the 
Association of American Medical Colleges found that both 
debt and students’ plans to pursue primary care or practice 
in underserved areas rose in parallel. Many Yale students 
feel debt has little to do with career choices and describe a 
host of other intricate factors—not the least of which are 
personal goals and dreams. 
When Nancy R. Angoff, m.p.h. ’81, m.d. ’90, hs ’93, 
associate dean for student affairs and associate professor 
of internal medicine, polled students several years ago, she 
found that for many, debt was a significant factor in their 
choice of specialty. But Angoff and other faculty believe that 
debt is not the greatest motivator in students’ career deci¬ 
sions. Nevertheless, all acknowledge the desire to ease the 
financial burden of becoming a physician or even to remove 
money from the equation completely. “I personally feel we’d 
be a lot better off as a country if there was no tuition for 
medical school,” says Robert H. Gifford, m.d., hs ’67, the 
school’s first deputy dean for education, who retired in 2000. 
Lowering student debt is a continuous priority for 
Alpern. Like Gifford, he would like to see the medical school 
eventually go tuition-free but admits it would be a challenge. 
The medical school, Alpern notes, was able to institute more 
generous financial aid policies in 2008 and then again in 
2009 and 2010 because the Yale endowment was steadily 
growing. “And we had plans to do more until the endow¬ 
ment dropped, so if the endowment recovers, we’ll be able to 
get back into the business of doing more to lower debt.” ym 
Sonya Collins is a freelance writer based in Atlanta, Ga. 
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Medicine and the military 
Life In the armed forces offers some physicians 
a chance to serve both country and patients. 
ByJill Max 
Scott Hines, M.D. ’99, made quite an impression when he 
showed up for his admissions interview at the School of 
Medicine. Proud of his position as a flight test officer in the 
U.S. Navy, he wore his dress whites, which he considered an 
expression of his identity. As a veteran of combat missions 
in Operation Desert Storm, Hines was used to pressure, but 
the interview put him on the spot in a different way. How, 
he was asked, could he justify going from a career in which 
his job was to kill people to a new calling—healing people? 
Hines didn’t see a conflict. As a military officer, his goal was 
to provide a strong defense that would deter war. He saw 
military service as a way to save lives, albeit in a different 
way from the work of a physician. 
The reasons physicians serve in the military or sol¬ 
diers go into medicine are as varied as the individuals who 
take these paths. For some, the armed forces offer a way 
to flnance their medical education; for others the choice 
reflects a desire to serve their country. Still others were 
obligated in the past to serve as a result of the doctors’ draft, 
which, from 1950 to 1973, required male physicians and 
other health care providers to serve in the military. While 
deployment overseas and separation from their families 
deter some from entering the military, travel, the experience 
of leadership, and the thrill of adventure entice others. One 
common ideal, however, unites those who choose both the 
military and medicine. As Sarah Goss of the Class of 2013, 
a West Point graduate and commissioned Army officer who 
plans to serve in the military after medical school, expressed 
it: “They both involve service and lifelong learning.” 
From TOPGUN to trauma platoon 
In 1985 Hines had just graduated from Boston College 
with a scholarship to attend Ohio State University College 
of Medicine. Instead he signed up to become a Navy pilot. 
“The day I walked into Aviation Officer Candidate School I 
knew that I was going to make a career of the Navy,” he said. 
“It felt right from day one for me.” 
Hines studied at the Navy Fighter Weapons School 
in Miramar, Calif, popularly known as topgun. He served 
for three years during the Gulf War, in which he completed 
almost 40 combat missions. After the birth of his first child 
Hines realized that his Navy career path would mean mul¬ 
tiple deployments and a lot of time away from his growing 
family. It was time for another change. 
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Medicine and the Military 18 
PREVIOUS PACE Justpriorto 
her graduation from West Point, 
Sarah Goss, a member of the 
medical school Class of 2013, 
posed in full dress regalia for her 
“firstie” or senior portrait. 
Hines applied to the School of Medicine and received 
a scholarship from the Navy. After medical school he 
did a transitional internship at the Naval Medical Center 
Portsmouth in Virginia and then became a flight surgeon— 
a general medical officer. In 2004 he completed his resi¬ 
dency in emergency medicine at Portsmouth in a program 
that is rigorous yet largely unrecognized. “A lot of folks 
think the only people who stay in military medicine are the 
ones who can’t cut it on the outside,” he said. “That is sim¬ 
ply not the case.” 
Hines believes that his years as a flight surgeon made 
him a better and more confident resident. He stayed on 
at Portsmouth as a staff physician in the emergency depart¬ 
ment. In 2008 he was deployed to a remote airstrip in 
northern Iraq for eight months and he came home to the 
realization that his deployment had taken a significant toll 
on his family; one of his three sons had difficulty adjusting 
to his return. Hines retired from the military in December 
2009. Even after 22 years of active service, he still wonders 
whether he did enough. 
An expert in bullet wounds 
Martin Fackler, m.d. ’59, became interested in medicine 
because his grandfather and uncle were physicians. The doc¬ 
tors’ draft was in effect when he went to medical school; after 
his internship at the University of Oregon at Portland, he 
served in the Navy on a transport service that carried troops, 
their dependents, and government employees all over the 
Pacific. Fackler was one of two naval doctors aboard the ship. 
After a general surgery residency at Chelsea Naval 
Hospital in Boston and training in plastic surgery at Bethesda 
Naval Hospital, Fackler was sent to the Naval Support Activity 
Hospital in Da Nang, Vietnam, in December 1967; one 
month later, the Tet Offensive began. “You just can’t get that 
kind of training in trauma surgery anywhere else except in 
the military in time of war,” he said. 
In Da Nang, Fackler stabilized incoming casualties. 
Most cases were flown out within a day or two, but exten¬ 
sive ones remained at Da Nang until healed. Thus, in Da 
Nang, Fackler had limited experience treating postoperative 
complications. His next post, however, was in Yokosuka, 
Japan, where patients were sent to recover from surgery. 
He expanded his overseas experience by transferring to the 
Army and becoming chief of surgery at Landstuhl Regional 
Medical Center in Germany—the largest military hospital ^ 
outside the continental United States. j 
After 20 years in the military, Fackler was thinking i 
of retiring but was invited to set up and direct a lab for 1 
the study of gunshot wounds at the Presidio Army base in , 
San Francisco. A competitive shooter since the age of 14— | 
he had been captain of the rifle team at Gettysburg College 
—Fackler jumped at the job, which also made use of his 
experience in Da Nang. For 10 years, Fackler devoted all 
his time to wound ballistics research, thanks to funding 
provided by the Army’s Medical Research and Develop- j 
ment Command. 1 
Fackler is now regarded as one of the world’s fore- I 
most ballistics experts, having developed wound profiles 1 
for 26 different types of bullets. He retired from the Army ! 
in 1991 after 31 years of active duty. Since then he has testi- 1 
fied in over 200 trials as a ballistics expert. He now lives in : 
Gainesville, Fla., where he is on the staff of the pathology : 
department of the University of Florida. He still receives 
calls to testify but rarely travels. 
William Heydorn, m.d. ’59, a classmate of Fackler’s, 
has also done his share of traveling with the Army, with two 
postings in Germany and one in Korea. Heydorn served under 
the doctors’ draft after completing his internship at Bassett 
Hospital in Cooperstown, NY. He completed a tour of duty 
in Germany, then a residency in general surgery, and began 
a 13-month tour in Korea in 1966, where he was the hospital 
commander and only fully trained general surgeon at the 44th 
Surgical Hospital. His first patient was a Korean farmer who 
had stepped on a land mine. Heydorn returned to Germany as 
a general surgeon and then trained in cardiothoracic surgery 
at San Francisco’s Letterman Army Hospital. Heydorn crossed 
paths with Fackler during his third tour at Letterman, and 
ended up spending the last 14 years of his career at Letterman 
as chief of surgery and commanding officer before retiring in 
1989 after 30 years of service. Heydorn now surveys hospitals 
for the Joint Commission International, an organization that 
accredits hospitals around the world; he has worked in 17 coun¬ 
tries during the last four years. 
Adrenaline and a sense of accomplishment 
It would have been easy for Heydorn to leave military ser¬ 
vice after 10 or 20 years, but he stayed because he enjoyed 
both the work and the places he visited. Lionel Nelson, 
19 
M.D. ’69, on the other hand, initially thought a career in 
the military wasn’t for him. When he received his draft 
notice in 1971, during his first year of surgical residency 
at Stanford, he joined his local Air Force Reserve unit. He 
'expected to be mobilized, but the Vietnam War was winding 
down. He didn’t much care for his military stint and spent 
the next few years building his otolaryngology practice and 
doing head and neck trauma surgery in San Jose, Calif In 
1984, the year he turned 40, he found himself looking for 
excitement. He found it one night at the bedside of a swat 
police officer he’d treated for a gunshot wound. The officer 
suggested that Nelson join the local Army Reserve Special 
Operations Civil Affairs Unit. From that time on, he was 
hooked. He trained to become a flight surgeon and over 
the next 18 years he left his practice several times a year 
for short missions as the physician and flight surgeon on 
small teams involved in civil-military operations, mostly 
in Southeast Asia. Nelson was expected to take care of the 
medical needs of the pilots and crew, which included inner 
ear, sinus, or vision problems that could adversely affect a 
mission, as well as any other medical issues that cropped 
up. He also addressed medical needs of the local population. 
Nelson retired from the Army Reserve in 2002, but in 
2008, in response to a growing need for flight surgeons, he 
volunteered for a tour of duty in Iraq. Three months before 
his 65th birthday, he became the brigade flight surgeon with 
Task Force 449 at Camp Striker in Baghdad. Embedded with 
the troops and far from the comforts of a support network, he 
found that his work differed from what he was used to in his 
otolaryngology practice; here he served as GP, flight surgeon, 
surgeon, podiatrist, and sometimes dentist. “There was no 
telling what challenge was about to come through your tent 
flap next,” he said of his three-month tour. “Life could change 
in a moment from mundane to high drama. It forced you to 
pull up medical knowledge from those deep brain recesses 
that you don’t remember learning, but must have at some 
time as a medical student or house staff” He described the 
experience as “an unforgettable adrenaline high accompanied 
by a great sense of accomplishment.” 
As the senior medical officer Nelson had a lot of expe¬ 
rience, but he also took flak for his age; some of the younger 
soldiers, he heard, were making bets on how soon he would 
fall and break his hip. Little did they know that at home 
Nelson rises at 4:30 a.m. for a 70-minute workout before 
The summer before her "plebe” 
or freshman year at West Point, 
medical student Sarah Goss spent 
six weeks in training, including 
rappelling at a site affectionately 
known as “Beast Barracks.” 
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Since his retirement after 30 years 
in the military, William Heydorn 
has surveyed hospitals for the 
Accreditation Counsel on Graduate 
Medical Education. In the past 
four years he has worked in hos¬ 
pitals in more than i8 countries 
in Europe, Asia, the Middle East, 
and South America. In 2010 he 
posed with the senior leadership 
of the Huashan Hospital at Fuday 
University in Shanghai. 
surgery. As it turned out, the soldiers who once laughed at 
him came to confide in him, viewing him as a father—or 
perhaps grandfather—figure. “Some of my most interesting 
experiences in Iraq were just sitting and talking,” he said. 
“The soldiers were young; for most of them it was the first 
time they had been away from home, they were in a hostile 
environment, and they were on edge from mortar attacks. 
You can call it psychiatry, but it was basically friendship.” 
“Nothing like it in civilian life” 
The idea of being a physician in the military often conjures 
visions of what Nelson experienced in Iraq: an austere envi¬ 
ronment, lots of noise, and tedium punctuated by mayhem. 
In reality, however, the military offers a variety of experi¬ 
ences. William M. Narva, m.d. ’56, spent most of his 35-year 
Navy career in the Washington, D.C., area. During medical 
school in 1952, the draft was still in effect but student defer¬ 
ments were not. Narva wrote to the Army, Navy, and Air 
Force, seeking a commission in the reserves. Within a week 
the Navy responded, and he enlisted as an ensign in the 
medical corps. “It’s 60 years later and I still haven’t heard 
from the Army and the Air Force,” he quipped. 
Narva accepted the dermatology training offered by 
the Navy, completing an internship at Bethesda and his resi¬ 
dency at a naval hospital in San Diego. After a five-year tour 
at a naval hospital in Oakland he was named chief of der¬ 
matology at the National Naval Medical Center in Bethesda, 
Md. Within a week, Narva found himself in the bedroom of 
President Lyndon B. Johnson. Narva treated every president 
up to George H.W. Bush. 
Narva continued his ascent with posts that included 
staff medical officer for the chief of naval operations, direc¬ 
tor of the Naval Reserve Division at the Bureau of Medicine 
and Surgery, and vice president of the Uniformed Services 
University of the Health Sciences (usu). Five years after being 
promoted to rear admiral in 1982, he was appointed attend¬ 
ing physician to the U.S. Congress, which included members 
of the Supreme Court. He never expected to spend his entire 
career in the Navy but every time he thought of retiring, a 
new opportunity would arise. “In our practice, we were get¬ 
ting referrals from all over the world,” he said. “Bethesda was 
a diagnostic center and there wasn’t a day that went by that I 
didn’t see something I had never seen before.” 
Except for a year in Vietnam in the mid-1960s, Robert 
Joy, M.D. ’54, M.A., spent most of his 26-year Army career 
doing research stateside. Joy began his military career in 
the ROTC during medical school. He took an Army intern- 
' ship at Walter Reed Army Medical Center in Washington, 
D.C., not only because it offered excellent training, but also 
because he had a wife and baby—a standard internship 
paid $50 a month, while the Army paid about $250. Joy was 
founding commander of the Army Research Institute of 
Environmental Medicine in Natick, Mass., and held senior 
staff positions in medical research in the Office of the 
Army Surgeon General and the Office of the Secretary of 
Defense. In 1976, he became the first Commandant of usu 
in Bethesda, where he founded the Department of Medical 
History in 1981. He has been professor emeritus at usu 
since 1996. 
At 81, Joy still goes into the office one day a week. 
Looking back over his long career, what he enjoyed the 
most was tutoring, advising, and encouraging young men 
and women. Beyond that, Joy relished being in command. 
“There’s nothing like it in civilian life,” he said. In some 
aspects, however, the Army is not unlike other careers; “It’s 
a system that’s workable if you know how to work it,” he 
said. “If you are respected for your work, are liked as a per¬ 
son, and are willing to be flexible, you can pretty much get 
what you want.” 
Not for everyone 
For some alumni, military service was a way to finance their 
education and serve their country, but from the beginning 
they viewed it as a short-term commitment along the way to 
other career plans. John Lundell, m.d. ’94, received an Air 
Force scholarship to attend the School of Medicine and owed 
five years of active duty after his residency ended in 1999. 
Two years later, the world changed abruptly: and both he 
and his wife, Andrea L. Lundell, m.d. ’94, who was also in 
the Air Force, faced the possibility of simultaneous deploy¬ 
ments. They had to arrange for relatives to care for their two 
young children in the event that happened. Andrea remained 
stateside, but John went to Iraq in 2003 as part of a mobile 
field surgical team. The next year he finished his commit¬ 
ment. Although he enjoyed his military service, he wanted 
an academic position and took a faculty spot at the University 
of California, San Diego, later moving to Baylor University 
in Dallas, where he has a private practice. “I got a lot of great 
experience at a young age and it gave me a lot of confidence,” 
Lundell said. 
Monika Dalrymple, m.d. ’96, financed her Yale under¬ 
graduate and medical education by joining the Air Force 
ROTC. She owed eight years after graduating, but it turned 
into 12 when the Air Force required her to do a military 
(rather than civilian) residency in diagnostic radiology at 
Wilford Hall Medical Center at Lackland Air Force Base in 
San Antonio. 
Neither Monika nor her husband, Neal Dalrymple, 
M.D., who also served in the Air Force, was ever called 
overseas. Neal finished his commitment just before 9/11, 
and Monika has a medical condition that exempts her from 
William Narva, shown in 1963, treat¬ 
ed every U.S. president from Lyndon 
Johnson to George H.W. Bush. 
serving in a desert environment. But she worried that the , 
Air Force would change the rules. She also found it difficult j 
to manage child care for her young daughter because she i 
had to be available 24/7 but never knew when she would get 1 
a call. “The military never really fit me personally,” she said, j 
At West Point, an interest in medicine 
Goss, currently a medical student, had no interest in the i 
military until her family toured the Naval Academy in 
Annapolis, Md., during a vacation. After a pre-college sum¬ 
mer program there, she entered West Point. During military i 
training in the summer between her freshman and sopho¬ 
more years, she got a blister that developed a mrsa infection.! 
While she was in the hospital, the idea of being a military 
officer and a physician took hold. The summer between her 
junior and senior years she spent a month at Brooke Army 
Medical Center in San Antonio, where she worked with 
Doctors in the Armed Forces 
Monika Dalrymple, m.d. ’96 joined the Air Force rotc in college and 
served 12 years in the military. She presently specializes in gastrointestinal 
radiology within a group practice in San Antonio. 
Mitchell Edson, m.d. ’56 a captain in the Navy, practices four days a 
week at Washington Hospital Center in Washington, D.C., where he was 
chief of the urology residency program between 1978 and 1996. He com¬ 
pleted residencies in surgery and urology at the St. Albans Naval Hospital 
in New York City, and was chair of the Department of Urology at the 
National Naval Medical Center in Bethesda, Md. 
Martin Fackler, m.d. ’59 served on a Navy transport ship at a Navy hos¬ 
pital in Da Nang, Vietnam, and in hospitals in Japan and Germany. After 
20 years in the military he started and directed a lab for the study of gun¬ 
shot wounds at the Presidio in San Francisco when it was an Army base. 
He is considered one of the world’s foremost ballistics experts. 
J. McLeod “Mac” Griffiss, m.d. ’66 a retired colonel in the Army Reserves, 
is professor of laboratory medicine and chief of immunochemistry at the 
University of California, San Francisco, and a specialist in infectious dis¬ 
eases at the San Francisco VA Medical Center. 
William Heydorn, m.d. ’59 served in Army hospitals in Korea, Germany, 
and San Francisco. Heydorn now surveys hospitals for the Joint 
Commission International, an organization that accredits hospitals 
around the world. 
Scott Hines, m.d. ’99 served in the Navy before attending medical 
school. He saw combat in the first Gulf War as a fighter pilot and served 
in Iraq as a flight surgeon during the second Gulf War. He retired from 
the military in 2009 after 22 years of service. 
Robert J.T. Joy, M.D. ’54 served in the Army from 1954 to 1981 as a battal¬ 
ion surgeon and was founding commander of the Army Research Institute ■ 
of Environmental Medicine. He held senior staff positions in medical 
research in the Office of the Army Surgeon General and in the Office of 
the Secretary of Defense. In 1981 he founded the Department of Medical 
History at the Uniformed Services University of the Health Sciences and 
became professor emeritus in 1996. 
Craig H. Llewellyn, m.d. ’63, m.p.h. retired from the Army as a colonel 
and now divides his time between Florida and Vermont. He is professor 
and chair of the Department of Military and Emergency Medicine at the 
Uniformed Services University of the Health Sciences School of Medicine; 
founding director of the Center for Disaster and Humanitarian Assistance 
Medicine; and a member of the executive committee of the National 
Disaster Life Support Educational Consortium. He also works with aca¬ 
demic institutions as well as federal, state, and county organizations in 
organizing and teaching emergency medical preparedness. 
John C. Lundell, m.d. ’94 received an Air Force scholarship to attend medi¬ 
cal school, as did his wife, Andrea L. Lundell, m.d. ’94. John Lundell served in 
Iraq during the second Gulf War; he is presently practicing as an anesthesi¬ 
ologist in Dallas. Andrea Lundell practices radiology in Rockwall, Texas. 
William M. Narva, m.d. ’56 spent most of his 35-year Navy career in 
the Washington, D.C., area. He was staff medical officer for the chief of 
naval operations, director of the Naval Reserve Division at the Bureau 
of Medicine and Surgery, and vice president of the Uniformed Services 
University of the Health Sciences. Five years after being promoted to 
wounded vets returning from Iraq and Afghanistan, includ¬ 
ing many amputees. “That experience sealed the deal for 
me,” she said. “Even the ability to pick up a fork or open a 
door had such an incredible effect on their spirit.” Back at 
West Point, she devoted her senior project to designing and 
building a “bionic” foot with a group of fellow cadets. The 
group incorporated a motor within the foot that engages 
when the patient steps down, creating propulsion to mimic a 
human gait. In May 2009, Sgt. ist Class Patrick King, who 
lost his foot in Iraq, was the first to try the device, which will 
eventually be tested on other military amputees. 
After medical school, Goss plans on doing her resi¬ 
dency at a military hospital, after which she’ll owe 10 years 
iof active service and six years of reserve service. She is 
leaning toward emergency medicine or orthopaedics, and 
is open to spending her entire career in the military. Like 
all physicians who enlist in the armed services in today’s 
post-9/11 world, Goss has no choice but to reconcile herself 
to being deployed overseas, which she knew was a definite 
possibility when she enrolled at West Point. 
Goss may find it difficult to imagine what awaits 
her. But Lionel Nelson is very clear regarding what he liked 
about serving in the military: “Besides the chance to see 
wondrous places far off the tourist trail and the chance to 
give back to the country,” he said, “it was almost always a 
great adventure, a significant sense of accomplishment, and 
rarely routine or dull.” ym 
—Jill Max is a freelance writer in Trumbull, Conn. 
rear admiral in 1982, he was appointed attending physician to the U.S. 
Congress, which included members of the Supreme Court. A specialist in 
dermatology, Narva treated every president from Lyndon B. Johnson to 
George H.W. Bush. 
Lionel M. Nelson, m.d. ’69 had no interest in the military until 1984, 
when he joined the local Army Reserve Special Operations Civil Affairs Unit 
in San Jose, Calif. After training as a flight surgeon he went on short mis¬ 
sions in civil-military operations in Southeast Asia. In 2008 he volunteered 
|for a mission in Iraq. He presently practices otolaryngology in San Jose. 
Sunny Ramchandani, m.d. ’04 is a lieutenant commander in the United 
States Navy. He is the integrated chief of general internal medicine at the 
Walter Reed National Military Medical Center. He deployed to Afghanistan 
as the Senior Medical Mentor for the Afghan National Security Forces in 
2009, guided the execution of a new health care reconstruction strategy, 
and received the Bronze Star Medal. 
Gabriel Rocha, pa-c ’09 enlisted in the Army in 2002 and trained as a 
medic. In 2003, he was deployed to Baghdad and treated casualties from 
the bombing of the United Nations headquarters there. Rocha has since 
joined the Navy, where he will serve as a physician associate. 
Benjamin D. Smith, m.d. ’01, HS ’06 served in the United States Air Force 
from 2006 through 2010, when he left with the rank of major. For four years 
he was a staff radiation oncologist in the Air Force. He is now an assistant 
professor in the Department of Radiation Oncology, Division of Radiation 
Oncology, at the University of Texas MD Anderson Cancer Center in Houston. 
In 2010 he received the Meritorious Service Medal from the Air Force. 
Richard S.K. Young, m.p.h. ’73, m.d. ’73 a pediatric neurologist and chair 
of pediatrics at the Hospital of Saint Raphael in New Haven, is a colonel in 
the Connecticut Army National Guard. He has completed three tours in Iraq. 
Heather C. Yun, m.d. ’01 a major in the United States Air Force, is medi¬ 
cal director of infection control at San Antonio Military Medical Center 
and assistant professor of medicine at the Uniformed Services University 
of the Health Sciences. She is also assistant chief of the Infectious Disease 
Service, San Antonio Military Medical Center; and associate program direc¬ 
tor of the Infectious Diseases Program, San Antonio Uniformed Services 
Health Education Consortium. 
Are you working in military medicine or another of the fields we’ll be 
profiling in our “Alumni Career Paths” series? Do you know medical school 
alumni, former Yale house staff, or fellows who are? Send us the names 
and then check the Web edition of Yale Medicine to view an expanding list of 
alumni with similar interests. You can write to us at ymm@yale.edu and view 
the listatyalemedicine.yale.edu. 
“Alumni Career Paths” future articles: 
• International health and research 
• The front lines of clinical practice 
• Academic medicine 
• Physician/writers 
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24 Faculty 
Michael Schwartz 
New assistant dean for 
curriculum named 
MICHAEL L. SCHWARTZ, PH.D., 
was named assistant dean for 
curriculum in October. Schwartz 
is an associate professor of neuro¬ 
biology who has directed the core 
neurobiology course “Structure 
and Function of the Nervous 
System" since 1985 and has served 
as director of medical studies in 
the department since 1987. He 
was appointed director of medical 
courses for the School of Medicine 
in 2007 and has since chaired both 
the Course Review Committee and 
Course Directors Committee. 
As assistant dean for curricu¬ 
lum, Schwartz will be responsible 
for overseeing the content, imple¬ 
mentation, and review of the 
medical student curriculum, and 
for ensuring that it is designed 
and integrated to achieve the 
school’s educational objectives 
as well as meet national accredi¬ 
tation standards. Schwartz will 
chair the curriculum committee 
and work with the directors of 
courses, modules, clerkships, 
and electives. In addition, he will 
play a vital role in implementing 
curriculum reform, which is part 
of the school’s strategic plan for 
medical education. 
Scott Strobel 
New czar appointed 
to lead West Campus 
SCOTT STROBEL, PH.D., the Henry 
Ford II Professor of Molecular 
Biophysics and Biochemistry, was 
appointed in December to succeed 
Michael Donoghue, PH.D., as vice 
president of West Campus Planning 
and Program Development. In this 
position Strobel will direct the 
second phase of growth at Yale’s 
136-acre facility in West Haven. 
Donoghue, the G. Evelyn 
Hutchinson Professor of Ecology 
and Evolutionary Biology, de¬ 
veloped the overall blueprint and 
launched many major initiatives 
at the site during his two-year 
term as the inaugural West 
Campus czar. 
Strobel is an expert on the 
structure and function of rna, a 
field in which Yale is a recognized 
world leader. He is also commit¬ 
ted to improving education in the 
sciences. With a Professor Grant 
from the Howard Hughes Medical 
Institute, Strobel takes students 
to South American rain forests 
each year to collect materials for 
the isolation and study of new 
microorganisms. His goal for the 
West Campus is to take a stimu¬ 
lating environment for the study 
of science to a new level. 
NOTES 
Ten Yale faculty members are 
among 214 new narsad Young 
Investigators to receive grants 
to pursue research related to 
schizophrenia, depression, bipolar 
disorder, autism, adhd, and such 
anxiety disorders as OCD and 
PTSD. Each scientist will receive 
$60,000 over two years. The 
researchers include: 
Jessica A. Cardin, ph.d., assis¬ 
tant professor of neurobiology; 
Silvia Corbera, ph.d., postdoc¬ 
toral associate in psychiatry; 
Janghoo Lim, ph.d., assistant 
professor of genetics; Douglas 
J. Guarnieri, ph.d., associate 
research scientist in psychiatry; 
Jason K. Johannesen, ph.d., as¬ 
sistant professor of psychiatry; 
Roger J.Jou, m.d., m.p.h., clinical 
fellow in the Child Study Center; 
Ruth Sharf, ph.d., postdoctoral 
associate in psychiatry; Megan 
V. Smith, DR.P.H., m.p.h. ’00, 
FW ’og, associate professor of 
psychiatry; Bao-Zhu Yang, ph.d., 
assistant professor of psychiatry; 
and Lingjun Zuo, ph.d., associate 
research scientist in psychiatry. 
Three Yale faculty are among 
503 members of the American 
Association for the Advancement 
of Science (a a as) to be named 
AAAS Fellows this year for their 
distinguished efforts to advance 
science or its applications in 
society and public policy as well 
as in research and education. The 
new fellows received a certificate 
at the 2011 annual meeting in 
Washington, D.C., in February. 
Jorge E. Calan, ph.d., d.v.m., 
chair of the Section of Microbial 
Pathogenesis, was honored for his 
contributions to the field of mi¬ 
crobial pathogenesis and his stud¬ 
ies of the interaction of enteric 
bacterial pathogens with their 
host cells. Haifan Lin, ph.d., direc¬ 
tor of the Yale Stem Cell Center, 
Paul Barash I M 
was honored for his contributions' t 
to stem cell research and devel- | I 
opmental biology, particularly I 1 
for work in stem cell niche theory i s 
and the regulatory role of small : < 
RNAs in stem cells and germ line 
development. Hongyu Zhao, i 
PH.D., the Ira V. Hiscock Professor 
of Public Health (Biostatistics) 
and professor of genetics and 
statistics, was honored for funda¬ 
mental contributions to statistical, 
genomics and genetic epidemiol- ; 
ogy, for outstanding service to 
the fields of statistics and human 
genetics, and forthe training of , 
many young scientists. 
Paul G. Barash, m.d., professor j 
of anesthesiology, received the 
Distinguished Service Award of i 
the Society of Cardiovascular 
Anesthesiologists in recognition : 
of his contributions both to the ! 
specialty of cardiac anesthesia ; 
and to the society—of which he is: 
a founding member. Barash was 
recognized on the 50th anni¬ 
versary of the founding of the t 
University of Kentucky College I 
of Medicine for his contributions i 
to the field of anesthesiology 
through Clinical Anesthesia, the 
textbook for which he serves 
as senior editor. He is the only 
alumnus of the College of Medi¬ 
cine to be honored with both the , 
Commonwealth Award of the 
University of Kentucky (2004) 
and the Distinguished Alumnus 
Award (2007). 
Henry J. Binder, M.D., professor 
of medicine (digestive diseases) 
and of cellular and molecular 
physiology, was listed among the 
top 75 gastroenterologists in the 
country in November by Becker’s 
ASC Review, a publication provid¬ 
ing business, legal, and clinical 
news related to ambulatory 
surgery centers. Binder is also the 
Jorge Galan Haifan Lin Hongyu Zhao 
25 
iHenry Binder Mama 
Borgstrom 
i (/Vinner of the 2005 Distinguished 
\chievement Award from the 
H^merican Gastroenterological As- 
' iociation for his work on colonic 
I :on transport and diarrhea. 
iLarna P. Borgstrom, m.p.h. ’79, 
ijaresidentand CEO of Yale-New 
‘" daven Hospital, has been named 
:o the Association of American 
Medical Colleges (aamc) 2010- 
|2on board of directors. Borgstrom 
will serve a two-year term on 
the 17-member aamc governing 
iboard, which represents all 133 
U.S.-accredited and 17 Canadian- 
accredited medical schools. 
Tobias J.E. Carling, m.d., ph.d., 
HS ’02, FW ’08, assistant profes- 
isor of surgery, has been named 
the first Doris Duke-Damon 
Runyon Clinical Investigator, the 
Doris Duke Charitable Founda¬ 
tion and the Damon Runyon 
Cancer Research Foundation 
announced in June 2010. Carling 
will receive a total of $486,000 
over three years for his project 
titled “Molecular Genetics of 
Endocrine Tumor Disease." 
Linda C. Degutis, m.s.n. ’82, 
, DR.P.H. ’94, assumed the director¬ 
ship of the Centers for Disease 
i Control and Prevention’s National 
: Centerfor Injury Prevention and 
Control in November. As director 
of the injury center, Degutis will 
work to fulfill the agency’s mission 
, of preventing injuries and violence 
and reducing their long-term con¬ 
sequences. She was most recently 
research director of the Depart¬ 
ment of Emergency Medicine at 
the School of Medicine, and direc¬ 
tor of the Yale Center for Public 
Health Preparedness at the School 
of Public Health. 
Rosemarie Fisher, m.d., associate 
dean and professor of medicine 
(digestive diseases), received in 
September the highest honor 
bestowed on internal medicine 
educators, the Dema C. Daley 
Founders Award, by the Associa¬ 
tion of Program Directors of Inter¬ 
nal Medicine at the association’s 
spring meeting. 
Thomas M. Gill, m.d., Humana 
Professor of Medicine (Geriatrics), 
was elected to the Association 
of American Physicians (aap) 
during its annual meeting, held in 
Chicago in April 2010. The aap is a 
nonprofit professional organiza¬ 
tion founded in 1885 for "the 
advancement of scientific and 
practical medicine.” 
Harlan M. Krumholz, m.d., m.sc., 
the Harold H. Hines Jr. Professor 
of Medicine, has been invited to 
join the board of governors of 
the Patient-Centered Outcomes 
Research Institute (pcori) of the 
U.S. Government Accountability 
Office. The Patient Protection 
and Affordable Care Act of 2010 
established pcori as a nonprofit 
organization to assist patients, 
clinicians, purchasers, and policy¬ 
makers in making informed 
health decisions. 
John M. Leventhal, m.d., hs ’76, 
professor of pediatrics, won a 
2010 Ray E. Heifer Society Award 
for distinguished contributions 
to thefield of child abuse and 
neglect in April 2010. The Heifer 
Society, named for the pediatri¬ 
cian who pioneered research on 
child abuse in the late 1960s, is 
a national honorary society for 
physicians who work in the field. 
Thomas H. McGlashan, m.d., pro¬ 
fessor of psychiatry, has received 
three awards in the past two 
years: the Stanley Dean Award for 
research in schizophrenia from 
Thomas Gill 
the American College of Psychia¬ 
trists, the Richard J. Wyatt Award 
from the International Early Psy¬ 
chosis Association for research in 
early identification and treatment 
of psychosis, and the Award for 
Research in Psychiatry from the 
American Psychiatric Association 
for “significant contributions to 
our understanding of the impact 
of early detection and preventive 
interventions in schizophrenia.” 
He has also been nominated 
to serve a four-year term as a 
member of the National Advisory 
Council of the National Institute 
of Mental Health. 
Nancy A. Moran, ph.d., the Wil¬ 
liam H. Fleming Professor of Biol¬ 
ogy, received the International 
Prize for Biology from the Japan 
Society for the Promotion of 
Science in December. Moran re¬ 
ceived the award for her work on 
symbiotic relationships between 
insects and the bacteria that live 
within them. 
Charles A. Morgan III, m.d., 
associate clinical professor of 
psychiatry, received the 2010 Sir 
Henry Wellcome Medal and Prize 
from the Association of Military 
Surgeons of the United States in 
November. Morgan was honored 
for his article “Effect of Carbohy¬ 
drate Administration on Recovery 
From Stress-Induced Deficits in 
Cognitive Function; A Double- 
Blind, Placebo-Controlled Study 
of Soldiers Exposed to Survival 
School Stress,” which appeared in 
the journal Military Medicine in 
February 2009. 
Marvin Moser, m.d., clinical 
professor of medicine, was 
honored by the American Society 
of Hypertension for his 50 years 
of achievements in research and 
treatment with the creation of 
John Leventhal 
the Marvin Moser Clinical Hyper¬ 
tension Award. 
Sara Rockwell, ph.d., professor 
of therapeutic radiology and 
of pharmacology, gave the 7th 
Robert F. Kallman Memorial 
Lecture at Stanford University 
in August. She also received the 
Distinguished Service Award from 
the Radiation Research Society at 
the society’s annual meeting in 
Maui in September. 
Clarence T. Sasaki, m.d., ’66, hs ’73, 
the Charles W. Ohse Professor of 
Surgery, has received the 2010 ala 
Award from the American Laryn- 
gological Association for unique 
and significant contributions 
to the advancement of medicine. 
The American Broncho- 
Esophagological Association 
also honored Sasaki with the 
2010 Chevalier Jackson Award 
for lifelong outstanding 
advancement in broncho- 
esophagology, the association’s 
highest recognition. 
Joan Steitz, ph.d.. Sterling Pro¬ 
fessor of Molecular Biophysics 
and Biochemistry, was one of 
five panelists at a congressional 
briefing in September, “For 
Women in Science: 21st-Century 
Policy and Politics.” 
Bauer Sumpio, m.d., ph.d., hs ’86, 
professor of surgery (vascular) 
and of diagnostic radiology, 
became president-elect of the 
New England Society for Vascular 
Surgery at its annual meeting in 
Rockport, Maine, in September. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
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26 students 
Shelf exams are the 
stuff of dreams 
In the Class of 2013’s Second-Year 
Show, faculty devise an alternate 
reality for the class president. 
Anyone who mastered the convo¬ 
luted plot of the Leonardo DiCaprio 
movie Inception would have had little 
trouble following the story line of 
Staph Inception, the Class of 2013’s 
Second-Year Show. Loosely based on 
the movie, the show depicted faculty 
invading the dreams of class president 
Chris Sauer in the hope of persuading 
him to support shelf exams—National 
Board of Medical Examiners standard-1 
ized tests that students oppose. 
The plot follows Sauer playing 
himself in videos and dance routines 
as a “Mysterious Girl” (played by 
Katherine Chau) lures him from Club 
Med to a clinical suite where faculty 
members chloroform him. They then 
use an inception device invented by 
the whiskey-swigging James Jamieson, 
M.D., PH.D., head of the m.d./ph.d. pro 
gram (played by Graeme Rosenberg), 
to implant an alternate reality in his 
dreams. These dreams take Sauer back* 
to high school and lead him on a dif¬ 
ferent path through college and med 
school. His high school crush Quinn, 
played by Stephanie Meller, is really 
Nancy R. Angoff m.p.h. ’81, m.d. ’90, 
HS ’93, associate dean for student 
affairs. She’s in cahoots with other 
instructors to steer Sauer toward sup¬ 
port for the shelf exams. 
As Sauer travels through four layers 
of dreams he must, among other 
things, choose between Quinn and 
singing in a boy band; attend a career 
fair; resist the temptation of a life of 
debauchery in fashion design; and 
finally be saved by a dream “defense” 
that was also implanted in his brain. 
Charisse Mandimika was the 
show’s executive producer and Misia 
Yuhasz was the executive director. 
Writers and directors included Yuhasz,' 
Felicity Lenes, Greg Stachelek, Nick 
Theodosakis, and Brian Zhao. 
—John Curtis 
TOP Stephanie Meller played Quinn, the high 
school crush of Chris Sauer, president of the 
Class of 2013, who played himself. 
ABOVE Amanda Hernandez played the Lead 
Fashion Design Girl, who, at a career fair, tries 
to lure Sauer away from medicine and into the 
world of fashion. 
RIGHT Sauer and cast in the show’s finale. 
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From a TV series, a physician 
Dffers a vision of “what makes 
lis caregivers” 
rhe fictional physician and title char- 
la icter in the television series House is 
ho one’s idea of a role model. “He’s 
arrogant, a drug addict, a jerk, and 
! |in SOB,” said Lisa Sanders, m.d. ’97, 
|hs ’01, during her Commencement 
), [address to the 31 graduates of the 
Physician Associate Program in 
[December. And she should know. 
■ [Sanders, an assistant clinical profes¬ 
sor of medicine, is a consultant to the 
's show, which was inspired in part by 
her “Diagnosis” column for The New 
York Times Magazine. Yet despite this 
I description of Gregory House, she 
[said, “People come up to me and say, 
‘I wish my doctor was Dr. House.’ ” 
’ The appeal of House, said Sanders, 
may be that although he hates 
'patients, he loves diagnoses and 
wrestles with symptoms until he can 
make sense of them. House, she said, 
I .“embodies a willingness to get into the 
problem and fix the problem.” 
i Sanders went on to describe a resi- 
i dent at Waterbury Hospital who re¬ 
flected that persistence as she took 
on a patient whose case had perplexed 
I other physicians for a year. The 
i patient’s frequent nausea and vomit¬ 
ing had forced her to drop out of the 
University of Connecticut. A half- 
dozen visits to the hospital and a full 
workup had yielded no insights into 
the problem. The resident found no 
obvious causes: the student was other¬ 
wise healthy, smoked and drank only 
occasionally, and was not pregnant. 
Only extremely hot showers relieved 
her symptoms. Finally, after countless 
searches through the literature, the 
resident turned to “Dr. Google.” 
Her Web search—she Googled 
nausea, vomiting, and hot showers— 
unearthed the diagnosis. The patient 
was suffering from cannabinoid 
hyperemesis syndrome, a clinical con¬ 
dition linked to long-term marijuana 
use. The resident, Sanders said, suc¬ 
ceeded where other physicians had 
failed because of her “willingness to 
become fully engaged with the prob¬ 
lem, to take it on as a problem, to own 
it, to really figure it out.” 
“This commitment we make to our 
patients—to take on their problems— 
this is what makes us caregivers,” 
Sanders said. 
After Sanders’ talk, Mary Warner, 
PA, M.M.sc., director of the Physician 
Associate Program, and Dean Robert 
J. Alpern, m.d.. Ensign Professor of 
Medicine, presented diplomas to the 
graduates on the stage of Woolsey Hall. 
Three students received awards for 
exceptional performance: Matthew 
Brogan, pa-c ’10, received the Dean’s 
Academic Award; Heather Dobbin, 
PA-c ’10, received the Dean’s Clinical 
Award; and Megan Duet, pa-c ’10, 
received the Dean’s Humanitarian 
Award for outstanding service to others. 
The Didactic Instruction Award, for 
dedication and excellence in the class¬ 
room, was given to John S. Francis, 
M.D., assistant professor of medicine. 
The Clinical Instruction Award, for 
exemplary teaching at a clinical rotation 
site, went to Hartford Family Medicine 
Center. The Jack Cole Society Award, 
for contributions in support of the phy¬ 
sician associate profession, was given 
to Rita A. Rienzo, pa, m.m.sc., assistant 
professor of medicine. 
-J.C. 
TOP Dean Robert Alpern awarded a diploma to 
Courtney Johnson at the Commencement of the 
Physician Associate Program in December. 
MIDDLE Ross Roberts looked on as Jamie Sun 
helped Adam Simon with his mortarboard before 
the start of Commencement in Woolsey Hall. 
ABOVE Lisa Sanders, assistant clinical profes¬ 
sor of medicine and author of the “Diagnosis” 
column in The New York Times Magazine, gave 
the Commencement address. 
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28 Alumni FACES 
Yvette Fay Francis-McBarnette broke race and 
gender barriers at the medical school and in 
her career as a pediatrician. In the 1960s she 
launched the Foundation for Research and 
Education in Sickle Cell Disease. 
Breaking barriers in 
medicine and race 
The second black woman to enter the 
School of Medicine became a pioneer 
in sickle cell disease. 
A medical student in a time charged 
with racial tension in America, Yvette 
Fay Francis-McBarnette, m.d. ’50, 
echoes black Yalies before her who 
consistently reported getting along well 
with their white classmates. “We were a 
close-knit, supportive group,” she said. 
Perhaps this atmosphere motivated 
a 22-year-old Fay Francis, as she was 
known, to write a letter to the Pittsburgh 
Courier during her second year of medi¬ 
cal school. “I have been urging all the 
prospective [black] medical students I 
know to apply,” she wrote, “but most 
[feel] it would be a waste of time. This 
is not true.” Francis-McBarnette con¬ 
cluded that as long as blacks were not 
represented in top schools, “the num¬ 
ber of Negro doctors and nurses [would 
continue] decreasing.” 
The daughter of college-educated 
schoolteachers who emigrated from 
Jamaica, Francis-McBarnette always 
knew that she would go to college. 
After skipping several grades in school, 
she enrolled at Ffunter College when 
she was just 14 and earned a bach¬ 
elor’s degree in physics in three and a 
half years. At 18, Francis-McBarnette 
was too young for medical school and 
unable to get a job in a lab in New 
York City. Those jobs were reserved for 
white applicants, she was told. So she 
got a master’s in chemistry at Columbia 
instead. In 1946, at the age of 19, she 
was the second black woman to enroll 
at the Yale School of Medicine. 
Despite her letter to the Pittsburgh 
Courier, Francis-McBarnette had no 
involvement in the civil rights move¬ 
ment. But in the medical profession, she 
broke barriers for women and blacks. 
While running a private pediatric 
practice, directing a clinic at Jamaica 
ITospital in Queens, and completing a 
second residency in internal medicine, 
Francis-McBarnette raised six children 
with her husband of 54 years, Olvin 
McBarnette, now a retired district super 
intendent for the New York City Board 
of Education. Among her children are 
three attorneys and a schoolteacher. 
In medicine, Francis-McBarnette 
broke barriers for sufferers of sickle cell 
disease. She began using prophylactic 
antibiotics 15 years before their effec¬ 
tiveness was confirmed by an article in . 
The New England Journal of Medicine. 
Francis-McBarnette first heard of 
sickle cell disease and its mostly black 
victims in the 1950s during her pedi¬ 
atrics residency at Chicago’s Michael 
Reese ITospital. The hospital, which 
closed its doors in 2009, served the 
city’s black population, which was 
increasing due to the migration of 
African Americans from the South to 
the North. “I went home and tested all i 
my relatives [for sickle cell],” she said. 
In 1966, in private practice and an 
attending pediatrician at Jamaica . 
ITospital, she launched the Foundation 
for Research and Education in Sickle Cell 
Disease with colleagues who included 
Doris Wethers, m.d. ’52. The foundation 
was instrumental in opening the first 
comprehensive sickle cell clinic of which 
Francis-McBarnette became director. 1 
The pediatrician was soon invited ‘ 
to Washington to sit on an advisory ■ 
committee before then-President 
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Richard M. Nixon signed the National 
Sickle Cell Anemia Control Act in 
May 1972. 
t Since 1970 she had been successfully 
1 treating sickle cell children with prophy¬ 
lactic antibiotics. “I stayed on antibiotics 
for 35 years,” said Cassandra Dobson, 
D.N.sc., a lifelong patient of Francis- 
McBarnette, who started on the regimen 
in 1971. “If I hadn’t, I would’ve died.” 
And by 1970, five years before 
HNew York State mandated the screen¬ 
ing of infants for sickle cell disease, 
Francis-McBarnette’s organization 
had already screened some 20,000 
schoolchildren. That year in the May 
1 issue of the Journal of the National 
Medical Association, the doctor called 
for treatment that would allow those 
with sickle cell disease “to pursue 
their education, earn a living, and rear 
their families.” These endeavors were 
t unheard-of for sickle cell patients, 
iwho barely lived to adolescence when 
Francis-McBarnette started practicing. 
“I was told I was going to die at 5, 
at 10, at every milestone of my life,” 
Dobson said. 
On the pediatrician’s then- 
controversial advice that her patients 
do anything they wanted to do, 
including bear children, Dobson had 
children, became a registered nurse, 
and earned her doctorate in nursing. 
Francis-McBarnette recently attended 
Dobson’s 50th birthday party, where 
Dobson said in a speech that she 
wouldn’t be celebrating this milestone 
if it weren’t for “Dr. Francis.” 
When Francis-McBarnette’s first 
patients lived beyond age 18, Francis- 
McBarnette referred them to adult 
doctors, but they refused to go. “They 
don’t know anything about me. I’m 
staying right here with you,” her 
patients told her. So in 1978, at age 52, 
Francis-McBarnette completed a 
residency in internal medicine and 
a fellowship in hematology at Bronx- 
Lebanon Hospital Center so that she 
could continue to care for her former 
pediatric patients. 
Like Dobson, Maureen Michel has 
also been a lifelong patient of Francis- 
McBarnette. When she was visiting New 
York from Haiti in 1975, Michel, then 
9 years old, was hospitalized. Now 44, 
Michel saw Francis-McBarnette until 
the doctor retired in 2000. 
Today, in the course of searching 
for a new doctor, Michel still meets 
many who do not know what sickle 
cell disease is. “My whole life, every 
time I go to the emergency room, I 
call Dr. Francis. ‘Do you think this 
medication is good for me.^’ When she 
retired, I didn’t know if I would ever 
find any doctor like her, and to tell you 
the truth, I never have.” 
—Sonya Collins 
A doctor and pilot’s journey from 
a NYC housing project to Atlanta 
by way of Vietnam 
Norman Elliott’s journey to Yale began 
on a combat mission from Vietnam to 
the Philippines in 1972. A first lieuten¬ 
ant flying rescue for the Air Force dur¬ 
ing the Vietnam War, Elliott, m.d. ’79, 
was evacuating a 17-year-old airman 
who’d attempted suicide by swallowing 
Drano. “I’d work with the physicians 
at stabilizing the patients. That was 
how I came to enjoy medical work,” 
Elliott said. 
The physician on that flight was 
Phil Steeves, m.d. ’70. Elliott confided 
to Steeves that he would like to be a 
doctor, but at 23 and with several years 
of military service still ahead of him, 
“I thought I was going to be too old.” 
Steeves assured Elliott that there 
were plenty of older med students at 
Yale who’d come from other careers. 
Once back in the States and after five 
years of active Air Eorce duty, Elliott 
enrolled at the School of Medicine 
in 1975 and continued to fly for the 
reserves throughout his studies. While 
his classmates took trains to New 
York for the weekend, he jokes, he 
was often flying to Europe. 
Today Elliott’s life looks like child¬ 
hood fantasies come true. The boy who 
grew up building model airplanes, 
watching Sky King on television, and 
reading the Steve Canyon comic strip 
in the projects in Queens, N.Y., has 
chased typhoons all over the Pacific 
and hurricanes through the Gulf of 
Mexico as a weather reconnaissance 
pilot. And he is fondly known as “Doc” 
to the Atlanta Braves, for whom he is 
now head team physician. 
30 Alumni FACES 
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Norman Elliott started his career as a pilot in the t 
Air Force, then switched to medicine. He is now 
the head team physician for the Atlanta Braves. 
Elliott ended up in Atlanta by 
chance. The New Yorker always imag¬ 
ined the South as too rural for him, but 
after a short visit to Atlanta in 1978, 
Elliott said, “This is where Em staying.” 
Upon graduation from Yale, Elliott 
went to Atlanta for his residency in 
internal medicine at Emory. He then 
became a flight surgeon at the School 
of Aerospace Medicine at Brooks Air 
Eorce Base in Texas in 1983 and joined 
the Alabama Air National Guard, 
following a fellowship in gastroenterol¬ 
ogy in Birmingham, Elliott returned to 
practice at Emory, all the while climbing 
the ranks of the Air National Guard to 
become Alabama State Air Surgeon and 
a brigadier general. 
In 1992, Elliott was recommended by 
a colleague for a medical staff position 
with the Atlanta Braves. Hank Aaron, 
the Braves’ senior vice president, wanted 
to address both a shortage of team phy¬ 
sicians and a shortage of minorities in 
front office positions in major league 
baseball. Elliott’s partner learned about 
the opening and referred Elliott, who 
was offered the job by Aaron himself 
Elliott and four other internists 
split medical duties at 80 home games 
that require the presence of one intern¬ 
ist and one orthopaedic surgeon. At any 
game, Elliott may take care of players 
on the visiting and the home team, 
their families, umpires, and front 
office staff He attends to immediate 
medical needs, makes referrals, writes 
prescriptions, and conducts physicals 
at spring training. 
Elliott’s favorite part of the job is 
swapping stories with the pros. Once 
in the locker room after a game, 
“I was filling out some papers, and 
Bobby Gox, Jimy Williams, and Terry 
Pendleton saw me and said, ‘Hey, Doc, 
come on over!”’ Elliot couldn’t believe 
these guys were inviting him to talk 
baseball with them. “This was the 
thing I worshipped. And these were 
the guys that knew.” 
Elliott grew up a Yankees fan, though 
his father loved the Mets. “I couldn’t 
be a Mets fan. My father tried to take 
me to Shea Stadium, and I said, ‘The 
Yankees aren’t playing there.’ ” 
Elliott is happy that his father lived 
to see him join the Braves. His father 
never made it to Atlanta for a game, but 
he waited for his son’s calls afterward 
telling him “what really happened in the 
locker room. He loved that.” 
Elliott has raised two children in 
Atlanta—Jason, 25, and Kristen, 21 
—with his wife of 27 years, Pam, a 
special education teacher in the pub¬ 
lic schools. When he’s not at a home 
game, Elliott sees patients at three 
hospitals and is a clinical assistant 
professor at Emory University and 
Morehouse School of Medicine. 
Practicing in three regions as distinct 
as downtown Atlanta, the city’s suburbs, 
and the rural foothills, Elliott likes most 
that he meets people from different 
backgrounds and helps reduce their 
suffering, as he observed Steeves doing 
on the flight to the Philippines nearly | 
40 years ago. As it turns out, Elliott got 
his first lesson in gastroenterology that 
day, and the 17-year-old airman lived. 
—Sonya Collins 
« 
Familiar Faces 
Do you have a colleague who is making j 
a difference in medicine or has followed 
an unusual path since leaving Yale? We’d j 
like to hear about alumni of the School of j 
Medicine; Physician Associate Program; 
and the medical school’s doctoral, fellow¬ 
ship, and residency programs. Drop us a 
line at ymm@yale.edu or write to Faces, 
Yale Medicine, 1 Church Street, Suite 300, 
New Haven, CT 06510. 
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Malin Dellinger John Patti 
1960s 
Vlalin Dellinger, m.d. ’60, is now 
3 medicolegal consultant after 
more than 40 years in practice 
3S a medical oncologist. He is 
also co-editor of Everyone’s 
'3uide to Cancer Therapy, now in 
ts fifth edition. 
I97OS 
Stephen B. Arnold, m.d. ’74, a car- 
jioiogist in the East Bay area, was 
aonored by the American Heart 
^ssociation in 2009 for outstand- 
ng contributions to reducing 
lardiovascular disease and build- 
ng a healthier community. Arnold 
s an associate clinical professor 
3f medicine at the University of 
California, San Francisco. 
Duke E. Cameron, m.d. '78, 
HS ’83, has been named cardiac 
iurgeon in charge at the Johns 
Hopkins Hospital and director of 
;he Division of Cardiac Surgery 
3tthe Johns Hopkins University 
School of Medicine. Cameron is 
also a co-director of the school’s 
Heart and Vascular Institute, 
as well the inaugural James T. 
Dresher Sr. Professor of Surgery 
and director of pediatric cardiac 
surgery. Cameron, who joined 
;he Hopkins faculty in 1984, 
/vill also become director of the 
, Dana and Albert "Cubby” Broc- 
:oli Center for Aortic Diseases. 
lohn A. Patti, m.d. '71, was 
elected chair of the American 
i College of Radiology (acr) Board 
if bf Chancellors in May 2010 at 
;he organization’s 87th Annual 
Meeting and Chapter Leader- 
>hip Conference in Washington, 
D.C. He will serve as chair from 
May 2010 to May 2011. Patti is 
3 radiologist at Massachusetts 
Seneral Hospital in Boston 
Robert Tina Poussaint 
Posteraro 
and a member of the faculty of 
Harvard Medical School. 
Robert H. Posteraro, m.d. ’73, a 
diagnostic radiologist, was named 
Outstanding Faculty Member of 
the Year in the Clinical Practice 
Management Program at Texas 
Tech University Health Sciences 
Center’s School of Allied Health 
Sciences in Lubbock. 
1980s 
Lisa Matzer, m.d. '88, recently 
opened a new cardiology office in 
Burbank, Calif, where she special¬ 
izes in preventive cardiology and 
women’s cardiac health. 
Tina Young Poussaint, m.d. ’83, 
was elected president of the 
American Society of Pediatric 
Neuroradiology last year. Pous¬ 
saint is an associate professor 
of radiology at Harvard Medical 
School and director of the Neuro¬ 
imaging Center of the Pediatric 
Brain Tumor Consortium at 
Children’s Hospital Boston. 
1990s 
Owen Garrick, m.d. ’98, m.b.a., is 
president-elect of the American 
Medical Association Founda¬ 
tion (amaf). Garrick has served 
on the AMAF board of directors 
since 2004 and will assume the 
position of president on June i 
for a one-year term. He is chief 
operating officer of Bridge Clinical 
Research, based in Oakland, Calif 
Alexander P. Miano, m.d., hs ’99, 
FW ’00, was appointed medical 
director of psychiatric services 
in the emergency department 
of the University of Connecticut 
Health Center in Farmington 
in July. He will continue his 
practice in adult psychiatry in 
Jennifer Blair and 
Roberto Cipriano 
the metropolitan Hartford area. 
He lives with his wife, Sharon, 
and theirtwo sons, Michael and 
Scott, in West Hartford. 
2000s 
Jennifer M. Blair, m.d. ’04, and 
Roberto Cipriano were married 
on September 5 in New Haven, 
Conn. Blair has worked as a writer 
in New Haven and New York City 
and as an emergency medicine 
physician in Illinois, Connecticut, 
and Maine. Blair and Cipriano, an 
architect, traveled to Indonesia in 
October, where they will spend 
two years as volunteers in the 
ASRi Clinic founded and directed 
by Kinari Webb, m.d. ’02. 
Candace Hillary Feldman, 
M.D. ’08, M.P.H., and Evan Zane 
Macosko, M.D., PH.D., were mar¬ 
ried on May 23,2010, in Tarry- 
town, N.Y. Feldman is a resident in 
internal medicine at Brigham and 
Women’s Hospital in Boston and 
Macosko is a resident in psychiatry 
at Massachusetts General Hospi¬ 
tal in Boston. 
Kavita Mariwalla, m.d. ’04, hs ’08, 
FW ’09, and Kabir Bhasin, m.d., 
HS ’09, were married on June 5, 
2010, in New York City. Mariwalla 
is the director of dermatologic 
and Mohs surgery at Beth Israel 
Medical Center and St. Luke’s- 
Roosevelt Hospital Center in 
Manhattan. Bhasin is a cardiology 
fellow at Mount Sinai Medical 
Center in Manhattan. Members 
of the bridal party included 
Thomas Fernandez, m.d. ’05; John 
K. Forrest, m.d. ’05; and Jason 
Griffith, m.d. ’08. 
Sean M. McBride, m.d. ’08, and 
Blake M. Landro were married 
on October 16 in Boston at the 
Museum of Science. McBride 
is a second-year resident in 
radiation oncology at Harvard. 
Landro is an advertising account 
manager for Google. 
Sunny Ramchandani, m.d. ’04, 
M.P.H., was named a White 
House Fellow in June 2010. 
Ramchandani is a lieutenant 
commander and physician in the 
U.S. Navy. He is the Integrated 
Chief of General Internal Medi¬ 
cine at the Walter Reed National 
Military Medical Center, where 
he co-founded a primary care 
delivery model that has been 
adopted by the U.S. Military 
Health System. He served in Af¬ 
ghanistan In 2009 as the senior 
medical mentor of the Afghan 
National Security Forces and 
received the Bronze Star Medal. 
Curtis Weiss, m.d. ’05, and Alex¬ 
andra Block announce the birth of 
their son, Micah Block Weiss, on 
March 20,2010. Mom, Dad, and 
Micah are doing well. Micah was 
so excited to meet everyone that 
he came two weeks early. Weiss is 
a pulmonary and critical care fel¬ 
low at Northwestern University. 
2010s 
Elias N. Kassis, m.d. ’10, and Sylvia 
R. Baedorf m.p.h., were married 
on June 5,2010, in Geneva, N.Y. 
The groom is a resident at Mas¬ 
sachusetts General Hospital and 
the bride is a research education 
manager at Boston University 
Medical Center. 
SEND ALUMNI NEWS TO 
Claire M. Bessinger, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
VISIT US ON THE WEB 
yalemedidne.yale.edu 
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32 in Memoriam 
Samuel D. Kushlan, m.d. ’35, 
HS '38, a pathbreaking New Ha¬ 
ven gastroenterologist and one 
of the oldest living alumni of 
the School of Medicine, died on 
October 16. He was 98. A mentor 
and role model for generations 
of physicians in training at Yale, 
Kushlan had continued to teach 
as a retired clinical professor of 
medicine until last summer. 
Born in New Britain, Conn., 
in 1912, the son of Lithuanian im¬ 
migrants, by the age of 10 Kush¬ 
lan knew that he wanted to be 
a physician. He was admitted to 
the School of Medicine after his 
junior year at Yale College and, 
upon graduation in 1935, won 
the Campbell Prize, awarded to 
graduating students who secure 
the highest rank on Step Two 
of the National Board Examina¬ 
tion. He conducted his student 
research and wrote his thesis 
underthe supervision of Francis 
Gilman Blake, m.d., the chair 
of the Department of Internal 
Medicine and a world-renowned 
expert on infectious disease. 
Following medical school, 
Kushlan trained as an intern 
and resident at what was then 
New Haven Hospital. His main 
diagnostic tools were the medi¬ 
cal history and physical exam. 
X-rays were the only imaging 
technique available, and in 
those pre-penicillin days, the 
principal medications were 
aspirin, digitalis, phenobarbital, 
quinine, and morphine. 
Except for a brief stint at 
Harvard in 1938, Kushlan spent 
his entire career at Yale. He 
established the Section of 
Gastroenterology in 1938 and 
was the first physician in Con¬ 
necticut to perform gastroscopic 
endoscopy. For many years he 
maintained an active practice in 
New Haven and provided con¬ 
sultations throughout central 
Connecticut. 
In 2001, Kushlan was award¬ 
ed the medical school's highest 
honor, the Peter Parker Medal, 
and in 2003 the Connecticut 
Chapter of the American College 
of Physicians bestowed upon 
him its Lifetime Achievement 
Award. In 2007, he received the 
Yale Medal in recognition of his 
innumerable contributions to 
his alma mater. 
Robert W. McCollum Jr., m.d., 
PH.D., HS ’51, a professor and 
dean of public health for almost 
30 years who made significant 
contributions to the under¬ 
standing of viral diseases, died 
of heart failure on September 13 
at his home in Etna, N.H. He 
was 85. 
In the 1950s, McCollum 
worked with a Yale team, led by 
Dorothy M. Horstmann, m.d., 
that used blood samples from 
polio patients to isolate the 
polio virus and discovered that 
before it reached the spinal 
cord and paralyzed patients, it 
circulated in the blood. That 
finding formed a basis for the 
development of polio vaccines. 
In 1982 McCollum left Yale to 
become dean of the Dartmouth 
Medical School, where he played 
a central role in the creation of 
the Dartmouth-Hitchcock Medi¬ 
cal Center in Lebanon, N.H. 
David F. Musto, m.d., hs ’67, 
professor of psychiatry in the 
Child Study Center and professor 
of the history of medicine, died 
on October 8 in Shanghai, China. 
He was there for a ceremony 
markingthe donation of his 
books and papers on the history 
of drug policy to Shanghai Uni¬ 
versity and the establishment 
there of a Center for Interna¬ 
tional Drug Control Policy Stud¬ 
ies. He was 74. Musto, a member 
of the Yale faculty since 1969, 
was internationally recognized 
as an historian of drug policy. 
Following his residency 
at Yale Musto served in the 
U.S. Public Health Service as 
special assistant to the director. 
National Institute of Mental 
Health, until 1969. He published 
widely on the social history of 
policies involving alcohol, nar¬ 
cotics, AIDS, and mental health 
and is known for his study of 
drug policy. The American Dis¬ 
ease: Origins of Narcotic Control, 
published in 1973. 
He was a member of the 
White House Strategy Council 
on Drug Abuse Policy during the 
Carter administration, historical 
advisor to the U.N. Commission 
on Narcotic Drugs from 1978 to 
1980, a member of the National 
Council of the Smithsonian 
Institution from 1981 to 1990, 
and historical consultant to the 
Presidential Commission on the 
Human Immunodeficiency Virus 
Epidemic. He also served on the 
National Advisory Committee of 
the Robert Wood Johnson Foun¬ 
dation’s program to combat drug 
and alcohol abuse, was a charter 
fellow of the College on Prob¬ 
lems of Drug Dependence, and 
was a member of the alcohol ad¬ 
visory committee of the National 
Association of Broadcasters. 
We have also received word 
of the passing last year of the 
following alumni: 
David A. Berkowitz, m.d. ’69, 
died on October 28 in Newton, 
Mass. He was 66. 
F. Calvin Bigler, m.d. ’57, died 
on July 16 in Winfield, Kan. He 
was 78. 
Levon Boyajian, m.d. ’56, died 
on March 22 in Englewood, N.J. 
He was 80. 
Stephen C. Cary, m.d. ’61, hs ’64, 
died on October 29 in Ashland, 
Ore. He was 78. 
Robert V. Diserens, m.d. ’58, 
died on November 8 in Phoenix, 
Ariz. He was 77. 
Richard E. Dormont, m.d. ’40, 
died on July 5 in Minot, N.D. 
He was 95. 
Robert S. Easton, m.d. ’45, died 
on January 6 at his home in 
Peoria, III. He was 88. 
Lloyd D. Flint, m.d. '41, died on 
February 2 at his home in Myrtle 
Beach, S.C. He was 92. 
Frank L. Golbranson, m.d. ’47, 
died on January 10 in San Diego, 
Calif. He was 88. 
Stanley I. Greenspan, m.d. '66, 
died on April 27 in Bethesda, 
Md., of complications from a 
stroke. He was 68. 
William K. Hadley, m.d. ’59, 
died on March 1 in San Francisco 
Calif. He was 81. 
O. Roger Hollan, m.d. ’45, hs ’46 
died on August 25 of complica¬ 
tions related to heart disease. 
He was 87. 
Robert L. Janco, m.d. ’70, died 
on March 9 in Malvern, Pa. He 
was 66. 
Haskins K. Kashima, m.d. ’58, 
died on November n of compli¬ 
cations from Alzheimer disease 
in Lutherville, Md. He was 78. 
Jay W. Kislak, m.d. ’58, hs ’59, 
died on June 24 in Truro, Mass. 
He was 76. 
Eugene G. McCarthy, m.d. ’60, 
died on November i6 in New 
York City. He was 76. 
William F. O’Connell, m.d. ’45, 
died on September 29 in Red 
Bluff, Calif. He was 88. 
Philip H. Philbin, m.d. ’47, died 
of pneumonia on October io in 
Bethesda, Md. He was 88. 
Jack S. Rice Jr., m.d. ’64, died 
on November 5 in San Angelo, 
Texas. He was 71. 
Lee S. Sannella, m.d. ’40, died 
on March 19 in Santa Rosa, Calif. 
He was 93. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine 
I Church Street, Suite 300, 
New Ftaven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
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SingerSi dancers raise money n 
With the help of an assortment of singe 
or HP 
rs and 
•REP 
dancers, the 
i8th annual Grannum Talent Showcase 
$3,000 on February n for the Health Prc 
and Enrichment Program (hprep). 
raised 
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more than 
ns Recruitment 
HPREP is a 10-week program for area hi 
Hon+’c irt \A/hirh minr»ri+u TYKaHiral sfiiHpnt*; nfff 
gh school stu- 
‘r lectures on 
health topics. The show is named for th e late Peter Grannum, 
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20 years and director of medical studies 
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2 Letters 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or fewer) and 
news items to Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length, style, and content. 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
To serve this great nation 
I particularly enjoyed the article 
on Norman Elliott, M.D. ’79 [Yale 
Medicine, Spring 2011], He is a 
distinguished School of Medicine 
graduate, and it pleases me to 
be reminded these many years 
later that I played a small part in 
his career. 
I was an Air Force flight sur¬ 
geon in the Vietnam War, which 
is how I first encountered Dr. 
Elliott. In addition to flying com¬ 
bat in supersonic fighters in that 
war, I served many years in the 
Air National Guard in tactical 
fighters (F-15S). I was fortunate 
to have had very interesting 
deployments—from the Jungles 
of South America to the perma¬ 
nent ice of Antarctica (even the 
South Pole itself). I met many 
fascinating folks in our military 
service, but the warmest feeling 
as I look back is the opportunity 
I was given to serve this great 
nation—none of which would 
have occurred without the 
medical education I was privi¬ 
leged to have. 
Philip Steeves, m.d. '70 
Wenham, Mass. 
On medicine and the 
military 
I enjoyed your article on 
"Medicine and the military” 
[Yale Medicine, Spring 2011]. 
I had the privilege of working 
with Robert J.T. Joy, M.D. ’54, 
while we were both at the 
Uniformed Services University 
of the Health Sciences at Walter 
Reed Army Medical Center. 
My time at the Yale School 
of Medicine has been one of 
the highlights of my educa¬ 
tional career. 
Mahlon V.R. Freeman, m.d. ’55 
Col., U.S. Army Medical Corps Ret. 
Denton, Texas 
Killing is never the goal 
"Medicine and the military” 
[Yale Medicine, Spring 2011] 
reports an admissions interview 
at the School of Medicine in 
which a former Navy pilot’s job 
was described as "to kill peo¬ 
ple.” Perhaps the lack of rotc 
at Yale is responsible for the 
persistence of such misinformed 
and distorted thinking. 
Having testified dozens of 
times in courts of law defending 
law enforcement officers, I am 
familiar with such nonsense from 
plaintiffs’ lawyers in trying to 
mislead a jury. In the military as 
in law enforcement, the "job” is 
saving the lives of the innocent by 
deterring violence and stopping 
aggression. True, some killing 
results; but everything possible 
is done to avoid it. Killing is never 
the goal. 
Martin L. Tackier, m.d. ’59 
Col., U.S. Army Medical Corps Ret. 
Cainesville, Fla. 
Editor’s note: In May, U.S. 
Secretary of the Navy Ray Mabus 
and University President Richard 
C. Levin signed an agreement 
to establish a rotc unit at Yale 
—the Navy’s only such unit in 
Connecticut. The first class of 
midshipmen will enter Yale in 
the fall of 2012. 
A remembrance of the 
Cushing collection 
An article in a previous issue 
[“Cushing collection once 
again open for research,” Yale 
Medicine, Spring 2010] didn’t 
mention that prior to being 
housed in the basement of 
Harkness Dorm, the Cushing 
collection was stored in rooms 
in the basement next to the 
neuropathologist’s office down 
the hall from the morgue. While 
I was attending Derby High 
School, I worked as a mortician’s 
assistant to Frank and Walter in 
the morgue during the summers 
of the early 1950s. One of my 
jobs was to move the collection 
to the rooms beneath Harkness. 
I will never forget loading the 
jars containing the specimens 
onto the gurneys and wheel¬ 
ing them through the tunnel to 
their new destination. 
Walter W. Karney, m.d. ’62 
Professor Emeritus of Medicine 
Uniformed Services University 
School of Medicine 
Rockville, Md. 
3 starting point 
Health care for the uninsured, and encouraging physician-scientists 
Many physicians at the School of Medicine have devoted their time and skills to providing 
free care for the uninsured. But, as we learn in an article by Ayelet Amittay, m.s.n. ’io, such 
efforts often ran into obstacles and could not always guarantee continuity of care. Now area 
doctors have founded a local chapter of the national organization Project Access. Project 
Access-New Haven recruits specialists to take on uninsured patients in New Haven and six 
neighboring towns. By handling paperwork, scheduling, and other administrative matters. 
Project Access ensures continuity of care and makes it easy for physicians to donate their 
services. Both New Haven hospitals support the program and provide ancillary services, 
including labs and tests. More than 300 area physicians have signed up since last year and 
more than 100 patients have received treatment. 
Our cover story by Colleen Shaddox explores the status of physician-scientists. For 
almost four decades, concerns in the academy have focused on the difficulties of maintain- 
[ing dual careers in science and medicine—including longer training periods and lower 
salaries than those of clinicians in private practice. And as a new generation with strong feel¬ 
ings about the balance between work and life enters the ranks of academic medicine, those 
concerns have intensified. A committee led by Peter Aronson, m.d., fw ’77, the c.n.h. Long 
iProfessor of Medicine (Nephrology) and professor of cellular and molecular physiology, has 
jbeen looking into the issue and seeking ways to encourage medical students and young doc¬ 
tors to take this career path. 
' John Curtis 
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4 chronicle news from cedar street 
Yale forms partnership 
to develop cancer drugs 
Under the pact, Gilead Sciences 
can bring to market compounds 
discovered by Yale scientists. 
Yale and Gilead Sciences, a biopharma- 
ceutical company based in Foster City, 
Calif., announced in late March that 
they had forged a multi-year alliance to 
accelerate the discovery and develop¬ 
ment of drugs to treat cancer. 
Over the next four years Gilead 
will provide up to $40 million to 
support cancer research at the School 
of Medicine, and may provide up to 
$100 million—the largest corporate 
commitment in Yale’s history—over 
10 years if the partnership is renewed in 
2015. Yale will maintain ownership of 
all intellectual property generated by the 
medical school's research, and Gilead 
will have the first option to license any 
compound it deems promising. 
The partnership comes at a diffi- 
cidt time for drug development. Basic 
research conducted over decades is 
bearing fruit, but the cost of drug devel¬ 
opment has risen as clinical trials and 
regulations have grown more complex. 
The average cost to develop a single 
approved drug has risen to $1.3 billion— 
a 60 percent increase since 2005. 
“The collaboration brings together 
one of the world’s top research univer¬ 
sities and a biopharmaceutical com¬ 
pany dedicated to addressing unmet 
medical needs, with the goal of find¬ 
ing new treatments for cancer,” said 
Yale President Richard C. Levin. “This 
truly is transformative support that 
leverages Yale Cancer Center’s top sci¬ 
entists, our West Campus technology 
investments, and the resources of the 
new Smilow Cancer Hospital.” 
The partnership benefits both 
industry and academia. Early-stage 
research carried out in settings like 
the School of Medicine is identifying 
more potential drug targets than ever. 
Research grants, however, are not 
designed to sustain the many addi¬ 
tional steps involved in drug discovery. 
With the cost of bringing drugs to the 
marketplace rising, pharmaceutical J| 
companies have become more selec- 
tive about which targets to pursue. As 
a result, some pharmaceutical compa¬ 
nies have been forming scientific alii- | 
ances with universities. st 
The Yale-Gilead project will be gov- jg 
erned by a joint steering committee jp 
chaired by Joseph Schlessinger, ph.d., I 
chair and the William H. Prusoff it] 
Professor of Pharmacology. The six- 
member committee will include Richard [], 
P. Lifton, M.D., PH.D., chair and Sterling $ 
Professor of Genetics and a Howard fo 
Hughes Medical Institute investigator; jp 
and Thomas |. Lynch Jr., m.d. ’86, the ji 
Richard Sackler and Jonathan Sackler a 
Professor of Medicine, director of Yale Ai 
Gancer Center, and physician-in-chief ij 
of Smilow Cancer Hospital. They will 
be joined by three Gilead scientists: si 
Howard Jaffe, m.d. ’82, president \\ 
and chair of the board of the Gilead ; h 
Foundation; William A. Lee, ph.d., « 
senior vice president, research; and jj 
Linda Slanec Higgins, ph.d., vice jj 
president, biology. |( 
Norbert W. Bischofberger, ph.d., 
Gilead’s chief scientific officer, said that * 
collaborating with Yale dovetails with the \ 
company’s renewed focus on oncology. [j 
“Based on the strong track record of \ 
the Yale cancer research team, I am 
confident this collaboration will lead to j, 
important advances in the understand- [, 
ing of the genetic basis of cancer as we a, 
collectively seek to develop novel tar- [■ 
geted therapies for patients in areas of n 
unmet medical need.” , 
“When we find cancer targets that ’ 
are new, we will work with Gilead on ,! 
designing drugs, which they can then 
test in the clinic,” Schlessinger said. 
“This is a tremendous opportunity for 1 
Yale and Gilead.” j 
—Peter Farley i 
Prime movers at Gilead Sciences in the new 
collaboration with the School of Medicine are , 
(clockwise from left) Howard Jaffe, president 
and chair of the board of the Gilead Foundation; 
Linda Slanec Higgins, vice president, biology; p 
and William Lee, senior vice president, research. ^ 
Army visits Yale to highlight 
its worldwide medical and 
humanitarian missions 
To Afghan villagers, said General (Ret.) 
r,Stanley McChrystal, soldiers in combat 
;i^ear, helmets, and body armor who don’t 
speak the language, don’t understand 
the culture, and race by in their armored 
vehicles “might as well be Martians.” 
McChrystal, former commander of 
U.S. forces in Afghanistan and now a 
senior fellow at Yale’s Jackson Institute 
for Global Affairs, was a featured 
speaker at “Common Ground: Army 
Medicine in Support of Humanity,” 
an event held in April to describe the 
Army Medical Department’s humani¬ 
tarian operations around the world. 
“The ability to use medical relation¬ 
ships becomes extremely important,” 
McChrystal told the audience in 
Harkness Auditorium. “I’ve watched 
coalition forces do everything from 
inoculations to basic checkups for kids, 
and it is something that breaks down 
the walls that can exist between us.” 
Col. Frederick C. Lough, m.d., 
who served at a military hospital in 
Afghanistan described some of the 
challenges facing military physicians. 
Although the hospital was near the 
historic city of Herat, the city was 
deemed too dangerous to visit, said 
Lough, now director of cardiac sur¬ 
gery at George Washington University 
Hospital. The military hospital was 
run by a Spanish contingent from 
NATO but also staffed by Bulgarian 
and American physicians. Language 
was often an issue, said Lough, not¬ 
ing that the morning report was 
conducted in Spanish. The European 
doctors also differed in their approach 
to medicine and were less trusting 
of technology, he said. Although the 
team treated many Afghan civilians, 
the team members were often con¬ 
cerned about follow-up for serious con¬ 
ditions. “Then what? There is no rehab 
after care,” he said. 
A visit to a medical Deployable 
Rapid Assembly Shelter (drash) unit 
on display in Harkness Ballroom fol¬ 
lowed the talks in the auditorium. The 
unit—which can be up and running in 
an hour and includes a surgical bed as 
well as an assortment of essential medi¬ 
cal equipment—represents the next 
level of care after battlefield treatment. 
Injured soldiers would be moved from 
the DRASH to a field hospital and then 
to the Army’s regional medical center in 
Landstuhl, Germany. 
Maj. Michael Filipowicz, the officer 
in charge of a medical recruiting station 
in Wallingford, Conn., said his goal in 
organizing the event was to build a rela¬ 
tionship with Yale. “I am trying to break 
down the walls of misunderstanding 
and to promote the humanitarian mis¬ 
sions that we do, and enlighten everyone 
that we’re not just about taking care 
of soldiers, but taking care of civilians 
around the world,” he said. 
—John Curtis 
SCHOLARSHIP FUND HONORS ALUMNUS 
Boston Scientific, a developer, manufac¬ 
turer, and marketer of medical devices, 
established in February a $1.7 million 
scholarship endowment for the School of 
Medicine. The Donald S. Bairn, m.d. ’75, 
Scholarship Fund will honor the late car¬ 
diology pioneer who served as Boston 
Scientific’s chief medical and scientific offi¬ 
cer from 2006 until his death in 2009. 
A Donald S. Bairn Scholarship will be 
awarded annually, beginning in August 
2011, to a first-year student to cover half of 
tuition for all four years of medical school. 
The School of Medicine will seek candidates 
based on financial need and demonstration 
of the intellectual and clinical excellence 
that Bairn’s career exemplified. 
Bairn had been an expert in interventional 
cardiology during his 25 years at Harvard 
Medical School, Beth Israel Deaconess Medical 
Center, and Brigham and Women’s Hospital in 
Boston before joining Boston Scientific. 
—J.C. 
HOSPITALS EXPLORE MERCER 
Yale-New Haven Hospital (ynhh) and 
the financially troubled Hospital of Saint 
Raphael (hsr) announced in March that 
they are exploring a possible merger, ynhh 
would buy hsr’s assets and invest about 
$135 million in capital improvements to 
produce an integrated hospital with two 
campuses. The integration would create 
cost and operational efficiencies. 
Employees of HSR would most likely 
become part of the combined hospital; 
YNHH would provide pay and benefits 
consistent with those of ynhh employees in 
similar positions. The merged institution would 
continue to honor hsr’s Catholic heritage. 
“With the prospect of significant health 
care changes on the horizon, hospitals across 
the nation are exploring innovative ways to 
enhance access to high-quality care while 
driving down costs,” said Mama P. Borgstrom, 
M.p.H. ’79, president and CEO of ynhh. 
"The proposed integration is in the best 
interest of this community, our patients, and 
our two organizations,” said Christopher M. 
O’Connor, president and CEO of hsr. 
—J.C. Peter Arnold, a nurse anesthetist, explains the 
workings of the dr ash unit to a visitor. 
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6 chronicle news from cedar street 
Teamwork and collaboration 
lead to better medical care in 
hospital settings 
Being a good team player may make 
all the difference when trying to save 
patients suffering from heart attacks. 
Top-tier hospitals with low acute 
myocardial infarction (ami) mortality 
rates achieve those results not only 
though state-of-the-art care but also 
because they foster a work atmosphere 
in which people combine their talents 
and strive toward a common goal, 
according to a study published in 
the March 15 issue of the Annals of 
Internal Medicine. 
“While protocols and processes are 
important for ami outcomes, it really is 
critical to pay attention to the environ¬ 
ment in which those are implemented,” 
said Leslie A. Curry, m.p.h., ph.d., 
research scientist at the School of 
Public Health and lead author 
of the paper. 
Curry and her colleagues found that 
hospitals with the lowest ami mortal¬ 
ity rates exhibit a “positive culture” 
characterized by shared organizational 
values and goals: consistent involve¬ 
ment of senior management; broad staff 
presence and expertise in ami care; 
effective communication and coordina¬ 
tion among interdependent groups: and 
an approach to problem solving that 
emphasizes learning and growth. In 
low-performing hospitals, they found, 
staff often work in isolation, com¬ 
municate poorly with members of the 
multidisciplinary health care team, point 
fingers when problems arise, and have 
no common vision regarding delivery of 
excellent health care. 
“The importance of a positive cul¬ 
ture has not been highlighted in the 
medical literature or in medical educa¬ 
tion, and our study may be heralding 
a factor that is as powerful as any new 
treatment,” said co-author Harlan M. 
Krumholz, m.d., m.sc., the Harold H. 
Hines jr. Professor of Medicine. 
Surprisingly, the Yale investiga¬ 
tors did not find any specific process 
or protocol, such as the use of rapid 
response teams or clinical guidelines, 
which differentiates high- from low- 
performing hospitals. “We may know 
what to do given current evidence, 
but how we provide care may also be 
very important,” Krumholz said. “An 
environment of coordination, com¬ 
munication, and collaboration may 
make a difference in making sure that 
mistakes are avoided and treatments 
achieve their promise.” 
Researchers focused on improv¬ 
ing the quality of health care have 
long sought to identify the factors that 
distinguish top-performing hospi¬ 
tals with stellar heart attack survival 
records. Prior studies, however, have 
failed to identify a silver bullet. The 
Yale group took a decidedly different 
approach with a provocative method¬ 
ology called positive deviance. This 
approach examines exceptional per¬ 
formance (so-called positive deviance) 
to understand how it leads to high 
outcomes relative to others. The Yale 
team explored myriad aspects of the 
hospital setting qualitatively rather 
than quantitatively—an approach 
that better reveals the importance of 
social interactions and organizational 
culture, which are difficult to measure 
using common research methods like 
surveys. “The nice thing is that we dis¬ 
covered a lot of approaches that do not 
require huge financial investments, 
which bodes well for improving qual¬ 
ity without increasing costs,” said 
Elizabeth Bradley, m.b.a., ph.d. ’96, 
professor of public health and a co¬ 
author of the paper. 
The Yale group is now validat¬ 
ing their initial qualitative findings, 
culled from ii hospitals that ranked in 
either the top or bottom 5 percent in 
risk-standardized mortality rates, by 
conducting a nationally representative 
survey of more than 500 U.S. hospi¬ 
tals to identify and confirm specific 
hospital behaviors that promote posi¬ 
tive AMI outcomes. “Soon we’ll be able 
to give hospitals more concrete advice 
about actions they can take to provide 
quality ami care,” said Curry. 
—Kara A. Nyberg 
7 
Refugee clinic fills needs 
for both patients and 
I physicians-in-training 
when Sachin Jain, m.d., m.p.h., aslced 
his patient about her eating habits, she 
consulted with her interpreter, who 
answered, “A typical Iraqi diet.” 
■ “What’s that?” Jain pressed, elicit¬ 
ing a list that included meat, starch, 
vegetables, and fried foods. 
' He then asked questions that don’t 
usually come up in a medical visit: Had 
she ever been a victim of violence? Ever 
i witnessed it? Did she feel safe now? 
Jain is one of the resident coordina- 
I tors of the Adult Refugee Clinic, which 
I serves eight patients each week in Yale- 
i New Haven Hospital’s Primary Care 
I Center. (A pediatric refugee clinic, which 
provides medical screening and primary 
care for children in newly arrived refu¬ 
gee families, shares the space.) About 
200 refugees settle in Greater New 
Haven each year, with Iraqis forming the 
largest group. The refugees also come 
from such countries as Afghanistan, the 
Democratic Republic of Congo, Cuba, 
Ethiopia, Iran, Somalia, and Sudan. 
The adult and pediatric clinics offer 
physicians-in-training an opportunity 
to see latent tuberculosis, various 
parasitic infections, and undiagnosed 
congenital disorders—diseases and 
conditions that are relatively rare 
in the United States. For the resi¬ 
dents, however, the most important 
lessons involve communication. 
Understanding the patient’s story 
! is essential to providing care, many 
clinic staffers said, and language is 
only part of the challenge. 
Intern Sara Schwab, m.d., groaned 
on a recent shift when told she’d be 
using a phone interpreter—it’s always 
better to have a live interpreter in the 
room because they can pick up on 
nonverbal cues like body language. 
Schwab walked toward the exam 
room asking people, “You don’t speak 
Arabic, do you?” 
But whether on the phone or in per¬ 
son, standard questions can be mired in 
misleading assumptions. For example, 
a physician might ask, “Have you ever 
been hospitalized?” But in some coun¬ 
tries hospitalization is a rare event. 
“There is a lot more detective work,” said 
Katherine Yun, m.d., hs ’09, a postdoc¬ 
toral fellow who serves as an attending 
in the Pediatric Refugee Clinic. 
The adult clinic got its start in 2007 
when Teeb Al-Samarrai, m.d. ’06, hs ’09, 
who was born in Iraq, was recruited to 
translate in the pediatric clinic during 
her residency. Al-Samarrai, now a cdc 
Epidemic Intelligence Service Officer 
at the New York City Department of 
Health and Mental Hygiene, learned 
that refugee patients often ended up in 
the emergency room because it was dif¬ 
ficult to get appointments with primary 
care providers. An adult refugee clinic 
at Yale had closed when its organizers 
left the medical school, so Al-Samarrai 
recruited residents and faculty to fill the 
need. Last year, the adult clinic became 
part of the ambulatory care curriculum 
so that it will have ongoing coverage. 
That reorganization creates an 
opportunity for residents not only to 
treat a diverse population but also 
to change the way they interact with all 
their patients. Jain recalled a lifelong 
New Haven resident who had various 
complaints and a reputation for non- 
compliance. “I went into my refugee line 
of questioning,” Jain said. The patient 
recounted an adolescence marred by vio¬ 
lence and memories of being mistreated 
by the health care system. 
Symptoms that had frustrated other 
doctors suddenly made sense to Jain, 
who had finally gotten the whole story. 
—Colleen Shaddox 
CHRELIN LEVELS LINKED TO FERTILITY 
Mice whose mothers had low levels of 
ghrelin are less fertile and produce smaller 
litters, Yale researchers reported in the May 
issue of Endocrinology. Such hormones as 
ghrelin, which are involved in energy bal¬ 
ance, hunger regulation, and metabolism, 
have also been shown to regulate reproduc¬ 
tive function in humans. Ghrelin levels are 
typically low in obese women. 
The Yale team studied the effects of 
ghrelin deficiency on the developmental 
programming of fertility in female mice, 
noting that abnormal functioning of uter¬ 
ine tissue led to lowered rates of embryo 
implantation. 
“While our study involved mice, we believe 
our findings have significant implications for 
women,” said lead author Hugh S. Taylor, 
M.D., HS ’92, FW ’98, professor of obstetrics, 
gynecology, and reproductive sciences. “Our 
results suggest that low ghrelin levels could 
program the development of the uterus in 
the female children of obese women. These 
women may then be less fertile as adults.” 
—John Curtis 
EXOME SEQUENCING YIELDS TARGET GENE 
Yale researchers have identified genetic 
mutations that can trigger severe hyperten¬ 
sion through tumor formation in the adrenal 
gland—in a gene they had no plans to study, 
according to Richard Lifton, m.d., ph.d., chair 
and Sterling Professor of Genetics, professor 
of medicine, and corresponding author of a 
paper published in the February 11 issue of the 
Journal Science. 
“This gene was not on anybody’s list 
to sequence in an investigation of this dis¬ 
ease,” said Lifton, who is a Howard Hughes 
Medical Institute investigator. “We really hit 
the jackpot.” The findings are a major step 
in understanding the causes of high blood 
pressure, which afflicts one out of every 
three Americans. 
Lifton and his team, which included 
investigators from Uppsala University in 
Sweden, New York Medical College, and 
Henry Ford Hospital, found the mutations 
using whole-exome sequencing—a tech¬ 
nique that decodes all of a patient’s genes 
rather than just a few suspect gene targets. 
—J.C. 
v
a
le
 
M
ed
ic
in
e 
a
u
tu
m
n
 
20
11
 
8 Books & ideas 
QUESTIONS 
g^NSWERS 
m Depression 
e ‘1-* 
n 
The legacy of Milton Winternitz 
A new book honors the achievements of the dean who led 
the medical school at a crucial time. 
The man who laid the foundation of the modern School of 
Medicine has been largely forgotten, says Howard Spiro, m.d., 
professor emeritus of internal medicine (digestive diseases). 
And yet, as the dean of the medical school from 1920 to 1935, 
Milton C. Winternitz, M.D., created a legacy that touches every 
student and faculty member who walks along Cedar Street. 
He established the Yale system of 
medical education; introduced sala¬ 
ries for full-time faculty; was one 
of the founding fathers of clinical 
medicine at Yale; and built the hub 
of the campus, including the iconic 
Sterling Hall of Medicine. 
Spiro, founding director of 
the Program for Humanities in 
Medicine, and co-author Priscilla 
Waters Norton seek to refresh 
historical memory with their new 
book. Dean Winternitz: Yale Medical 
School’s Passionate Humanist. 
The book describes how the 
dean employed “superhuman 
energy” to introduce psychiatry at 
Yale, to strengthen ties with New 
Haven Hospital, and to grant rela¬ 
tive autonomy to students who were “here to learn rather than 
to be taught.” He established the short-lived Institute of Human 
Relations to advance “social medicine,” a progressive interdisci¬ 
plinary approach that drew on law and sociology as well as medi¬ 
cine, and took into account the socioeconomic, psychological, 
and spiritual aspects of illness. 
The authors also describe the fallout from the dean’s 
caustic personality, including his forced resignation from 
the deanship in 1935. 
A decade after the 1910 Flexner Report revealed short¬ 
comings in medical education nationwide, [Winternitz] 
“saved the medical school from becoming a second- or third- 
rate place.” 
—Cathy Shufro 
Dean Winternitz: 
Yale Medical School’s 
Passionate Humanist 
Published by the Program 
for Humanities in Medi¬ 
cine, New Haven, Conn., 
2010. Available from 
Amazon in paperback and 
in Kindle format. 
Behavioral and Psychopharma- 
cologic Pain Management 
edited by Michael H. Ebert, m.d., 
professor of psychiatry; and 
Robert D. Kerns, ph.d., professor 
of psychiatry, psychology, and 
neurology (Cambridge Univer¬ 
sity Press) This book discusses 
the theory and evidence-based 
practice of behavioral, psycho¬ 
therapeutic, and psychopharma- 
cological treatments in modern 
pain medicine. The book reflects 
the interdisciplinary approach con¬ 
sidered the current standard for 
the practice of pain management 
andean be used as a textbook for 
specialized training in the field. 
Contributors span the fields of 
psychiatry, psychology, anesthesia, 
neurology, nursing, and physical 
medicine and rehabilitation. 
100 Questions and Answers 
about Depression, 2nd ed. 
by Ava T. Albrecht, m.d., assis¬ 
tant clinical professor of psychia¬ 
try; and Charles Herrick, m.d. 
(Jones & Bartlett Publishers) 
Incorporating the views of pa¬ 
tients as well as doctors, this guide 
presents information about the 
causes of depression, treatment 
options, and coping techniques. 
The book addresses risk factors 
associated with depression, brain 
stimulation therapies, and physio¬ 
logical drug dependence. 
Oxford American 
Handbook of Cardiology 
edited by Jeffrey R. Bender, 
M.D., Robert I. Levy Professor 
of Medicine (cardiology) and 
professor of immunobiology; 
Kerry S. Russell, m.d., ph.d., 
associate professor of medicine 
(cardiology); Lynda Rosenfeld, 
M.D., associate professor of 
medicine (cardiology); and 
Sabeen Chaudry, m.d., senior 
fellow of medicine (cardiology) 
(Rowman & Littlefield) The text 
covers common cardiac condi¬ 
tions, including coronary artery 
disease, arrhythmias, valvular 
and congenital heart disease, 
cardiomyopathies, and heart 
failure, and includes a chapter 
on preventive cardiology. The 
handbook also includes practice 
guidelines, management strate¬ 
gies, and a summary of recent 
major clinical trials in cardiol¬ 
ogy—all designed for use by 
residents, fellows, students, and 
general practitioners. 
Cytology and Surgical Pathology 
of Gynecologic Neoplasms 
edited by David Chhieng, m.d., 
professor of pathology; and Pei 
Hui, M.D., PH.D., associate profes¬ 
sor of pathology (Humana Press) 
This text provides a reference 
for practicing pathologists and 
cytopathologists with a focus 
on gynecological tumors, spe¬ 
cifically common ones and their 
benign mimics. Topics include 
morphologic recognition, resolv¬ 
ing common diagnostic prob¬ 
lems seen in routine practices, 
and a discussion of the current 
classification of gynecologic 
malignancies. The book also 
addresses the practical applica¬ 
tions of such ancillary studies as 
molecular diagnostic testing and 
im mu nohistochemistry. 
Sleep: An Issue of Clinics 
in Chest Medicine 
edited by H. Klar Yaggi, m.d., 
M.P.H., associate professor of 
medicine (pulmonary), Teofilo L. 
Lee-Chiong Jr., m.d., and Vahid 
Mohsenin, m.d., professor of 
medicine (pulmonary) (Saunders) 
Sleep medicine topics covered in 
this special issue of the journal 
include the neurobiology of 
on campus 9 
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lYlJM fiHoft S Infertility 
Cytology and 
Surgical Pathology 
of Gynecologic 
Neoplasms 
•) WllfY'IUCKVmi 
sleep, adult obstructive sleep 
apnea (osa), central sleep apnea 
(including complex sleep apnea 
and Asv), pediatric sleep-related 
breathing disorders, hypoventi- 
ilation syndromes, metabolism 
in OSA, cardiovascular conse- 
iquences of sleep apnea, home 
sleep apnea testing, insomnia, 
excessive sleepiness, narcolepsy, 
restless leg syndrome and move- 
iment disorders, the parasomnias, 
icircadian rhythm sleep disorders, 
jmedication effects on sleep, and 
[polysomnography. 
Infertility 
edited by Emre Seli, m.d., associ¬ 
ate professor of obstetrics, gyne¬ 
cology, and reproductive sciences 
(Wiley-Blackwell) The authors 
I provide a strong focus on effec¬ 
tive diagnosis and management 
of infertility, assisting gynecolo¬ 
gists and family practitioners 
Ito improve the care of patients 
who have trouble conceiving. 
[Following a review of the fac¬ 
tors affecting fertility, the book 
discusses evaluation of fertility, 
management and treatment, 
[Complications, preimplanta¬ 
tion screening, and fertility 
preservation. The volume is part 
of the publisher’s Gynecology in 
Practice series. 
Three Boys Like You 
by William M. Gould, m.d. ’58 
(iUniverse.com) Robert, Tony, 
and Philip believe that their 
friendships will last forever, but 
they are wrong. In 1949, the 
three high school boys engage 
in a prank that unexpectedly 
deteriorates into a crime. An 
' innocent man is blamed. The 
i novel shows how each of the 
i three deals with the moral rami¬ 
fications of his actions. Together 
again as adults in the midst of 
civil war in Guatemala, the three 
men find that the past intrudes 
on the present as their personal 
values clash. Will Robert, Tony, 
and Philip move beyond their 
haunted memories? Will they 
have futures at all? 
Visual Fields: Examination and 
Interpretation, 3rd ed. 
edited by Thomas J. Walsh, m.d., 
clinical professor of ophthalmol¬ 
ogy and visual science and of neu¬ 
rology (Oxford University Press) 
This edition contains revisions 
and updates of earlier materi¬ 
al as well as a discussion of 
newer techniques for assessing 
disorders of the visual field. 
It provides an overview of 
the techniques of visual field 
examination in a number of 
eye disorders and will be of 
interest to ophthalmologists, 
neuro-ophthalmologists, retina 
specialists, and optometrists. 
The book begins with a short 
history of the field of perimetry 
and goes on to present basic 
clinical aspects of examination 
and diagnosis of visual field 
defects in the optic nerve, optic 
disc, chorioretina, optic chiasm, 
optic tract, lateral geniculate 
field bodies, and the calcarine 
complex. It includes a discussion 
of several new techniques of 
automated perimetry. 
The descriptions above are based 
on information from the pubiishers. 
SEND NOTICES OF NEW BOOKS TO 
Gheryl Violante, Yole Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e- 
mail to cheryl.violante@yale.edu 
Health and social justice 
are connected 
As in the days of the "robber 
barons," today’s North American 
philanthro-capitalists have 
enormous influence over the 
global health agenda, convinced 
that a businesslike approach 
can resolve social problems 
more effectively than govern¬ 
ment or civil society, said Anne- 
Emanuelle Birn, sc.D., professor 
and Canada Research Chair 
in International Health at the 
University of Toronto. Speaking 
to this year’s Downs Fellows in 
March, Birn said that philan¬ 
thropic work has often promoted 
short-term, narrowly technical 
approaches that favored donor 
interests over local needs. A 
costly Rockefeller Foundation 
campaign to eradicate yellow 
fever in Mexico in the early 
1920s, she said, was of minor 
local importance but eliminated 
a public health threat to ports in 
the United States. 
Birn argued that global health 
efforts should not be separated 
from addressing poverty and 
social injustice. For example, 
in Sri Lanka, Cuba, and Costa 
Rica, maternal and child health 
improvements have been coupled 
with women’s empowerment, 
fair-wage movements, universal 
education, and other elements of 
a welfare state. "There is a real¬ 
ity that the philanthrocapitalists 
reject,” she said, "that health, 
well-being, and social justice are 
inextricably integrated." 
—John Curtis 
Transformative moment 
for health care 
Although the 2010 Patient 
Protection and Affordable Care 
Act faces legal and political 
challenges, it provides, said 
Howard Koh, m.d. ’77, m.p.h., 
a "transformative” moment. 
"All patients want good 
care, good insurance so they 
can get good care, and not to 
be patients in the first place,” 
said Koh, assistant secretary for 
health at the U.S. Department 
of Health and Human Services, 
when he delivered the Herbert 
Goldenring Memorial Lecture 
for the Department of Pediatrics 
in April. Noting that the act 
includes io titles, or sections, 
Koh said, "The law puts those 
10 titles together in a unified 
package to give patients what 
they want.” 
The act expands coverage 
for young adults, provides tax 
credits for small businesses 
to help purchase coverage for 
employees, guarantees coverage 
for children with pre-existing 
conditions, closes the Medicare 
“donut hole” (coverage gap) for 
prescription payments, provides 
preventive care, and promotes 
public health. A similar program 
in Massachusetts, where Koh 
was commissioner of public 
health from 1997 to 2003, “has 
driven down the rate of the unin¬ 
sured to 2.5 percent, the lowest 
in the country,” he said. 
"We are at a historic time as 
to the status of this law,” Koh 
said. "It is a moment that gives 
us an extraordinary opportunity 
to make our country healthier 
by 2020 and beyond.” 
—J.C. 
How the 1960s affected the 
School of Medicine 
The Vietnam War and the civil rights movement led students 
to question the School of Medicine’s curriculum and policies. 
By David Baker 
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OPPOSITE In May 1970 thousands of students 
converged on New Haven to protest the trial of 
Black Panther leader Bobby Seale, on charges 
that he was involved in the killing of a suspected 
informant. The School of Medicine did not es¬ 
cape the era of protests, as students questioned 
the curriculum and administration poiicies. 
AT RIGHT A poster for the May Day 1970 
protest in New Haven. 
The Yale School of Medicine was not 
immune to the student protests that 
gripped the country in the 1960s and 
early 1970s. Opposition to the Vietnam 
War and increasing criticism of social 
injustice led to questioning of the medi¬ 
cal school’s curriculum and administra¬ 
tive policies, culminating in a student 
strike in the spring of 1970. 
In September 1968, the school had 
yielded to students’ desire for more flex¬ 
ibility and compressed the time allotted 
to preclinical and clinical instruction, 
leaving the fourth year open for elec¬ 
tives. The thesis, required for the Yale 
medical degree since 1839, seemed 
archaic to students eager to shift the 
emphasis in their education from 
research to healing and activism, but 
the administration held Arm and 
maintained the requirement. Students 
welcomed the introduction that year 
of a six-week clinical rotation during 
the summer after the first year. Free 
to choose their own summer pro¬ 
grams, many students ventured into 
urban community health centers or 
American Indian reservations. 
Yale medical students also orga¬ 
nized independently to respond to 
the social challenges of their profes¬ 
sion. The Student Health Project 
was founded at Yale in 1969 to enact 
reforms in medical education and 
broaden the role of medicine to 
encompass individual community 
service projects. 
New Haven became a center of 
nationwide attention in May 1970 when 
demonstrators protested the upcom¬ 
ing trial in the city of Black Panther 
leader Bobby Seale on charges that he 
had been involved in the murder of 
a Panther suspected of being an FBI 
informant. The Panthers were believed 
by many to be targets of oppression by 
law enforcement, and sympathizers 
considered the case against Seale weak. 
Medical students had expressed 
support for the Panthers in the fall of 
1969 but did not immediately endorse 
a call for a university-wide strike. 
Undergraduates voted to strike in April 
1970, and an estimated 75 percent of 
Yale College classes were canceled. 
University President Kingman 
Brewster’s statement of sympathy for the 
protestors’ views at a faculty meeting 
on April 23,1970, had a calming effect 
on the student body. The main rally on 
the New Haven Green on May i attracted 
an estimated 15,000 persons—far fewer 
than expected—and there were no sig¬ 
nificant violent incidents despite incen¬ 
diary speeches by Yippie leaders Abbie 
Hoffman and Jerry Rubin. 
During the two days of protests, 
some faculty and students from the 
School of Medicine, including mem¬ 
bers of the Medical Committee for 
Human Rights, staffed impromptu 
People’s First Aid Stations in Yale’s 
residential colleges to treat the effects 
of tear gas or other injuries, which 
were rare and mostly minor. 
Medical students voted to join 
the university-wide strike on May 6, 
1970, following the U.S. invasion of 
Cambodia on April 29 and the shoot¬ 
ing of four students by Ohio National 
Guardsmen at Kent State University 
on May 4. Medical students agreed to 
suspend classes and other scheduled 
activities, while also arranging to 
meet with faculty during the strike 
to ensure maintenance of professional 
standards and such obligations as 
patient care. 
The same spirit of compromise 
marked such other instances of stu¬ 
dent activism following May Day 
1970 as the deliberations concerning 
academic governance. Students had in 
preceding years gained membership 
on the faculty Curriculum Committee 
as well as on the Student-Faculty 
Hospital Committee and a board to 
recruit underrepresented minorities to 
the student body. In 1970 the students 
attempted to gain an equal voice in 
deciding admissions, promotions, and 
graduation standards. The Committee 
on Governance, a faculty body, resisted 
this effort while creating a Medical 
School Gouncil composed of students 
and faculty, “to provide an influential 
forum for discussion of significant 
School-wide issues.” After its found¬ 
ing in 1970, the Gouncil continued to 
meet for more than 30 years, evolving 
gradually into a speakers’ forum for 
the exchange of information about 
current events within the school and 
across the medical profession. 
This article has been adapted from Medicine at 
Yale: The First 200 Years, a book celebrating the 
bicentennial of the Yale School of Medicine. 
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Medical care for 
the uninsured 
Local physicians launch a chapter of a national program that provides 
free specialty care to those In need. 
By Ayelet Amittay, M.s.N. ’io 
Photograph by Robert Lisak 
German Leon’s left eye was bothering him. It was swollen 
and although it didn’t hurt, it got tired when he was reading. 
He wanted the swelling to go away. 
Leon, 39, lives with his wife and three children in 
Fair Haven. He makes sandwiches at a New Haven coffee 
shop, but his job provides no insurance coverage. In April he 
was in a second-floor office at the Hospital of Saint Raphael 
(hsr) in New Haven, where Edna L. Cruz-Cedeno, a patient 
navigator, was determining his eligibility for treatment 
through Project Access-New Haven (pa-nh.org/). 
As she explained to Leon, Project Access offers free 
medical care to the uninsured by recruiting physicians 
who offer their services at no charge. During the interview, 
Cruz-Cedeno’s goal was to determine whether Leon is eli¬ 
gible to receive care under Project Access. Patients must 
live in New Haven or one of its six contiguous towns. They 
must be without health insurance and their income must 
be no more than 250 percent of the federal poverty level. 
They must provide proof of residency and income. And their 
medical situation must fit within the project’s guidelines. 
Cruz-Cedeno asked Leon about his medical history. 
Does he have a history of alcoholism? Arthritis? Cancer? 
Diabetes? High cholesterol? Asthma? “We are the first con¬ 
tact the patient will have,” she said. "We’ll get a referral. 
One of our on-call doctors reviews it. We will do the initial 
screening, financials, location; make sure they qualify; pro¬ 
vide appointment information and reminders, follow-up, 
and communication with specialists.” 
Leon qualified for the program and received an 
appointment at a private ophthalmology practice in New 
Haven. “After the visit. Project Access will receive the 
specialist return form from the physician,” said Giselle 
Carlotta-McDonald, a patient navigator who followed up 
the case the next day. “The form will specify what the next 
step will be for the patient, such as if they will need any lab 
work, imaging tests, medication, or follow-up appointment. 
It will also let us know if the patient doesn’t need any fur¬ 
ther treatments.” 
Once accepted, patients receive a Project Access ID 
card valid for six months, which they present at each medi¬ 
cal appointment. Physicians commit to seeing the patients 
through their treatments, hsr and Yale-New Haven Hospital 
(ynhh), which support the program, assume responsibility 
for ancillary care—including costs for lab work, imaging, 
operating rooms, and physical therapy. And the program 
takes advantage of prescription assistance from pharmaceu¬ 
tical companies. 
Project Access-New Haven is one of 55 chapters of a 
nationwide program designed to provide specialty care to 
the uninsured. More than 250 physicians in the New Haven 
area have signed on to the program since it began opera¬ 
tions in 2010. 
“It’s a no-brainer,” said Peter J. Ellis, m.d., m.p.h., 
director of the fourth-year primary care clerkship at the 
School of Medicine, and one of the program’s founders. 
“Once physicians hear about the project, they say yes.” 
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14 Medical care for the uninsured 
PREVIOUS PACE Peter Ellis and 
Suzanne Lagarde joined forces to 
launch a local chapter of Project 
Access, a national organization 
dedicated to providing free medical 
care for the uninsured. 
An epiphany in Mississippi 
The story of New Haven's chapter of Project Access begins 
in Mississippi in 2006, when Siizanne P. Lagarde, m.d., 
HS ’77, Fw ’80, was on a church trip to rebuild houses after 
Hurricane Katrina. “My skills were far greater in medicine 
than they were in Sheetrock.” said Lagarde. assistant clinical 
professor of medicine. So she walked down the street to the 
Coastal Family Health Center in Biloxi and volunteered her 
services as a GI specialist. 
Among her many uninsured patients was a man with 
rectal cancer. The diagnosis took only 30 minutes, but Lagarde 
spent hours calling hospitals, only to learn that the earliest 
appointment for treatment was eight months away because 
the patient had no insurance. “These people have nothing for 
specialty care,” Lagarde said, “But if all the hospitals had were 
uninsured patients, they couldn’t survive either.” 
This story is as familiar to physicians in New Haven as 
it is to those in Mississippi. As Connecticut’s unemployment 
rate rises—it reached 9.6 percent in February—people are 
losing health insurance along with their jobs. Despite the pas¬ 
sage of the 2010 Patient Protection and Affordable Care Act, an 
estimated 14.9 percent of New Haven residents—more than 
19,000 people—remain without health insurance. Unable to 
access regular medical care, they often put off treatment or 
turn to emergency rooms when their medical problems can no 
longer be ignored. On her return to New Haven, Lagarde won¬ 
dered what she could do to help the uninsured here. 
Then she heard about Peter Ellis. He had recently 
begun working in New Haven after several years in 'Waterbury, 
where he had organized a chapter of Project Access. A nation¬ 
wide program founded in 1996, Project Access provides gap 
coverage for patients who cannot afford health insurance but 
aren’t eligible for such public programs as Connecticut’s State 
Administered General Assistance (saga) or Medicaid. By pro¬ 
viding patients with pro bono primary care until they meet 
spend-down limits to qualify for saga. Project Access helps 
end the cycle of repeat visits to the emergency room. Ellis 
and Kevin D. Carr, m.d., hs ’02, an internist and attending 
physician at 'Waterbury Hospital, launched Connecticut’s first 
Project Access in Waterbury in 2004. 
Tackling health care in New Haven 
Lagarde thought that she and Ellis would work well 
together—he had the experience in setting up the program. 
and she knew the political/medical landscape of New Haven. 
They worked with Yale’s Robert Wood Johnson Clinical 
Scholars Program to analyze the problem. The Scholars’ 
answer was clear. “Doctors can’t get patients into specialty 
care,” said Scholar Katherine Goodrich, m.d., fw ’10. 
“Right now,” explained Steven Wolfson, m.d., past 
president of the New Haven County Medical Association, 
Project Access board member, and associate clinical professor 
of medicine (cardiology) at Yale, “seeing uninsured patients 
happens piecemeal, in private in doctors’ offices. But then we 
get stuck—what do we do when they need a service we can’t 
provide.^ It’s hard enough to do pro bono work without these 
roadblocks in the way.” 
Such roadblocks take their toll. Although physicians 
like Wolfson continue to provide free care to the uninsured, 
according to a 2006 report by the Center for Studying Health 
System Change, a nonpartisan policy research organization 
in Washington, D.C., physicians are donating fewer hours of 
charity care and fewer physicians are choosing to provide this 
care than was the case in the 1990s. In 2005, about 68 percent 
of the physicians surveyed donated time to uninsured patients, 
down from 76 percent in 1997. 
Katrina Clark, m.p.h. ’71, director of the Fair Haven 
Community Health Center, said efforts by physicians on 
behalf of individual patients are crucial but do not address the 
global need for an organized and consistent means of provid¬ 
ing the uninsured with health care. The barriers that doctors 
and their patients face are mostly organizational, according to 
Clark. If a patient does get an “uncompensated care” appoint¬ 
ment at YNHH, communications between primary care doc¬ 
tors and specialists often falter, resulting in poor continuity 
of care. And many physicians, said Erica Spatz, m.d., a Robert 
Wood Johnson Clinical Scholar, don’t provide specialty care 
to the uninsured. “So then it falls to a small group of physi¬ 
cians to attend to those patients, and they get asked again and 
again, so wait times increase.” 
“We don’t want a little more free care for a few more 
people a month,” Clark said. Instead she and her colleagues are 
hoping for a systemic change in providing uninsured patients 
continuity of care and access to all the services they need. 
As Peter N. Herbert, m.d. ’67, hs ’69, senior vice presi¬ 
dent for medical affairs and chief of staff at ynhh, phrases 
it, “Physicians, we want philanthropy from you in the form of 
your care, but it won’t be such that it will bankrupt you.” 
Project Access encourages doctors to take on a few 
patients—usually two or three per month—to ensure that no 
individual care provider must bear an overwhelming burden. 
“We look for parity, because no good deed goes unpunished,” 
said Patrick Curley, Project Access’ executive director. 
Patients have responsibilities, too. There is a two-strike 
policy in place to reduce the number of no-show appointments 
and wasted resources. “You miss one appointment, that’s fine,” 
said Curley. “Two strikes, you’re out.” 
According to Curley, each patient case will have between 
eight and lo “touch points,” or points of contact with the 
patient navigator. “It is our goal to try to get them their care in 
a reasonable amount of time,” he said. 
These contact points also allow Project Access staff to 
measure the project’s impact, Ellis said. “How many patients 
have you seen? What is the quality of care? Are you impact¬ 
ing the number of ER visits? Everyone wants to save money, 
and there is a lot of interest in using patient navigators to keep 
people out of the hospital,” he said. 
“We want to measure who does what when, every time 
'a doctor saw someone and something was done,” said Curley. 
“We want to know the value of work that has been done.” 
Support for Project Access comes from New Haven’s 
two hospitals, such donors as the Community Foundation for 
Greater New Haven, and the medical staffs at both hospitals. 
HSR has provided office space and computers for an executive 
director, a consultant who recruits physicians, and two patient 
navigators—one full- and one part-time—who steer patients 
to volunteer specialists. Originally referrals came only from 
the health center in Fair Haven; in its first few months Project 
Access enrolled 102 patients. “It just seemed natural to start 
small,” said Ellis. Now the program is accepting referrals from 
the emergency department at ynhh and the primary care 
clinic at hsr. ynhh is also providing 3.5 staff positions to sup¬ 
port and monitor the program. The hospitals stand to benefit 
from the program as well. Studies around the country have 
shown, said Curley, that each dollar spent on the program saves 
at least $5 in the emergency department. 
For physicians in the emergency room. Project Access 
fills another need. Ian Schwartz, m.d., hs ’06, medical direc¬ 
tor of the emergency department at ynhh, said that of the 
80,000 adult visits each year, only 20 or 25 percent qualify 
as true emergencies. Many patients come because they lack 
insurance or because they can’t get an appointment for urgent 
or specialty care through their primary care provider. “We 
need to make arrangements, whatever their problem is, to get 
them followed on an outpatient basis so they’re not right back 
in the emergency department a few days later with another 
problem,” Schwartz said. “We aspire to deliver the highest 
quality care to our patients, whether they’re admitted to the 
hospital or go home. We are a triage center and a diagnosis 
center, but there’s a next step of really good outpatient care— 
aggressive care—that’s needed. We spend a large amount of 
time trying to make sure that there is a reasonable, practical 
outpatient plan.” Through Project Access, Schwartz said, 
emergency room physicians can arrange follow-up care that 
might not otherwise be possible. 
Stephanie L. Arlis-Mayor, m.d., director of the out¬ 
patient clinic at hsr, said that Project Access ensures that 
patients are better able to navigate the health care system. 
“It allows our patients to be seen in the right place by the 
right person at the right time,” said Arlis-Mayor, who also 
sits on the Project Access board. “That’s advantageous to 
any health care system. It decreases the stretch and stress 
on the resources. There are cost savings overall because 
patients are being seen in the ambulatory world, where it’s 
far less expensive to see patients than it is in the emergency 
or inpatient world.” 
“Project Access will not cure all the ills of people,” 
said Herbert. “But it is an approach to a certain segment of 
the population that could make a specific difference. That’s 
why [Project Access] deserves the full support of the hospital 
and the community, because they represent all that is good 
about medicine.” ym 
—Ayelet Amittay is a 2010 graduate of the Yale School of Nursing. Additional 
reporting by John Curtis. 

Is the physician-scientist an 
endangered species? 
Citing the dearth of role models, burden of debt, and long periods of training, 
la committee looks for ways to encourage medical students to pursue dual careers. 
! By Colleen Shaddox 
Illustrations by Otto Steininger 
One of the challenges of interviewing Danny Balkin is that 
he keeps asking the questions—about the writing process, 
the state of journalism, and the quality of frozen yogurt 
purveyors in New Haven. If there is such a thing as a born 
investigator, Balkin is one. The m.d./ph.d. student’s face 
widens into a kid-in-a-candy-store smile as he talks about 
the possibility of harnessing his laboratory’s basic research 
to benefit families whose sons have Lowe syndrome—a rare 
X-linked genetic disorder that causes mental retardation, 
kidney disease, and cataracts in boys. 
Balkin works in the lab of Pietro De Camilli, m.d., 
iEugene Higgins Professor of Cell Biology and professor of 
neurobiology, on research intended to illuminate the mecha- 
i nisms of Lowe syndrome. That connection to real-life patients 
is critical for Balkin, as it has been for generations of physician- 
scientists who tailored their investigations to solve clinical prob- 
i lems. Yet voices in the medical and research communities have 
warned of a looming shortage of physician-scientists since the 
1970S. From 1983 to 1998, according to a 2002 article in The 
New England Journal of Medicine, the percentage of physician- 
scientists in the United States dropped from 4 percent of the 
total number of doctors to 2 percent. 
Still, much of the evidence surrounding the issue 
remains anecdotal. Moreover, as Ann C. Bonham, ph.d., 
chief scientific officer of the Association of American 
Medical Colleges (aamc), asks, just what is a physician- 
scientist? Bonham believes that the definition goes beyond 
simply physicians with dual degrees. “Having a broad 
definition of physician-scientists is very important,’’ she 
said. “We have come to think about it as physicians who are 
engaged in some form of science—whether it’s basic science, 
clinical research, health outcomes research, community- 
based participatory research, or prevention research.” 
However the group is defined, the importance of the 
physician-scientist in medicine is more than just academic. 
This dual role brings an important perspective to research. 
“The thing that’s so irreplaceable about physicians is that 
they approach research questions differently because they 
are inspired by their personal experience taking care of 
patients,” explained Andrew 1. Schafer, m.d., chair of the 
department of medicine at Weill Cornell Medical College. 
In 2009 Schafer edited The Vanishing Physician-Scientist?, 
a collection of essays by academic physicians and physician- 
scientists from more than a dozen institutions. For the 
record, the question mark in the title is significant. “I actu¬ 
ally think that they are not going to vanish,” he said, but 
shoring up the vocation of physician-scientist will take a lot 
of work. “We, the community of academic medicine, are 
going to have to make some major, major changes.” 
“We’re at risk of having two separate worlds that don’t 
interact—the research world and the clinical world,” warned 
Dean Robert J. Alpern, m.d., Fnsign Professor of Medicine. 
The physician-scientist is an effective bridge between those 
worlds, he said, adding that any drive to increase the num¬ 
bers of physician-scientists is “going to have to come from 
schools like Yale.” 
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Is the physician-scientist an endangered species? 
Barriers to physician-scientists 
A Yale committee chaired by Peter S. Aronson, m.d., fw ’77, 
the c.N.H. Long Professor of Medicine and professor of cel¬ 
lular and molecular physiology, spent much of 2010 devising 
strategies to promote student interest in the physician- 
scientist career track at Yale. To be sure, the medical school 
already offers students opportunities in research. Medical 
students must write a thesis based on original research in 
order to graduate. Each year the school also admits about a 
dozen m.d./ph.d. candidates. In 2006 the school began offer¬ 
ing a master’s degree in health science (m.h.s.) to students 
who engage in full-time research for at least two years, meet 
coursework requirements, and complete either a laboratory- 
based or clinical thesis project. Since then, eligibility for the 
M.H.S. degree has been extended to participants in the Robert 
Wood Johnson Clinical Scholars Program, the ycci/ctsa 
Scholars Program, and the Department of Surgery Residency 
Program. Other clinical departments are also seeking 
approval to enroll interested residents and fellows. 
Yet the Aronson committee’s final report, issued in 
September 2010, identified a number of barriers to those 
wishing to pursue dual careers: extra years spent in training 
at lower pay; the burden of medical school debt; the under¬ 
representation of physician-scientists on medical school 
admissions committees; a dearth of physician-scientists on 
bedside teaching rounds; and a disproportionate tendency 
for women—who represent half of m.d. and m.d./ph.d. stu¬ 
dents—to leave research at all stages of their careers. (Schafer 
also notes that as young scientists and doctors of both gen¬ 
ders strive for “work/life balance,” traditional career paths 
must be reevaluated.) 
The report made a number of recommendations, 
including tracking the careers of medical school alumni. 
“There should be systematic collection and analysis of data 
on careers of Yale graduates with respect to measures of suc¬ 
cess as physician-scientists (e.g. grants, academic positions, 
citations),” the document says. “It is also important to compile 
easily accessible data on student demographics and experi¬ 
ences while at Yale (e.g. time in research, type of research, 
funding of mentor, advanced degree programs, elective 
courses, etc.) so that these variables can be correlated with 
career outcomes.” 
At the heart of the report were recommendations for 
encouraging physician-scientist careers while students are still 
at the medical school. Because of Yale’s thesis requirement, 
research is already a part of student life—the Office of Student 
Research matches students with faculty investigators and helps 
them find funding for research projects. More than half of Yale 
medical students opt to spend a fifth year on research—but 
John N. Forrest Jr., m.d., hs ’67, professor of medicine, direc¬ 
tor of the Office of Student Research, and a member of the 
Aronson committee, worries that the extra year is becoming a 
necessity as research time within the four-year curriculum is 
shrinking. “It’s fallen because good things have been put in the 
curriculum,” he said, noting that summer clerkships are now 
available to students who might otherwise have spent those 
months doing research. Over the past 20 years, according to 
the committee’s report, the time available for research over four 
years has decreased from ii months to 6 months. 
The group’s recommendations include calls for more 
guaranteed time for research throughout the four-year cur¬ 
riculum, loan forgiveness for medical school graduates who 
meet such career benchmarks as a K08 or K23 award from the 
NiH, elective courses relevant to basic and clinical research, an 
enhanced advisory system for students interested in physician- 
scientist careers, and greater integration of faculty who are 
physician-scientists into clinical teaching programs. 
The report also proposed the creation of “Summer Zero,” 
a six-week program before medical students begin their first 
year at Yale. The program, to be called START@Yale (Summer 
To Advance Research Training at Yale), would come with a 
stipend and would feature a hands-on research experience. It 
would also include lectures and discussions of topics in labora¬ 
tory and clinical research, with an emphasis on the importance 
of research in advancing patient care. “It is a great concept 
and means that the students’ first exposure at the School of 
Medicine would be in hands-on research” Forrest said. 
Growing the m.d./ph.d. program 
The dean’s office is still considering the specifics of the com¬ 
mittee’s recommendations. “If I had an infinite amount of 
money,” Alpern said, “I’d probably do everything in the report.” 
“All of this stuff costs money,” sighed James D. 
Jamieson, m.d., ph.d., professor of cell biology, director of the 
m.d./ph.d. program, and a member of Aronson’s committee. 
The committee suggested an expansion of the m.d./ph.d. pro¬ 
gram, which provides full support for its students. A majority 
of them go on to faculty positions and obtain research grants. 
The thing that s so 
irreplaceable about 
physicians is that they 
approach research 
questions differently 
because they are 
inspired by their 
personal experience 
taking care of patients. 
Andrew Schafer, m.d., chair of medicine at 
Weill Cornell Medical College 
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“We’re at risk of having 
two separate worlds 
that don’t interact— 
the reseiiarch world 
and the clinical world.’’ 
a 
Dean Robert Alpern, m.d., 
Ensign Professor of Medicine 
“We are committed to helping the m.d./ph.d. pro¬ 
gram grow,” said Carolyn W. Slayman, ph.d., Sterling 
Professor of Genetics, professor of cellular and molecular 
physiology, and depirty dean for academic and scientific 
affairs. There’s a consensus among chairs, she said, that it 
would be ideal to expand the program from about 12 percent 
to between 15 and 20 percent of each class. “It’s something 
that Yale does very well,” she said. 
Part of that success comes from choosing the right 
type of student from the start, said Jamieson. “These are 
people who ask questions and have the best interests of 
their patients at heart,” he said. He’s a zealous advocate for 
weighing research experience heavily at admission and for 
rigorous science throughout the curriculum. “You’re teach¬ 
ing people how to bloody well think—not to memorize 
facts!” But Jamieson admits that flat government funding 
is a hurdle for young physician-scientists, and not one that 
individual medical schools can easily move aside. Without a 
nationwide investment in research, he predicts that the best 
and brightest investigators will pursue careers overseas. 
The AAMc’s Bonham sees some bright spots on the 
horizon for up-and-coming physician-scientists. The health 
care reform bill passed in 2010 created the Patient-Centered 
Outcomes Research Institute, charged with setting priori¬ 
ties for comparative effectiveness research. “That kind of 
research will need physicians and physician-scientists, and 
there is dedicated funding,” Bonham said, adding that this 
field of research also creates new collaborative niches out¬ 
side the traditional bounds of laboratory or clinical research.. 
“There will be opportunities for engaging medical students,, 
fellows, and junior faculty in comparative effectiveness 
research,” she said. “That necessarily implies teams with 
health outcomes researchers, clinicians, nurses, social scien-' 
tists, and implementation scientists.” 
Yale does have several programs in place to aid junior ' 
faculty in establishing themselves as researchers who’ll 
be competitive for nih funding. Getting started, warned 
one leading researcher, can be daunting. “You need about 
four or five years of concentrated investigation in your field . 
of interest,” said Robert S. Sherwin, m.d., fw ’74, c.n.h. 
Long Professor of Medicine and director of the Yale Center 
for Clinical Investigation (ycci). ycci Scholars are early- 
career scientists in clinical or translational research who 
receive salary support as well as mentorship and access to 
resources in such areas as biostatistics and bioinformatics 
or study coordination and recruitment, ycci also houses the] 
Investigative Medicine Program, which supports physicians 
seeking a ph.d. to pursue patient-oriented research. The 
School of Medicine has several other named Scholars slots 
elsewhere that support early-career scientists. 
The time it takes to establish a research career is in 
part a reflection of a rapidly expanding body of knowledge. 
“Many of the things I learned in medical school are of little 
value today,” Sherwin said with a smile. “Our knowledge of 
the biological basis of disease has expanded dramatically and 
become much more complex than it was when I started.” 
Although Aronson considers medical school “the 
broadest biological training you can have,” the flnancial 
implications of getting dual degrees discourage some young 
people. The ph.d. route offers a faster track to a job in aca¬ 
demia than pursuing two degrees, followed by completing a 
residency and possibly a fellowship, Aronson explained. 
But there are great rewards to be had, said Aronson. 
He takes pride in the accomplishments of his “scientiflc 
grandchildren,” the students of his students. And, of course, 
there are the potential advances in medicine. “My father and 
most of his family died in their 50s,” said Aronson. “Thanks 
to the discovery of statins, I have had the chance for a longer 
life than the previous generation.” 
Aronson’s committee came up with a proposal, which 
they caution is preliminary, to streamline the m.d./ph.d. 
program and the path to establishing independence as a 
researcher. The objective is to shorten the time spent in train¬ 
ing. Currently, says David A. Hafler, m.d., m.sc., chair and 
Gilbert H. Glaser Professor of Neurology, scientists starting 
out often write their first Roi and establish their laboratories 
quite late in their careers. Hafler suggested a novel program 
that combines the m.d./ph.d. and residency into one pro¬ 
gram. Students would apply for admission to the m.d./ph.d. 
program in their third year, be interviewed to stay at Yale 
for their residency, and begin graduate coursework in their 
fourth and fifth years. The existing option—in which stu¬ 
dents apply to the program when entering medical school— 
would still be available. Students on the new track would do a 
two-year clinical residency and specialty fellowship followed 
by three more years of intensive research. The proposal saves 
about three years compared with the more traditional path. 
Exposing students to research 
Complexity and time pressures keep many physician- 
scientists off the wards—the place they are most likely to 
inspire medical students, said Alpern. To be competitive 
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22 Is the physician-scientist an endangered species? 
for NiH grants requires the average academic physician 
to spend a majority of his or her time on research. Some 
maintain clinical skills by becoming “very subspecialized,” 
he said. But most will have little contact with students. “The 
role model for the students is the clinician,” he said. 
Not all four faculty tracks at the medical school lend 
themselves equally to contact with students. Most physician- 
scientists enter the Traditional track, a path to tenure in which 
faculty spend most of their time in research, with some time 
devoted to teaching. The Clinician-Scholar track was added 
in the 1980s to allow faculty to spend more time in practice 
without impeding their advancement. The Investigator track is 
designed for faculty who spend most of their time in research. 
Students are most likely to be supervised in their 
third and fourth years by Clinician-Educators, a role created 
in the 1990s as the school sought to expand and develop 
more areas of excellence within its clinical practice. Yale 
was more willing to support the medical school’s expansion 
with Clinician-Educators, who are not eligible for tenure 
and would not lock the university into the kind of long-term 
financial commitment associated with employing tenured 
faculty, Slayman explained. She cautioned, however, against 
a simplistic understanding of the tracks. Many Clinician- 
Educators, who have grown in number from 135 in 2001 
to 278 today, are not only great clinicians but also boast 
impressive research achievements. Nevertheless, she said, 
medical students spend more time on the wards with people 
who think of themselves primarily as clinicians. 
To get more physician-scientists on the wards, some 
medical schools use a system of co-attendings. Physician- 
scientists and clinicians form a partnership that offers students 
a taste of the investigatory approach while a clinically current 
doctor is involved with every patient, said Aronson. “Many of 
us do teach medical students,” said Aronson, a role he said he 
enjoys. But with the decrease in residents’ work hours, the role 
of the attending has become more critical. “It makes it more 
difficult to do part time and do efficiently,” he said. 
To give students more exposure to physician-scientists, 
the Department of Pediatrics offers a “Bedside to Bench” 
elective seminar that pairs students with a physician- 
scientist mentor. The student and mentor select a pediatric 
patient as a focus—the student makes a presentation on 
that patient to the group and reviews what’s known about 
his or her disease. Then the heart of the students’ work 
begins—figuring out the most important unanswered ques¬ 
tions about the biological basis of the disease and outlining 
a program of research that would provide answers. 
“We encourage them to think creatively,” said Clifford 
W. Bogue, M.D., FW ’93, interim chair of pediatrics and one 
of the seminar directors. The seminar presents “an oppor¬ 
tunity to expose them to what it means to be a physician-sci¬ 
entist.” Originally for m.d./ph.d. students only, the seminar 
is now open to all first-year medical students and typically 
draws 50 to 60 a year, he said. Part of the attraction may be 
a taste of clinical contact in the first year. “They’re dying for 
some sort of clinical relevance,” said Bogue. 
The bulk of clinical time typically comes in the latter 
half of medical school. Clinical practice is “the last thing 
they are seeing,” said Balkin, the m.d./ph.d. student, who 
reflected that timing alone could contribute to a choice to 
pursue clinical practice over investigation. 
Balkin is a regular at the Leadership in Biomedicine 
Lecture Series sponsored by the Office of Student Research. 
Top investigators talk not only about their research but also 
about the paths that led them to it. Balkin recalled Richard P. 
Lifton, M.D., PH.D., chair and Sterling Professor of Genetics, 
telling about a reviewer who deemed “impossible” a study 
that Lifton had proposed in 1988 as a resident in Boston. That 
only made the young investigator absolutely determined to 
soldier on. The proposal outlined what would become Lifton’s 
landmark research in hypertension. Balkin said those talks 
help him see what’s possible and spur him on his path. 
“We need to make the students aware of what an 
exciting lifestyle it is to be a physician-scientist,” said 
Alpern. “To have the nih give you a million dollars a year to 
play in your lab is really fun.” 
Being committed to the career path is half the battle, 
according to Schafer. He throws in a trick question when inter¬ 
viewing potential fellows, asking them what they’d do if they 
absolutely could not get funding for their research. About 90 
percent reply that they’d devote themselves to clinical practice. 
A select few say the idea of not combining medicine with basic 
science is “inconceivable.” Those applicants get the job. 
Balkin feels much the same. “The problems are the 
problems,” he said. “But if you want to do research, you will 
find a way to make it work.” ym 
Colleen Shaddox is a writer in Hamden, Conn. 
^(1 
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well think 
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James Jamieson, M.D., PH.D., 
professor of cell biology, director of the 
m.d./ph.d. program, and a member : 
of Aronson’s committee 
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Faculty NOTES 
Thomas Steitz Michael Higley David Spiegel Alanna Scott Miller 
Schepartz 
Nobel laureate named 
to Royal Society 
THOMAS STEITZ, PH.D., Sterling 
Professor of Molecular Biophysics 
and Biochemistry, and a winner 
of the Nobel Prize for Chemistry 
in 2009, was one of 52 scientists 
named in May as fellows or 
foreign members of the Royal 
Society, the United Kingdom’s 
national academy of science. 
Steitz, a Howard Hughes Medical 
Institute investigator, was one 
of eight foreign scientists to be 
honored by the society, which 
has counted Isaac Newton and 
Charles Darwin among its mem¬ 
bers. Steitz was selected “for his 
pioneering contributions to the 
mechanisms involved in the pro¬ 
cesses of gene replication, tran¬ 
scription, control, and translation 
that are fundamental to all life.” 
Steitz, colleague Peter 
Moore, ph.d.. Sterling Professor 
of Chemistry and professor of 
molecular biophysics and bio¬ 
chemistry, and others at Yale 
were instrumental in discovering 
the structure of the ribosome, the 
cell’s protein-making factory nec¬ 
essary for life. The work has led to 
creation of a new generation of 
antibiotics now in clinical trials. 
Scientists in England and Israel 
shared in the Nobel Prize for their 
research on the ribosome. 
Founded in 1660, the Royal 
Society has three roles: as a pro¬ 
vider of independent scientific 
advice, as a learned society and as 
a funding agency. Its membership 
includes renowned scientists from 
the United Kingdom and beyond. 
Grant awarded for study 
of artificial enzymes 
Two Yale researchers, alanna 
SCHEPARTZ, PH.D., the Milton 
Harris ’29 ph.d. Professor of 
Chemistry and professor of 
molecular, cellular and devel¬ 
opmental biology, and scott j. 
MILLER, PH.D., department chair 
and the Irenee du Pont Professor 
of Chemistry, have received a 
$1 million grant from the W.M. 
Keck Foundation to support a 
three-year study to create artificial 
enzymes using beta-peptide bun¬ 
dles. These miniature synthetic 
proteins were discovered in the 
Schepartz laboratory in 2007. The 
enzyme project has far-reaching 
implications in the field of syn¬ 
thetic chemistry as well as in bio- 
mimetics and synthetic biology. 
The construction of an artificial 
enzyme has long been considered 
a “Holy Grail” of modern chemis¬ 
try. Natural enzymes are known 
to accelerate chemical reactions 
dramatically. If this behavior can 
be mimicked to drive desirable 
reactions in research or industry, 
scientists will have unprecedent¬ 
ed control over the creation of 
new and useful materials. Some 
researchers believe that artificial 
enzymes could be used to tar¬ 
get specific cellular functions or 
applications and could work with 
greater efficiency than their natu¬ 
ral counterparts. 
Schepartz and Miller are focus¬ 
ing on beta-peptide bundles in 
part because of their novelty; 
these tiny protein-like structures 
offer unique advantages for cata¬ 
lyst development. In addition, 
beta-peptide bundles are stable, 
relatively predictable in their 
behavior, and well suited to sys¬ 
tematic study in the laboratory. 
Four Yale scientists, including 
two in biomedical sciences, were 
among n8 named in February as 
2011 Sloan Research Fellows by 
the Alfred P. Sloan Foundation. 
The two-year fellowships are 
awarded annually to researchers 
in science, mathematics, 
computer science, and econom¬ 
ics from the United States and 
Canada, and include $50,000 in 
research funding. The Fellows in 
the biomedical sciences are: 
Michael J. Higley, m.d., ph.d., as¬ 
sistant professor of neurobiology, 
and David A. Spiegel, m.d. ’04, 
PH.D. ’04, assistant professor of 
chemistry. Higley’s lab seeks to 
understand how synaptic connec¬ 
tions among brain cells support 
the processing, storage, and 
retrieval of information in healthy 
individuals and how these con¬ 
nections are disrupted during the 
cognitive decline associated with 
neuropsychiatric disease. Spiegel’s 
lab develops novel chemical strat¬ 
egies for modifying the human 
immune system that can be used 
to treat such diseases as cancer, 
HIV infection, and diabetes. 
Sidney J. Blatt, ph.d., professor 
of psychiatry and of psychol¬ 
ogy, announced his retirement 
effective June 30. Blatt has been 
the longstanding chief of the 
Section of Psychology in Psy¬ 
chiatry; under his leadership, the 
predoctoral training programs 
in psychology at the Con¬ 
necticut Mental Health Center 
Sidney Blatt Hilary 
Blumberg 
and Yale-New Haven Hospital 
ranked among the top programs 
in the country. Since his arrival 
at Yale in 1960, Blatt distin¬ 
guished himself with his rigor¬ 
ous approaches to the study of 
the psychoanalytic dimensions 
of psychological processes, 
particularly depression and 
its treatment. He has received 
numerous honors, including the 
Sigmund Freud Professorship at 
Hebrew University of Jerusalem; 
the Mary S. Sigourney Award of 
the Sigourney Trust; seven visit¬ 
ing professorships: and distin¬ 
guished research awards from 
two divisions of the American 
Psychological Association. 
Hilary P. Blumberg, m.d., associ¬ 
ate professor of psychiatry and 
director of the Mood Disorders 
Research Program at Yale, was 
awarded a $3.7 million grant from 
the National Institute of Mental 
Health in March to expand her 
research on bipolar disorder. 
Blumberg’s lab will use brain im¬ 
aging and genetic tests to study 
bipolar disorder in adolescents 
and adults. Researchers plan to 
track changes in brain circuitry 
as the disorder progresses from 
adolescence to adulthood and to 
identify genes related to this pro¬ 
gression. The goals of the research 
are to find new ways to intervene 
early in the disease process and 
to develop new therapies based 
on the age and genetic profiles of 
individual patients. 
Marie E. Egan, M.D., associate 
professor of pediatrics (respira¬ 
tory), has received a 2010 
Hartwell Individual Biomedical 
Research Award for research 
on cystic fibrosis. The award 
provides research support 
for three years at $100,000 
direct cost per year, as well as 
25 
Marie Egan Jorge Calan 
videoconferencing equipment to 
enable periodic communications 
with the Hartwell Foundation. 
Located in Memphis, Tenn, the 
foundation funds innovative 
biomedical applied research with 
potential benefits for children. 
Jorge E. Galan, d.v.m., ph.d., the 
Lucille P. Markey Professor of Mi¬ 
crobial Pathogenesis, professor 
of cell biology and chair of the 
Section of Microbial Pathogen¬ 
esis, received in February the 
2011 Robert Koch Award, one of 
the most prestigious honors in 
the field of microbiology. Galan 
was honored for his work in 
describing how such foodborne 
pathogens as Salmonella and 
Campylobacter cause so much 
damage. The award, given by 
the Robert Koch Foundation in 
Berlin, Germany, carries a prize 
of 100,000 euros and honors the 
work of the German physician 
who sought a cure for tubercu¬ 
losis in the i88os. 
Jo Handelsman, ph.d., was 
named the Frederick Phineas 
Rose Professor of Molecular, 
Cellular and Developmental 
Biology this spring. Handelsman, 
who is also a Howard Hughes 
Medical Institute investigator, 
is noted for her research on 
diversity in microbial commu¬ 
nities and their role in infec¬ 
tious disease, as well as for 
her efforts to improve science 
education and increase the 
Jo Handelsman Rajita Sinha William 
Tamborlane 
Mary Tinetti 
participation of women and 
minorities in science at the 
university level. Her term as 
Frederick Phineas Rose Profes¬ 
sor runs through June 30, 2015. 
in January she was one of 11 in¬ 
dividuals selected by President 
Barack Obama to receive the 
Presidential Award for Excel¬ 
lence in Science, Mathematics 
and Engineering Mentoring. 
Handelsman co-founded the 
Women in Science & Engineer¬ 
ing Leadership Institute at 
the University of Wisconsin- 
Madison, was appointed the 
first president of the Rosalind 
Franklin Society, and served on 
the National Academies’ panel 
that wrote the 2007 report Be¬ 
yond Bias and Barriers: Fulfilling 
the Potential of Women in Aca¬ 
demic Science and Engineering. 
Abeel A. Mangi, m.d., was ap¬ 
pointed surgical director in March 
of the Centerfor Advanced Heart 
Failure, Mechanical Circulatory 
Support and Heart Transplanta¬ 
tion at Yale-New Haven Hospital. 
Mangi is an associate professor of 
surgery at the School of Medicine. 
He specializes in complex and re¬ 
operative cardiac surgery; heart, 
heart-lung and lungtransplanta- 
tion; ventricular assist devices; 
total artificial hearts; extracor¬ 
poreal membrane oxygenation; 
operations for heart failure and 
aortic or mitral valve repair and 
replacement; off-pump coronary 
bypass grafting; septal myec¬ 
tomy; surgical treatment of left 
ventricular outflow tract obstruc¬ 
tion; treatment of chronic pulmo¬ 
nary emboli; and ascending aorta 
and aortic arch replacement. 
Jennifer Prah Ruger, ph.d., 
associate professor of health 
policy at the School of Pub¬ 
lic Health, is a recipient of a 
2011 Guggenheim Feilowship. 
The award will support the 
completion of her forthcoming 
book, Clobal Heaith Justice and 
Governance, to be published 
by Oxford University Press. 
Ruger specializes in global and 
domestic public health and 
health policy, with a focus on 
the intersections of ethics, 
economics, and poiitics in health 
and health care. 
Rajita Sinha, ph.d., professor of 
psychiatry, succeeded Sidney 
Blatt as chief of the Section of 
Psychoiogy in July. Sinha is inter¬ 
nationally known for her work 
on the psychobiology of stress 
and its effects on addictive 
behaviors. She directs two large 
NiH-supported research centers, 
the Office of Research on Wom¬ 
en’s Health and the National 
Institute on Drug Abuse Special¬ 
ized Center of Research on sex/ 
gender issues and addiction, as 
well as the Yale Stress Center. 
In her capacity as chief, Sinha 
will work with the psychology 
faculty to build on the strengths 
of the psychology section with 
regard to professional develop¬ 
ment, clinical care, research, 
and education. 
William V. Tamborlane, m.d., 
FW ’77, professor of pediatrics 
(endocrinology), received the T2- 
Translation Award by the Society 
for Clinical and Translational Sci¬ 
ence. This award recognizes the 
translation of research from early 
clinical use to applicability in clini¬ 
cal practice. The award was be¬ 
stowed on April 28 at the national 
joint meeting of the Association 
for Clinical Research Training/So¬ 
ciety for Clinical and Translational 
Science/American Federation 
for Medical Research meeting in 
association with the Association 
for Patient-Oriented Research. 
Tamborlane was recognized for 
his work, which has provided 
new delivery methods for the 
physiologic replacement of insulin 
while preventing many of the 
catastrophic long-term complica¬ 
tions of childhood diabetes. 
Mary E. Tinetti, m.d., director 
of the Yale Program on Aging 
and the Gladys Phillips Crofoot 
Professor of Medicine (Geriat¬ 
rics), professor of epidemiology 
(chronic diseases), and of inves¬ 
tigative medicine, in the Section 
of Geriatrics, has been awarded 
the Edward Henderson Award 
from the American Geriatrics 
Society. Tinetti was the first 
investigator to show that older 
adults at risk for falling and 
injury can be identified; that 
falls and injuries are associated 
with a range of serious adverse 
outcomes; and that multifac¬ 
eted risk-reduction strategies 
are both effective and cost- 
effective. Tinetti was also the 
2010 recipient of the Maxwell 
A. Pollack Award for Productive 
Aging from the Gerontological 
Society of America. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
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26 students 
On selfishness In the 
service of others 
“You have to own your good works,” 
speakertells Class of 2011 during May 
Commencement ceremonies. 
Mother Nature provided the rain, but 
the proud teachers, family members, 
and friends supplied the lightning—in 
the form of camera flashes—during 
Commencement ceremonies on May 23. 
The bicentennial class of 81 gradu¬ 
ates marched down Cedar Street to 
Amistad Park as the cheers of loved 
TOP Frank Bia, medical director of AmeriCares 
and a former member of the Yale faculty, deliv¬ 
ered the Commencement address this year. 
ABOVE Students Lionel McIntosh and Westin 
Amberge waited at Cross Campus for the 
graduation procession to begin. 
ones and the skirl of bagpipes led 
them to the shelter of a tent that they 
entered as students and left as doctors. 
In his Commencement address, 
Frank J. Bia, m.d., m.p.h., fw ’79, pro¬ 
fessor emeritus of medicine and medi¬ 
cal director since 2008 of the disaster 
relief organization AmeriCares, 
discussed the virtue of selflshness in 
medical service. “You cannot share 
what you don’t even have yourself” he 
said to the Class of 2011, the last group 
of students he taught in the classroom 
and at the bedside. 
The altruistic model of medicine as a 
social contract that subsumes a doctor’s 
needs to those of her patients is flawed 
and irrational, Bia said. In his 40 years 
as a doctor, Bia learned that good work 
and service come from a selflsh place— 
a place where “sel/ishness becomes a 
virtue when your own happiness is tied 
to service. What matters is that you own 
your own motives completely,” said Bia. 
“If good works are done solely at the 
request, or even the mandate, of others, 
you will not be happy—not as happy as 
you deserve to be.” 
In 1982, Bia and his wife, Margaret 
}. Bia, M.D., FW ’78, professor of 
medicine, spent some time at Hopital 
Albert Schweitzer Haiti shortly after 
both of his parents had passed away. 
When he spoke of his experiences at 
grand rounds on his return, he grew 
increasingly frustrated by colleagues 
who remarked that he had done such 
good and selfless work in Haiti. 
“I needed Haiti a helluva lot more 
than Haiti needed me,” said Bia. “I 
found myself making a difference— 
one patient at a time—and that made 
me happy.” The concentrated clini¬ 
cal work in the Haitian countryside, 
Bia said, both healed his grief and 
renewed his understanding of medi¬ 
cine’s social contract. 
“You deserve to be the beneflciary of 
your own moral actions,” Bia concluded. 
The graduating class wrote an 
oath for Yale physicians that echoed 
Bia’s sentiment. “I know that I cannot 
effectively care for patients without 
also caring for myself” the students 
read. Following Yale tradition, the oath 
is based on the Hippocratic Oath and 
other classical statements. 
Bia’s remarks were preceded by 
the presentation of a class gift to the 
American Red Cross for disaster relief 
efforts in the southern United States 
and in Japan. 
The Bohmfalk Prizes for outstand¬ 
ing teaching went to John Fenn, m.d., 
clinical professor of surgery (vascu¬ 
lar), in the clinical sciences, and 
to Peter Marks, ph.d., m.d., associate 
professor of medicine (hematology), 
in the basic sciences. 
The Leonard Tow Humanism in 
Medicine Award was bestowed on 
W. Scott Long, M.D., associate clinical 
professor of medicine. 
The Leah M. Lowenstein Award, 
presented by the Office for Women in 
Medicine to a member or members of 
the faculty who represent the highest 
degree of excellence in the promotion 
of humane and egalitarian medical 
education, went to Marcella Nunez- 
Smith, M.D., M.H.S., assistant profes¬ 
sor of medicine. 
The Francis Gilman Blake Award 
was given to Andrea G. Asnes, m.d., 
assistant professor of pediatrics. 
The Betsy Winters House Staff 
Award went to Anup Patel, m.d. ’09. 
The Alvan R. Feinstein Award was 
given to Richard J. Gusberg, m.d., 
professor of surgery (vascular) and of 
diagnostic radiology. 
—Stephanie Soucheray 
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“One of our own” returns 
to Yale as Farr lecturer on 
Student Research Day 
George Lister, m.d. ’73, HS ’75, spent 
'more than 20 years on the Yale faculty 
as a professor of pediatrics and anes¬ 
thesiology and founder and chief of the 
Section of Critical Care and Applied 
Physiology (now the Section of Critical 
Care Medicine). He left Yale in 2003 for 
the University of Texas Southwestern 
'Medical School, where he holds the 
iRobert L. Moore Chair and is the chair 
lof Pediatrics and pediatrician-in-chief 
[at Children’s Medical Center of Dallas. 
II Lister returned to Yale on May 9 to 
I deliver the 24th annual Farr Lecture 
'I on Student Research Day. His talk was 
'titled “Sowing Seeds for a Career in 
Medicine: Reflections, Projections.” 
“We bring back one of our own,” said 
I Dean Robert J. Alpern, m.d.. Ensign 
I Professor of Medicine, in his introduc¬ 
tion of Lister. Alpern had lured Lister 
away from Yale when he was dean of the 
medical school in Dallas. 
In his talk. Lister recalled the 
things of value he had found at Yale 
as a medical student. “I found faculty 
who were accessible and invested in 
students,” he said. “I found faculty 
who valued curious and industrious 
learners. I found faculty who were 
helping students focus on flguring 
things out. And I was amazed by the 
talents of my classmates.” 
After describing his part in a 
national effort to determine the causes 
of sudden infant death syndrome and 
find a way to prevent it. Lister concluded 
by offering some of the lessons he had 
“learned along the way—regrettably, 
some more than once.” 
“Surround yourself with people who 
are smarter than you are, then look over 
your shoulder.” 
“What afflicts the patient and what 
challenges the physician create an excite¬ 
ment for the doctor-patient relationship. 
That intersection creates a bond for the 
doctor-patient relationship.” 
“The opportunity to learn from the 
patient ...is really the beginning of being 
a physician.... Every patient interaction 
presents an opportunity to learn.” 
“Take mastery of your education. No 
one else will. Instead of asking residents 
or attendings what to do, consider a prob¬ 
lem; propose an approach or rationale; 
request affirmation.” 
“Do not ignore an observation just 
because it disagrees with the explanation. 
What does not fit often provides a novel 
insight into a patient’s problem.” 
“In medicine, not doing something 
erroneous is a lot smarter than doing some¬ 
thing clever.” 
“Don’t promise the patient or family 
what you can’t deliver. The only things 
you can promise are your presence and 
attention.” 
Sixty-four students, including nine 
in the m.d./ph.d. program, presented 
posters at the event in The Anlyan 
Center. Six students—Isaac Benowitz, 
Noah Capurso, Tyler Durazzo, Jamie 
Harrington, Alexandra Miller, and Keri 
Oxley—made oral presentations. 
—fohn Curtis 
TOP Faculty posed with the five oral present¬ 
ers at this year’s Student Research Day. Front 
row: keynote speaker George Lister, Alexandra 
Miller, Isaac Benowitz, and Jamie Harrington; 
back row, John Forrest, director of student 
research, Tyler Durazzo, Keri Oxley, Noah Ca¬ 
purso, and Dean Robert Alpern. 
MIDDLE Anna Engberg discussed her research, 
on a novel dendritic cell therapy for solid tu¬ 
mors, with medical students Leonard Edokpolo 
and Oge Eze. 
ABOVE Eyiyemisi Damisah studied the neuro¬ 
chemistry of spontaneous recurrent seizures. 
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28 Alumni FACES 
Alumnus brings social 
perspective to post 
New York State’s new health 
commissioner will apply lessons 
learned in public health. 
When Nirav R. Shah, m.d. ’98, 
M.p.H. ’98, HS ’01, was a medical stu¬ 
dent, he found a research paper that 
proved to be such a useful study tool 
that he left a photocopy at the library’s 
front desk with a note urging his class¬ 
mates to use the paper. 
Yale’s teaching philosophy, with its 
emphasis on collaboration rather than 
competition, “was extremely useful for 
learning,” said Shah, who is now apply¬ 
ing the same principles to his new job 
as New York State Commissioner of 
Health. “It’s fundamental in public ser¬ 
vice,” he said. “You all have a common 
goal, and you have to figure out how to 
advance your shared agenda, so working 
together as a group is key.” 
Shah, the youngest person as 
well as the first Indian-American to 
be named to the post, became com¬ 
missioner in January 2011. Before 
that, he had been an attending physi¬ 
cian at Bellevue Hospital Center in 
Manhattan, associate investigator 
at the Geisinger Center for Health 
Research in central Pennsylvania, and 
assistant professor at the New York 
University School of Medicine 
in Manhattan. 
Shah’s medical career got off to an 
inauspicious start during his first week 
at Yale when he met Ralph I. Horwitz, 
M.D., Fw ’77, chair of the Department of 
Internal Medicine, with whom he hoped 
to collaborate on research related to work 
he had done as a Harvard undergrad. 
Shah was so nervous that he spilled 
Horwitz’s coffee on his desk. 
Despite that ill-fated introduction, 
Shah and Horwitz had “a phenomenal 
working relationship”—one that pres¬ 
aged Shah’s interest in public health 
and led to his staying at Yale for his 
residency in internal medicine. Shah’s 
research, which explored better methods 
for answering clinical questions as well 
as the comparative merits of random¬ 
ized controlled trials and observational 
studies, was published in The New 
England Journal of Medicine in June 
2000. “Everyone thought observational 
studies are fatally flawed, but we showed 
that in fact you can get great answers,” 
Shah said. 
Shah’s interest in bringing a popula¬ 
tion health perspective to interactions 
with patients took root while he was 
at Yale. He offered this example: “You 
know that tobacco is the number-one 
killer—but your patient who is a smoker 
has three or four complaints he wants 
you to address, and tobacco probably 
isn’t one of them. What do you do.^” 
Shah is grateful that Yale allowed 
him to spend his fourth year earning a 
public health degree. “Gaining a popu¬ 
lation and public health perspective 
helped flavor the type of doctor I became 
and the kind of questions I ask.” 
Shah’s other area of interest is car¬ 
ing for the medically underserved—a 
highly germane field of expertise in 
a state where nearly one in every five 
residents receives Medicaid assistance. 
“At Bellevue it was the urban immigrant 
poor,” he said. “At Geisinger, where I 
spent nearly half my time, it was rural 
under served elderly patients.” 
Those experiences helped prepare 
Shah for the challenges he faces in his 
new job. As New York’s top health offi¬ 
cial, his mission is to rein in a Medicaid 
bill that amounts to one-third of the 
state budget, or about $i billion a week. 
“We’re taking an all-hands-on-deck 
approach,” he said. “It’s going to be a 
transparent process that engages all 
aspects of the health care system.” 
Shah again credits his Yale educa¬ 
tion with giving him the tools he needs. 
While at Yale, he organized a confer¬ 
ence against gun violence. “We had 
community, clergy, police, gang mem¬ 
bers, and affected family members all 
around a table together,” he said. While 
the conference was a success, Shah’s 
subsequent plan, a gun turn-in pro¬ 
gram, failed for administrative reasons. 
“Understanding the various stakehold¬ 
ers’ perspectives and all of the lessons 
I learned through that experience fac¬ 
tor into what I need to know as a state 
health professional,” he said. 
Shah, his wife, Nidhi, and their two 
young children recently moved from 
Manhattan to Albany for his job. “One 
Nirav Shah became the health commissioner for 
the state of New York in January. His wife, Nidhi, 
attended the ceremony with their two children. 
reason I was able to do this is because of 
the phenomenal support I’ve received. 
My wife changed her life in support of 
this shared vision.” 
Only two months into his new 
job, he and Governor Andrew Cuomo 
began to tackle Medicaid. Cuomo got 
the hospitals and unions^—two historic 
adversaries—to agree to work together 
for improved health care at a reduced 
cost. Meanwhile, Shah traveled the state 
listening to people and gathering more 
than 4,000 ideas on how to achieve 
this goal. “We heard from a woman 
who asked why she left the hospital in 
an ambulance, which cost $400, rather 
than a taxi, which would have cost less 
than $40,” Shah said. 
- The list of suggestions was boiled 
down to 79 and submitted to the legis¬ 
lature for approval. This reform agenda 
was approved by the legislature in the 
spring, and Shah said that, if enacted, 
the suggestions could reduce the state’s 
Medicaid budget by $2.3 billion in the 
first year alone. 
Shah knows the goal is ambitious, 
especially for somebody who is still 
learning the bureaucratic intricacies 
pf Albany, but he said he’s ready for 
the challenge. “What can I say? I’m 
an optimist.” 
—Jennifer Kaylin 
In retirement, a urologist finds 
a new career bringing health 
care to rural Kenya 
Three years ago, Ralph F. Stroup, m.d., 
HS ’73, a retired urologist, stepped out 
of his comfort zone and into the village 
of Chumvi, Kenya, home to nomadic 
Maasai pastoralists. Accustomed to 
providing state-of-the-art medical care, 
Stroup was struck by the reality of the 
primitive health care conditions he 
encountered. Here in Kenya’s Central 
Highlands, women were giving birth 
in huts without running water or elec¬ 
tricity while herds of cattle and goats 
roamed outside. The situation tugged 
at Stroup’s heartstrings. The result is 
Kenyan Health Care Initiatives (khci), 
a humanitarian effort affiliated with 
the nonprofit organization International 
Consultants and Associates. Stroup has 
been raising funds to improve health 
care in two rural towns in this East 
African country. 
Stroup did not foresee during his 
first visit to Kenya in 2008 that he 
would soon be deeply involved in cre¬ 
ating educational programs, raising 
awareness, and soliciting funds to sup¬ 
port basic health care infrastructure 
and clean water acquisition in the 
Central Highlands of Kenya. At the 
time, Stroup had traveled to Nanyuki, 
Kenya—a town of about 31,000 three 
and a half hours north of Nairobi—to 
help facilitate a workshop for health 
care workers on techniques for com¬ 
munity mobilization against hiv/ 
AIDS. Then came an invitation from 
his hosts to visit the Laikipia District 
north of Mount Kenya, home to thou¬ 
sands of Maasai who follow the water 
as they graze their cattle and goats. 
Water has been increasingly hard to 
obtain due to several years of severe 
drought, and the Maasai are just 
beginning to recover from the loss of 
nearly 70 percent of their herds—their 
main source of income and food. 
During Stroup’s first visit to the 
Laikipia District, he traveled more 
than two bone-jarring hours by 
safari van along cattle paths to reach 
Chumvi, where a small health care 
clinic provides primary care to 8,000 
people. The clinic, staffed by a full¬ 
time nurse, faced closure due to lack 
of funding, and Stroup promised to 
find funds in the United States. “I am 
a firm believer in finding ways to con¬ 
nect people with people, and resources 
with people, so that we can greatly 
enhance the accessibility of good-level 
primary health care in these remote 
areas,” said Stroup. Stroup came 
through, and he now provides about 
$5,000 of support to the clinic each 
year through khci. 
The Chumvi clinic opened a new 
two-bed maternity unit in July. Stroup’s 
efforts also support another clinic in 
nearby Lokusero that serves about 
9,000 Maasai. The clinic was an unfin¬ 
ished shell when Stroup first visited in 
August 2008: however, his initiative has 
raised money for construction, includ¬ 
ing two outhouses and nurses’ quarters, 
as well as the purchase of furniture and 
medical equipment. 
Stroup works on a shoestring budget 
and does all of his own fundraising. 
He spreads the word about his efforts 
to church groups, local medical soci¬ 
eties, and Rotary Clubs in southern 
Connecticut. Although all the dona¬ 
tions are relatively small, Stroup 
brings in about $15,000 to $20,000 
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Alumni FACES NOTES 
Ralph Stroup, a retired urologist, has launched 
a program to bring medical care to rural Kenya. 
per year for the projects in Nanyuki 
and Lokusero. Stroup’s motivation 
is simple; “Immersion experiences like 
this have been life-changing for me. 
I now have a group of friends who 
have irrevocably changed who I am as 
a person,” he said. 
For a man who is retired, Stroup 
finds plenty to keep him busy aside 
from helping out his Maasai friends. 
Although Stroup spent his career in 
a private urology practice with four 
other physicians in New Haven, he has 
always had a clinical faculty appoint¬ 
ment at Yale. Stroup is an assistant 
clinical professor in surgery (urology) 
at the School of Medicine and works 
part time as the attending in charge 
of the urology residents’ clinic. Stroup 
also makes time for more leisurely 
pursuits, including gardening, travel, 
photography, and volunteer work. He 
also enjoys visiting his grandchildren 
with his wife, Mary Ann, who served 
as the charge nurse when an ambu¬ 
latory surgery center first opened 
at Yale-New Haven Hospital in the 
1980s, and who now works part time 
as a school nurse. 
Stroup said the most agonizing issue 
troubling the people of Lokusero is a 
lack of running water, even though the 
government installed a well in 2009. 
The well pump runs on diesel fuel, 
which the community can’t afford. At 
the top of Stroup’s priority list is obtain¬ 
ing funds for a solar-powered well 
pump. He has raised half the $20,000 
for the pump and is determined to raise 
the rest of the money by the end of the 
year. “The Maasai of Laikipia District 
have experienced great hardship during 
the past two years,” he said, “and clearly 
their needs for the basics of life—clean 
water, adequate food, access to health 
care, and health care education—are an 
ongoing issue.” 
—Kara A. Nyberg 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or has followed 
an unusual path since leaving Yale? We’d 
like to hear about alumni of the School of 
Medicine; Physician Associate Program; 
and the medical school’s doctoral, fellow¬ 
ship, and residency programs. Drop us a 
line at ymm@yale.edu or write to Faces, 
Yale Medicine, 1 Church Street, Suite 300, 
New Haven, CT 06510. 
Herbert and Grace Boyer 
with Dean Robert Alpern. 
Pioneer in genetic 
engineering and biotech ' 
wins Parker Medal , 
If' 
In the early ig6os, a doctoral A 
student at the University of 11 
Pittsburgh wrote to Edward A. » 
Adelberg, PH.D.’49, chair of the « 
Department of Microbiology at « 
the Yale School of Medicine, to f 
ask for bacterial strains needed i 
for a research project. The strains k 
were in the mail within a week, il 
and a scientific collaboration and it 
friendship had begun. 
The student, Herbert w. boyer, 
PH.D., FW ’66, came to Yale in 1963 
as a postdoc in Adelberg’s lab. “The 
whole concept and the fruit of my 
career,” said Boyer at a ceremony 
in the Historical Library in April, 
“date back to Ed Adelberg and my 
association with him.” 
Boyer was back at Yale to receive ^ 
the Peter Parker Medal, awarded 
to him and his wife, Grace, for out¬ 
standing contributions to the School 
of Medicine. The award came on the 
20th anniversary of the dedication 
of the Boyer Center for Molecular 
Medicine, built thanks to a gift from 
the Boyers in 1990. “We thought the 
building of the Boyer Center was so 
critical that it really marked the time 
to give the Peter Parker Medal,” said 
Dean Robert J. Alpern, M.D., Ensign 
Professor of Medicine. 
After completing his postdoc at 1 
Yale, Boyer went to the University 
of California, San Francisco, where 
he began working with Stanley 
Cohen, PH.D., a professor at 
Stanford. The two found a way to 
use recombinant dna to produce 
proteins with potential medical 
applications, including insulin 
and human growth hormone. 
This technology opened the door 
to the biotech industry. Boyer 
formed Genentech in partnership 
with venture capitalist Robert A. 
Swanson in 1976. 
Alpern noted that Boyer 
founded the company at a time 
when alliances with business were 
frowned upon in academia. Now, 
Alpern said, such relationships 
are common practice. And Boyer 
was also ahead of his time in his 
embrace of interdisciplinary sci¬ 
ence, Alpern said, and that set the 
path to the Boyer Center, which is 
a “collection of faculty members 
from many different departments, 
all working together on many dif¬ 
ferent problems.” 
Carolyn W. Slayman, ph.d., 
deputy dean for academic and sci¬ 
entific affairs, described Boyer’s 
days as a postdoc at Yale. “Herb 
was a ringleader among the 
postdocs in organizing activities 
for the graduate students and 
making science exciting for every¬ 
body,” she said. 
' Boyer paid tribute in his brief 
remarks to Adelberg, a profes¬ 
sor emeritus of human genetics 
who died in 2009. “Not only was 
he a fine scientist, but he was 
a gentleman of the first order,” 
Boyer said. 
Eliot Sorel Cynthia 
Booth Lord 
1950s 
William M. Could, m.d. ’58, has 
announced the publication of his 
second novel, Three Boys Like You, 
which is the story of a compli¬ 
cated boyhood friendship and 
how it changed over more than 
30years. Gould, who lives in 
northern California, is a practicing 
physician, jazz musician, and 
writer. His first novel, A Little Score 
to Settle, a tale of suspense about 
a man’s search for his father, was 
published in 2008. 
1970s 
Felix Freshwater, m.d. ’72, hs ’74, 
published a humorous look at 
medical Jargon in the April 2011 
issue of the foumo/ of Plastic, 
Reconstructive & Aesthetic 
Surgery. In the article. Freshwater 
proposed an alternative to both 
the Oxford English Dictionary 
and the Dictionary of American 
Regional English, to be called the 
Yale American Plastic Surgery 
dictionary, or yaps. Entries include 
DIEP, "acronym for a type of pa¬ 
tient to be avoided—demanding 
individual expecting perfection,” 
and "fillerologist—specialist in in¬ 
jecting fillers.” Freshwater lives in 
Miami, where he treats diseases 
of the hand and performs recon¬ 
structive plastic surgery. 
Eliot Sorel, m.d., fw ’75, led work 
groups in developing two policies 
that were adopted by the Ameri¬ 
can Psychiatric Association’s (apa) 
Assembly and its board of trust¬ 
ees last year. Those policies were 
titled Conflicts of Interest: Prin¬ 
ciples & Guidelines, and Psychiatry 
& Primary Care Integration. Sorel 
directs and teaches courses in 
the School of Public Health and 
Health Services at the George 
Washington University, where he 
AlexMadlener Farzad 
Mostashari 
has professorial appointments 
in global health, health services 
management and leadership, 
and psychiatry and behavioral 
sciences in the School of Medicine 
and Health Sciences. 
1990s 
Cynthia Booth Lord, pa-c ’91, 
clinical associate professor and 
director of the physician assistant 
program at the School of Health 
Sciences at Quinnipiac University, 
was appointed to the Primary 
Care Coalition of Connecticut in 
March. The coalition comprises 
Connecticut health care profes¬ 
sionals, including physicians, 
nurse practitioners, physician as¬ 
sistants, and public health work¬ 
ers, as well as community health 
centers, government health 
programs, and private medical 
practices, and works to build and 
promote a more effective system 
of primary health care in the 
state. Lord is a former president of 
the American Academy of Physi¬ 
cian Assistants. 
Alex Madlener, M.D. ’95, hs ’99, 
has created a firm in North Haven, 
Conn., to help physicians manage 
their finances. His firm. Open 
Circle Wealth Partners, offers 
comprehensive and individualized 
wealth management services. 
Madlener worked at Paine Web¬ 
ber, Charles Schwab, and cigna 
Individual Financial Services 
before entering medical school. 
Farzad Mostashari, m.d. ’96, was 
named National Coordinator for 
Health Information Technology 
at the U.S. Department of Health 
and Human Services in April. 
Mostashari joined the office of the 
National Coordinator in July 2009. 
Previously, he served in the New 
York City Department of Health 
and Mental Hygiene as assistant 
commissioner for the Primary Care 
Information Project. Mostashari 
also led the nyc Center of Excel¬ 
lence in Public Health Informatics, 
funded bytheCDC, and a project 
funded by the Agency for Health¬ 
care Research and Quality that 
focused on quality measurement 
at the point of care. Mostashari 
also established the Bureau of 
Epidemiology Services at the nyc 
Department of Health. He was 
one of the lead investigators in 
the outbreaks of West Nile virus 
and anthrax in New York City and 
among the first developers of real¬ 
time electronic disease surveil¬ 
lance systems nationwide. 
2000s 
Alfred I. Lee, m.d. ’04, ph.d. ’04, 
was named an assistant pro¬ 
fessor of hematology at Yale 
Cancer Center in March. Lee will 
continue his research efforts at 
Yale on clinical lymphoma and 
critical care hematology and will 
be actively involved in medical 
education. Lee was previously an 
instructor in medicine at Harvard 
Medical School, where he was 
the recipient of several teaching 
awards. A graduate of Stanford 
University, Lee completed his 
residency training at Brigham 
and Women’s Hospital in Boston, 
where he served as chief medical 
resident, followed by a fellow¬ 
ship in hematology/oncology at 
Dana-Farber Cancer Institute. 
SEND ALUMNI NEWS TO 
Claire M. Bessinger, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
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in memoriam 
Madeline S. Crivello, m.d. ’77, 
died on February 19, in Naples, 
Fla., after a lengthy fight with 
cancer. She was 58. After a resi¬ 
dency and fellowships in diag¬ 
nostic radiology, Crivello spent 
several years in private practice 
at Framingham Hospital in Mas¬ 
sachusetts, followed by many 
years in practice as director 
of women's imaging and active 
involvement in the radiology 
residency program at Mount 
Auburn Hospital in Cambridge, 
Mass. She was diagnosed in her 
40s with aggressive breast can¬ 
cer and underwent extensive 
therapy at Dana-Farber Cancer 
Institute. She went on to de¬ 
velop one of the first women’s 
imaging centers in New England, 
where she found great fulfill¬ 
ment as a leading advocate for 
women’s health in the Boston 
area. Although a lifelong non- 
smoker, she was diagnosed with 
primary lung cancer in 2008. 
William H. Prusoff, ph.d., a 
member of the School of Medi¬ 
cine faculty for 57 years, died on 
April 3. He was 90 and lived in 
Branford, Conn. Prusoff was born 
in 1920 in Brooklyn, N.Y., the son 
of a grocer. In the late 1930s the 
family moved to Miami, where 
Prusoff majored in chemistry 
at the University of Miami. His 
poor eyesight kept him out of the 
Armed Forces during World War II, 
but he spent the war as a muni¬ 
tions inspector in Memphis and 
a water-quality tester for troops 
stationed in Miami. 
Afterthe warand unsuccess¬ 
ful attempts to enter medical 
school (including Yale), he 
obtained a ph.d. in chemistry at 
Columbia University and then 
joined Arnold Welch, ph.d., at 
Western Reserve University (now 
Case Western Reserve). When 
Welch came to Yale to head the 
pharmacology department 
in 1953, Prusoff came with 
him. Prusoff soon synthesized 
5-iododeoxyuridine, one of the 
first nucleoside analogues, which 
was shown to have antiviral activ¬ 
ity. The first clinically useful anti¬ 
viral drug, it found widespread 
use as a preventive of herpes 
virus keratitis in infants. Prior to 
the synthesis of this compound, 
researchers had thought the de¬ 
velopment of effective nontoxic 
antiviral agents was impossible. 
Prusoff has been called the father 
of antiviral chemotherapy for this 
seminal work. 
But his major contribution 
was still to come. As the Ai DS 
epidemic was raging in the 1980s, 
Prusoff and his late Yale colleague 
Tai-Shun Lin, ph.d., showed that 
an unsuccessful cancer compound 
known as stavudine or d4T was 
active against human immunode¬ 
ficiency virus (hiv). After securing 
the patent for d4T, Yale licensed 
it to Bristol-Myers Squibb, which 
sold it underthetrade name Zerit 
in 1994. Zerit soon became a com¬ 
ponent of the first combination 
drug therapy for hiv. 
The William H. Prusoff 
Foundation supported numerous 
programs under his direction, 
including the Yale Initiative for 
the Interdisciplinary Study of Anti- 
Semitism. Prusoff also endowed 
lectureships in virology and 
pharmacology at Yale, funded 
scientific prizes, and supported 
the research of individuals and 
laboratories at Yale. When Doc¬ 
tors Without Borders and Yale 
students called on the university 
and Bristol-Myers Squibb to make 
Zerit available at low cost in 
impoverished areas of the world, 
Prusoff actively joined in the 
campaign. The company acceded 
in March 2001. 
David Seligson, m.d., sc.d., 
professor emeritus of labora¬ 
tory medicine, died at home in 
Branford, Conn., on March 3. 
He was 94. Born in Philadelphia, 
Seligson was the founding 
chair and chief of the Depart¬ 
ment of Laboratory Medicine at 
the School of Medicine and at 
Yale-New Haven Hospital. The 
discipline of clinical chemis¬ 
try and the broader field of 
laboratory medicine as they are 
practiced today are the results 
of his vision and creativity. 
Recruited from the University of 
Pennsylvania to Yale and Grace- 
New Haven Hospital as the first 
director of the hospital’s clinical 
laboratories in 1958, Seligson 
established the infrastructure of 
the Department of Laboratory 
Medicine, creating divisions of 
clinical chemistry, microbiology, 
transfusion medicine (blood 
banking), and hematology. 
Recognizing the growing 
need for clinical laboratory data 
in the modern practice of medi¬ 
cine, Seligson pioneered the use 
of automation. One of the first 
applications of a digital computer 
In the clinical laboratory was 
made in Seligson’s department 
at Yale, and shortly thereafter 
data were transmitted directly 
from the laboratory computer 
to data stations on the patient 
wards. Seligson was also among 
the first to highlight the clinical 
importance of test specificity and 
accuracy, as compared to simple 
reproducibility. He retired in 1988. 
We have also received word of the 
passing of the following alumni: 
J. Alfred Berend, m.d. ’56, died 
on January 18 of heart failure 
in San Diego, Calif. He was 79. 
Berend had been an internist at 
the Scripps Clinic in La Jolla, Calif., 
for 31 years. 
Colin M. Bloor, m.d. ’60, HS ’62, 
Fw ’64, distinguished professor 
emeritus of pathology at UC San 
Diego School of Medicine, died on 
September 9,2010, in San Diego 
Hospice from complications of a 
stroke. He was 77. 
Benjamin Bursten, m.d. ’58, HS ’62, 
died on December 4 in Oak Ridge, 
Tenn. A specialist in forensic 
psychiatry, he was 83. 
Linus W. Cave, m.d. '46, died on 
September 4,2010, in Dover, N.J. 
He was 87. 
Robert Evans, m.d., a clinical 
professor and psychoanalyst at 
the Child Study Center, died on 
May 13,2010, in North Branford, 
Conn. He was 95. 
Michael A. Gilchrist, m.d., hs ’69, 
died on October 31,2010, in 
Chelmsford, Mass. A pediatrician, 
he was 66. 
Barbara (Wilmer) Gibson, m.d. ’55, 
died on January 17 in Burlington, 
Vt. She was 80. 
Val S. Greenfield, m.d. ’56, a retired 
ophthalmologist, died on March 16 
in Voorhees, N.J. He was 78. 
Marshall R. Holley, m.d., hs ’69, 
former associate clinical professor 
of obstetrics/gynecology at Yale, 
died of cancer in New Haven on 
December 5. He was 75. 
Harold March, m.d. ’50, died on 
January 23. He was 92. 
Elmer T. Mitchell Jr., m.d. ’56, a 
specialist in plastic surgery, died 
on December 27 in Port St. Lucie, 
Fla. He was 80. 
Adrian M. Ostfeld, m.d., for¬ 
mer chair and longtime faculty 
member in the Department of 
Epidemiology and Public Health, 
died on January 28 in Hamden, 
Conn. He was 84. 
Joel M. Rappeport, m.d., professor 1 
of medicine (hematology) and pe¬ 
diatrics at Yale and a pioneer in the* 
treatment of patients with bone 
marrow failure, died on January 16 i 
at his home in Woodbridge, Conn.. 
He was 71. 
Sara S. Sparrow, ph.d., professor 
emerita of psychology and chief' 
psychologist in the Child Study 
Center from 1977 to 2002, died 
in New Haven on June 10,2010. 
She was 77. 
Carter Stilson, m.d. '42, hs ’46, 
died on January 7 in New Haven. 
He was 94. 
Walter P. Sy, m.d., hs ’56, an anes¬ 
thesiologist, died on February 17 
in Westmoreland, N.H. He was 74. 
Irving N. Wolfson, m.d. ’43, a 
retired cardiologist, died at his 
home in Worcester, Mass., on 
July 8,2010. He was 90. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
End note 33 
' Biomedicine in the New Century 
In the signature event held on April 28 and 29 to 
celebrate the School of Medicine's 200th year, 
15 world-renowned scientists, clinicians, and scholars 
—including seven Nobel laureates—gathered to give 
lectures on “Biomedicine in the New Century.” 
“This bicentennial symposium is really the 
most important event of our celebration,” Dean 
Robert J. Alpern, M.D., Ensign Professor of Medicine, 
told the audience in the Mary S. Harkness Audi¬ 
torium. “We now find ourselves in a great era of 
advances in biomedical research. When we got 
together to decide how to celebrate our anniversary, 
there was uniform agreement that it had to be done 
with a scientific symposium, bringing in scientists of 
the highest regard. I think you are in for a real treat.” 
—John Curtis 
iMany of the speakers at the Bicentenn&^^fpposium 
joined President Richard Levin, Dean Rc|)ert Wp^rfi, 
and other medical school faculty for a cHnner on 
April 28. Front row, from left: Levin, Chasles Sawyers, 
Joseph Goldstein, David Baltimore, Eric landel, 
Elizabeth Blackburn, Elaine Fuchs, Robeifetii^^^itz, 
and Alpern. Back row, from left: Peter Kim, 
Sharp, Harold Varmus, Michael Brown, aid IVUchael 
Marmot. Speakers Robert Califf, Susan Lildqf ist, 
and Huda Zoghbi were unable to attend ®e dinner, 
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Yale Medicine 
Med students The ethics of Doctors 
get iPads seeding trials and writers 
4 6 12 
I A 21st-century NGO 
A handful of Yale medical students opened a clinic and hospital in a remote corner of Nepal. 
From 8,000 miles away, via the Internet, they provide support. Here’s how they do It. 
i8 
■ t. 
ON THE COVER Nyaya Health has 
brought health care to a remote 
corner of western Nepal. The pro¬ 
gram has hired community health 
workers like Kamala Koli, who 
conducts screening for malnutri¬ 
tion in her village, Mastamandu, 
in the area surrounding Nyaya’s 
Bayalpata Hospital. 
THIS PACE Taraman Kunwar, 
a health assistant (mid-level 
practitioner) for Nyaya Health, 
sees patients in the Bayalpata 
Hospital outpatient department. 
Photos by Roshani Andrews 
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2 Letters 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or fewer) and 
news items to Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length, style, and content, 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
Public Health Service 
as a career 
The U.S. Public Health Service 
Commissioned Corps (usphs), 
one of the seven uniformed 
services, offers an alternative 
experience for physicians seek¬ 
ing a military service career 
[‘‘Medicine and the military,” 
Yale Medicine, Spring 2011]. 
Similar to those in the military, 
physicians in the usphs are 
commissioned officers who 
have the same basic responsi¬ 
bilities and benefits. The head 
of the USPHS is the U.S. Surgeon 
General. Physicians in the usphs 
practice preventive/population 
medicine at the Centers for 
Disease Control and Prevention 
(CDC); research medicine at the 
National Institutes of Health; 
clinical medicine with the 
Federal Bureau of Prisons and 
the Indian Health Service; and 
military medicine with the U.S. 
Coast Guard. 
My career was with the CDC 
and began with an assignment 
to the Epidemic Intelligence 
Service (eis) program, which is a 
two-year learn-on-the-job expe¬ 
rience for physicians and other 
doctoral-level health profession¬ 
als. As an EIS officer, I learned 
the skills needed to carry out 
applied epidemiology and 
population medicine through 
community-based experiences. 
These included investigations 
of cholera in Bahrain and in the 
Maidive Islands; shigellosis in 
the Marshall Islands; suspected 
botulism in Peru; and norovirus 
on a cruise ship—plus sev¬ 
eral domestic investigations, 
including the first outbreak of 
Legionnaires’ disease. These 
experiences prepared me 
for subsequent assignments 
that included a three-month 
tour with the World Health 
Organization in Geneva, fol¬ 
lowed by work as a state epi¬ 
demiologist in the Florida State 
Health Department; deputy 
program director at CDC (which 
included leading a bioterrorism 
response team at the 1984 
Los Angeles Olympic Games); 
and director of the Sexually 
Transmitted Disease Program 
in San Diego, Calif. I retired 
from the USPHS in 2004 after 
30 years of service. 
I encourage medical school 
students interested in a career 
as a commissioned officer in 
any of the uniformed services 
to discuss opportunities with 
current and former commis¬ 
sioned officers and to look for 
such introductory opportuni¬ 
ties as the CDC’s senior medical 
students elective programs. As 
I reflect on my career with the 
USPHS, I realize how fortunate 
I was to have had so many 
professionally rewarding experi¬ 
ences, worldwide travel, and an 
opportunity to provide services 
to those in need. 
Robert A. Cunn, m.d. ’66, m.p.h. 
Captain, U.S. Public 
Health Service (retired) 
La Jolla, Calif. 
Physician Associates 
slighted in article 
I read your article about medi¬ 
cine and the military expecting 
that you would mention the 
contributions of Yale PAs in 
the military. Once again I was 
disappointed—and frankly, 
insulted. I served as an Army PA 
in both Iraq and Afghanistan, 
as have many other Yale PAs, 
I'm sure. When patients and 
physicians with whom I served 
learned where I had been edu¬ 
cated, they usually expressed 
increased confidence in my care, 
and I did my best to live up to 
their expectations. Based on the 
commendations and additional 
duties assigned to me, I believe 
I lived up to the standards 
expected of a Yale graduate. 
How disappointing, then, to 
return home and see that the 
school’s magazine continues to 
ignore us. 
Peter Fish, PA ’97 
Major, U.S. Army 
Global Health Program 
not the first 
I feel compelled to point out that 
although Michele Barry, m.d., 
HS ’77, and Frank J. Bia, m.d., 
M.P.H., Fw ’79, were innovators 
in sending residents abroad, they 
were not the first to do so [‘‘Yale’s 
global health program celebrates 
30 years,” Yale Medicine OnWne 
Extra, July 2011]. 
I served as an intern and 
junior assistant resident on the 
Osier Medical Service at Johns 
Hopkins from 1966 to 1968. 
Each year, the Department of 
Medicine sent two residents to 
work on the cholera wards of the 
Infectious Diseases Hospital in 
Calcutta, and I was sent there in 
early 1968, This was a time when 
clinical investigators under the 
direction of Nate Pierce, m.d., 
were working on the formula for 
oral rehydration therapy (ort). 
Within a short period of time, 
a formula was worked out and 
introduced in the field, ort saved 
thousands of lives in the cholera 
epidemics that accompanied the 
Indo-Pakistan War of 1971, and it 
became the backbone of who’s 
global Diarrheal Diseases Control 
Program a few years later. 
Needless to say, my experi¬ 
ence in Calcutta, together with 
my two years with the Yale-China 
Association in Hong Kong in 1959- 
1961, changed my life. I imagine 
that Yale’s global health program 
has had similar effects on the 
residents who have been sent 
abroad over the past 30 years. 
David S. Fed son, m.d. ’65 
Sergy Haut, France 
CORRECTION 
An obituary in the Autumn 2011 
issue of Yale Medicine incorrectly 
listed the house staff years of 
Walter P. Sy, m.d. He completed 
his residency in 1965. 
starting point 
A clinic in Nepal and doctors who write 
In the fall of 2006, Jason Andrews, M.D. ’07, then a student at the School of Medicine, 
approached Yale Medicine to ask if we’d be interested in writing about a project he and his 
classmates had undertaken. They were starting a clinic in Achham, a remote region in 
jwestern Nepal. Students often ask us to write about their projects. I told Jason what I tell the 
I others—let’s wait until your project is up and running. The clinic, called Nyaya, the Nepali 
word for justice, soon opened its doors—but getting a story proved challenging. A writer in 
Kathmandu, Nepal’s capital, was willing to visit the site, but an uprising by Maoist rebels 
forced her to cancel the trip. Indeed, it can take three days to travel from Kathmandu to 
Achham, a trip of about 260 miles that usually takes about 30 hours but is often stymied by 
landslides, flooding, and bad roads. Last summer Stephanie Soucheray, our summer writ¬ 
ing intern, began interviewing Andrews and others for the article from our offices in New 
Haven. Her story shows how a group of students created a sustainable locally staffed clinic 
that has brought health care to an area that desperately needs it. 
And our series on alumni career choices continues with Cathy Shufro’s profiles of six 
physicians who are also writers. Some started out as doctors and turned to writing later in 
their careers. One was a journalist who became a doctor who is now a consultant for a TV 
doctor show, and another studied medicine in order to write about it. Each has found a way 
to bring some of the mysteries of medicine to a broad audience. 
John Curtis 
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4 chronicle news from cedar street 
TOP Richard Belitsky and Michael Schwartz 
decided to offer iPads to all medical students in 
an effort to go green. The medical school was 
spending about $i,ooo on paper copies of the 
medical curriculum—about the cost of an iPad. 
ABOVE Jorge Ramallo-Pardo uses the iPad on 
his clinical clerkships to keep notes on patients. 
Students begin new 
semester with iPads 
The devices save paper and allow 
a more interactive curriculum, say 
students and faculty. 
A move to make the School of Medi¬ 
cine a greener campus has demon¬ 
strated the potential of new technology 
to change the ways in which faculty 
teach and students learn. 
“It’s hard to think of anything 
else that has had such a profound 
and rapid impact,” said Michael 
L. Schwartz, ph.d., assistant dean 
for curriculum, referring to a pilot 
program in which a handful of stu¬ 
dents were given iPads to download 
course curricula, take notes in class, 
and update course material. Based 
on the success of the pilot program 
conducted during the 2011 spring 
semester, all 518 medical students 
received iPads this fall. 
Schwartz said it costs roughly 
$1,000 per student to provide paper 
copies of all course materials, which 
is about the same price as an iPad and 
supporting apps. “We pretty much 
break even,” he said, “but the iPad is 
better for the environment—and as an 
information delivery system, it’s much 
more versatile.” 
It takes students about 30 minutes 
to download the entire curriculum 
for one year on the iPad, although 
they are advised to download the fall, 
winter, and spring courses separately 
because faculty update documents 
until the start of the course. But what 
administrators are realizing is that the 
iPad is more than just an efficient and 
environmentally smart curriculum 
delivery system; it enhances the way 
courses are taught. 
Robert L. Camp, ph.d. ’92, m.d. ’97, 
who teaches pathology to first- and 
second-year students, said the iPad 
is ideal for small-group teaching. 
“Computer screens, which we used to 
use, create a barrier between you and 
the person you are talking to. It’s not 
interactive. But the iPad is more like 
a piece of paper. You hold it more like 
a book and you can pass it around. It 
tends to engender more group think¬ 
ing and group discussion.” 
Nine students participated in the 
pilot iPad program—six were tech- 
savvy and three weren’t. They met 
with Schwartz, IT specialist Gary 
Leydon, and curriculum coordinator 
Leigh Cromey once a week during the 
spring semester to discuss the iPad 
and how it was working. 
“Originally they wanted to see how 
much we could depend on it,” said 
Nicholas Bergfeld, a member of the pilot 
ENERGY INSTITUTE AT WEST CAMPUS 
group who is now in his second year. 
“Using it to take notes in class was their 
Lbaseline goal, but we quickly exceeded 
■ that.” The iPads altered the learning pro- 
I cess in a positive way, he said. In a pathol¬ 
ogy lab, for example, they allowed for a 
; much greater level of collaboration by 
I synching with the instructor’s presenta- 
I tion, enabling students to answer survey 
questions and draw on the slides in real 
I time. “It made the class a lot more inter- 
|i active, a lot more fun,” he said. During 
his clinical studies, Bergfeld can foresee 
the iPad enhancing his interaction with 
patients. “You and the patient can look at 
their lab test results. X-rays, or whatever 
■else together. It enables a greater level of 
personal connection.” 
A self-described “paper person,” 
Vicki Bing said she had “huge reserva¬ 
tions” before joining the pilot program. 
I “I absolutely have to have everything 
printed out, so I didn’t know how an 
I iPad could replace that.” But after a 
■ semester of using the tablet, she said, 
! “I really, really loved it.” Bing said she 
appreciates having access to all the 
course material while listening to a lec- 
j ture. She also welcomes the iPad’s porta¬ 
bility. “I travel a lot, and I used to bring 
paper copies of everything with me to 
I study on the road,” she said. “With the 
I iPad it’s so much easier. It’s all right 
; there with the touch of a finger.” 
I In giving its students iPads, Yale 
is part of a growing trend at medical 
schools across the country, includ- 
: ing those at Brown; the University of 
California, Irvine; Stanford; and the 
, University of Minnesota. 
Yale’s program is different in that 
the school is giving iPads to all its stu¬ 
dents, not just first- and second-years. 
Yale has also encrypted its iPads so that 
they are security/privacy-compliant. 
This feature will allow third- and 
fourth-year students to use them 
during their clinical electives. The 
original plan was to give iPads only 
to first- and second-year students, but 
third- and fourth-years, who use their 
personal laptops for their clinical elec¬ 
tives, balked at a recent requirement 
that their laptops be encrypted—they 
considered it an invasion of privacy 
and an inconvenience because the 
encryption program shut down their 
computers every few minutes. The solu¬ 
tion? School officials decided to provide 
encrypted iPads to third- and fourth- 
year students for their clinical work. 
Bergfeld said that the overall mes¬ 
sage he’s hearing from fellow students 
is that they are looking forward to 
incorporating the iPad into their study 
habits. “The administration spent a lot 
of time making sure it was feasible,” he 
said. “So far it’s everything we could 
have hoped for.” 
—Jennifer Kaylin 
First-year students use the iPads during a cell 
biology lecture by Peter Takizawa. 
A $25 million gift from a Yale College alumnus 
and his wife will help launch the Energy 
Sciences Institute on Yale University’s West 
Campus, President Richard C. Levin announced 
in September. The institute will join the five 
other institutes on the West Campus in cancer 
biology, chemical biology, microbial diversity, 
systems biology, and biodesign. 
During the institute’s start-up phase, 
the university will recruit new faculty mem¬ 
bers, including a director; dedicate 40,000 
square feet of laboratory space on the West 
Campus to the institute; and launch inter¬ 
disciplinary research programs spanning 
Yale’s science and engineering departments. 
The institute will bring together physicists, 
chemists, geologists, biologists, and engi¬ 
neers to develop solutions to the world’s 
energy challenges. 
“The cutting-edge research that will 
be conducted at this new Energy Sciences 
Institute is vitally important,” said Thomas F. 
Steyer, a hedge fund manager and graduate 
of the Class of 1979, who made the gift with 
his wife, Kathryn A. Taylor. 
—John Curtis 
HOSPITALS TO MERGE 
Yale-New Haven Hospital (ynhh) and the 
Hospital of Saint Raphael (hsr) announced 
in September that they had signed an agree¬ 
ment that would create a single hospital 
with two campuses. According to officials 
of both hospitals, the merger will enhance 
health care quality, access, and efficiency for 
Greater New Haven and the broader region. 
Under the agreement, ynhh will pur¬ 
chase the assets of hsr; hsr will continue 
to provide medical care consistent with the 
ethical and religious directives of Catholic 
Health Care Services; hsr liabilities will 
be addressed; and ynhh will make invest¬ 
ments in the hsr campus and expand its 
clinical activity. 
With the agreement in place, the 
Connecticut Attorney General’s Office, the 
Connecticut Office of Health Care Access, 
and the Federal Trade Commission will begin 
a regulatory review of the transaction. 
—J.C. 
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6 chronicle news from cedar street 
A Yale clinician ponders 
the ethics of a seeding trial 
masquerading as research 
In the June 2011 issue of Archives 
of Internal Medicine, researchers 
described their discovery of a seeding 
trial for the epilepsy drug gabapentin, 
sold under the trade name Neurontin. 
The trial was conducted 15 years ago 
by Parke-Davis (bought by Pfizer in 
2000). Under the guise of study¬ 
ing gabapentin’s dosing—which had 
already been clinically established— 
the company enlisted more than 
2,000 patients and 700 investigators. 
The trial’s real goal was to increase 
prescriptions of the drug. 
David A. Kessler, m.d., the com¬ 
missioner of the Food and Drug 
Administration and later dean of 
the School of Medicine, sounded 
an alarm about the use of seeding 
trials in a 1994 article in The New 
England Journal of Medicine. The arti¬ 
cle described such trials as having 
little scientific value and as “thinly 
veiled attempts to entice doctors 
to prescribe a new drug being mar¬ 
keted ... .” Fourteen years later Harlan 
M. Krumholz, m.d., m.s., the Harold 
J. Hines Jr. Professor of Internal 
Medicine, reported in the Annals 
of Internal Medicine on a 1999 seeding 
trial by Merck to market its arthritis 
drug Vioxx. 
Last summer Joseph S. Ross, m.d., 
M.H.s. ’06, assistant professor of medi¬ 
cine and co-author of the Vioxx report 
and senior author of the gabapentin 
report, met with Yale Medicine to dis¬ 
cuss seeding, whistle-blowing, and the 
future of industry-sponsored trials. 
How did you and your colleagues 
discover that a 15-year-old trial may 
have been a seeding trial? 
Several years ago colleagues published 
in Annals of Internal Medicine an 
interesting review of a limited set of 
litigation documents that described 
Parke-Davis’ promotion of gabapentin. 
Marketing involvement in the Study 
of Neurontin: Titrate to Effect, Profile 
of Safety (steps) trial was briefly men¬ 
tioned, but discussion was incomplete. 
The recent availability of the complete 
documents produced as part of the liti¬ 
gation provided a unique opportunity to 
examine the steps trial in more detail. 
Can you describe the elements of 
STEPS that pointed to a seeding trial? 
Seeding trials are challenging to iden¬ 
tify, but the internal documents clearly 
demonstrated that steps was a seeding 
trial posing as a legitimate scientific 
study. For instance, the trial itself, not 
trial results, was part of a marketing 
strategy used to promote gabapen¬ 
tin and increase prescribing among 
investigators without informing trial 
patients or investigators. Investigators 
were selected for participation based 
on whether they were high prescribers 
in their area. After the trial, examina¬ 
tion of rates and dosages of gabapentin 
prescribing showed that steps inves¬ 
tigator participation in the trial was 
positively associated with greater gaba¬ 
pentin prescribing. 
What are the risks of seeding trials? 
Seeding trials pose several real 
dangers. First, they undermine the 
integrity of the clinical trial research 
process, exposing subjects to an experi¬ 
mental medication for marketing, 
rather than scientific purposes. Second, 
seeding trials unethically recruit 
In an article published last year, Joseph Ross and 
colleagues criticized the practice of “seeding 
trials," which are designed not for medical or 
iscientific purposes but to boost sales of a drug. 
to participate because they 
not provided with full informed 
Finally, seeding trials under¬ 
mine the medical literature when they 
are published, because the trials are 
designed by marketing to show the 
I product’s benefit, thus biasing the evi- 
i dence available in the literature. 
i 
I There is a whistleblower element 
to the article. Were you worried 
about offending fellow investigators 
and physicians? 
My colleagues and I made the deci¬ 
sion that it is more important to take 
a stand against these unethical trials 
tin an effort to prevent them in the 
future. We expect that many compa¬ 
nies have long conducted seeding 
(trials as standard operating procedure. 
We are not interested in punishing 
acts from the past but hope that by 
exposing past practices, the public 
and professional outcry will prevent 
them in the future. 
What’s your recommendation for 
staying ethical in pharma-sponsored 
Phase IV clinical trials? 
Promoting the importance of ethical 
conduct is one step, so if evidence of 
other seeding trials is found in the 
future, the profession would frown 
ever more severely. Other steps that 
may prevent seeding trials include 
clinical trial registries. Similarly, steps 
to enhance the current institutional 
review board system could also be help¬ 
ful. However, at the end of the day, 
physicians and the pharmaceutical 
industry need to make the decision not 
to participate in unethical clinical trial 
research and to keep the focus on sci¬ 
ence rather than on marketing. 
—Stephanie Soucheray 
WHY AGING MAKES US FORGETFUL 
Anyone who has searched for missing bifo¬ 
cals only to find them in the crisper drawer 
can find an explanation—and some hope— 
in a study from Yale researchers about the 
battle against age-related memory loss. Amy 
F.T. Arnsten, ph.d., professor of neurobiology 
and of psychology, reported in the July 27 
issue of Nature that the neural networks of 
middle-aged and older brains are weaker and 
slower than those of younger brains. 
Arnsten’s study focused on age-related 
changes in the prefrontal cortex (PFC), the 
area responsible for abstract thought and 
reason as well as information recall {Why 
did I come upstairs?) in the absence of visual 
cues. As we age, the pfc accumulates exces¬ 
sive levels of a signaling molecule called 
cyclic adenosine monophosphate (camp), 
which can weaken prefrontal neuronal firing 
and may make these circuits more vulner¬ 
able to neurodegeneration. 
The good news is that inhibiting camp 
with guanfacine, an FDA-approved hyper¬ 
tension medication, can combat the deterio¬ 
ration of neural networks. 
—S.S. 
MENTHOL CIGARETTES MORE ADDICTIVE 
Menthol cigarettes may be more addictive 
than cigarettes without menthol because 
they reduce the protective respiratory 
responses to irritants in cigarette smoke, 
according to a study by researchers at Yale 
and the University of Connecticut School of 
Pharmacy, published online in September 
in The Journal of the Federation of American 
Societies for Experimental Biology. 
The scientists also say that the biggest 
danger is to young smokers. “Menthol may 
make smoke inhalation easier to tolerate and 
therefore promote nicotine addiction and 
smoking-related illness,” said author Sven-Eric 
Jordt, PH.D., associate professor of pharma¬ 
cology at the School of Medicine. “Studies 
indicate that most young people smoke men¬ 
thol cigarettes. So they are being exposed 
to higher levels of nicotine and other toxic 
substances at a young age, which may lead to 
rapid addiction and ultimately to the develop¬ 
ment of smoking-related disease.” 
—John Curtis 
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8 Books & ideas 
Challenging 
and Emerging 
Conditions in 
Emergency 
Medicine 
r |0$HUA i »RO(HR Ml' 
Diagnostic 
Imaging 
rOR TIIL 
Emergency 
Physician 
Lessons from the Titanic 
The ship’s infamous sinking provides insights into 
management and leadership. 
There’s a trend in business publishing these days: books 
built around unlikely case studies. Consider Shackleton’s 
Way: Leadership Lessons from the Great Antarctic Explorer; and 
Tony Soprano on Management: Leadership Lessons Inspired by 
America’s Favorite Mobster. Now there’s a new title, co-authored 
by David C. Tate, ph.d., fw ’00, assistant clinical professor 
of psychiatry: Sink or Swim: How 
Lessons from the Titanic Can Save 
Your Family Business. Surely no 
business owner would seek to 
emulate the combination of design 
flaws, construction weaknesses, 
and operational misjudgments that 
sank the Titanic. 
But it turns out that the story of 
the Titanic can offer insights into 
the pitfalls of running a small fam¬ 
ily business. As Tate and co-author 
Priscilla M. Gale, m.b.a., write, 
“What initially seemed counter¬ 
intuitive ... turned out to be abso¬ 
lutely correlative.” 
Tate and Cale provide psycho¬ 
logical insights into the personal frailties and structural prob¬ 
lems that, taken together, doomed the Titanic. They examine 
team fragmentation (some iceberg warnings never reached 
the captain); ineffective leadership (the captain never alerted 
his officers that the ship was sinking); and overconfidence (the 
Titanic carried only half the lifeboats necessary because the 
ship was “a lifeboat in herself’). For each factor that contrib¬ 
uted to the 1912 disaster, the authors reflect on similar prob¬ 
lems that can arise in ordinary family firms. 
They argue that the U.S. economy depends on such insights: 
Family firms employ nearly six in 10 workers and generate half 
the nation’s gdp. But earnings are only part of the authors’ point. 
In firms that endure, “the family will have learned to be stew¬ 
ards of values that bring enrichment.” Ultimately, a family firm’s 
legacy “is about enrichment, not riches.” 
—Cathy Shufro 
Sink© Swim 
How Lessons from the Tilarnc 
Can Save Your Family Business 
Prtstillo M. Cole ond Dovid C Tote 
Sink or Swim: How 
Lessons from the 
Titanic Can Save Your 
Family Business 
Challenging and Emerging Condi¬ 
tions in Emergency Medicine 
edited by Arvind Venkat, m.d. ’00, 
with contributions by Esther 
Choo, M.D. ’01 (Wiley) This book 
provides guidance for evaluating 
and diagnosing complex disease 
presentations in the emergency 
room. It addresses such chronic 
conditions as congenital heart 
disease, cystic fibrosis, morbid 
obesity, intellectual disability, and 
intestinal failure. 
Diagnostic Imaging for 
the Emergency Physician 
by Joshua S. Broder, m.d. ’99 
(Saunders) This text takes a step- 
by-step approach to selecting and 
interpreting commonly ordered 
diagnostic imaging tests. It pre¬ 
sents clinical decision rules; de¬ 
scribes time-efficient approaches 
for the emergency physician to 
identify critical radiographic find¬ 
ings that impact clinical manage¬ 
ment; and discusses such topics 
as radiation risks, oral and IV 
contrast in abdominal CT, and mri 
versus CT for occult hip injury. 
Evidence-Based Practices 
and Treatments for Children 
with Autism 
edited by Brian Reichow, ph.d., 
associate research scientist in the 
Child Study Center; Domenic V. 
Cicchetti, ph.d., senior research 
scientist in the Child Study 
Center; Fred R. Volkmar, m.d., 
Irving B. Harris Professor of 
Child Psychiatry and director 
of the Child Study Center; and 
Peter Doehring, ph.d. (Springer) 
This book offers perspectives on 
topics related to autism ranging 
from the historical underpin¬ 
nings of autism treatment to 
the use of psychopharmacol¬ 
ogy and the implementation 
of evidence-based practices. 
In addition, the book presents 
a methodology for evaluation 
designed to reduce the risks and 
inconsistencies associated with 
variations among definitions of 
autism terminology. 
The Psychosis-Risk Syndrome: 
Handbook for Diagnosis and 
Follow-Up 
by Thomas H. McGlashan, m.d., 
professor emeritus of psychia¬ 
try; Barbara C. Walsh, ph.d., 
research associate in psychiatry; 
and Scott W. Woods, m.d., 
professor of psychiatry (Oxford 
University Press) This handbook 
details the diagnostic tools and 
building blocks that constitute 
the Structural Interview for 
Psychosis-Risk Syndromes, or 
SIPS. The handbook covers the 
SIPS evaluation, the initial inter¬ 
view, the evaluation process, and 
the summary session consisting 
of findings and future options. 
On Becoming a Psychotherapist: 
The Personal and Professional 
Journey 
edited by Robert H. Klein, ph.d., 
lecturer in psychiatry; Harold 
S. Bernard, ph.d.; and Victor L. 
Schermer, m.a. (Oxford Univer¬ 
sity Press) This book explores 
how psychotherapists develop 
as practitioners both through 
professional training and 
personal experience. The book 
addresses current controversies 
that surround what constitutes 
the optimal set of experiences 
and characteristics for the devel¬ 
oping psychotherapist. 
Recursive Partitioning 
and Applications, 2nd ed. 
by Heping Zhang, ph.d., profes¬ 
sor of public health (biostatistics) 
and in the Child Study Center; 
and Burton H. Singer, ph.d.. 
on campus 9 
former chair of the Department 
of Epidemiology and Public 
Health (Springer) This book 
focuses on recursive partition¬ 
ing strategies in statistical 
analysis as a response to the 
challenge of pathway charac¬ 
terization. The book addresses 
statistical issues—conceptual 
and computational—in the 
context of important scientific 
questions. This edition includes 
new material devoted to forests 
from predictive and interpretive 
perspectives. 
Clinical Nuclear Cardiology: 
State of the Art and Future 
Directions, 4th ed. 
[by Barry L. Zaret, m.d., Robert 
W. Berliner Professor of Medicine 
i(cardiology), and professor emeri¬ 
tus of medicine; and George A. 
;Beller, m.d. (Mosby) The authors 
iaddress the latest developments 
in technology, radiopharmaceu- 
Ticals, molecular imaging, and 
[perfusion imaging. The fully 
,j searchable text at expertconsult. 
com includes illustrated case 
studies that use a variety of imag- 
I ing modalities, 
i 
I The Essence of Analgesia 
and Analgesics 
i edited by Raymond S. Sinatra, 
PH.D., M.D., professor emeritus of 
: anesthesiology; Jonathan S. Jahr, 
j M.D.; and J. Michael Watkins-Pitch- 
j ford, M.D. (Cambridge University 
j Press) This manual provides clini¬ 
cians with information about the 
pharmacologic principles and clini- 
i cal use of pain medications. Each 
chapter provides an overview of a 
particular drug, covering chemical 
structure, mode of activity, indica¬ 
tions, contraindications, common 
dosages and uses, advantages and 
disadvantages, and drug-related 
adverse events. 
Inside Public Psychiatry 
by Selby C. Jacobs, m.d., m.p.h., 
professor emeritus of psychiatry 
and of epidemiology (People’s 
Medical Publishing House-USA) 
This book tells the story of public 
psychiatry, with examples from 
the author’s experience running 
the Connecticut Mental Health 
Center in New Haven. 
The Comprehensive Treatment 
of the Aging Spine: Minimally In¬ 
vasive and Advanced Techniques 
by James J. Yue, m.d., associate 
professor of orthopaedics and 
rehabilitation; Richard D. Guyer, 
M.D.; J. Patrick Johnson, m.d.; 
Larry T. Khoo, m.d. ’95; and 
Stephen H. Hochschuler, m.d. 
(Saunders) This book provides 
state-of-the-art coverage of both 
operative and nonoperative treat¬ 
ments for clinical pathologies of 
the aging spine. The authors cover 
such topics as minimally invasive 
fusion, dynamic stabilization, and 
intraspinous and biologic devices. 
Preventive Cardiology: 
A Companion to Braunwald’s 
Heart Disease 
by Nathan D. Wong, m.p.h. ’85, 
PH.D. ’87,; Roger Blumenthal, 
M.D.; JoAnne Foody, m.d. (Saun¬ 
ders) This edition addresses the 
prevention and risks of cardio¬ 
vascular disease, with the aim 
of delaying the onset of disease 
and moderating its effects and 
complications. 
The descriptions above are based 
on information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Gheryl Violante, Yoie Medicine. 
I Church Street, Suite 300, 
New Haven, CT 06510, or via 
e-mail to cheryLviolante@yale.edu 
Finding the right words for pain 
For a person in great pain, wrote 
Virginia Woolf, “language at 
once runs dry.” Woolfs words 
resonate for David Biro, m.d., 
PH.D., who couldn’t describe 
his own suffering after a bone 
marrow transplant. The "pri¬ 
vacy” of his pain isolated him 
from his loved ones. Biro told 
the audience at a Humanities in 
Medicine lecture in October. 
Biro, a dermatologist at the 
State University of New York 
Downstate Medical Center in 
Brooklyn, came to recognize 
that metaphors convey the 
experience of pain on a level 
that ordinary language cannot. 
As Biro researched his book 
Listening to Pain, he found 
three types of metaphors: first, 
images (often cliches) that sug¬ 
gest weapons—a shooting pain 
in the wrist or a knife in the gut; 
second, images of pain "mir¬ 
rored” outside one’s self, as by 
the silent screamer in Edvard 
Munch’s paintings; and third, 
images that convey the anato¬ 
my of pain, as in painter Frida 
Kahlo’s 1944 self-portrait, which 
shows her shattered spine as a 
broken stone column. 
Even a faltering attempt to 
communicate about pain. Biro 
said, eases the sufferer’s isola¬ 
tion. "As long as the conversa¬ 
tion lasts, we are not alone.” 
—C.S. 
Support federal research funding 
Bracketing her remarks with 
anecdotes drawn from personal 
experience, U.S. Representative 
Rosa DeLauro gave an impas¬ 
sioned defense of continued 
federal funding for biomedical 
research, even as Congress looks 
to balance the budget by cut¬ 
ting spending. 
Speaking at the October 
Medical Student Council 
Perspectives on Medicine series, 
DeLauro told the packed audience 
that in 1991 she was diagnosed 
with stage i ovarian cancer. 
“Because of the grace of God and 
biomedical research, my life was 
given back to me,” she said. Since 
then, the 10-term congress- 
woman has been a progressive 
voice for health policy reform. 
DeLauro said one of the 
proudest moments of her career 
was March 23, 2010, the day 
President Barack Obama signed 
the Patient Protection and 
Affordable Care Act into law. 
"It has the ability to transform 
people’s lives,” she said. Noting 
that some lawmakers want to 
repeal it to reduce the deficit, 
she said, “I will fight that as hard 
as I can, with every fiber I have. 
It is not a slush fund to deal with 
the deficit." 
—Jennifer Kaylin 
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The Search for the Cushing Brains 
With the neurosurgeon’s collection on display, a trip to the 
“brain room” and a rite of passage are no more. 
By Stephanie Soucheray 
By now the story of Harvey Cushing’s 
brains is well-known. When the neuro¬ 
surgeon died in 1939, he left his brain 
tumor collection, patient registry, and 
glass plate photos to Yale, his under¬ 
graduate alma mater. For decades the 
650 jars of brain specimens sat aban¬ 
doned and ignored in the basement 
of Harkness Hall. Dripping limestone 
walls were the only companions for 
Cushing’s malignant tumors and 
detailed photographs, a collection he 
had begun building in 1902. After 
years of neglect, the collection went on 
'public display in the Cushing Center 
in the basement of the Cushing/ 
Whitney Medical Library in 2010. 
Before the brains’ removal from the 
basement of Harkness, Yale employees 
found a large white poster board on the 
floor. “Leave Only Your Name. Take 
Only Your Memories” was scrawled on 
top of the board; underneath were the 
signatures, doodles, and “we were here” 
markings of several generations of 
Yale medical students who had ducked 
under dusty pipes and stumbled across 
abandoned anatomy dummies in the 
recesses below their dormitory to And 
the brain collection. 
The public unveiling of the 
Cushing brains marked the end of an 
era. For decades, students who visited 
the brains were privy to a pilgrim¬ 
age and rite of passage. Though the 
brains weren’t hidden per se, they 
were obscured in a faraway room, and 
the trip wasn’t exactly condoned by 
the school. “We tried to keep students 
out with locks and reinforced wooden 
panels,” explained Terry Dagradi, a 
Yale photographer who has curated 
Cushing’s photographs. “No matter 
what we did. the students found a way 
to get down there and into the brains.” 
“I remember thinking, ‘I’m inhal¬ 
ing diseased brain matter,’ ” said 
Jessica Bod, a fifth-year student who 
was among the last to see Cushing’s 
brains in their basement tomb. She had 
“bid on an adventure” with classmate 
Sascha Qian during the Hunger and 
Homelessness Auction in 2008. The 
adventure brought her into the bowels 
of Harkness, where entry into the brain 
room required removing a panel in the 
door and crawling through. 
“It was definitely creepy, and I 
remember whoever went first had to 
lead in the dark,” said Bod. “I hadn’t 
realized the brains were actually under 
the dorm. It was very ‘Harry Potter.’ ” 
Antony F. Chu. m.d. ’02, visited the 
basement a few times as a student. He 
had a job in the audiovisual department, 
which meant he also had a set of keys 
that could open a number of Harkness 
doors. Visiting the brains, he said, was 
a bonding—and inspiring—activity. No 
one had exact directions to the “brain 
room,” so each new group of students 
had to forge its own path. 
“I’ll never forget the shadows of the 
brains on the walls,” said Chu, who 
described the experience as one born 
of curiosity and wonder. Nobody (to 
his knowledge) ever tried to remove or 
damage the brains. “There was such a 
sense of something bigger and greater 
in that brain room.” 
Dagradi felt that same sense of other¬ 
ness the first time she entered the 
room. Her feelings intensified after 
she began to print some of Cushing’s 
10,000 glass plate photographs. “There 
are these really detailed and touching 
portraits of children, girls with big 
bows in their hair,” said Dagradi. “The 
photos really had an impact on me.” 
Though Bod is glad that the brains 
are well-preserved, she feels nostal¬ 
gic for their former basement home. 
“Going to find the brains was like 
standing on the seal of the library or 
the second-year show, a tradition that 
made the School of Medicine,” said 
Bod. “Future students won’t have that.” 
Do you have a memory of a nocturnal 
jaunt to the Cushing brains that you’d like 
to share? If so, please write to Terry Dagradi, 
terry.dagradi@yale.edu, and tell us about 
your visit to the basement of Harkness. 
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iDoctors who write 
School of Medicine alumni discuss how writing helps them reaffirm their belief in medicine. 
3y Cathy Shufro 
Making the first cut in a surgical patient shares something 
OTth writing the first line of an essay, says surgeon and writer 
Richard A. Selzer, m.d., hs ’6i. 
“You are making an incision when you sit above a blank 
aage,” says Selzer, the nationally known author of 13 books of 
essays and short stories, mostly about medicine. “Call it blood 
and ink,” he says. “That’s the story of my life.” 
When he first began writing seriously in the mid-1970s, 
Selzer recalls, “My colleagues in surgery found it mystifying. 
They said, ‘What’s the matter with you? Isn’t surgery enough 
For you?’... I was alone.” 
No longer: Yale-trained physicians have increasingly 
combined medicine and writing. Notable among them are 
National Book Award winner Sherwin B. Nuland, m.d. ’55, 
HS ’61; memoir writer Dora Calott Wang, m.d. ’90; her 
classmate, journalist and author Randi Hutter Epstein, m.s., 
M.D. ’90; poet Dagan Coppock, m.d. ’04: and The New York 
Times Magazine columnist and author Lisa Sanders, m.d. ’97, 
HS ’00. They say that their understanding of medicine 
informs their writing. And except for Epstein, who never 
intended to practice medicine, they all find that their writing 
has provided insight into their work as physicians. 
The prevalence of great physician-writers suggests 
an affinity between medicine and writing. Among the best- 
known practitioners are the Russian short-story writer and 
playwright Anton Chekhov; the poets John Keats and William 
' Carlos Williams; and Sir Arthur Conan Doyle, who created 
Sherlock Holmes and his physician sidekick. Dr. Watson. 
Contemporary physician-writers include Oliver Sacks, m.d.; 
Jerome Groopman, m.d.; Atul Gawande, m.d.; and Abraham 
Verghese, m.d., author of the popular novel Cutting for Stone. 
Khaled Hosseini, m.d., wrote The Kite Runner; Robin Cook, 
M.D., writes medical thrillers; and the late Michael Crichton, 
M.D., wrote popular fiction on everything from dinosaurs to 
marijuana smugglers to extraterrestrial plagues. 
Staying sane and the urge to write 
Selzer began writing when he was a medical officer in the 
Army in Korea during the mid-1950s. “In order to keep my 
sanity,” he says, “at the end of every day, I would write down 
what happened.” On returning to New Haven to begin his 
surgery residency, Selzer says, “I completely forgot about this 
journal. I was busy learning to become a doctor and had no 
intention of being a writer.” 
And then in the mid-1970s, halfway into his 25-year 
career on the Yale faculty, Selzer again felt the urge to write. 
“One day the gate to my imagination sprang open,” he says. 
“It was an awakening, an epiphany. I began to see my life in 
literary terms. I began writing furiously.” Between 1976 and 
1982, he wrote three of his best-known books: Mortal Lessons: 
Notes on the Art of Surgery; Confessions of a Knife; and Letters to 
a Young Doctor. His writing, he says, “is unconscious. It just 
pours out.” When he finds a passage of prose or poetry that 
strikes him, Selzer says, “I write it down and study it.” 
Although Selzer bases his stories on his own experi¬ 
ences, he says, “I give myself all the freedom in the world 
to make things up. But each story has a grain of truth. 
I’m not really interested in the facts. I’m interested in the 
truth, which lies beneath the real. It is the real real that lies 
beneath the real.” 
Selzer describes writing as “the reason for which I was 
born.” He continues to write, using Yale’s Beinecke Library 
as an office. His latest book. Diary, was published by Yale 
University Press last spring. 
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14 Doctors who write 
Finding a second calling 
Sherwin Nuland became a surgeon, as he describes it, “quite 
simply because it’s such great fun.” But when he sat down 
to write a series of biographies of historically important doc¬ 
tors more than two decades into his career, he found a sec¬ 
ond calling. Now he is internationally known as a writer and 
scholar. The biographies became his first book. Doctors: The 
Biography of Medicine, published in 1988. His best-known 
book. How We Die: Reflections on Life’s Final Chapter, won 
a National Book Award in 1994 and was on The. New York 
Times’ best-seller list for eight months. Nuland’s work 
includes short biographies of Leonardo da Vinci and the 
12th-century physician-philosopher Moses Maimonides. 
Nuland also wrote a memoir. Lost in America: A Journey with 
My Father, which he says may be his best work. 
The surgeon’s schedule presented opportunities 
for Nuland to write: during delays between cases, usually 
unexpected, he would retreat to the library and write. 
“The Medical Historical Library is two football fields away 
from the operating room,” he says. “I just never wasted any 
time.” Because few physicians have such gaps in their day, 
he says, “I couldn’t have done this if I was in pediatrics or 
internal medicine.” 
Nuland says writing informed his life as a surgeon. “I 
wrote for about six or seven years before beginning to do it full 
time. There’s no question that writing, as well as the research 
and contemplation required to do it, gave me a much greater 
perception of what we call the human condition; helped me 
to understand the perspective of patients and families; and 
acquainted me with the uncertainties of medical knowledge 
and clinical decision making.” 
When surgeons and writers make decisions, Nuland 
says, they draw on everything that’s occurred in their lives up 
to that moment. But whereas a surgeon in the OR deliberates 
before making a choice, “In writing, you’re not nearly as aware 
that you’re making decisions. You’re allowing your unconscious 
mind to float free.” 
At 80, retired from surgery since age 61, Nuland 
continues to study and write—with time off to luxuriate in 
the company of visiting grandchildren. He reads aloud each 
newly written paragraph to make sure that he’s considered 
the nuance and resonance of each word. “You’ve got to be 
absolutely meticulous. You’ve got to hit that thing right on 
the head.” 
Nuland also requires himself to be meticulous about 
facts. “The danger for medical writers is distorting things to 
make for literary effect.” Over time, he believes, a reader wil 
recognize and resent distortions. 
He imagines that reader as “a person very much like 
myself who has had a different life experience from my 
own.” Of his own experiences, Nuland values, above all, his 
35 years as a surgeon. Although he hasn’t entered the OR for 
nearly 20 years, he views healing the sick as “the greatest - 
satisfaction of life.” 
“To carry a sick person through the burden of illness is 
a gift to the person who does it.” 
“Doctors have not been well” 
Dora Calott Wang’s memoir tells the story of an intimate rela¬ 
tionship and how a third party damages it: the relationship is 
the one between doctor and patient, and the interloper is the 
insurance industry. 
A psychiatrist at the University of New Mexico, Wang 
uses her personal story to describe the changes wrought by for- 
proflt health care. “I thought memoir was a form begging to be 
applied to the telling of history,” says Wang. Her 2010 book is 
The Kitchen Shrink: A Psychiatrist’s Reflections on Healing in a 
Changing World. 
“I wasn’t interested in the traditional doctor narrative 
about the romance of healing the patient, where the doctor is 
almighty and the patient is vulnerable. I wanted to write a dif¬ 
ferent kind of doctor narrative, because the truth is the medicah 
system and doctors have not been well,” she says. “It’s ridicu¬ 
lous that doctors should go through all this training and have 
to defer to the decisions of insurance clerks.” 
Wang was already interested in writing while in 
medical school, and the medical school chaplain, Alan 
C. Mermann, m.d., m.div. ’79, encouraged her to take a 
year off to earn a master’s in English at the University of 
California, Berkeley. Selzer introduced her to the idea of 
writing at night. To write Kitchen Shrink, she slept from 8 
at night until 2 a.m., then worked on the book for six hours 
before starting her day as a doctor (and mother) at 8 a.m. 
“There’s this excitement of getting up early and seeing 
what’s going to come out on the page.” 
Wang wrote 40 drafts of the book. “It’s not linear. ... 
You change one thing, and the whole book changes. It’s like 
a river: you do something upstream, and everything down¬ 
stream gets affected.” : 
Wang sees a correlation between seeking truth as a psy¬ 
chiatrist and seeking it as a writer. “A lot of my work as a psy¬ 
chiatrist is to get patients to see the truth. I think it’s time we 
tackled the truth of what’s happened to the medical profession. I 
What does it mean that the insurance industry holds the purse ■ 
strings on medical decisions.^ After all, our medical system is 
the moral infrastructure of our country, where life-or-death 
decisions are made each moment. Like a patient in denial, our 
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CLOCKWISE FROM TOP LEFT: 
Lisa Sanders left a successful jour¬ 
nalism career for medicine after 
watching a medical correspondent 
save a drowning woman. 
Sherwin Nuland found a second 
calling when he began writing 
biographies of historically impor¬ 
tant doctors. 
Richard Selzer began writing when 
he was a medical officer in the 
Army during the Korean War. 
“In order to keep my sanity, at the 
end of every day, I would write 
down what happened.” 
Dora Calott Wang used her own 
experiences as a psychiatrist to 
tell the story of changes wrought 
by for-profit health care. “It’s 
ridiculous,” she said, “that doctors 
should go through all this training 
and have to defer to the decisions 
of insurance clerks.” 
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Doctors who write 
nation needs to face the truth. How can anything in this nation 
be healthy until we’ve healed the medical system?” 
Despite her frustrations, Wang says, “I still think 
we’re in a very privileged position of seeing so much of life 
and gaining the wisdom from knowing so many lives in 
intimate detail.” 
A career in medical journalism 
Randi Hutter Epstein had already been accepted by the 
Columbia University Graduate School of Journalism when 
she arrived in New Haven for her medical school interview. 
She expected to be rebuffed when she told the admissions 
committee that she did not plan to become a clinician but 
rather to write about medicine. Instead, she found encour¬ 
agement. And she got in. 
By the end of her second year, however, Epstein had 
qualms. “I thought if I’m not going to practice, I should drop 
out of med school.” Robert H. Gifford, m.d., hs ’67, then the 
associate dean for student affairs, refused to let her leave. 
“He said, ‘What you gain from being on the wards during 
third and fourth year will help you with your writing.’ ” 
After graduation, Epstein worked as a medical 
reporter for the Associated Press (AP) in London. “There 
were glimmers where 1 thought maybe I could practice and 
write. But I think my heart was in reporting and investigat¬ 
ing, which is so time-consuming and I never thought I’d 
be able to do it all—have a full-time practice, write reported 
pieces, and raise my children,” says Epstein, the mother of 
four children. “I’m incredibly impressed with the doctor- 
writers who are balancing it all.” 
She faced culture shock working for the AP. As a 
medical student, she says, “I was very used to talking about 
‘maybes’ and gray zones.” She quickly discovered that wire 
service writing is “black and white.” “It scared me at first,” 
she says, “because nothing is certain.” And although her 
editors scanned her prose for style, “no one checked my 
facts. ... But I did, relentlessly. My professors continued to 
be my professors. I learned so much from them while I was 
at Yale, and then I relied on them when I got my job at the 
Associated Press. I had a lot of their home numbers, and 
I’ve woken some of them up, saying, ‘I need a quote, I need 
your advice; I’m on deadline!’ This was before e-mail.” In 
addition, she says, “I kept my medical school biostatistics 
book by my side. There were certain epidemiologists I knew 
really well.” 
Now an independent journalist and author, Epstein 
contributes to the “Science Times” section of The New 
York Times and has written for publications including 
GlobalPost, Psychology Today, and The Washington Post. She 
finds satisfaction not only in providing information about 
medical topics but also in creating a sense of community 
among readers. She remembers in particular a story for 
the Ladies’ Home Journal in which she wrote about women 
with autoimmune diseases. Readers told her that they “felt 
validated, with their fears and worries, when they read about 
these other women going through the emotional turmoil of 
living with these chronic diseases.” Her first book. Get Me 
Out: A History of Childbirth from the Garden of Eden to the 
Sperm Bank, was published in 2010. 
Dedicated to a poem 
When Dagan Coppock is working on a poem, it follows him 
everywhere, feeling this presence is what Coppock calls 
being “dedicated to a poem.” 
“It moves in and out of your consciousness during the 
day,” says Coppock, who recently left a primary care practice 
near Boston to spend two years in Botswana as a preceptor 
for Beth Israel Deaconness Medical Center training program. 
“If you don’t write it down, you’ll forget it. I think that poets 
in the course of living are always on guard for inspiration,” 
he says. “They are looking for the clues, the god in the gaps, 
in every moment. If a poet suddenly thinks his love is like 
a red, red rose, he wants to know why—what’s the connec¬ 
tion? A poem is like a bit of detective work to connect the dots 
between the two apparently disparate aspects of a metaphor. 
“A doctor is a detective, too. ... A doctor tries to make a 
diagnosis or sort out some other problem, and a connection 
can seem just as revelatory or inspirational. Maybe I’m biased, 
but I think that primary care providers get more chances at 
such moments.” 
Coppock never considered making poetry his career. 
“I always thought that it was never enough to be only a poet. 
You have to be a mechanic and a poet, a teacher and a poet, a 
chef and a poet, a doctor and a poet. ... it doesn’t matter. You 
have to be something else—something which gives impulse 
to your writing. Besides, I would have been too lonely being a 
writer alone.” 
Between college and medical school Coppock traveled 
to Nigeria on a f ulbright grant to write poetry and study the 
poetry of traditional healers. “When I came to Yale med, I 
needed a reader, a mentor, someone to help me find a com¬ 
munity. Dr. Selzer was that person. With his help, we started 
a writing group. It kept me sane and healthy and circum¬ 
spect during medical school.” Coppock co-edited a collec¬ 
tion of poetry by medical students and residents titled Body 
Language: Poems of the Medical Training Experience, published 
in 2006. 
He sends his poems to medical journals rather than 
literary magazines—his work has appeared in JAMA: The 
Journal of the American Medical Association and in the Journal 
of General Internal Medicine. Poetry in medical journals, he 
believes, validates the connection between medicine and the 
humanities. Especially as doctors are pressured to do more 
in less time, he says, “Medicine can become a very automatic 
field, where we don’t reflect.” Poetry, he says, “forces you to 
think about things.” 
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What might be missing from life 
In the late 1980s, cbs television producer Lisa Sanders was on 
I the banks of the Nantahala River in North Carolina taping a 
, show on Whitewater rafting with health reporter Bob Arnot, 
, M.D. Suddenly Arnot disappeared. 
When Sanders spotted him again, Arnot was on his 
knees beside the churning river, doing cpr. Sanders was sur- 
I iprised by the rush of admiration she felt as he revived a woman 
who had nearly drowned. 
“It was the first time I’d thought about what might be 
missing from my life,” she says. She’d won an Emmy Award 
and had worked in news for three major networks, but Sanders 
left a 12-year television career to study medicine in 1992. 
As it turns out, internal medicine has reconnected 
her with journalism. Since 2002, Sanders has written the 
“Diagnosis” column for The New York Times Magazine. The col¬ 
umn allows her to think about what she finds most compelling 
about medicine: the complex deliberations that lead to diagno¬ 
sis. Before studying medicine, she’d imagined diagnosis to be 
formulaic; plug in facts, find answer. 
Each monthly column tells the story of a patient with 
a constellation of baffling ailments. The story moves from 
mysterious symptoms to false diagnoses to resolution. Since 
March, the column has also appeared online (minus the 
correct diagnosis). The first time the column went online, 
11,400 readers contributed guesses in less than two days. That 
response pleases Sanders: “I want this to be a conversation.” 
The column brought her back to television when pro¬ 
ducer Paul Attanasio asked Sanders to serve as technical advi¬ 
sor for a new medical drama “about an irritating, arrogant, 
drug-addicted doctor who hates patients and loves diagnosis.” 
“That’s not going to fly,” she remembers thinking. 
It flew: House M.D. has been an international hit on 
Fox since beginning its run in 2004. Sanders invents medi¬ 
cal problems for the show’s characters. And although she also 
reviews scripts for medical accuracy, she doesn’t mind the 
liberties that House takes with matters of law: House frequently 
orders his team to break into patients’ homes to And clues to 
their ailments. “I think it’s a very good metaphor for the prob¬ 
ing, impertinent questions that doctors ask—for that violation, 
that intimacy with a stranger, that is part and parcel of going 
to see a doctor,” says Sanders. That intimacy, she says, “is why 
I that trusting relationship has to be there.” 
Sanders often writes before dawn. She enjoys the silence 
of the house and the absence of inquiries about errant items of 
clothing and similar matters from her two teenage daughters. 
Rising early allowed her to write her latest book. Every Patient 
I Tells a Story: Medical Mysteries and the Art of Diagnosis, while 
keeping up with her day job teaching Yale residents and seeing 
patients at Waterbury Hospital. 
fust as seeing patients provides material for Sanders’ 
writing, writing informs her work as a doctor and reminds 
her that seemingly routine symptoms sometimes signal 
something unusual. “We have a limited number of symptoms 
and a vast spectrum of diseases,” she says. “Writing reminds 
you every day that there’s something interesting happening. It 
may remind you that curiosity killed the cat—but satisfaction 
brought it back.” ym 
—Cathy Shufro is a freelance writer in Woodbridge, Conn. 
LaLisa Alita Anderson, M.D. ’01 published a collection of oral histories 
titled On the Other Side: African Americans Tell of Healing in 2001. In 2006 
she was an American Philosophical Society Fellow. About five years ago she 
placed her creative writing on hold; she presently works in a medical com¬ 
munications agency in Atlanta that supports pharmaceutical clients as they 
conduct oncology research and bring oncology drugs to market. 
Pauline W. Chen, m.d., hs ’98 is a surgeon, author, and columnist for 
The New York Times. She published Final Exam: A Surgeon’s Reflections on 
Mortality in 2007. 
John A. Elefteriades, M.D. ’76, HS ’81, FW ’83 chief of cardiothoracic 
surgery and the William W.L. Glenn Professor of Cardiothoracic Surgery, 
has written four textbooks, including Your Heart: An Owner’s Guide, with 
Lawrence S. Cohen, m.d., hs ’65, the Ebenezer K. Hunt Professor Emeritus 
of Medicine. Elefteriades also wrote The Woman’s Heart: An Owner’s 
Guide, with Teresa Caulin-Claser, m.d., and he is the author of Transplant, 
a medical thriller. 
Robert L. Klitzman, M.D. ’85 wrote When Doctors Become Patients in 
response to his own grief over the death of his sister, who died in the 
World Trade Center on September n, 2001. Klitzman, a research scientist 
and associate professor of clinical psychiatry at the hiv Center for Clinical 
and Behavioral Studies at the New York State Psychiatric Institute and at 
Columbia University, is the author of five other books. He got his start 
as a writer by reviewing books at Yale, where his role models included 
Richard A. Selzer, M.D., HS ’61, and Sherwin B. Nuland, M.D. '55, HS '61. 
Bernie S. Siegel, M.D., HS ’61 has written frequently about medicine and 
the healing process. His books include Faith, Hope & Healing: Inspiring 
Lessons Learned from People Living with Cancer; A Book of Miracles: 
Inspiring True Stories of Healing, Gratitude, and Love; and Help Me to 
Heal: A Practical Guidebook for Patients, Visitors, and Caregivers (Essential 
Tools, Strategies, and Resources for Healthy Hospitalizations and Home 
Convalescence). 
Alan A. Stone, M.D. ’55 the Touroff-Clueck Professor of Law and 
Psychiatry at Harvard Law School, uses literature to interest students 
in the themes of psychology and justice. He is the author of Movies and 
the Moral Adventure of Life and Law; Psychiatry and Morality: Essays and 
Analysis; and co-editor of The Abnormal Personality through Literature 
with Sue Smart Stone. 
Are you a physician who writes or works in another of the fields we’ll be 
profiling in our “Alumni Career Paths” series? Do you know medical school 
alumni, former Yale house staff, or fellows who are? Send us the names 
and then check the Web edition of Yale Medicine to view an expanding list of 
alumni with similar interests. You can write to us atymm@yale.edu and view 
the list at yalemedicine.yale.edu. 
“Alumni Career Paths” future topics: 
• International health and research 
• The front lines of clinical practice 
• Academic medicine 
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A 21st-century NGO 
\ handful of Yale medical students opened a clinic and hospital in a remote corner of Nepal, 
^^rom 8,000 miles away, via the Internet, they provide support. Here’s how they do It. 
By Stephanie Soucheray 
The last time Ryan Schwarz, m.d. ’ii, m.b.a. ’ii, was in 
Kathmandu, he told a Nepali man that he was traveling to 
Achham, a district in the western part of the country, on 
behalf of Nyaya, a nonprofit health organization. 
“The man looked at me and smiled, and said, ‘Assam 
is a beautiful part of India’,” Schwarz said. “I told him, ‘No, 
Achham. Here in Nepal.’ He just looked and shrugged. He 
had never heard of it.” 
Achham, a region of 250,000 people, is South Asia’s 
land that time forgot, or more likely ignored. The journey 
from Kathmandu, about 260 miles away, can take up to 
three days—more if monsoons have washed out the few dirt 
roads on which rickety buses travel. The region is slowly 
recovering from a decade-long civil war and suffering the 
effects of HIV, malnutrition, and lack of maternal care. Five 
years ago, the region didn’t have a single allopathic doctor. 
Now Achham is home to Nyaya Health, a nongovern¬ 
mental organization (ngo) started by three Yale students in 
2005. Nyaya runs the Bayalpata Hospital, a fully operational 
free hospital that is staffed by Nepali health care workers 
and treats more than 150 patients per day. A dedicated— 
and e-mail addicted—group of Yale medical students and 
graduates monitors the operations of the hospital from their 
smartphones in New Haven, Boston, and San Francisco. 
They do not see themselves as “running” the hospital and 
are careful on their yearly visits not to interfere with its day- 
to-day operations. Instead, the Yale students and graduates 
handle donations, publicity, and finances so that their vision 
of a free health care system in rural Nepal can be realized 
by the people to whom it matters the most: the Nepalese. 
Nyaya, which means “justice” in Nepali, is not the 
first NGO started by Yale medical students, but it may be the 
first NGO undertaken by members of the millennial genera¬ 
tion—people born between 1980 and 1995. Nyaya’s found¬ 
ers use the Internet; involve the local government to ensure 
that their efforts will be protected; and don’t worry about the 
lack of an office, a proper mailbox, or even roads. 
“A different generation, a generation ahead of us, 
may not have the same understanding of our work that we 
do,” said Schwarz. “But we believe that free health care is 
every citizen’s right, and we think of citizenship as global, 
not national.” 
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20 A 21st-century NCO 
It’s that philosophical underpinning and the explosion 
of the millennials’ interest in global health—not to mention 
the Internet—that allows Nyaya to create a radical health care 
system 8,000 miles away from New Haven and, in the process, 
show how to build a 21st-century ngo. 
An encounter in New Haven 
|ason Andrews, m.d. ’07, visited Achham in 2006 between his 
fourth and fifth years of medical school. His wife, a Nepalese 
photographer, was working on a documentary there about 
women and children with hiv—an infection carried back to 
Achham by men who had traveled to India for work. Noting 
the region’s abandoned hospital, Andrews saw an opportunity 
in a country that had fascinated him since his undergradu¬ 
ate days at Yale when he met a Nepali chef at the Royal India 
Restaurant in New Haven. “I came back and e-mailed two of 
my friends about the abandoned hospital,” Andrews said. 
Achham was supposed to be the site of a district 
hospital 25 years ago, but at the last minute, in response 
to demands from a community with more political infiu- 
ence, the government moved the hospital to a location eight 
hours away. “There was a devastating history to that hos¬ 
pital, which we later confirmed with several people,” said 
Andrews. Troops arrived after the change was announced 
and six protesters were killed. 
With no hospital in the region, doctors and nurses 
moved elsewhere and Achham remained a health care 
desert. In Nepal, health care is based on a user-fee system 
largely out of reach to the rural poor. Because the region is 
so isolated and travel so difficult, the lack of accountability 
in government-run clinics has resulted in a shadow medical 
economy. Rural doctors take supplies and drugs from gov¬ 
ernment clinics and open up private practices in small 
villages, selling expired antibiotics at exorbitant prices. 
Andrews, along with Duncan Smith-Rohrberg Maru, 
M.D. ’09, PH.D. ’09, and Sanjay Basu, m.d. ’09, ph.d. ’09, 
decided that they could change that landscape. They knew, 
however, that implementing their vision of a free first-world 
health care operation in the abandoned hospital was an ambi¬ 
tious undertaking in a region where most citizens don’t have 
electricity. So they started with the Sanfe Bagar Medical Clinic. 
“The clinic was in an old grain shed,” said Smith- 
Rohrberg Maru, a resident in medicine and pediatrics at 
Brigham and Women’s Hospital in Boston. “It was a classic 
NGO beginning, but we knew it was not possible to start off 
with a full hospital.” 
After organizing a pharmacy, painting the walls, and 
repopulating the clinic with Nepalese doctors, Nyaya turned 
over the clinical operation to the Nepali government in May 
2009. That last step is a bit antithetical to traditional ngo 
models, but it’s vital to the Nyaya vision. 
“It was never meant to be a drop-in or expat-staffed 
model,” said Andrews, an infectious diseases fellow at 
Massachusetts General and Brigham and Women’s hospitals. 
“It’s not Doctors Without Borders. The idea has always been to 
create a sustainable model of health care for that community.” 
Nyaya staffed both the clinic and the hospital with local 
Nepalese—everyone from the hospital’s accountant to the 
medical director, chef to ambulance driver is a local. Though 
Yale students are encouraged to visit Achham, their role is 
always to help the hospital meet its needs—not get in the way. 
With the free clinic in the hands of the Nepali govern¬ 
ment, Nyaya turned its sights back to Bayalpata Hospital, 
which opened on June 21, 2009. With a staff of more than 30 
Nepalese health care providers, the hospital tends to more than 
3,000 patients per month. 
Working with the local government 
“How people live in Achham is fairly typical for rural and 
poor Nepal, but the isolation, the lack of transportation, and 
the lack of services set it apart,” said Bibhav Acharya, m.d. ’ii, 
a resident in psychiatry at the University of California, San 
Francisco. Acharya, the executive vice president of Nyaya, is 
Nepalese but hails from the central part of the country. 
Achham looks like a lot of other impoverished places 
around the world. Multiple generations of families live in 
mud homes. Agriculture is the only way to make a living, but 
a feudal social system means a handful of families control 
the debts, crops, and fates of most people in the region. Most 
of the population is illiterate and few have ever had access to 
regular health care. 
When Andrews, Smith-Rohrberg Maru, and Basu 
approached Kaveh Khoshnood, m.p.h. ’89, ph.d. ’95, assis¬ 
tant professor of epidemiology (microbial diseases), to be fac¬ 
ulty advisor for their project in 2006, Khoshnood asked the 
same skeptical questions he asks of any students thinking of 
starting an ngo. 
“Is there a need for this? Should somebody else be 
doing this? Can you really direct something there from here?” 
asked Khoshnood. “But they had considered [those things]. 
There was simply no other health care provider.” 
Khoshnood was surprised by how thoroughly the 
founding members of Nyaya had thought out their plans. 
Khoshnood said students often spew a lot of rhetoric about 
“long-term capacity building”—a buzz phrase that means 
whatever an ngo creates will endure long after its creators 
have moved on. Nyaya has figured out one counterintui¬ 
tive way to make sure their ngo is sustainable: involve the 
government. “So many ngos get frustrated by corruption 
and bureaucracy in governments, so they just bypass them,” 
said Khoshnood. “But then, when the ngo leaves there’s a 
vacuum of services.” 
Nyaya has secured government approval for every 
action taken in Achham, not always an easy feat given the 
region’s isolation and political turmoil. Between 1996 and 
2006 Maoist insurgents were fighting the government in a 
21 
war that ended when the ruling monarchy tumbled. The 
democratic government, however, hasn’t been exactly 
to pour money into the region. Furthermore, foreign 
and climbers, the bulk of the country’s tourist trade, 
the lowland west in favor of the high peaks of eastern 
., home to Mount Everest. “Most money doesn’t travel 
west,” said Schwarz. “Tourism money stays in the east.” 
By involving the government in their plans, Nyaya has 
ensured that some government money will be planted in the 
hospital and that Nyaya will be accountable to the community 
lit serves. The government funded the clinic’s first health 
; officer, and Nyaya takes pride in the government’s regular—if 
small—allowances for daily operations. Most of the more 
than $500,000 Nyaya has raised since its founding—about 
74 percent—comes from individual donors, with foundations 
providing another 19 percent. 
“If we work with the government we can ensure that if 
we run out of money, they can step in,” said Acharya. “If we 
collaborate, we help make the government responsible.” 
Getting the proper permits, proposals, and agreements 
was a headache for the founding members of Nyaya, but 
cooperating with a government is not nearly as difficult as 
confronting a society that places a greater value on health care 
for men than for women. 
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22 A 21st-century NGO 
ABOVE LEFT Every day the 
Bayalpata Hospital outpatient 
department sees between 150 
and 200 patients, along with 
many more in the emergency 
room and inpatient wards. 
ABOVE RIGHT Amir Bista, medi¬ 
cal director of Bayalpata Hospital, 
sees patients in the outpatient 
department. 
RIGHT More than three quarters 
of the patients at Bayalpata 
Hospital walk more than three 
hours each way, and more than 20 
percent walk more than 10 hours 
each way, crossing mountains and 
rivers, where no roads or other 
means of transport exist. 
Yale medical and Yale College 
students, including Bibhav 
Acharya, M.D. ’11; Jason Andrews, 
M.D. ’07; Chhitij Bashyal, b.a. ’io; 
Sanjay Basu, m.d. ’09, ph.d. ’09; 
Jen Garnett, m.p.h. ’08; Jen 
Guo; Duncan Smith-Rohrberg 
Maru, M.D. ’09, PH.D. ’09; Ruma 
Rajbhandari; Ryan Schwarz 
M.D. 'n, M.B.A. ’ll; and Aditya 
Sharma m.d. ’07, have led the 
Nyaya team since 2006. Despite 
numerous challenges, they have 
succeeded in developing a health 
system that provides care to a 
region of hundreds of thousands 
of people. 
“In this part of Nepal, there is a cultural stigma against 
blood,” said Acharya. “It’s thought of as unclean.” That means 
that during menstruation and for ii days after childbirth, 
women are isolated and made to sleep in cow sheds. And most 
families don’t believe women’s health is “worth” the expense. 
While conducting a survey to gauge community health 
needs, Acharya encountered a very sick woman outside a small 
private medical practice near Achham. “She and her son came 
; out of a clinic. I asked her what her symptoms were, she said she 
I had had a fever for several weeks,” said Acharya. “I asked her 
j what kind of treatment she got. She said, ‘What do you mean.^’ ” 
j The woman wasn’t there for herself—her son was 
j showing signs of illness. Her husband, she said, had told her 
' not to tell the doctor she was ill, too—they could afford medi- 
, cal care only for the male child. 
I Nyaya found a sustainable and double-pronged way 
to overcome the lack of health care for women; Nyaya health 
care is free, so there’s no argument within families about 
;who may get care. And the female patients trust their peers, 
the community health care workers (chw), who are nearly all 
women. A chw can have a nurse- or physician assistant-like 
role in the hospital, or act as a community educator. In most 
hospitals in Nepal chws are unpaid, but those who work for 
Nyaya make a decent living. Nyaya also supplements their 
government medical training with specialized programs. So 
far, the model has worked—65 percent of all patients seen at 
the hospital are women. 
Product of a new generation 
Nyaya’s directors and founders are young, not unusual for an 
NGO, but remarkable for a successful one. In many ways, Nyaya 
is the product of a generational shift reflected in its founders, 
who value flexibility, transparency, and social connectedness, 
and see health as a global right. 
Members of their generation have come to expect sev¬ 
eral job or career changes over a lifetime, a handful of homes, 
and maybe even more than one marriage. They also live their 
lives online, on social networks, and on mobile phones. With 
change and flexibility a cornerstone of their lives, Nyaya’s 
founders were willing to allow the hospital to define itself in a 
way that serves the community. “We started out with the hiv 
focus,” said Acharya. “But then we saw children dying of diar¬ 
rhea and malnutrition, so we had to shift our focus. Our ques¬ 
tion is always, ‘What’s killing people.^’ ” 
Along with flexibility came transparency, which has set 
the organization apart in a sea of 32,000 ngos in Nepal. “With 
so many ngos, you have no idea of what actual work they do,” 
said Khoshnood. “With Nyaya you can go to the blog daily and 
see that they had an immunization campaign, or that they 
painted a building on the hospital campus.” 
Nyaya is an open-source organization—every financial 
statement and every up-and-down confronting the organiza¬ 
tion can be found online, either on its blog or its wiki page. 
“We don’t keep things hidden as far as how we operate,” said 
Andrews. “Any volunteer can read our financial model, our 
clinical model—it’s all totally open. Being open has let more 
people come in.” Khoshnood said donors are attracted to this 
transparency and the instant gratification of seeing their 
efforts on the Web. 
The Web doesn’t just make this transparency possible— 
it allows Nyaya to function. Such normal hospital functions as 
reviewing charts or offering advice on a mysterious case take 
place via the Internet or over a satellite phone service that is one 
of the hospital’s highest monthly bills. Andrews oversees weekly 
mortality and morbidity meetings online, and because of the 
organizational structure of Nyaya (new presidents assume their 
roles every 18 months or so), constant e-mail is essential. 
Familiarity with the Internet is only one element of a 
generational shift. Where do the motivation and inspiration to 
start such a project come from? That answer lies in an even 
larger question: why is the millennial generation so taken with 
global health? 
As a professor of epidemiology, Khoshnood has seen an 
explosion in global health course offerings, student interest, 
and volunteerism in the last 10 years. He said that the hiv epi¬ 
demic, the resulting activism, 9/11, and a realization that events 
around the world can have repercussions for the United States 
led this generation toward thinking of global health as both 
a vocation and a career. The Internet and mogul foundations 
like the Gates Foundation made having a career in such a field 
seem possible. 
Schwarz came to Nyaya with a deeply held conviction, 
shared with other members, that health care is a fundamental 
human right. Everything flows from this uncomplicated belief 
Though Nyaya has been successful, the members say 
they’re just starting to feel proud of their health care model, 
and it’s nowhere near perfect. First, they need a surgical 
ward—too many women who make it to the hospital’s mater¬ 
nity ward staffed with six full-time midwives die when a cesar¬ 
ean is needed. Second, since the organization is flexible, it’s 
always looking for holes in its services. In that way, the hospital 
will never be perfect or complete. 
Only when the members slow down and look up from 
the constant barrage of e-mails do they allow themselves to be 
a bit impressed with their work. They’ve turned an abandoned 
hospital in a small corner of the world into a house of healing 
and justice, ym 
—Stephanie Soucheray is a freelance writer based in Durham, North Carolina. 
To read more about Nyaya's work and find out how you can help, please visit 
www.nyayahealth.org. 
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Faculty 
Paul Cleary 
Public Health dean 
appointed to second term 
PAUL D. CLEARY, PH.D., the Anna 
M.R. Lauder Professor of Public 
Health, was reappointed in June 
to a second five-year term as dean 
of the School of Public Health 
and chair of the Department of 
Epidemiology and Public Health. 
In his first term, applications for 
admission to the School of Public 
Health increased 30 percent. In 
September 2009, the new m.p.h. 
Global Health Concentration 
admitted its first cohort of 
students. The school’s doctoral 
program also has been indepen¬ 
dently recognized by the National 
Research Council of the National 
Academy of Sciences as one of the 
finest in the nation. 
Cleary has developed and 
expanded the school’s public 
health service and practice 
activities. A sustainable model 
for community service has been 
created through the new Office 
of Community Health, which 
focuses on regional programs 
and activities aimed at improv¬ 
ing the health of New Haven- 
area residents. In addition, 
the school has established the 
Community Alliance for Research 
and Engagement, a collaboration 
with the Yale Center for Clinical 
Investigation and the city of 
New Haven’s municipal offices, 
school system, and community 
organizations. 
The school has expanded its 
research portfolio under Cleary’s 
direction, especially in cancer pre¬ 
vention. He has also strengthened 
the school’s ongoing research on 
such global Infectious diseases as 
HIV/AIDS, as well as research on 
related legal and policy issues. 
The school is also deeply involved 
in Yale’s Global Health Initiative. 
Ruslan Medzhitov 
Shaw Prize awarded to 
immunobiologist 
RUSLAN M. MEDZHITOV, PH.D., 
the David W. Wallace Professor 
of Immunobiology, a member of 
Yale Cancer Center, and a Howard 
Hughes Medical Institute inves¬ 
tigator, is one of three scientists 
awarded the Shaw Prize in Life 
Science and Medicine for 2011. 
The Shaw Prize consists of three 
annual prizes: astronomy, life 
science and medicine, and math¬ 
ematical sciences. Each carries an 
award of $1 million. 
Medzhitov shares this year’s 
prize in life science and medicine 
with Jules A. Hoffmann, ph.d., 
professor at the University of 
Strasbourg, France; and Bruce 
A. Beutler, M.D., chair of the 
Department of Genetics at the 
Scripps Research Institute, La Jolla, 
Calif. The Shaw Prize Foundation 
honored them “for their discovery 
of the molecular mechanism of 
innate immunity, the first line of 
defense against pathogens.” 
Alanna Schepartz 
Director named to West 
Campus institute 
ALANNA SCHEPARTZ, PH.D., the 
Milton Harris ’29 ph.d. Professor 
of Chemistry, has been named 
director of the Chemical Biology 
Institute on the West Campus. 
Schepartz was chair of the faculty 
advisory committee that met to 
define and develop the institute 
over the past year. 
Schepartz will retain her 
position as professor in the 
Department of Chemistry and the 
Department of Molecular, Cellular 
and Developmental Biology and 
will split her time between the 
West Campus and Science Hill. 
The institute will promote 
innovation at the intersections of 
different scientific disciplines— 
not only in chemistry and biology 
but also in engineering, physics, 
and medicine. Chemical biology 
involves both synthetic biol¬ 
ogy—the design and synthesis 
of new molecules to tackle prob¬ 
lems that arise in biology and 
medicine—and the development 
of new reactions, materials, and 
processes inspired by those found 
in nature. 
Schepartz came to Yale in 1988. 
Over the past 23 years, her lab has 
broken fresh ground in designing 
and developing new molecules 
as tools to monitor, manipulate, 
or mimic interactions between 
and among proteins in live cells. 
Her lab’s work in developing the 
first synthetic protein was named 
one of 2007’s “most important 
research advances” in chemistry 
by Chemical & Engineering News. 
Robert Sherwin 
Diabetes researcher 
honored 
ROBERT S. SHERWIN, M.D., 
the C.N.H. Long Professor of 
Medicine, chief of the Section 
of Endocrinology, and director 
of the Yale Center for Clinical 
Investigation and the Diabetes 
Endocrinology Research Center, 
received the American Diabetes 
Association’s prestigious 2011 
Albert Renold Award in June. 
The Albert Renold Award is 
presented to an individual whose 
career is distinguished by outstand 
ing achievements in the training 
of diabetes research scientists and 
facilitation of diabetes research. 
Sherwin has served as director of 
the training program in diabetes 
and metabolism at Yale for 26 
years, where he has taught many 
diabetes researchers to design 
studies, collect and analyze data, 
and present the results. 
25 NOTES 11 
karen Peter Cresswell 
{inderson 
.even faculty members at the 
i.chool of Medicine were among 
; '5 of the state’s leading experts 
n science, engineering, and 
technology elected to the Con- 
lecticut Academy of Science 
ind Engineering in May. 
The faculty members are: 
Caren S. Anderson, ph.d., profes- 
■ or of pharmacology; Thomas O. 
i Carpenter, m.d., professor of pe- 
;liatrics and of orthopaedics and 
ehabilitation; Peter Cresswell, 
’H.D., the Eugene Higgins 
Professor of Immunobiology and 
! Professor of cell biology and of 
iermatology; Robert S. Galvin, 
w.D., adjunct professor of medi- 
;ine and health policy; Jeffrey R. 
jruen, m.d., professor of pediat¬ 
rics, genetics, and investigative 
iWdicine; Charles J. Lockwood, 
^.D., former chair. Department 
pf Obstetrics, Gynecology and 
Reproductive Sciences; and 
Ruslan M. Medzhitov, ph.d., the 
David W. Wallace Professor of 
immunobiology. 
Ralph E. Hoffman, m.d., fw ’8o, 
professor of psychiatry; and 
Flora M. Vaccarino, m.d,, hs ’71, 
Harris Professor in the Child 
Study Center and professor of 
neurobiology, are among 15 re¬ 
searchers to share in $1.5 mil¬ 
lion in narsad Distinguished 
Investigator Grants. Each grant, 
awarded by the Brain & Behav¬ 
ior Research Foundation, pro¬ 
vides funding of up to $100,000 
for a one-year study of brain and 
behavior disorders. 
James A. Brink, m.d., professor 
and chair of diagnostic radiolo¬ 
gy, was elected president of the 
American Roentgen Ray Society 
in June. The society is dedicated 
to the advancement of medicine 
through the science of radiology 
and its allied sciences. 
Jeffrey Gruen James Brink Eve Colson Alan Dardik 
Eve R. Colson, m.d. ’89, associate 
professor of pediatrics, has been 
named a Macy Faculty Scholar by 
the Josiah Macy Jr. Foundation. 
The award provides $100,000 in 
salary support for each of two 
years and is given to as many as 
five American faculty members 
in health professions education 
each year. The program aims to 
accelerate reforms in education 
for health professionals and 
to accommodate the dramatic 
changes occurring in health care. 
Alan Dardik, m.d., ph.d., associate 
professor of surgery (vascular), 
has been appointed assistant 
editor of the Journal of Vascular 
Surgery, which provides vascular, 
cardiothoracic, and general 
surgeons with the most recent 
information in vascular surgery. 
Myron Genel, m.d., professor 
emeritus of pediatrics, received 
the President’s Certificate for 
Outstanding Service from the 
American Academy of Pediatrics 
in May. Genel was honored at 
the Pediatric Academic Societ¬ 
ies’ annual meeting in Denver. 
Genel ended his 27-year tenure 
as chair of the Public Policy 
Council, an advocacy voice of 
academic pediatric societies, in 
December 2010. 
Akiko Iwasaki, ph.d., associate 
professor of immunobiology 
and of molecular, cellular, and 
developmental biology, was 
named a recipient of the 2012 
Eli Lilly and Company Research 
Award in August. The award, 
given by the American Society 
for Microbiology, recognizes 
fundamental research of 
unusual merit in microbiology 
or immunology by an individual 
on the threshold of his or her 
career. Iwasaki’s research 
focuses on innate viral recogni¬ 
tion mechanisms and their link 
to adaptive immunity. 
William L. Jorgensen, ph.d.. 
Sterling Professor of Chemistry, 
was among the 72 new mem¬ 
bers inducted into the National 
Academy of Sciences in May. 
Jorgensen, a co-founder of Rib-X 
Pharmaceuticals in New Haven, 
specializes in computational 
methods for drug design. 
Megan C. King, ph.d., assistant 
professor of cell biology, is one of 
15 researchers in the chemical and 
biological sciences named a 2011 
Searle Scholar in April. Each scholar 
will receive $300,000 to support 
their research overthreeyears. 
King will use her award to pursue 
research in mechanical coupling of 
the cell nucleus and cytoplasm. 
Jennifer M. McNiff, m.d., professor 
of dermatology, has received the 
Walter R. Nickel Award for Excel¬ 
lence in Teaching of Dermatopa- 
thology from the American Society 
of Dermatopathology. The award 
recognizes individuals who have 
made outstanding contributions in 
the teaching of dermatopathology. 
Clarence T. Sasaki, m.d. ’66, hs ’73, 
the Charles W. Ohse Professor 
of Surgery and section chief of 
otolaryngology, has been named 
president-elect of the American 
Laryngological Association. Sasaki 
gave the Baker Lecture at the as¬ 
sociation’s annual meeting in Chi¬ 
cago in April. Postdoctoral fellows 
Mikhail Wadie, m.d., and Juan Li, 
M.D., were Jointly honored at 
this meeting with the American 
Broncho-Esophagological Asso¬ 
ciation’s Broyles-Maloney Award. 
M. Bruce Shields, m.d., chair 
emeritus and the Marvin L. Sears 
William 
Jorgensen 
Professor of Ophthalmology 
and Visual Science, was honored 
in June with an international 
ophthalmology symposium to 
mark his retirement. During his 
career. Shields centered his clinical 
practice, research, and teaching 
on glaucoma. Before coming to 
Yale, Shields served as a faculty 
member in the department of 
ophthalmology at Duke Univer¬ 
sity; staff surgeon at the Durham 
(N.C.) Veterans Affairs Medical 
Center; and consultant at the 
Veterans Affairs Medical Center in 
Asheville, N.C. He directed Duke 
University’s Glaucoma Service 
and developed glaucoma treat¬ 
ments involving the application 
of laser technology. 
Brian R. Smith, m.d., chair and 
professor of laboratory medicine, 
has been selected to receive a 
2011 Alternative Training Path¬ 
way Grant from the American 
Society of Hematology. Smith’s 
grant will provide physicians 
specializing in internal medicine 
and pediatric hematology with 
clinically relevant training in 
transfusion and coagulation. 
Eiji Yanagisawa, m.d., hs ’59, clini¬ 
cal professor of otolaryngology, 
received a Presidential Citation at 
the annual meeting of the Ameri¬ 
can Laryngological Association in 
Chicago on April 27. The citation 
recognized his efforts as presi¬ 
dent of several otolaryngology 
societies; an honorary member 
of otolaryngology societies of 
several countries; and a guest 
lecturer around the world. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
26 students 
After five years, haven 
clinic still thriving 
A student-run free clinic on Saturday 
mornings provides health care to 
New Haven’s uninsured. 
The staff meeting starts at 8:30 on 
Saturday mornings. Thirty or more 
students in medicine, nursing, pub¬ 
lic health, the Physician Associate 
Program, and graduate and undergradu¬ 
ate programs—supervised by volunteer 
physicians, nurse-midwives, and physi¬ 
cian associates—gather on the second 
floor of the Fair Haven Community 
Health Center to orchestrate a free clinic 
called HAVEN (haven stands for health 
care, advocacy, volunteerism, educa¬ 
tion, and neighborhood.) over the next 
four hours. The session coordinator 
for the day, Kate Standish, entering 
her second year as a medical student, 
assigns teams of senior clinical team 
members (nursing or third- or fourth- 
year medical students): junior clinical 
team members (first-year medical, 
physician associate, or nursing stu¬ 
dents): and interpreters (students flu¬ 
ent in Spanish) to work with attending 
physicians. Charts are distributed, 
bagels inhaled, and the teams descend 
to the first-floor exam rooms where 
they will provide care to uninsured 
and underserved patients in New 
Haven. About 90 percent of haven’s 
patient base are immigrants. 
Since it opened five years ago, the 
clinic has seen hundreds of patients, 
filled countless prescriptions, referred 
patients to other health care providers 
in New Haven, and provided an 
opportunity for medical, nursing, and 
physician associate students to learn 
in a clinical setting. Six years ago stu¬ 
dents approached Nancy R. Angoff, 
M.p.H. ’81, M.D. ’90, HS ’93, associate 
dean for student affairs, with the idea 
of launching a free clinic in one of 
New Haven’s poorest neighborhoods. 
The students, though enthusiastic. 
il 
: !t 
had little in the way of a business plan 
“I told them, ‘You know a free clinic 
isn’t free,’ ” said Angoff 
The students regrouped and pre¬ 
sented Dean Robert J. Alpern, m.d.. 
Ensign Professor of Medicine, with a 
prospectus that overcame his initial 
reservations. He agreed to provide a 
$20,000 grant. In June, in his State of 
the School address on reunion weekend, 
Alpern called haven “one of the great 
stories” of the School of Medicine. 
The clinic also relies on the support 
of the Fair Haven Community Health 
Center, which provides the space on 
Saturday mornings. “Without them,” 
Angoff said of the health center’s staff 
and administrators, “it could not exist.” 
haven’s mission is hardly novel: 
trainees serving the poor and in the 
process learning at the bedside is 
a pillar of American medicine. But 
HAVEN is also the largest weekly les¬ 
son offered by the medical school in 
how to work in health care. By involv¬ 
ing nursing, physician associate, and 1 
public health students, the clinic is i 
a place where future doctors learn j 
to collaborate with other health care 
professionals—a valuable skill as pri¬ 
mary care increasingly falls to physi¬ 
cian associates and nurses. And unlike 
those in many free clinics, students at 
HAVEN really do work. From running 
the social services referrals depart¬ 
ment to scheduling and providing 
Medical student Leonard Edokpolo examined a 
patient at HAVEN, a student-run free clinic on 
a Saturday morning in June. HAVEN is based in 
the Fair Haven Community Health Center on 
Grand Avenue. 
lifestyle counseling, student volunteers 
at HAVEN get a 360-degree window of 
access into a patient’s life. 
“Whatever it means to live with 
illness, one can’t possibly understand 
that until one works with patients,” 
said Angoff. “haven is an opportunity 
right from the beginning to under¬ 
stand that.” 
1. Medical student Lauren Graber 
spent a year as the inaugural John A. 
Jones-HAVEN Fellow, an honor that 
means she was responsible for orga¬ 
nizing the clinic and performing 
community-based research. Graber said 
HAVEN provides students with a chance 
to care for patients consistently through 
their time at the School of Medicine. 
“Because of the collaboration between 
different years and experience, we have 
first-years reteaching older students 
about the social contextualization of 
care,” Graber said. 
Gontextualization of care is a big 
topic among haven volunteers, haven 
is rooted in understanding New Haven’s 
immigrant population—what countries 
they come from, how they earn money, 
iwhere they get (or don’t get) their grocer¬ 
ies. It’s that holistic approach to care that 
^appealed to Emily Thomas, a medical 
'student who serves as the education co- 
director of HAVEN. 
“These patients need additional 
education and support in order to be 
healthy,” said Thomas. Thomas works 
with the patient lifestyle counseling 
program, ando (“I walk” in Spanish), 
which helps treat chronic disease with 
i nutrition and exercise. On a Saturday 
in June, she found herself making 
j soy smoothies, introducing a Zumba 
I (dance-fitness) class, and counsel¬ 
ing a woman who wanted an iud. To 
steer more patients to ando, and such 
departments as social services and 
j women’s and men’s groups, medical 
; charts now carry a sticker that reminds 
; team members to screen patients for 
food insecurity and daily habits. “For 
me medicine is not performed in a 
vacuum,” said Thomas. “You have to 
understand the patient first.” 
After more than 250 Saturdays 
and 1,000 patient visits per year, the 
directors of haven have learned that 
their clinic can’t do everything. An in- 
house pharmacy was abandoned, and 
urgent care cases are now referred to 
Yale-New Haven Hospital or to Project 
Access, a program in which specialists 
donate free care. Most notably, haven 
patients are now transferred to the reg¬ 
ular Fair Haven clinic after one year. 
Standish said that haven sees itself as 
a “portal to care,” not a long-term solu¬ 
tion for its patients. 
But the clinic is a boon to students 
at the School of Medicine who are 
looking to explore a career in primary 
medicine or to apply the science and 
medicine that they learn in the class¬ 
room. “The first year of med school is 
focused on basic science and classroom 
learning. At haven I go into the com¬ 
munity and learn how to provide clini¬ 
cal care in the type of environment I 
want to work in,” Standish said. 
—Stephanie Soucheray 
TOP TO BOTTOM: 
Clinic directors Julia Lubsen and Kate Standish 
met with student volunteers Jonathan Levin, 
Michael Ma, and Joseph Patterson before the 
clinic opens to patients. 
Medical student Laura West and pharmacology 
student Michelle Mo track prescriptions and 
vaccinations and educate patients about their 
medications. 
Robert Gifford, former deputy dean for education 
at the medical school, served as a preceptor and 
advised students on cases they presented to him. 
Clinic directors Julia Lubsen and Kate Standish 
went over a roster of assignments. 
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28 Alumni FACES 
A friendship endures 
from Yale to Harvard 
After meeting as first-years, two 
doctors make history by becoming 
full professors at Harvard. 
Valerie E. Stone, m.d. ’84, m.p.h., and 
Tina Young Poussaint, m.d. ’83, met at 
the School of Medicine in 1979, when 
they were moving into Harkness Dorm 
as first-year students. They became 
good friends, and despite cross-country 
moves and different medical special¬ 
ties, they have remained close. When 
both landed in Boston—Stone at 
Massachusetts General Hospital (mgh), 
Poussaint initially at mgh and cur¬ 
rently at Children’s Hospital Boston— 
and on the faculty of Harvard Medical 
School (hms), they began meeting 
monthly over dinner to catch up on 
their lives and careers. Recently their 
dinner was also a celebration—Stone, 
an infectious disease specialist and 
internist, and Poussaint, a neuroradi¬ 
ologist and expert in neuro-oncologic 
imaging, had just been named full pro¬ 
fessors, making them the first African- 
American women to hold this rank in 
their respective departments, medicine 
and radiology—and only the second 
and third African-American women to 
achieve this rank at hms. 
Though both women have CVs 
as thick as novels, becoming a full 
professor is often uncharted terri¬ 
tory for even the most accomplished 
black women doctors. At a social 
gathering with fellow female African- 
American Harvard associate profes¬ 
sors a few years ago. Stone recalled, 
the group knew of only one black 
woman who had been named a 
professor at hms—in the Department 
of Psychiatry—about two decades 
earlier. That professor had since left 
Harvard and the group wondered 
whether another black woman would 
ever be named a full professor there. 
“We had just gone on so long with¬ 
out one, and history tends to predict 
history,” said Stone, who is also the 
first African-American woman on 
Massachusetts General Hospital’s staff 
to be named a full professor. “But I 
never thought that it was impossible for 
one of us to be promoted to full profes¬ 
sor—challenging, but not impossible. 
I really felt that it was just a matter 
of time for the medical school, and a 
matter of reaching the required level of 
achievement for one (or more) of us.” 
Both Stone and Poussaint said the 
lack of other female African-American 
full professors reflects the scarcity of 
minorities in medicine. “There are 
very few minority women who become 
doctors,” said Stone. “An even smaller 
percentage of those women go into 
academic medicine and many of those 
who start out in academic medicine 
don’t ‘stay the course’ for a variety of 
reasons, including the difficulties of 
getting grant funding and the paucity 
of minority mentors.” 
Poussaint, who directs the Neuro¬ 
imaging Center for the Pediatric Brain 
Tumor Consortium at Children’s 1 
Hospital Boston and in 2010 co¬ 
authored the Atlas of Pediatric Brain , 
Tumors, didn’t let the fact that none | 
of her career mentors or role models 
looked like her deter her from climb¬ 
ing the academic ladder. “If you perse- . 
vere and are strong and determined, 
anything is possible in 2011,” said 
Poussaint, the first female African- ; 
American professor at Children’s 
Hospital Boston. “My hope is that , 
academics in medicine will eventual- 
ly better reflect the composition of 1; 
this country.” | 
In Stone and Poussaint’s class at j 
Yale there were three African-American ; 
women and seven African-American [ 
men out of 102 students. Poussaint, a 
graduate of a women’s college, never , 
felt marginalized as part of a minor¬ 
ity group, noting that she was close to 
classmates of all races. “I went to Mount, 
Holyoke College, so for me diversity alsc; 
included men and women in the class¬ 
room together,” she said. 
There were times, however, during ( 
Poussaint’s first year when admin¬ 
istrative staff would call her by the 
names of the other black women in 
the class. “We three looked really dif¬ 
ferent, so it was clear we were just not 
being looked at very closely as indi¬ 
vidual human beings,” said Poussaint, 
Tina Poussaint and Valerie Stone became fast 
friends at the School of Medicine. They are 
among the first African-American women to 
receive tenure at Harvard Medical School. 
who is married to noted child psy¬ 
chiatrist and Harvard professor Alvin 
Poussaint, m.d. Together they have an 
, ii-year-old daughter. I Stone has a stepdaughter, a senior 
at Georgetown University, with her 
long-term partner, a research scientist 
jat HMS and the Beth Israel Deaconess 
Medical Center. 
Stone said that she is one of a 
number of those in her generation of 
physicians who were moved to make a 
difference in a disease which was first 
described while she was in medical 
school: AIDS. “I was a third-year medi¬ 
cal student when I first remember 
hearing about it,” said Stone. “I was 
fascinated by the clinical manifesta¬ 
tions of the disease and saddened 
by the way it was disproportionately 
affecting minorities and vulnerable 
populations.” Now Stone is a leading 
expert on hiv/aids among minor¬ 
ities and women; in 2009 she co¬ 
authored a book titled HIV/AIDS in 
U.S. Communities of Color. 
“ Both Stone and Poussaint said 
Yale’s emphasis on lifelong learning 
prepared them for long careers in 
medicine. “The Yale system promotes 
a sense of responsibility,” said Stone. 
“You keep up with the literature not 
't because of an upcoming test but 
»because you want to continue to grow 
as a physician.” 
—Stephanie Soucheray 
How a passion for golf set a 
slacker on his life’s course and 
to a president’s bedside 
Growing up in Cuba, Donald O’Kieffe, 
M.D. ’64, says he was “headed nowhere 
fast,” until a love of golf indirectly 
drove the future gastroenterologist to 
medical school and made him a key 
presence at ailing former President 
Dwight D. Eisenhower’s bedside. 
The son of a Minnesota banker and 
an Indiana homemaker and aspiring 
actress who once roomed with Ida 
Lupino, O’Kieffe was born in Hong 
Kong, where his father had been 
transferred by what was then Chase 
National Bank. When Japan attacked 
Pearl Harbor in 1941, O’Kieffe and 
his pregnant mother were evacuated to 
the United States, but Japanese forces 
held his father prisoner for another 
nine months. 
Once freed through a prisoner-of- 
war exchange, O’Kieffe’s father was 
assigned to Havana, Cuba, where 
O’Kieffe sank into the languor of the 
locale, studying sometimes and play¬ 
ing golf often. “I wasn’t motivated. 
It was the heat, the tropical climate,” 
O’Kieffe says. 
Certain that O’Kieffe was on the 
wrong track, his father laid before 
him brochures from the most pres¬ 
tigious American boarding schools. 
He chose to attend the Taft School in 
Watertown, Conn., whose brochure 
had a photo of a golf course on the 
cover. “It straightened me out and pro¬ 
pelled me into Yale.” 
During his years at Taft and later 
as an undergraduate at Yale College, 
O’Kieffe spent holidays in Havana— 
including New Year’s Day 1959, when 
Fidel Castro took over the island. The 
New Year’s Day fireworks turned out 
to be gunfire. “We were trapped down 
there. The port was closed, the air¬ 
port was closed, and there was a lot 
of shooting.” 
When the U.S. Embassy arranged 
emergency evacuations for American 
students, O’Kieffe and throngs of other 
students and parents met at the Hotel 
Nacional, where they caught a bus— 
with machine gunners behind sand¬ 
bags on the roof—to the airport. With 
more passengers than seats, O’Kieffe sat 
in the aisle during the flight, cradling 
a canister of film a network reporter 
had asked him to bring to New York. In 
New York, after O’Kieffe handed over 
the film, a news producer whisked him 
and a classmate off to the television 
studio to be interviewed. Back in New 
Haven, a reporter from the New Haven 
Register asked for an interview despite 
O’Kieffe’s protests that he’d be late for 
class. The next day the headline over his 
picture read “Yale Student Witnesses 
Cuban Revolution.” 
Life wasn’t any less exciting after 
the flight from Cuba. O’Kieffe served 
as a staff physician at Walter Reed 
Army Medical Center during the 
Vietnam War. The highlight of his 
career was a rotation in 1968, when he 
kept daily eight-hour vigils at the bed¬ 
side of former President Eisenhower, 
in critical condition after a second 
heart attack. “We were sitting just a 
few feet from him, and if it wasn’t the 
middle of the night, we’d be talking to 
him. We could see the constant parade 
of dignitaries coming in while he was 
in the hospital.” 
As a golf lover, O’Kieffe was given a 
special task. Eisenhower never missed 
weekend golf on television, and the 
chief of cardiology asked O’Kieffe to 
determine whether watching golf was 
bad for Eisenhower’s heart. O’Kieffe 
found that the former president’s 
heart rhythm was irregular only when 
Arnold Palmer was playing. Palmer, 
who was Eisenhower’s dear friend, 
had just quit smoking and had started 
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After a childhood in Hong Kong and Havana, 
Donald O'Kieffe came to the United States to 
complete his education and embarked on a path 
that would take him to a president’s bedside. 
wearing eyeglasses, and his game was 
patchy. O’Kieffe recommended that 
Eisenhower not watch Palmer play, and 
that became the policy. Eisenhower 
must not have held a grudge—his 
typed thank-you letter hangs in a frame 
on O’Kieffe’s office wall. 
“Dear Captain O’Kieffe ... I want 
you to know of my gratitude for your 
interest and professional skill during 
many hours of extra duty following my 
last heart attack,” the letter read. 
Eisenhower was not O’Kieffe’s last 
politician patient by far. Settling in 
D.C., O’Kieffe served as a medical con¬ 
sultant to the White House, the State 
Department, the National Institutes 
of Health, and the Peace Corps. In 
this role, he cared for Nancy Kissinger 
while she was hospitalized during 
Secretary of State Henry Kissinger’s 
historic trip to China in 1971. 
O’Kieffe performed the first colonos¬ 
copy in the D.C. area in 1972. Having 
trained at Walter Reed under H. Worth 
Boyce, m.d., a leading authority on the 
emerging field of endoscopic photog¬ 
raphy, O’Kieffe had access to the only 
existing equipment for the procedure. 
When he began his practice in D.C., 
O’Kieffe performed colonoscopies 
through an agreement with the manu¬ 
facturers before the scopes were made 
available commercially. “There was a 
great need. I wanted to start right then.” 
While patients and physicians 
rejected routine colonoscopy for the 
next 20 years, O’Kieffe became an 
ardent spokesperson for its benefits in 
lectures across the country and from 
his downtown practice on K Street— 
where he still treats a “parade of digni¬ 
taries”—including a Secretary of State, 
a former Secretary of Defense, mem¬ 
bers of the House and Senate, and 
many ambassadors—not unlike those 
who once visited Eisenhower. 
—Sonya Collins 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or has followed 
an unusual path since leaving Yale? We’d 
like to hear about alumni of the School of 
Medicine; Physician Associate Program; 
and the medical school’s doctoral, fellow¬ 
ship, and residency programs. Drop us a 
line at ymm@yale.edu or write to Faces, 
Yale Medicine, 1 Church Street, Suite 300, 
New Haven, CT 06510. 
NOTES i 
Ralph Greco Joseph Rend:' 
I 
I 
Three Yale alumni are among the 
72 new members inducted into 
the National Academy of Science 
in May in recognition of their 
distinguished and continuing | 
achievements in original researcl; 
The alumni are: 
ARTHUR L. BEAUDET, M.D. ’67, i 
the Henry and Emma Meyer I 
Professor and chair of molecu- i 
lar and human genetics, Baylor i 
College of Medicine. 
BRIAN K. KOBILKA, M.D. 'Si, 
professor of molecular and cel¬ 
lular physiology and of medicine,; 
Stanford University School of 
Medicine. 
IRA S. MELLMAN, PH.D.’78, { 
vice president of research oncol- 
ogy, Genentech, in South San 
Francisco, Calif. ' 
1960s 
Ralph S. Greco, M.D.’68, HS’73, 
the Johnson & Johnson Distin¬ 
guished Professor and director of 1 
the general surgery residency pro-j, 
gram at the Stanford University ' 
School of Medicine, was chosen ti ■
receive the 2012 John C. Cienapp I 
Distinguished Service Award I 
from the Accreditation Council fo ■ 
Graduate Medical Education in I 
March. Greco was honored for his f 
nearly 40 years of work as a sur¬ 
gery program director, human!- ' 
tarian.and innovatorof a surgery 
curriculum focused on resident 
well-being and wellness. > 
Joseph L. Renda, m.d. ’68, HS ’74 
associate clinical professor of 1 
medicine, was given the Com- i 
munityAchievement Award by 
the National Kidney Foundation ^ 
in February 2011. In addition, he i 
received the George F. Thornton 
Teaching Award in November, i 
given by the Connecticut Chap¬ 
ter of the American College of 
Physicians. Renda is the senior 
ami 
!ichard Boland 
I « 
Mark Cold 
Dartner of Associated Specialists 
n Nephrology and Hypertension 
n Waterbury, Conn. 
I97OS 
Z. Richard Boland, m.d. ’73, be- 
ame president of the American 
Jastroenterological Association 
an May 9. Boland also received 
;he Gastrointestinal Oncology 
section Research Mentor Award 
n May. He notes that he is still 
/vorking on colon cancer, the 
object of his Yale thesis. 
Vlark S. Gold, m.d., hs ’78, the 
Donald R. Dizney Eminent Scholar, 
)!■ Distinguished Professor and chair 
of psychiatry at the University of 
Florida (UF), has been named by 
the university and the UF Alumni 
Association the 17th Distin- 
~ guished Alumni Professor for 
2on to 2013. Gold has worked for 
heady 40 years to develop models 
of for understanding the effects of 
ro tobacco, cocaine, and other drugs 
' on the brain and behavior, 
bi 
j Jesse B. Jupiter, m.d. ’72, 
Hansjorg Wyss AO Professor of 
01 Orthopaedic Surgery at Harvard 
Medical School and Massachu- 
ii setts General Hospital, has been 
named an honorary member of 
the Royal College of Orthopaedic 
y Surgeons in Thailand. He gave 
the IFSSH Eponymous Swanson 
Lecture at the International Fed¬ 
eration of Societies for Surgery 
jjofthe Hand in October 2010. He 
lalso delivered the Edward Nale- 
Ibuff Visiting Lecture at the New 
England Baptist Hospital during 
!the pastyear and will receive 
a lifetime achievement award 
from the National Arthritis 
Foundation. 
Richard Low, m.d. ’76, has been 
chosen as the new president of 
Richard Wohns Paul Di Capua Richard Low Robert Posteraro 
the Yale Club of Argentina. Low 
has been an active member in 
Yale Club of Argentina activities. 
He is the founder and CEO of 
Praxis emr, a binational company 
with offices in California and 
Buenos Aires that produces elec¬ 
tronic medical records software. 
Robert H. Posteraro, m.d. ’73, 
was inducted as a fellow in the 
American College of Radiology 
during its 88th annual meeting 
and chapter leadership confer¬ 
ence in May in Washington, D.C. 
Posteraro is an assistant professor 
at Texas Tech University Health 
Sciences Center School of Allied 
Health Sciences. 
Richard N.W. Wohns, m.d. ’77, 
M.B.A., J.D., was listed as one of 
the top 100 spine surgeons in 
the United States by the 2010 
Becker’s Hospital Review. He 
also graduated from the Seattle 
University School of Law in May. 
Wohns is the founder and presi¬ 
dent of South Sound Neurosur¬ 
gery in Puyallup, Wash. 
1980s 
Michael A. Rothschild, m.d. ’88, 
and Alison Gail Max were married 
in June in New York. Rothschild 
is a pediatric otolaryngologist in 
private practice in New York, a 
clinical professor of otolaryn-gol- 
ogy and pediatrics at the Mount 
Sinai School of Medicine, and the 
director of pediatric otolaryngol¬ 
ogy at Mount Sinai Medical Cen¬ 
ter. The bride is a co-director of 
the lower school of the Calhoun 
School in Manhattan. 
1990s 
David L.S. Morales, m.d. ’95, a 
pediatric cardiovascular surgeon 
at Texas Children’s Hospital 
Heart Center, performed the 
first implantation in the United 
States of an artificial heart into 
the chest of an 18-year-old pa¬ 
tient. The operation took place 
on May 22 at Texas Children's 
Hospital in Houston. The patient 
was born with his heart on the 
wrong side of his chest and his 
heart vessels backwards. The 
artificial heart will serve as a 
bridge to transplantation of a 
donated heart. 
2000s 
Paul D. Di Capua, m.d. ’09, 
M.B.A. ’09, and Deborah Kathryn 
Lehman were married on July 3 
in Palm Beach, Fla. Di Capua 
is a third-year internal medicine 
resident at Ronald Reagan 
UCLA Medical Center in Los 
Angeles. Lehman is a student 
in the doctoral program in 
architecture at ucla. 
Barbara Latunik Esders, m.m.sc. 
’03, PA-c, and her husband, 
Theodore Esders, became the 
parents of twin girls, Leah Kath¬ 
erine and Emily Mary, on May 13, 
2010. The twins join big sisters 
Ella and Sophie. Esders is a 
physician assistant at Rochester 
General Hospital in New York. 
Robert McClynn, m.d. ’06, and 
Sarah Burge were married on Feb¬ 
ruary 5 in New Haven. McGlynn 
completed an ophthalmology 
residency at the New York Eye 
and Ear infirmary in New York City 
last year. He is now a fellow at the 
University of Illinois at Chicago. 
Sarah McGlynn is the preserva¬ 
tion librarian for the Cushing/ 
Whitney Medical Library. 
Paul Rolston, m.m.sc. ’02, pa-c, 
is a captain in the United States 
Army. He recently returned 
and Deborah Lehman Paul Rolston 
from a 15-month deployment in 
Iraq, where he served with an 
infantry company at a com¬ 
bat outpost. He worked with 
coalition forces teaching Iraqi 
physicians and developing local 
national medical assets. While 
doing so he continued to be 
the sole line medical provider 
for infantry soldiers engaged 
in combat operations in Abu 
Ghraib, Nasir Wa Salam, Sadr 
City, and in and around Bagh¬ 
dad. He is now serving the Army 
as the battalion surgeon for 
the Airborne Rangers at the 6th 
Ranger Training Battalion, Eglin 
AFB, Valparaiso, Fla. 
SEND ALUMNt NEWS TO 
Claire M. Bessinger, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger(g)yale.edu 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
HEALTH SCHOOLS TO PRODUCE 
ALUMNI DIRECTORY 
Yale’s health professional schools 
have contracted with Harris 
Connect, the largest alumni pub¬ 
lication company in America, to 
update contact information for 
all alumni. Harris will also help 
produce a hardcover directory 
of alumni. The “Alumni Today” 
publication will include a section 
for photos and memories from 
your days at Yale. Alumni will 
be contacted to verify and update 
contact and career information. 
YOUR PRIVACY IS IMPORTANT 
Yale University values your pri¬ 
vacy and treats your information 
in a secure manner. You decide 
whether or not your personal 
information is published—make 
your wishes clear to the repre¬ 
sentative with whom you speak. 
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32 in memoriam 
C. Davenport Cook, m.d., the 
fourth chair of the Department 
of Pediatrics who oversaw 
the expansion of subspecialty 
services, died in Old Lyme, Conn., 
on September 4. He was gi. 
During his lo-year tenure. Cook, 
a ninth-generation physician, 
recruited faculty and oversaw 
the opening of the nation’s first 
modern neonatal intensive care 
unit at Yale. His commitment 
to underserved populations led 
him to become a founder of the 
Hill Health Center and to work 
as a physician in the New Haven 
public schools. 
Gregory E. Gardiner, ph.d., 
died on September 7 at his 
home in Stonington, Conn. He 
was 67. Gardiner was the former 
managing director of Yale's 
Office of Cooperative Research, 
where he was responsible for 
development of technology 
and licensing of intellectual 
property created by Yale faculty. 
He devoted more than 30 years 
of industry, consulting, and 
investment experience to the 
Healthcare Croup of cmm. He 
was also a partner in Elm Street 
Ventures, which specialized in 
the life sciences. He served as 
a director of five biotech com¬ 
panies as well as a consultant 
and advisor to several invest¬ 
ment funds and pharmaceutical 
and biotech companies. 
John A. Kirchner, m.d., a world- 
renowned physician-scientist 
who served as chief of the Sec¬ 
tion of Otolaryngology at Yale 
School of Medicine for 30 years, 
died on July 31 at Yale-New 
Haven Hospital after a brief 
illness. He was 96. Kirchner was 
a skilled surgeon and prolific 
researcher, with expertise in 
the anatomy, physiology, and 
pathology of the larynx and 
pharynx, and in the surgical 
treatment of laryngeal cancers. 
Frank F. Richards, m.d., a 
professor emeritus of medicine 
(tropical) who served on the Yale 
faculty from 1968 until 2001, 
died on June 13 at Connecticut 
Hospice in Branford. He was 
82. Richards co-founded and 
directed the MacArthur Center 
for Molecular Parasitology and 
Tropical Diseases at Yale and was 
a co-founder and associate direc¬ 
tor of the Morgan-Tan Centers of 
Biological and Medical Research 
at Fudan University in Shanghai. 
Herbert S. Sacks, m.d., hs ’53, 
died on August 30 in New 
Haven. He was 84. Sacks was a 
renowned clinical professor of 
child and adolescent psychiatry 
at the School of Medicine, as 
well as an international medical 
consultant who worked with the 
U.S. Peace Corps and the Agency 
for International Development. 
He was a founding member of 
the Committee on International 
Health, which has awarded inter¬ 
national student travel grants to 
Yale medical, nursing, and physi¬ 
cian associate students for more 
than 40 years. 
Sacks’ international work 
focused on the psychological 
impact of population dislocation 
caused by natural disasters and 
water development projects. He 
was an early advocate for the 
integration of traditional healing 
practices into structured public 
health programs in conjunc¬ 
tion with village leaders and 
traditional healers. As president 
of the Connecticut Psychiatric 
Association, Sacks led a success¬ 
ful campaign to mandate group 
insurance coverage for outpa¬ 
tient psychiatric treatment—the 
first such state legislation in the 
country. In 1997, as president of 
the American Psychiatric Associa¬ 
tion, he spearheaded a national 
initiative for mental health parity 
in insurance coverage as part of 
a policy of universal access to 
mental health care. 
Robert L. Scheig, m.d. ’56, hs ’6i, 
FW ’62, professor emeritus of 
medicine at the State University 
of New York at Buffalo, died on 
April 8 at Hospice Buffalo. He 
was 80. After holding various ap¬ 
pointments at Yale, Scheig was 
appointed professor of medicine 
at the University of Connecticut 
School of Medicine in 1973 and 
was its acting head of medicine 
until 1979. In 1981 he became 
head of the department of medi¬ 
cine at Buffalo General Hospital 
and professor of medicine at the 
University of Buffalo. 
We have also received word of the 
passing of the following alumni 
and faculty: 
Michael D. Albis, m.d., hs ’50, a 
pediatrician in Hamden for many 
years, died on July 19 in Farming- 
ton Hills, Mich. He was 86. 
Carole L. Berger, ph.d., research 
scientist in the Department of 
Dermatology, passed away from 
a rapidly progressive malignancy 
on July 25. She was 66. 
Thomas J. Coleman, m.d. ’46, an 
orthopaedic surgeon, died on 
July 1 in Arcadia, Calif. He was 89. 
Charles J. Corbin, pa-c ’74, died on 
December 24,2009. He was 73. 
Lawrence G. Crowley, m.d. ’44, 
HS ’51, died on March 30 in 
Cupertino, Calif. He was 91. 
A surgeon, Crowley was the dean 
of the University of Wisconsin 
Medical School and dean and 
vice president for medical affairs 
at Stanford University after 1977. 
M. Michael Eisenberg, m.d., 
HS ’62, died in New York City 
on February 24. He was 80 and 
had been a professor of surgery 
at Weill Cornell Medical Center. 
Joseph I. Epstein, m.d. '43, of 
Portland, Conn., died at home 
on May 29. A general practitio¬ 
ner and allergist, he was 92. 
John H. Hageman, m.d. ’62, 
HS '68, a vascular surgeon, died 
on March 30 in Toledo, Ohio. 
He was 76. 
Paul J. Jakubiak, m.d., hs '66, a 
neurosurgeon in Williamston, 
Mich., died at home on April n. 
He was 74. 
John J. Jasaitis, m.d. ’59, died on 
June 11 in Neptune, N.J. Until his 
retirement in 2009, he was a 
general surgeon in Manhattan. 
A veteran of the Vietnam War, U 
he was 77. H 
Joseph F. Kell Jr., m.d. ’43, a Ij 
retired neurosurgeon, died on H 
March 15, 2010, in Richmond, VaH 
He was 92. H 
John B. LeRoy, M.D. ’50, who did H 
early research on human DNA, H 
died on April 22 in Eastham, H 
Mass. He was 87. H 
Roland D. Paegle, M.D.'61, a I 
professor of pathology, died on 
April 6 in Tierra Verde, Fla. 
He was 74. 
Boris G. Rifkin, m.d., formerly 
an associate clinical professor 
of psychiatry, died in Naples, 
Fla., on April i8 after a long 
illness. He was 80. Born in Cape 
Town, South Africa, he practiced 
psychiatry in New Haven and 
served as acting chair of the 
Department of Psychiatry at 
the Hospital of Saint Raphael 
in New Haven. 
Michael H. Sheard, m.d., fw ’65, 
professor emeritus of psychiatry,^ 
died on June 15. He was 83. 
William L. Shepard, m.d. ’53, 
a retired internist, died on June 
26 in San Luis Obispo, Calif. 
He was 83. 
Elihu S. Wing Jr, m.d. ’46, died 
on April 10 in Providence, R.I., 
where for many years he was in 
private practice and led medical 
missions to Haiti. He was 89. | 
James W. Wood, m.d., hs ’67, who I 
for many years was in a gastro¬ 
enterology practice in Greenwich, 
Conn., died on April 24 in Pittsford, 1 
Vt. He was 76. j 
SEND OBITUARY NOTICES TO | 
Claire M. Bessinger, Yale Medicine, j 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail j j 
to claire.bessinger@yale.edu | i 
li 
I 
I 
|End note 
Auction benefits the hungry and homeless 
The 19th Annual Hunger and Homelessness Auction, sponsored 
by Yale Health Professional Schools, raised more than $30,000 in 
November. Among the items offered were a faculty vs. students 
softball game, flights on faculty airplanes, and cruises on faculty 
yachts, a Capoeira lesson, and, of course, anatomy professor Bill 
Stewart's bow tie. Proceeds benefit New Haven charities. 
vale Medicine yale university, i church street, suite 300, new haven ct 06510 
yalemedicine.yale.edu 
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Tissue from the lab 
mends a broken heart 
Last year a 3-year-old Bridgeport girl became the 
first patient in the United States to receive an 
implant made of bioengineered tissue. 
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ON THE COVER Using 3 bioen- 
gineered graft made with cells 
from her own bone marrow, Yale 
surgeons rearranged blood flow in 
the heart of a girl born with only 
one functioning ventricle. 
Illustration by Steven Hall 
THIS PACE Angela Irizarry played 
in her bedroom with her brother, 
Alexander. Last year she became 
the first patient in the United 
States to receive a bioengineered 
heart vessel. 
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Tissue from the lab mends a broken heart 
Last year a 3-year-old Bridgeport girl became the 
first patient in the United States to receive an implant 
made of bioengineered tissue. 
By John Curtis 
Scholars work toward healthy communities 
Yale's Robert Wood Jehnsdn Clinical Scholars make, ' 
a point of engaging the community in their research: :. 
and making the world a healthier place. 
By Jennifer Kaylin , ' 
Faculty 
Students 
Alumni 
In Memoriam 
End Note 
yalemedicine.yale.edu ^ 
On our website, readers can submit class notes or a change of address;!:'.- 
check the alumni events calendar, arrange for a lifelong Yale e-mail alias','! 
through the virtual Yale Station, and search our electronic archive. 
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Letters 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or fewer) and 
news items to Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length, style, and content. 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
On physician-scientists 
Congratulations to Colleen 
Shaddox for a very interesting 
and timely article in the Autumn 
2011 edition [“Is the physician- 
scientist an endangered spe¬ 
cies?”]. i published an article in 
Yale Medicine: Alumni Bulletin 
of the School of Medicine in the 
spring of 1972, titled "Sicklemia: 
The Doctor Bird Visits a Political 
Arena." As a student advocate 
I helped to form the Sickle Cell 
Committee of South Central 
Connecticut between the com¬ 
munity of New Haven and 
the School of Medicine. Then I 
graduated from the School of 
Medicine in 1973 and have been 
practicing internal medicine 
ever since. I’m proud to have 
left a contribution to the com¬ 
munity. It’s important to be able 
to think outside the box if physi¬ 
cians are to contribute to sci¬ 
ence or their local communities. 
Robert E. Calloway, m.d. ’73, 
M.B.A. 
Houston, Texas 
Concern is expressed in the 
Autumn 2011 issue about the 
future of the physician-scientist. 
Clearly the benefits that medi¬ 
cal research has bestowed 
upon humanity are remarkable, 
thanks to the efforts and perse¬ 
verance of research physicians’ 
inquisitiveness and their relent¬ 
less pursuit of answers. But do 
medical researchers necessarily 
have to be m.d./ph.d.s? 
Almost 100 years ago, Sir 
William Osier, a respected clini¬ 
cian, author of a widely read 
medical textbook, and one 
of the founders of the Johns 
Hopkins University School of 
Medicine, believed that medical 
researchers should confine their 
labors to research institutes 
and that physicians should be 
trained by community-based 
physicians in private practice. 
He thought that the separation 
would be beneficial because It 
would lead to the training of 
more practical-minded physi¬ 
cians. Osier also believed that 
physicians living in the com¬ 
munity would bring a practical 
and humanistic viewpoint to the 
medical wards that research sci¬ 
entists who are focused on the 
purely scientific components of 
illness are incapable of. 
But Abraham Flexner—who 
was an educator, not a physi¬ 
cian—held the contrary position. 
He believed that physician- 
scientists should be trained in 
the university and that full-time 
professors of medicine should 
train physicians. With the back¬ 
ing of the Carnegie Foundation 
and the Rockefeller Foundation, 
Flexner prevailed. The orienta¬ 
tion of American medicine has 
been research-based ever since. 
Some believe that the lack of 
primary care physicians is partly 
due to the disproportionate 
attention to medical research 
compared to primary care. The 
effects of Flexner’s influence 
on medical education are now 
being questioned by some medi¬ 
cal educators. 
The point is that medical 
research is absolutely necessary 
for medicine to advance. How 
much research and what kind, 
however, are questions that 
need to be addressed. Osier’s 
idea of separating physician- 
clinicians and physician-scientists, 
as heretical as it may sound 
today, may have merit. Perhaps 
fewer m.d./ph.d.s will not have 
a generally negative effect on 
medical progress. Maybe more 
PH.D.s working in research insti¬ 
tutes and collaborating with 
physician-clinicians is a model 
that should be studied. 
It would lessen the focus 
on medical research and place 
more emphasis on the training 
of primary care physicians. Is 
that necessarily a bad thing? 
Edward J. Volplntesta, m.d. 
Bethel, Conn. 
In "Is the physician-scientist an 
endangered species?,’’ Colleen 
Shaddox outlines the School 
of Medicine’s noble efforts to 
encourage young people to 
become the medical researchers 
of the future. The major threat 
to the developing physician 
who undertakes basic science 
research is that this species is 
a financial liability in most aca¬ 
demic departments. 
When faculty members are 
told by their chairs that they 
must "cover their salary,” they 
encounter a conflict. On the one 
hand, a physician-scientist typi¬ 
cally needs two nih Roi grants to 
pay a significant portion of salary 
and cover the expenses of doing 
research. And it is hard to see how 
one could successfully run such 
a lab without at least 90 percent 
effort. To cover the remainder of 
his or her salary typically means 
generating income through clini¬ 
cal work. When one considers 
the costs of seeing patients (mal¬ 
practice, room rental, administra¬ 
tive support, etc.), however, the 
break-even time point is typically 
about 40 percent effort. In the 
current academic department 
business model, there simply is 
not enough time to be an effec¬ 
tive basic science researcher and 
see enough patients to cover 
the remaining salary costs. The 
exception to this situation occurs 
in wealthy departments—either 
surgical departments or those 
with profit-generating procedures. 
To the extent that departments 
must keep their financial house 
in order, there is a major disin¬ 
centive to carry physicians who 
undertake basic science research. 
Departments and medical schools 
must find intrinsic merit in 
physician-scientist faculty mem¬ 
bers and support them accord¬ 
ingly, or the physician-scientist will 
go the way of the dodo bird. 
Robert C. Kalb, m.d., hs '87, fw '90 
Professor, Neurology 
Perelman School of Medicine 
University of Pennsylvania 
Philadelphia, Pa. 
!! starting point 
Yale Medicine goes viral 
As one who came of age professionally in the era of print and attended a high school that 
kept academic records on punch cards churned out by an off-site computer as big as a ware¬ 
house, I'm still amazed by the possibilities of the digital age. Two e-mail messages that 
arrived on the morning of January 30 reminded me of the increasing power of social media. 
Debby Jagielow, director of alumni affairs for the medical school, wrote to say that our 
Winter 2012 cover story about Yale medical students who had launched Nyaya, a clinic in a 
remote corner of Nepal, was receiving many, many “likes” on Facebook. 
The next message came from Pete Farley, managing editor of our sister publication, 
Medicine@Yale. On January 29, a New York Times columnist, Nicholas Kristof, and Peter 
Singer, the Ira W. DeCamp Professor of Bioethics at Princeton, had tweeted the article by 
freelancer Stephanie Soucheray-Grell. “Great piece on Yale med students who started a new 
style of NGO, saving lives in one of the poorest regions of Nepal,” Singer tweeted, 
i That same day Facebook and Twitter drove 1,050 viewers to our site. Our website usu¬ 
ally draws about 900 visitors per month. 
Is there a lesson here? I like to think tliat this surge in Web traffic resulted from a series 
of fortunate events. We had a compelling story about a new approach to providing health care 
in the developing world—the story struck a chord with two well-known people who speak out 
on behalf of the marginalized and forgotten. The most gratifying news, however, came from 
; Nyaya’s founders, who said that Yale Medicine has helped put their project in the public eye, 
and that in turn will help them to fulfill their mission of saving lives in Nepal. 
I It was also gratifying to learn in January that an article in our Spring 2011 issue, 
“The High Cost of a Medical Education,” by freelance writer Sonya Collins, had won an 
Honorable Mention award from the Association of American Medical Colleges’ Group on 
Institutional Advancement. 
John Curtis 
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chronicle news from cedar street 
New center to support 
novel teaching methods 
Its goal is to enhance the learning 
experience for students and elevate 
the status of teaching. 
A new center opened in February in a 
handful of rooms on the second floor 
of Harkness Building A. The Teaching 
and Learning Center was created to 
address two issues at the heart of the 
School of Medicine’s effort to review 
its medical curriculum and bring it in 
line with the practice of medicine in 
the 2ist century. One issue is the place 
of new educational technology; the 
other is the long-standing tendency in 
academic medicine to reward research 
and clinical care over teaching. 
“We want to enhance the learning 
experience for our students and elevate 
the status of teaching by putting in place | 
the kind of support and expertise our j 
faculty can use to develop new teach- 1 
ing methods,” said Richard Belitsky, : 
M.D., deputy dean for education and the ' 
Harold W. Jockers Associate Professor 
of Medical Education, who is developing , 
and overseeing the center. 
The center is a direct resrdt of the 
School’s Strategic Plan for Medical i 
Education. A planning committee 
report issued in 2010 was imam- ,j 
biguous in determining that teaching '| 
should be a top priority. “The need to , 
better recognize, support, and reward 
teachers and educators has emerged 
as a central theme and clear recom¬ 
mendation of this strategic planning ; 
process, just as it had in each of the 
four prior strategic planning efforts,” : 
the report stated. 
5 
The Teaching and Learning Center 
(tlc) has a conference room, offices, 
and computers. It will offer programs, 
seminars, services, training, and 
consultation in three areas: educator 
development, assessment, and technol- 
jogy. The center will provide help with 
assessment methodology and inter¬ 
pretation of evaluation data in student 
learning, curriculum effectiveness, 
and quality of teaching. 
Belitsky sees the tlc as an impor¬ 
tant step toward “fulfilling the promise 
I of the strategic plan.” To be leaders in 
medical education, he said, “we need to 
think carefully about the learning strat¬ 
egies of our students. They are highly 
influenced by new technologies, so we 
need to make sure our faculty is facile 
with them, too.” One example is the 
school’s recent decision to give iPads 
! to all students. The electronic tablets 
! enable students to download the entire 
curriculum and will be used increas¬ 
ingly by professors as a teaching tool to 
j engage students in new ways. 
1 The center will have four associate 
I directors. Janet P. Hafler, m.ed., ed.d., 
I will serve as the associate director for 
i educator development; Frederick D. 
: Flaeseler, m.d., fw ’76, is the associate 
I director of learning and technology; 
: and Gary B. Leydon will be the associ¬ 
ate director for technology services. A j national search for an associate direc¬ 
tor for learning and assessment is 
j under way. 
i Gary Leydon, Rick Haeseler, Janet Hafler, and 
Richard Belitsky lead the new Teaching and 
• Learning Center, which opened in February. The 
, center’s goals are to enhance students’ learning 
experience and recognize excellence in teaching. 
I 
I 
Haeseler says he views his new role, 
which Belitsky describes as “marry¬ 
ing technology and pedagogy,” as an 
outgrowth of his work as director of 
the Standardized Patient Program and 
as founder and director of the Primary 
Care Clerkship. Haeseler expects that 
the strategic plan will inspire the inte¬ 
gration of a variety of pedagogies into 
the medical school’s new curriculum. 
The TLC could help facilitate this pro¬ 
cess by adapting such innovative tech¬ 
nologies as electronic medical records, 
cloud computing, handheld devices, 
asynchronous learning, distance learn¬ 
ing, and low- and high-fidelity simula¬ 
tion. Haeseler also brings to the tlc a 
team of seasoned standardized patients, 
who participate in a variety of teach¬ 
ing venues throughout the first three 
years of the medical school curricu¬ 
lum. He expects that the standardized 
patient program, with its many illness 
scenarios and its emphasis on patient- 
centered communication, will continue 
to evolve to meet the needs of faculty 
and students in achieving the school’s 
overarching goals. 
Still, with all the focus on new 
technologies, new pedagogies, and 
new ways of teaching and learning, 
Belitsky wants to make sure the old 
ways aren’t abandoned. He says he’ll 
be watching closely to make sure that 
whatever is introduced is “consistent 
with the Yale system and the learning 
environment we all cherish.” 
—Jennifer Kaylin 
YSM, PHARMA TO COLLABORATE 
Yale and the Johnson & Johnson Corporate 
Office of Science & Technology (cosat) 
have signed an agreement to fund activi¬ 
ties at the Yale Small Molecule Discovery 
Center (ysmdc). The ysmdc helps validate 
potential biological targets for new drugs 
and molecules. 
“This sponsorship of the ysmdc comes at 
a time when academic and pharmaceutical 
scientists are increasingly looking to collabo¬ 
rate in order to help fill the pharmaceutical 
pipeline with the medicines of tomorrow,” 
said Thomas E. Shrader, ph.d. ’90, director 
of strategic corporate partnerships in Yale’s 
Office of Cooperative Research. 
“This collaboration will allow Yale scien¬ 
tists to focus on the parts of this pathway that 
we do best—identifying novel disease targets, 
while getting cosat’s expertise in the areas 
where Yale, and most universities, have lim¬ 
ited experience,” said Michael S. Kinch, ph.d., 
managing director of the ysmdc. 
—John Curtis 
WHEN YOU GOTTA GO 
A strong need to urinate impairs cognitive 
faculties as much as fatigue or an alcohol 
buzz, according to researchers at Yale, 
Brown, the University of Melbourne, and the 
Australian company CogState. 
“Giving people lots of water and making 
them take tests while squirming in discom¬ 
fort may seem a bit quirky, but the research 
helps us evaluate the methods used to 
measure cognitive change,” said Robert H. 
Pietrzak, m.p.h., ph.d., assistant professor 
of psychiatry at the School of Medicine. The 
research garnered the zou Ig Nobel Prize in 
Medicine from the humor magazine Annals 
of Improbable Research. 
For the study, published in January 2011 
in Neurourology and Urodynamics, healthy 
adults drank 250 milliliters of water every 
15 minutes and took cognitive function tests 
every hour. The resulting impairment in 
attention and working memory matched that 
observed in people who have a 0.05 percent 
blood alcohol concentration or have remained 
awake for 24 hours. The subjects’ cognitive 
functions “returned to normal almost immedi¬ 
ately after voiding.” 
—J.C. 
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6 chronicle news from cedar street 
Gene therapy takes a step 
forward with a synthetic 
nanoparticle 
The particles injected into the tail 
of a lab mouse course through the 
animal’s veins, eluding immune sur¬ 
veillance as they make a stealth run 
toward the tiny tumor growing on 
its flank. When the particles hit the 
tumor, the raid begins in earnest. The 
particles slip through the outer cel¬ 
lular membranes and into the rogue 
cells. The genes packaged within the 
particles shed their protective polymer 
veil and hijack the cellular machinery. 
From there, the covert dna instructs 
the cells to produce apoptosis-inducing 
proteins, which trigger cell suicide and 
ultimately sabotage tumor growth. 
This gene therapy success story, 
published online in December in 
the journal Nature Materials, marks 
a paradigm shift in the method for 
delivering therapeutic genes to dis¬ 
eased cells. At the root of this triumph 
is a biodegradable nanoparticle cre¬ 
ated by Yale biomedical engineers that 
upends previous dogma. 
As W. Mark Saltzman, ph.d., the 
Goizueta Foundation Professor of 
Biomedical Engineering, co-principal 
investigator with associate research 
scientist Jiangbing Zhou, ph.d., and 
research scientist Zhaozhong Jiang, 
PH.D., explains it, researchers previ¬ 
ously used viruses to ferry genetic 
material into animal cells. These for¬ 
eign particles, however, appeared as 
red flags to the host’s immune system, 
resulting in their swift demise. Earlier 
engineers replaced the viral vectors 
with synthetic nanoparticles, which 
they believed needed a high positive 
charge to glom onto negatively charged 
DNA and condense it into a neat little 
package for intracellular delivery. 
These charged nanoparticles did the 
job, but their excess positive charge 
also destabilized cell membranes, 
causing considerable toxicity. 
The Yale researchers hypothesized 
that replacing some of the excess 
positive charge with hydrophobic 
regions might reduce the toxicity of the 
polymers yet still allow for condensa¬ 
tion of DNA. They developed a controlled 
system of polymer synthesis that allows 
them to tune the polymer constituents, 
tweaking where necessary to find the 
right balance between positively charged 
and water-insoluble units. 
Among the 20 polymers that the 
Yale team constructed, one exhibits 
the ideal mix of sticky positive charges 
and hydrophobic regions. When mixed 
with DNA, the polymer condenses to 
create nanoscale spheres that resemble 
minuscule water droplets on a pane 
of glass. The compacted dna tucked 
within the nooks and crannies of the 
polymer blobs is protected from enzy¬ 
matic assault when circulating in the 
body. Equally important, the nanopar¬ 
ticles pose no harm to the animal host. 
When tested in vitro, the nanopar¬ 
ticles delivered genes to target cells with 
50- to 170-fold-greater efficiency than 
commercially available gene therapy 
Biomedical engineer Mark Saltzman, pictured 
with medical student Maya Kotas (left) and 
graduate student Margaret Cartiera, has devel¬ 
oped a nanoparticle to deliver gene therapy. 
The particle has proven successful in vitro and 
in mouse models in introducing genes that 
thwart tumor cells while avoiding toxicity. 
vectors. Furthermore, tumor-bearing 
mice regularly dosed with the apoptosis- 
inducing gene therapy showed no toxic¬ 
ity during the entire course of treatment, 
and their tumors grew to only a fraction 
of the size of those in control mice. 
Closer inspection of the tumor tissue 
revealed that the suicide gene dramati¬ 
cally promoted the death of tumor cells. 
Saltzman envisions someday using 
the new polymer delivery system in 
humans to enable gene therapy for 
several diseases, including cystic fibro¬ 
sis, Huntington disease, and cancer, 
particularly brain tumors—a devas¬ 
tating disease that he says demands 
heroic efforts. “We’ve been developing 
techniques for introducing particles 
like these directly into the brain to 
treat malignant brain tumors for some 
years. Our hope is that these poly¬ 
mers give us another tool—a very safe 
tool—that we can use in that arena,” 
Saltzman says. 
—Kara Nyberg 
7 
Grant funds study of rare 
disorders linked to single 
mutant genes 
while some diseases stem from a web 
of influences including environment, 
lifestyle choices, and genetic luck, others 
result from a single mutant gene. While 
the inheritance patterns of these so- 
called Mendelian disorders are straight¬ 
forward, finding the errant genes is not. 
More than 6,000 rare Mendelian 
disorders have been identified in the 
United States. Collectively, they afflict 
more than 25 million people, but each 
affects fewer than 200,000 people. The 
fewer patients who have a disease, the 
harder it is to study, because both fund¬ 
ing and genetic samples are limited— 
yet discerning their genetic causes may 
lead to treatments and yield broader 
insights into human biology. 
“There are roughly 22,000 genes 
in the human genome,” said Richard 
R Lifton, M.D., PH.D., chair and 
Sterling Professor of Genetics and a 
principal investigator of a new grant 
from the National Institutes of Health. 
“Right now we know what diseases 
result when about 3,000 of those are 
mutated. We know almost nothing 
about what happens when the remain¬ 
ing ones are mutated.” 
The new four-year $11.2 million 
grant has established the Yale Center 
for Mendelian Genomics, to be located 
on the West Campus. The grant, 
announced in December, will fund two 
other centers devoted to Mendelian 
diseases—one at the University of 
Washington in Seattle and one operated 
jointly by Baylor College of Medicine 
in Houston and the Johns Hopkins 
University in Baltimore. 
At Yale, principal investigators 
include Murat Giinel, m.d., hs ’98, 
the Nixdorff German Professor of 
Neurosurgery and professor of genet¬ 
ics and of neurobiology; Shrikant 
Mane, ph.d., senior research scientist 
in genetics: and Mark B. Gerstein, 
PH.D., the Albert L. Williams Professor 
of Biomedical Informatics and 
co-director of the Yale Computational 
Biology and Bioinformatics Program. 
Underlying the new project is 
exome sequencing, a gene sequencing 
method that targets those parts of the 
genome that encode proteins. Many 
inherited diseases are thought to be 
due to mutations in the exome. “The 
new sequencing technologies enable 
us to pinpoint disease-causing genes 
even with only a few affected subjects. 
This has really opened up the field,” 
said Lifton, a Howard Hughes Medical 
Institute investigator. 
The new center hopes to identify 
patients with these mutations and 
learn the consequences of each genetic 
deviation. “Identifying the specific 
genetic causes of these diseases will 
be useful diagnostically: the therapeu¬ 
tic possibilities will only be revealed 
when we can link mutations to disease 
traits,” said Lifton. 
The Yale team also expects to learn 
some lessons in basic biology. The 
link between each gene mutation and 
disease can teach scientists a great deal 
about what happens when those same 
genes function normally, Lifton said. 
“It really tells us how each gene works 
in the context of the human body. And 
this tells us a great deal about how 
entire pathways work, which is very 
important to future drug development.” 
—Sarah P.C. Williams 
ABUSE, NEGLECT, AND GRAY MATTER 
Emotional abuse and physical neglect lead to 
less gray matter in adolescent brains, accord¬ 
ing to a School of Medicine study published 
in December in the Archives of Pediatrics and 
Adoiescent Medicine. 
The brain areas affected may differ in 
boys and girls, may depend on whether the 
youngsters were exposed to abuse or neglect, 
and may be linked to whether the neglect was 
physical or emotional. The study of 42 ado¬ 
lescents showed reduction in gray matter in 
youths who reported abuse or neglect, even 
though the youths had not been diagnosed 
with a psychiatric disorder. 
“This could help to explain their trouble 
with school performance, or increase their 
vulnerability to depression and behavioral 
difficulties,” said senior author Hilary P. 
Blumberg, m.d., associate professor of 
psychiatry and of diagnostic radiology and 
in the Child Study Center. More research is 
needed in order to develop improved inter¬ 
ventions to help the youths who have been 
exposed, Blumberg said. 
—John Curtis 
ORPHANS NEED MORE TLC 
Orphans may require more tlc than children 
reared by their biological parents, accord¬ 
ing to a study by Yale scientists published 
online in November in Development and 
Psychopathoiogy. 
Oksana Y. Naumova, ph.d., and colleagues 
compared whole-genome methylation pro¬ 
files based on blood samples from 14 7- to 
lo-year-olds raised in Russian orphanages and 
from 14 children growing up in typical fami¬ 
lies. Orphans showed changes in the genetic 
regulation of the systems controlling immune 
response and intercellular interactions— 
including mechanisms important in the devel¬ 
opment and functioning of the brain. 
The stress of separation, the study found, 
affects the long-term programming of genome 
function. “Parenting adopted children might 
require much nurturing care to correct these 
biological effects,” said senior author Elena L. 
Crigorenko, ph.d. ’96, the Emily Fraser Beede 
Associate Professor in the Child Study Center 
and associate professor of psychology and of 
epidemiology (chronic diseases). 
—J.C. 
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Books & ideas 
A physician’s obsession 
How a 19th-century doctor faced the demands of 
career and ambition. 
William Beaumont, m.d., “the father of gastric physiology,” 
achieved fame in a less complicated time. To further his 
understanding of digestion, he began studying a fur trapper 
left with a permanent hole in his stomach following a shot¬ 
gun accident in 1822. Born in Lebanon, Conn., Beaumont 
had skipped medical school, apprenticed to a Vermont doc¬ 
tor, then enlisted as a surgeon’s mate in the War of 1812. 
Those were simpler times. 
Or were they.^ In his novel¬ 
ized account of Beaumont’s 
life, Jason Karlawish, m.d., 
professor of medicine 
and medical ethics at the 
University of Pennsylvania, 
conveys the difficulties con¬ 
fronting a farmer’s son who 
sought not only to make a 
name in medical research but 
to earn a handsome income 
in a location pleasing to his 
wife. Karlawish suggests that 
19th-century pressures on 
physicians resemble those 
of the 2ist: competing with 
better-credentialed colleagues; 
working for unsympathetic 
bosses; negotiating with a recalcitrant study subject; and 
balancing between family and career. 
Beaumont did achieve recognition—faculty at the School 
of Medicine named a club, a lecture series, and a room 
after him in 1920. Speaking in the Beaumont Room in 
December, Karlawish said that Beaumont’s desire to under¬ 
stand the digestive system spurred him to virtually enslave 
the injured fur trapper. And that, Karlawish said, reminded 
him of the tragedy of teenager Jesse Gelsinger, who died 
in a 1999 gene therapy experiment. “Those research pres¬ 
sures,” said Karlawish, “can make you make decisions that 
you might not otherwise make.” 
—Cathy Shufro 
Open Wound: The 
Tragic Obsession of 
Dr. William Beaumont 
The Psychotherapy of Hope; The 
Legacy of Persuasion and Healing 
edited by Renato D. Alarcon, m.d., 
M.P.H.; and )ulia B. Frank, m.d. 
’77, HS ’81, FW '82 (Johns Hopkins 
University Press) Inspired by the 
work of Jerome D. Frank and his 
book Persuasion and Healing, this 
volume of essays broadly assess¬ 
es the current state of research 
and practice in psychotherapy. 
Challenging the claims made 
for the superiority of cognitive- 
behavioral, psychodynamic, and 
other varieties of therapy, the 
authors—Frank’s daughter and 
one of his former students—ex¬ 
amine the values and limitations 
of competing approaches to 
diagnosis and treatment. 
Am I My Genes? Confronting 
Fate & Family Secrets in 
the Age of Genetic Testing 
by Robert L. Klitzman, m.d. ’85 
(Oxford University Press) 
Although genetic testing has 
improved the diagnosis and 
treatment of such diseases as 
Huntington, cystic fibrosis, and 
Alzheimer, it leads to difficult 
decisions for people who fear 
being tested and question what 
to do with the results. The author 
interviewed 64 people who face 
these dilemmas and describes 
how they have dealt with the 
implications of genetic findings 
for their own lives and those of 
theirfamily members. 
Hematology: 
A Pathophysiologic Approach 
by S. David Hudnall, m.d., hs ’82, 
professor of pathology and of 
laboratory medicine (Mosby) 
This text, part of the Mosby 
Physiology Monograph Series, 
offers explanations of hemato¬ 
poiesis, immunology, hemostasis, 
hemoglobinopathy, metabolic 
disorders, genetics, and neoplasia 
by using an integrated problem- 
based approach to learning. The 
author shows how hematologic 
disorders are evaluated through 
blood counting, histopathology, 
immunohistochemistry, cyto¬ 
genetics, and coagulation testing. 
An online version is also available. 
Desmoid Tumors 
edited by Charisse Litchman, 
M.D. ’88, HS ’89 (Springer) This 
text, the first publication devoted 
entirely to desmoid tumors (DT), 
discusses this rare fibroblastic 
proliferative disease, which has an 
incidence of 2 to 4 new cases per 
million people per year. Clinical 
presentations, imaging guide¬ 
lines, and treatment paradigms 
are highlighted, along with a 
discussion of the unique issues in 
treating children with DT. The book 
also describes emerging research 
techniques and the role of advo¬ 
cacy groups in supporting research 
and promoting awareness of such 
rare diseases as DT. 
Resilience and Mental Health: 
Challenges Across the Lifespan 
edited by Steven M. Southwick, 
M.D., HS ’85, Glenn H. Greenberg 
Professor of Psychiatry, Post- 
Traumatic Stress Disorder, and 
Resilience; Brett T. Litz, ph.d.; 
Dennis Gharney, m.d., hs ’81; 
and Matthew J. Friedman, ph,d., 
M.D. (Cambridge University 
Press) This book brings together 
experts whose research has 
focused on adaptive responses 
to stress, which are less well 
understood than stress-related 
disorders. Each of the book's 
five sections examines relevant 
concepts, ranging from factors 
that contribute to and promote 
resilience to specific applications 
and contexts of resilience, as 
on campus 9 
well as interventions to enhance 
healthy adaptation to stress. 
Vultures at Twilight 
by Charles Atkins, m.d., lecturer 
in psychiatry (Severn House) 
Lil and Ada, longtime friends 
and neighbors in a Connecti¬ 
cut town, prove to be unlikely 
heroines when a severed finger 
shows up at the Friday night 
antiques auction, and they have 
to wonder: Where’s the rest of the 
body? That question leads to the 
revelation of small-town secrets 
and the unraveling of a mystery 
that shows that all is not well in 
a town famed for its postcard- 
perfect New England charm. 
Prenatal Diagnosis: 
Cases & Clinical Challenges 
by Miriam S. DiMaio, m.s.w., 
senior genetic counselor; Joyce E. 
Fox, M.D., Fw ’86; and Maurice 
J. Mahoney, m.d., j.d., fw ’70, 
professor of genetics, of obstet¬ 
rics, gynecology, and reproduc¬ 
tive sciences, and of pediatrics. 
(Wiley-Blackwell) This book is 
based on the authors’ decades of 
experience during an era of rapid 
development in in utero diagno¬ 
sis. The authors use real cases 
to portray diagnostic problems 
as a route to underlying biology, 
available testing options, and 
results that may be obtained. The 
authors discuss the challenges 
of management, interpretation, 
and counseling by emphasizing 
three types of clinical problems: 
chromosomal abnormalities; 
Mendelian disorders; and fetal 
structural abnormalities. 
The Practice of Perioperative 
Transesophageal Echocardiog¬ 
raphy: Essential Cases 
edited by Albert C. Perrino Jr., 
M.D., HS ’87, FW ’88, professor of 
anesthesiology; Scott T. Reeves, 
M.D., M.B.A.; and Kathryn Glas, 
M.D. (Lippincott Williams & 
Wilkins) This text provides 
more than too teaching cases, 
presented in a question-and-an- 
swer, self-test format. The cases 
cover clinical challenges faced 
by perioperative echocardiogra- 
phers, including disorders of the 
aorta, left ventricle, and right 
ventricle; valvular heart dis¬ 
ease; congenital heart lesions; 
catheter and device placement; 
and unsuspected masses and 
thrombi. A companion website 
contains the fully searchable 
text plus echocardiographic 
video clips for each case. 
Pediatric Psychopharmacology, 
2nd ed. 
edited by Andres Martin, m.d., 
M.p.H. ’02, Riva Ariella Ritvo 
Professor in the Child Study 
Center and professor of psychia¬ 
try; Lawrence Scahill, m.s.n. ’89, 
M.p.H. ’89, PH.D. ’97, professor 
of nursing and child psychiatry; 
and Christopher |. Kratochvil, m.d. 
(Oxford University Press) 
The editors have streamlined 
the flow of information to 
reflect the accumulation of 
scientific data since the first edi¬ 
tion. The overall structure of the 
book remains the same, with 
major sections on underlying 
biology, somatic interventions, 
assessment and treatment, and 
special considerations. 
The descriptions above are based 
on information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via 
e-mail to cheryl.violante@yale.edu 
Summer heat deadlier 
Research models that estimate 
how many people might die 
in urban heat waves will help 
government agencies better 
respond to them, said a biostat¬ 
istician who predicts that air 
pollution will make summers 
in the United States deadlier 
by the end of the century. The 
research is also an argument 
for stricter regulation of pol¬ 
lutants, according to Francesca 
Dominici, ph.d., m.p.fi., associ¬ 
ate dean for information tech¬ 
nology at the Flarvard School 
of Public Health. Dominici was 
a guest lecturer at a School of 
Forestry and Environmental 
Studies seminar in January. 
The most severe cardiovascu¬ 
lar and respiratory effects stem 
from elemental carbon and 
organic carbon matter—pol¬ 
lutants that are one-twentieth 
the diameter of a human hair. 
These particles are generated 
from vehicle emissions, diesel 
engines, and burning wood. 
In 1995, some 700 deaths in 
Chicago were attributed to a 
July heat wave, said Dominici. 
By 2081, a hot spell could kill 
between 2,100 and 17,500 
people there, she said—a figure 
that can’t be attributed only to 
a larger population. 
Dominici and her colleagues 
developed the models by study¬ 
ing recent weather records, envi¬ 
ronmental trends, and Medicare 
data. In Chicago, they found that 
hospital admissions for heat 
stroke between 1987 and 2005 
“identified a heat wave much 
better than the temperature 
[readings].’’ 
—John Dillon 
“Good science has won out” 
The controversy over childhood 
inoculation came to Yale when 
audience members confronted 
an expert who declared that the 
anti-vaccine movement is “fray¬ 
ing at the edges.” 
For 30 years news articles 
have blamed vaccines for seri¬ 
ous defects in children, leading 
parents to refuse inoculations 
for their children, said Paul A. 
Offit, M.D., chief of the Division of 
Infectious Diseases at Children’s 
Hospital of Philadelphia and 
author of the 2008 bookAuf/sm’s 
False Prophets. Though inaccu¬ 
rate, those articles are effective, 
he said, because “we’re very 
much moved by emotion.” But 
“the pendulum is swinging back,” 
said Offit, who delivered the 
Beaumont Lecture in January. 
When anti-vaccine blogger 
Jake Crosby tried to ask a ques¬ 
tion, Offit accused him of stalking 
him and asked him to leave. After 
Crosby left, Mary Holland, co¬ 
author of a book questioning vac¬ 
cine safety, told Offit he was “not 
willing to engage” with critics. 
Offit said that “good science 
has won out.” A turning point 
occurred in January 2011, when 
an editorial in bmj (formerly the 
British Medical Journal) called 
articles by a British physician 
that linked autism to the mmr 
vaccine an “elaborate fraud.” 
Offit urged vigilance to 
prevent the anti-vaccine move¬ 
ment—and largely forgotten 
childhood diseases—from re- 
emerging. “Never let anything 
go unchallenged,” he said. 
—J.D. 
World War I sacrifices for a greater good 
Government posters urged Americans to save food for troops and for civilians in war-torn Europe. 
By Jill Max 
The image is haunting: against a back¬ 
ground of imploring children with out¬ 
stretched arms, a gaunt woman cradles 
an infant in one arm and holds a little 
girl close with the other. Although 
it looks like a museum-worthy work 
of art, this picture on a World War I 
poster exhorted viewers, “Don’t waste 
food while others starve!” 
One week after entering the war 
in April 1917, the U.S. government 
established a Committee on Public 
Information (cpi) to involve the nation 
in the war effort. The committee’s 
materials included a poster cam¬ 
paign designed to help the U.S. Food 
Administration, headed by Herbert 
Hoover, in its drive to feed the troops and 
ensure an adequate food supply for the 
civilian population at home and abroad. 
“It was considered effective at instilling 
patriotic feelings and actions of self- 
sacrifice,” said Susan Wheeler, curator 
of prints and drawings at the Cushing/ 
Whitney Medical Library, which dis¬ 
played Yale’s collection of World War I 
food posters in the fall of 2011. 
The poster campaign was overseen 
by the Division of Pictorial Publicity, 
led by Charles Dana Gibson, one of 
the best-known artists of the time and 
creator of the Gibson Girl. The division 
invited other top artists and illustrators 
to contribute designs. Every Friday the 
group and government officials met 
over dinner to decide what kind of 
poster was needed. By the end of the 
war, 700 poster designs had been sub¬ 
mitted on a variety of topics, including 
food. The cost to the government was 
only $13,000, as the artists donated 
their time and materials. 
George Creel, a Denver journalist 
who chaired the cpi, later recalled, “I 
had the conviction that the poster must 
play a great part in the fight for public 
opinion. The printed word might not 
be read, people might not choose to 
attend meetings or to watch motion 
pictures, but the billboard was some¬ 
thing that caught even the indifferent 
eye.” Indeed, because the posters were 
widely displayed in shops, schools, 
and other locations, it was impossible 
to escape their messages. 
The earliest cpi posters were sim¬ 
ple text designs instructing the public 
not to waste food, with tips on which 
items to conserve to “serve the cause 
of freedom.” Such famous figures as 
Abraham Lincoln, Woodrow Wilson, 
and Joan of Arc appeared as symbols 
of patriotism and self-sacrifice. 
Images from the front lines helped 
the public visualize the ravages of war- 
torn Europe. Eight artists commissioned 
as captains accompanied the American 
Expeditionary Forces overseas and 
produced more than 300 drawings, 
including scenes of a food convoy wind¬ 
ing through a snowy landscape and an 
American soldier standing over a fallen 
German. These images helped the 
public understand how small sacrifices 
at the dinner table might be trans¬ 
formed into meaningful contributions 
to the war effort. 
Food posters were tied to such 
other media as pamphlets, films, 
poetry, and music. In his poem 
“Thoughts Inspired by a War-time 
Billboard,” Wallace Irwin memorial¬ 
ized a poster by the artist Wallace 
Morgan in the line “Wallie Morg’s 
‘Feed a Fighter’ lurks deep in his 
trench....” The popular marching 
song, “We’re Off to Can the Kaiser,” 
was adapted by the Belgian artist J. 
Paul Verrees for one of the best-known 
posters of the National War Garden 
Commission, which urged citizens to 
“Can Vegetables, Fruit and the Kaiser 
Too.” The poster was reissued in 1919 
after the end of the war with the head¬ 
ing, “The Kaiser Is Canned.” 
The medical library’s 10 food 
posters are part of its larger collec¬ 
tion of about 500 posters related to 
public health and nutrition. They 
can be viewed online at http:// 
cushing.med.yale.edu/gsdl/cgi-bin/ 
library?p=about&c=mdposter. 
11 
During World War I the U.S. 
government tried to involve 
the public in the war effort by 
urging people to save food for 
troops and civilians in Europe. 
The earliest posters offered 
tips on ways to avoid wasting 
food, and evoked such figures 
as Abraham Lincoln, Woodrow 
Wilson, and Joan of Arc. The 
artists who created the posters 
were among the best-known 
of their day, including Charles 
Gibson, creator of the Gibson 
Girl. They donated their time 
and talents to the war effort. 
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Tissue from the lab mends a broken heart 
A 3-year-old Bridgeport girl becomes the first patient in tiie tin ted States 
to receive a bioengineered blood vesse' 
By John Curtis 
Angela Irizarry was still in her mother’s womb when tests 
hevealed that one of her heart’s two ventricles wasn’t working, 
i She was destined to be a “blue baby.” With only one functional 
.ventricle, oxygenated and deoxygenated blood would mix 
within that ventricle, causing hypoxia and the bluish color¬ 
ation of the skin that gives the syndrome its name. In 1968 a 
surgeon named Francis Fontan, m.d., devised a procedure that 
has become the standard of care to palliate this condition. It 
involves three surgeries to redirect blood flow: one a few days 
after birth; a second a few months later; and a third when the 
child reaches the age of three. In that final procedure a plastic 
tube is inserted to channel blood from the inferior vena cava 
to the lungs. For Angela, however, surgeons had something 
different in mind. She would undergo the first two surgeries 
as usual—but for the third, a biodegradable scaffolding seeded 
with cells from her own bone marrow would replace the plas¬ 
tic tube. She would be the first patient in the United States to 
receive a bioengineered cardiac blood vessel. 
A meeting at mit 
On the window sill of his office in the Boardman Building, 
Toshiharu Shinoka, m.d., ph.d., keeps a photo of his days as 
a postdoctoral fellow in Boston in the 1990s, where he met 
his friend and colleague, Christopher K. Breuer, m.d. Also in 
the group photo are Joseph P. Vacanti, m.d., an expert in tis¬ 
sue engineering; and Robert hanger, ph.d., the mix professor 
renowned for his innovative medical devices. Shinoka, associ¬ 
ate professor of surgery and pediatrics and director of pediat¬ 
ric cardiovascular surgery, and Breuer, associate professor of 
pediatric surgery and pediatrics, met while studying under 
Vacanti and hanger at Children’s Hospital Boston. 
“What made me become interested in tissue engi¬ 
neering was the fact that on a daily basis in my training I 
would see problems arise that we coiddn’t fix. I would watch 
children die and watch families fall apart. That obviously 
left a bad taste in my mouth,” said Breuer. “In surgery there 
are many problems we could fix if we had adequate tissue. 
Tissue engineering provided means of creating an abundant 
source of tissue for surgical reconstructive procedures.” 
The pair first attempted to engineer intestines, but 
found that the science of the day was not up to the task of pro¬ 
ducing such complex tissue. They switched to blood vessels 
and found a technique that worked. They created a biodegrad¬ 
able scaffolding with a matrix for seeding cells as well as sites 
for cell attachment and tissue formation, then implanted it in 
a lamb. “The scaffolding degrades and the remaining tissue 
is viable and it’s made from people’s own tissue, so you can 
avoid problems like rejection,” Breuer said. 
But problems remained. “Using our original method 
it took three months to grow the cells, and seed, and incu¬ 
bate the scaffold. Surgeons don’t have three months to 
wait for a blood vessel,” Breuer said. Waiting that long also 
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14 Tissue from the lab mends a broken heart 
increased the odds of contamination and the risk of evolu¬ 
tion running its course—cells in culture could differentiate 
and change their identity or even become tumor cells. 
The collaboration ended when Breuer entered the U.S. 
Air Force and Shinoka returned to Tokyo Women’s Medical 
University Hospital to continue his research. He switched 
from blood vessel cells to bone marrow cells, which are so 
abundant that they don’t need to be grown in culture. That 
cut the time needed to make the grafts from a few months 
to a few hours. Shinoka began implanting the biodegradable 
grafts in humans with promising results. 
When Breuer heard of Shinoka’s success he was still 
in the military and attending to injured veterans of the war 
in Afghanistan. “It was one of those days in your life where 
you get hit by lightning,” Breuer said. “I just knew what 1 
was going to do with the rest of my career.” 
By 2003 Breuer had moved to Yale, lured by a new tis¬ 
sue engineering initiative and faculty, including W. Mark 
Saltzman, ph.d., chair and Goizueta Foundation Professor of 
Biomedical Engineering and Chemical and Environmental 
Engineering, who had also trained under Langer at mix; 
Jordan S. Pober, m.d. ’77, ph.d. ’77, hs ’78, Ensign Professor 
of Immunobiology, professor of dermatology and of pathol¬ 
ogy, and director of the Human and Translational Immunology 
Program: and William C. Sessa, ph.d., Alfred Gilman 
Professor of Pharmacology and director of the Vascular Biology 
and Therapeutics Program. “It was a wonderful environment 
in which to perform translational research,” Breuer said. 
Three years later he urged Shinoka to join him. “It 
was very suitable for our future research so I decided to 
come over here,” Shinoka said. “In the United States no one 
was doing this kind of approach.” 
Rearranging the heart 
“When I was hve months pregnant they asked me to have a 
test because I was 37 years old and there was a risk that the 
baby would have defects,” recalled Claudia Irizarry, Angela’s 
mother. She works as a secretary in a church; her husband, 
Angel, is a contractor. “They figured out that all her organs 
were backwards. In the same ultrasound they saw that she 
had this heart condition. Right away they told me that she 
was going to need three surgeries.” 
Congenital heart disease is a common birth defect, 
occurring in one in 100 hve births. Single-ventricle physiol¬ 
ogy, a relatively uncommon subcategory of congenital heart 
disease, stems from several heart anomalies but leaves chil¬ 
dren with only one functional ventricle. One of the two ven¬ 
tricles may be larger than the other, or there may be no wall 
between the two ventricles. These defects force the function¬ 
ing ventricle to do the work of two, pumping blood for both 
the lungs and the rest of the body. It also mixes oxygen- 
rich blood leaving the lungs with deoxygenated blood from 
the veins from the lower body, leading to the “blue baby” 
syndrome. Without surgical intervention, about 70 percent 
of children with the defect die in the first year of life. Few 
reach adulthood. The Fontan procedure, though palliative 
rather than curative, has been the only solution. 
“What this operation did was rearrange the plumbing, 
so that that one ventricle could pump blood to the body, and 
then that blood would return and go through the pulmonary 
circulation passively, without a ventricle pushing it through. 
This prevented the mixing of blood so the children were no 
longer cyanotic,” Breuer said. 
Despite its benefits, the Fontan procedure posed prob¬ 
lems. It required the use of synthetic materials that could lead 
to blood clots and other complications. It also meant a lifetime 
of blood-thinning drugs for the patients. The synthetic grafts 
left children vulnerable to infections. And the grafts could not 
grow with the children. “Children can outgrow their opera¬ 
tions, just the way they can outgrow their shoes. Imagine living 
in a world where every time you outgrow your shoes you have 
to go back to the operating room,” Breuer said. 
Angela would receive a biodegradable graft—a scaf¬ 
folding made with bioengineered tissue seeded with cells 
from her bone marrow. It would connect the inferior vena 
cava—the vein that transports deoxygenated blood into the 
heart’s right atrium—with the arteries that carry blood 
to the lungs. She would require neither immune suppres¬ 
sants nor blood thinners. The bioengineered graft would 
also reduce the risk of infection. The operation would raise 
Angela’s oxygenation level, give her more energy, and lead to 
better growth and development. 
“We wanted to choose the right patient for undergoing 
this procedure. Just as important, we wanted to find the right 
family,” Breuer said. “We talked to a number of people but 
felt the Irizarry family were quite a special family. They were 
probing and they asked appropriate questions.” 
Building a blood vessel 
Shinoka had used his technique in 25 patients in Japan. But 
when it came time to seek fda approval, there were ques¬ 
tions about how it worked. The fda wanted to know what 
was happening during the graft’s formation and why. The 
answers would take years to find and fill 3,000 pages. 
Shinoka and Breuer believed at the time that bone 
marrow cells were a source of stem cells that turned into 
blood cells. But the bone marrow cells they were seeding 
onto the grafts disappeared after a week. They repeated the 
experiment, with the same results. If the stem cells were 
differentiating into blood cells, why did they vanish? After 
more experiments, which involved inserting a fluorescent dye 
into the cells so they could be tracked in mice, the research¬ 
ers realized that even though they were getting the right 
result, they had misunderstood the mechanics of what was 
happening. The stem cells were not engineering new tissue. 
Rather, the stem cells were using molecules typically seen in 
15 
„\ngela Irizarry, now 4, shown 
Lith her mother Claudia, is the 
Ifirst patient in the United States 
ijto receive a bioengineered heart 
||ressel. Angela was born with only 
pne functioning heart ventricle. 
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Tissue from the lab mends a broken heart i6 
—- 
“; 
Toshihara Shinoka and Christopher 
Breuer met in the 1990s as post¬ 
docs at MIT, where they shared 
an interest in creating bioengi¬ 
neered tissue for use in surgery. 
Now both are at Yale, where they 
worked on the first implantation 
of a bioengineered heart vessel in 
the United States. 
17 
inflammation to induce cells to leave nearby blood cells and 
regenerate. “It was much like how a salamander regrows its 
tail, or a starflsh regrows an arm that’s been cut off,” Breuer 
said. “The scaffolding enabled the body to recreate a blood 
■vessel. It enabled us to identify some of the molecular signals 
!that were really important for this process, which we could 
then manipulate in our model systems.” 
“It’s a milestone in tissue engineering,” said Gary S. 
Kopf, M.D., professor of surgery, who performed Angela’s 
surgery with Shinoka. “Dr. Breuer and Dr. Shinoka’s lab 
work is pioneering in terms of working out the mechanism 
of how tissue-engineered blood vessels form.” 
“Moving this to the clinic is clearly a landmark 
accomplishment,” said hanger, the mix professor. “This is 
a very significant achievement, that they have been able 
to take this very basic work in the laboratory and test it in 
people. You need to get the right biocompatibility. You need 
the right mechanical properties. You have to make it cell- 
:ompatible. You have to do it in such a way that there are no 
Foreign body reactions.” 
Between the lab and the operating room 
The surgery began at 6 a.m. on a morning in August 2011, 
when the surgeons aspirated Angela’s bone marrow. They 
needed 5 ccs of bone marrow for each kilogram of her body 
weight, between 55 and 70 ccs total. The operating room team 
included two attending surgeons, one surgical fellow, two anes- 
:hesiologists, two perfusionists, and two nurses. A five-minute 
walk away in the Richard D. Frisbee iii Laboratory of Stem 
Cell Transplantation and Hematopoietic Graft Engineering, 
five postdoctoral fellows seeded the scaffolding with Angela’s 
none marrow—a three-hour procedure. The timing had to be 
■ ust right. The seeded scaffolding had to be ready when the 
surgeons needed it so as not to prolong the surgery. Before the 
aperation the team practiced preparing the scaffolding more 
man 20 times with bone marrow purchased from a blood 
bank, Shinoka said. “We had stopwatches and we were trying 
to save every second we could,” Breuer said. 
In addition, per fda regulations, more than 10 tests 
I jhad to be performed on the graft before it could be im¬ 
planted to ensure that it was neither toxic nor infected. 
I While the fellows were preparing the graft, Shinoka 
and Kopf were in the operating room, preparing Angela’s 
heart. They needed about two hours to remove scar tissue 
[from her previous surgeries. Throughout the operation 
ithe surgical team was in contact with the hematology fel¬ 
lows preparing the graft. “We were communicating every 
30 minutes. The timing was pretty good,” Shinoka said. 
Once the surgeons had the graft, which measures 
18 mm in diameter by 4 to 5 centimeters in length, they 
connected Angela to a cardiopulmonary bypass machine for 
'an hour while they implanted it. The entire operation lasted 
! about eight hours. 
The procedure, said Kopf follows the path of the tra¬ 
ditional Fontan procedure. “It is the same exact surgery,” 
he said, noting the one difference. “Instead of using a piece 
of plastic, usually Gore-Tex, we used the tissue-engineered 
graft. In terms of the surgery, I would say it is a little easier 
to use. It is thinner and more flexible and seems to hold the 
sutures very well. It doesn’t seem to have any bleeding, and 
the Gore-Tex does have a little more bleeding.” 
Angela is not only the first patient in the United 
States to receive a bioengineered blood vessel but also the 
first of six patients participating in a five-year clinical trial. 
Breuer and Shinoka will monitor her for three years after 
her surgery. They will watch for complications from the 
graft and determine whether the graft does in fact grow 
with the child. Over time the surgeons plan to measure its 
size and compare it to normal blood vessels. 
“We have taken a very cautious approach,” Breuer 
said. “We wanted to learn as much as we could from each 
patient before we went on to the next patient. We will do 
one patient, wait for six months; do two patients, wait six 
months; do three patients, wait six months.” 
A child’s recovery 
So far the surgeons have been pleased with Angela’s recov¬ 
ery, as have her parents. Angela has reached all her post¬ 
operative milestones, Breuer said. “The last time I saw her 
in clinic she was a normal 3-year-old running around. I 
think Angela will be a very normal child.” 
“Before when she wanted to run with her brother, she 
got tired,” said Claudia Irizarry. “Now, she doesn’t want to stop. 
She can keep going. Her oxygen level is very, very good now.” 
On a chilly day in December, Claudia kept her 
daughter inside, even though she’s strong enough to play 
outside and ride a bicycle. She has never attended day care 
or school, nor can she play with children other than her 
brother, because during her recovery she’s still susceptible 
to infections. At home, where she lives with her parents, 
brother, and grandmother, Angela likes to play games on the 
computer, watch Scooby-Doo on television, and curl up in 
her mother’s lap. 
“If God sent me the baby, God also sent me the 
angels to care for her,” Claudia said. “I always believed that 
everything was going to be okay. She is very positive. She’s 
very happy. My hope for her is the same that all moms have, 
that she can do whatever she wants, that she can grow up 
and be a good person. I tell her I hope she grows up to be a 
doctor, to help kids the same way they helped her.” ym 
John Curtis is the editor of Yale Medicine. 
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Scholars work 
toward healthy 
communities 
Yale’s Robert Wood Johnson Clinical 
Scholars make a point of engaging 
the community in their research and 
making the world a healthier place. 
By Jennifer Kaylin 
When Oni Blackstock, m.d., arrived in New Haven in the 
summer of 2010 to begin her fellowship as a Robert Wood 
Johnson Foundation (rwjf) Clinical Scholar, she and some 
of the other fellows took a walking tour of the city’s West 
River neighborhood—home to many of the patients treated 
by Yale physicians. 
“I was really excited,” says Blackstock. “I know a lot of 
people who have spent years in New Haven and have never 
gone to these communities. I think it’s really important to get a 
sense of the reality of your patients’ lives. You don’t get that Just 
seeing them in the office.” 
The tour served its purpose. Blackstock saw the urban 
neglect, the effects of unemployment, lack of access to healthy 
foods, limited recreational facilities, and the residents’ reli¬ 
ance on public transportation. She also saw, in the community 
leaders who led the tours, the neighborhood’s strength and 
resiliency. What Blackstock didn’t see, at least initially, was 
how what she learned on the tour would dovetail with her own 
clinical interests, inform her work as an rwjf fellow, and most 
likely influence her medical career well into the future. 
As the tour was winding down, the scholars were 
taken to a meeting of the West River Neighborhood Services 
Corporation. Community residents had gathered to discuss a 
number of issues, including where they were going to buy their 
food now that the Shaw’s Supermarket chain had closed its 
store on Whalley Avenue. 
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20 Scholars work toward healthy communities 
“As a primary care doctor 1 care a lot about food inse¬ 
curity and its health consequences, and I knew that we would 
be able to help the West River residents in some capacity,” says 
Blackstock, who attended Harvard Medical School. 
With the loss of Shaw’s, community organizers were 
weighing other food distribution options—possibly a food 
co-op, another supermarket, or a buyers’ club—but first they 
needed to figure out what neighborhood residents want and 
would be prepared to support. Blackstock and Jed Barash, 
M.D., a first-year scholar, worked with neighborhood corpora¬ 
tion members to develop a survey tool to gauge community 
needs and feelings. 
Although a Stop & Shop supermarket has recently 
opened in the old Shaw’s site, Blackstock says strong support 
remains for an alternative. Their survey specifically asked 
whether Stop & Shop satisfies the neighborhood’s grocery 
needs. Noting that some residents expressed concern about 
Stop & Shop’s prices, she said, “We believe affordable quality 
food remains a need, even with the presence of Stop & Shop.” 
ABOVE & RIGHT Scholars Clara 
Filice and Gregg Furie are examin¬ 
ing the public health impacts of a 
plan ';o fill in the Route 34 Connec¬ 
tor and ’juild apartment buildings 
and office space above it. 
?op Such urban issues as pedes¬ 
trian safety, gun violence, motor¬ 
cycle safety, and access to afford¬ 
able food, have been subjects for 
research by clinical scholars. 
This finding is something that wouldn’t be known with- ' 
out engaging the community. Replacing one large supermarke ' 
with another would seem to be the ideal solution—but when 
residents were surveyed, a different picture emerged. ; 
“When the research is generated by the community, it’s j 
a more holistic, honest, and genuine way to approach research,’ | 
says Blackstock. “Forming these partnerships helps com- I 
munity members understand what research is, and it builds a jj 
bond between academia and the community.” 
This bonding, administrators of the Yale rwjf 
Clinical Scholars Program would say, is exactly how their 
program is supposed to work. “What we’re aiming for is 
alignment of the scholars’ passions and the needs of the 
community they are serving,” says Marjorie Rosenthal, m.d. 
M.P.H., the program’s assistant director. 
Such community-based participatory research is an 
important facet of the program, says Program Director 
Harlan M. Krumholz, m.d., the Harold J. Hines Jr. Professoi 
of Internal Medicine. “We have maintained our traditional 
commitment to teaching core competencies in research 
and enriched our curriculum with this work. We are a pro¬ 
gram that trains people for a variety of roles in a range of 
organizations, but we are trying to change the paradigm of 
research too—with an emphasis on thinking about the end- 
user of the knowledge.” S 
i 
People who ask the next question 1 
In 1973, Yale was one of the founding sites for the nascent 
RWJF Clinical Scholars Program, a two-year fellowship that j 
teaches research skills, health policy, leadership, media/com- j 
munication skills, and community health. The other three sites f 
-Ml 
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are the University of Michigan, the University of Pennsylvania, 
^ and the University of California, Los Angeles. 
Young doctors apply for rwjf fellowships after they’ve 
completed their residencies, with seven or eight scholars a 
year being accepted into the Yale program. Upon successful 
completion of the program, they receive the degree of Master of 
Health Sciences Research. 
Rosenthal said that the ideal clinical scholar candidate is 
someone who is interested in the interplay between research and 
'policy. “We’re looking for people who, when they’re on rounds, 
are continually asking the next question,” she says. “If the patient 
has anemia, they’re not satisfied asking, ‘How should we treat 
this?’ They want to know why the patient has it; is there some¬ 
thing about the social structure that contributed to this?” 
Krumholz adds that the successful rwjf scholar is 
willing to challenge the conventional wisdom. “Just because 
that’s the way things have been done for a long time doesn’t 
mean it’s the right thing,” he says. “The inclination is to just 
go along. We want critical thinkers who have the courage of 
their convictions.” 
The program is divided into a didactic year followed 
by a year devoted to research. Coursework includes training 
in clinical epidemiology, community-partnered research, 
health economics, health policy, health systems management, 
organizational behavior, and leadership development. The four 
foundational courses are biostatistics; clinical and health services 
research methods; principles and processes of community- 
Ibased research approaches; and principles of health policy 
and management. 
Central to scholars’ training is the expectation that they 
Iwill conduct two or more health services research projects dur¬ 
ing their fellowship and contribute to scholarship in clinical 
jjresearch. They are encouraged to undertake at least one project 
jthat involves primary data collection and tackle projects that 
juse different methodological approaches. Scholars are also 
(expected to maintain their clinical skills through interactions 
with patients at Yale-New Haven Hospital, the VA Connecticut 
Healthcare System in West Haven, or affiliated clinic, hospital, 
or community-based health centers. 
To date, 151 scholars have graduated from the Yale pro¬ 
gram, with seven more graduating in 2011. Graduates work in 
a wide range of jobs in academia and politics as well as holding 
other positions in the public, private, and nonprofit sectors. 
Stephen Cha, m.d., fw ’06, is the chief health care policy advi¬ 
sor to U.S. Representative Henry Waxman, D-Calif; Katherine 
Goodrich, m.d., fw ’10, is the chief medical officer of the Office 
of Planning and Evaluation at the U.S. Department of Health 
and Human Services; David M. Krol, m.d., fw ’01, is the 
team director and senior program officer of human capital at 
the Robert Wood Johnson Foundation; Eric S. Holmboe, m.d., 
PH.D., fw ’98, is the chief medical officer and senior vice 
president of the American Board of Internal Medicine; and 
Anu Gupta, m.d. ’97, hs ’00, fw ’02, oversees the hiv/aids 
philanthropic portfolio of Johnson & Johnson’s Corporate 
Contributions Division. 
A move to community-based research 
The original program’s stated mission, according to Krumholz, 
was training fellows to be “skilled in clinical research to the 
same extent that people were in basic sciences,” and to under¬ 
stand research methods, develop fluency in the language of 
clinical research, and become astute readers of the scientific lit¬ 
erature. “Our ulterior motive,” he adds, was to sharpen critical 
thinking skills. “We wanted them to be able to pinpoint the key 
leverage points in medicine and make a difference.” 
The founding director of Yale’s clinical scholars pro¬ 
gram was the late Alvan Feinstein, m.d.. Sterling Professor 
of Medicine and Epidemiology. Under his direction the Yale 
program developed a reputation for excellence in training 
its scholars in clinical research methods. As the rwjf pro¬ 
gram matured both nationally and at Yale, however, its mission 
evolved. In the most recent funding cycle, which began in 2005, 
national directors maintained the rigorous training in re¬ 
search methods, but added a new emphasis on community- 
based participatory research. 
“We fully embraced the idea,” says Krumholz. “Too 
often we’re doing research without soliciting input from the 
people we’re seeking to help.” Krumholz calls the result “con¬ 
fetti papers”—research papers that are published, maybe even 
attract some press coverage, but generate “no conversation.” 
He says this lack of feedback usually occurs because there 
wasn’t enough front-end work with the end-users. “Other 
researchers may cite the paper,” he said, “but that doesn’t 
matter if it doesn’t lead to action.” 
Now, six years into the latest funding cycle, Krumholz 
calls Yale’s community-based participatory research initiative 
“the jewel of our program.” At least 15 percent of the scholars’ 
time is devoted to research in partnership with organizations 
serving New Haven. The work is guided by the Steering 
Committee on Community Projects, composed of a cross- 
section of community representatives and Yale affiliates work¬ 
ing with the New Haven community. So far, seven projects 
have been completed and disseminated; another 10 are either 
under way or being planned. 
Yet in the beginning it was far from a given that com¬ 
munity leaders would agree to partner with the scholars. “People 
were suspicious when we proposed this,” Krumholz recalls. 
“They’d had people like us approach them before and write 
them into their grants, only to lose interest in them as soon as 
the grant came through. I made a personal promise that we 
wouldn’t abandon them—that this was a sincere, genuine offer.” 
New Haven’s size and demographics make it an ideal 
place to conduct community-based participatory research, says 
Georgina Lucas, m.s.w., deputy director and steering commit¬ 
tee chair of the Yale rwjf clinical scholars program. “It’s a 
microcosm of a much larger urban area,” she said. “You can 
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22 Scholars work toward healthy communities 
get your arms around it, and it’s small enough that you can 
build relationships and disseminate information.” 
The challenge, she adds, is completing a project within 
the two years the scholars are in the program. “People don’t 
realize how much time community research takes,” she says. 
“You need to engage your stakeholders to get complete and 
accurate information and to create effective and sensitive inter¬ 
ventions, but that means building relationships and trust— 
which takes time.” 
Gun violence and motorcycle helmets 
When Chisara N. Asomugha, m.d., m.p.h., fw ’09. was in the 
program, her community-based participatory research focused 
on youth-related gun violence in New Haven. Working with the 
New Haven Family Alliance, she used an established research 
approach called Photovoice to collect data. New Haven youths 
between the ages of 14 and 19 were given cameras and asked to 
photograph scenes reflecting their community’s strengths and 
challenges. The photographs were then used as a stimulus for 
focus group discussions with an eye toward gaining insights 
into local policy and service needs. 
After the project was completed, the photographs 
were displayed in the New Haven Public Library, while 
Asomugha, who attended the Duke University School 
of Medicine, shared her final report with Mayor John 
DeStefano Jr. Soon afterward she was hired as New Haven’s 
deputy mayor for community services. 
Gregg Furie, m.d., drew inspiration for his community 
research project from the city’s plan to remove the Route 34 
Connector in an effort to reconnect the medical campus and 
adjacent neighborhoods with the rest of the city. He’s been 
working with fellow scholar and pediatrician Clara Filice, 
M.D., and the city’s health, planning, and economic develop¬ 
ment departments to conduct a health impact assessment that 
will focus on pedestrian and bicycle safety, activities for walk¬ 
ers, and reducing accidents. “It’s a way to introduce health as 
a consideration in public policy decision making,” says Furie, 
who got his medical degree from Harvard. “City planning 
and public health have different objectives, so we’re trying to 
make sure the public health impact doesn’t get lost.” 
In talking about their research projects, all the schol¬ 
ars say they are gratified to have the opportunity to contrib¬ 
ute to addressing real health needs; but they also recognize 
that through the cidtivation of personal relationships with 
community members and the process of consensus build¬ 
ing—which is so important for the success of a community 
project—they are developing other skills that will be valu¬ 
able in their later careers. 
Adam Landman, m.d., fw ’10, wanted to do a research 
project on the correlation between wearing a motorcycle 
helmet and serious injuries. Krumholz questioned whether 
the topic might be too obvious—of course wearing a helmet 
reduces the likelihood of serious injury. 
“One of the most beneficial parts of the program,” 
Landman says, “is learning to clearly articulate the impor¬ 
tance and value of the research you’re doing.” In the case of 
the helmet study. Landman and Michael Phipps, m.d., his 
RwjF partner, were able to persuade their professors and col¬ 
leagues that the project was worthwhile. “We knew from the 
outset that the results wouldn’t be novel,” Landman says, “but 
we were okay with that. There had been discussions in the 
past about making helmet use mandatory in Connecticut, but 
there was no recent data to inform the decision making. Our 
goal was to use our research skills and rigorous methodology 
to inform an important public health topic.” 
In her new job as deputy mayor, Asomugha is already 
seeing the value of acquiring a deeper understanding of the 
social determinants of health that she gained through her 
training as a clinical scholar. She cites an incident she says 
is not atypical, concerning a woman who had been scru- 
prdous about getting her daughter to her medical appoint¬ 
ments. “They rode their bikes and were always on time,” 
Asomugha says. “After one appointment, the doctor gently 
told the mother that her child should wear a helmet when 
bike riding. The woman missed her next appointment, and 
the doctor didn’t know what had happened.” Upon hear- j 
ing the story, Asomugha quickly understood—the mother 
couldn’t afford a helmet. Embarrassed and unwilling to risk 
what she saw as further rebuke, she skipped her appoint¬ 
ment. “It’s the unintended consequences of trying to do a 
good thing,” Asomugha says. “It’s very common, and it’s 
something we need to try to anticipate and avoid.” 
Peggy Chen, m.d., fw ’10, learned a similar lesson dur¬ 
ing her time in the clinical scholars program. She was helping .' 
the New Haven Healthy Start Program Consortium develop 
a brochure about obesity and the importance of exercise and 
healthful eating. i 
“We came up with an initial draft and thought, ‘This 
is great. They’re going to love it,’ ” Chen says. “They changed 
every word and all the photos.” The problem, Chen came to 
learn, was that the brochure, complete with photos of over- j 
weight women standing on scales, had the scolding tone of | 
a finger-wagging gym teacher. “You’ll get high blood pres¬ 
sure: you’ll get diabetes, blah, blah, blah. These women have 
gotten negative messages from everywhere else. They didn’t 
need another one from us.” The new draft, which empha¬ 
sizes all the positive things that can happen when one lives | 
a healthful lifestyle, was quickly approved. 
The community takes notice 
It’s not just the scholars who see the value in the program’s 
community research component; community partners in 
New Haven and rwjf’s national program office have also 
taken notice. 
Rebecca Allen, director of programs and services for the 
Columbus House homeless shelter, remembers when Ryan 
J 
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Greyson, m.d., a rwjf scholar, contacted the shelter’s executive 
director, Alice Cunningham. Greyson’s project was to find ways 
to improve communication between the shelter and Yale-New 
Haven Hospital. “We get lots of people coming through here 
^wanting to talk or do research,” she says, “but Ryan brought 
it to a whole new level. He partnered with clients and staff. 
He gave us feedback and held our hand every step of the way. 
Usually doctors don’t speak our language, but Ryan does. He’s 
always very understandable and approachable.” 
Desmond Runyan, m.d., d.p.h., the rwjf national pro¬ 
gram director, was even more effusive. “The Yale program is 
doing exceptional work in the community,” he says. “Harlan 
and his staff are doing a superb job.” This finding is all the 
more noteworthy, he adds, because Yale hasn’t always enjoyed 
the most collaborative relationship with its host city. “Yale has 
a reputation for having a town/gown split, so it’s remarkable 
how strong the ties are now, how invested people have become. 
: Overall, the success of community-based research is best exem¬ 
plified in Yale.” 
Runyan also cites Yale’s leadership component as an 
area where it excels. About four years ago, under the steward¬ 
ship of Irwin Birnbaum, j.d., the medical school’s former chief 
' operating officer, and David Berg, ph.d., clinical professor 
of psychiatry, the clinical scholars program began offering 
seminars in leadership development and organizational man¬ 
agement. Scholars are given an opportunity to shadow health 
industry leaders and attend group discussions when such lead¬ 
ers come to campus. 
But in this latest iteration of the clinical scholars program, 
it is the commitment to community-based participatory research 
i 
LEFT Clinical scholars helped 
organize a farmstand in the West 
':iver neighborhood. The stand, 
operated by CitySeed, opened in 
July 2011. CitySeed outreach coor¬ 
dinator Cara Donovan (left) sold 
fresh vegetables to residents. 
ABOVE TOP HarlanKrumhoiz,di¬ 
rector of the scholars program, led 
a seminar with scholars in October. 
ABOVE Clinical scholar Oni 
Biackstock (right) worked with 
community groups in New Haven’s 
West River neighborhood on 
issues including access to healthy 
food. She joined, from left, 
community partner Ann Greene, 
scholar Jed Barash, community 
partner Stacy Spell, and commu¬ 
nity organizer Billy Bromage. 
that is exciting the scholars, winning over hearts and minds in 
the community, and impressing the program’s national adminis¬ 
trators who make those all-important funding decisions. 
Whether it’s helping establish Project Access, a new 
program that helps the uninsured gain access to health spe¬ 
cialists: helping Integrated Refugee and Immigrant Services 
assess the health needs of new refugees and develop interven¬ 
tions; or designing a method to evaluate the progress made 
on Mayor DeStefano’s Teen Pregnancy Prevention Council, 
Yale’s clinical scholars are collaborating with community 
members to address their neighbors’ health needs in the hope 
of changing their circumstances. If their work proves to be 
valuable beyond New Haven, so much the better. 
“At the end of our lives and careers, to just look back 
on a big curriculum vitae would be a shame,” Krumhoiz 
says. “We should strive to leave a legacy of better health in 
the community.” ym 
Jennifer Kaylin is a writer in New Haven. 
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.t' 
Richard 
Edelson 
Melissa Grafe 
New urology chair 
named 
PETER C. SCHULAM, M.D., PH.D., 
was named chief of the Depart¬ 
ment of Urology at Yale-New 
Haven Hospital and chair of the 
department at the School of 
Medicine in January. Urology, 
previously a section within the 
Department of Surgery, has re¬ 
cently been elevated to depart¬ 
mental status. 
Schulam comes to Yale from 
the Ronald Reagan Medical Center 
at UCLA, where he was vice chair 
of urology, chief of the division of 
endourology and minimally inva¬ 
sive surgery, and director of both 
the kidney stone treatment center 
and the surgical living kidney 
donor program. 
Schulam has long-standing 
clinical interests in adrenal disor¬ 
ders; bladder, prostate, and kid¬ 
ney cancer; donor nephrectomy; 
and kidney stones and kidney 
reconstruction. He is nationally 
known for his expertise in mini¬ 
mally invasive surgery and lapa¬ 
roscopic techniques. 
A native of New Haven, Schulam 
received his medical degree as 
well as his PH.D. in immunology 
at Baylor College of Medicine 
in Houston. 
He replaces Robert M. Weiss, 
M.D., the Donald Guthrie 
Professor of Surgery (Urology), 
who has led the Section of 
Urology within the Department 
of Surgery. Weiss will continue his 
laboratory research and his active 
urology practice. 
National Physician 
of the year 
RICHARD L. EDELSON, M.D. 
’70, chair and the Aaron B. and 
Marguerite Lerner Professor of 
Dermatology, was one of five 
physicians to receive a National 
Physician of the Year Award from 
Castle Connolly Medical Ltd. in 
March. Edelson is an internation¬ 
ally recognized pioneer in the 
research and treatment of cuta¬ 
neous T-cell lymphoma (CTCL), 
a cancer affecting the skin. He 
identified and characterized this 
cancer, and his research group 
played a central role in decipher¬ 
ing the basic properties of CTCL 
cells in order to develop effective 
therapies. Edelson, who served as 
director of the Yale Cancer Center, 
received a Clinical Excellence 
Award. Castle Connolly Medical 
Ltd. publishes guides to the best 
doctors in the United States. 
Edelson developed extracorpo¬ 
real photochemotherapy (ecp) for 
CTCL patients in clinical trials at 
Yale Cancer Center. ECP, the first 
FDA-approved selective immuno¬ 
therapy for cancer, has been 
used more than 3 million times 
worldwide to treat CTCL, organ 
transplant rejection, and graft- 
versus-host disease, the major 
complication following bone mar¬ 
row transplantation. 
Edelson, who served as direc¬ 
tor of the Yale Cancer Center, 
received the Clinical Excellence 
Award at a ceremony in March. 
Castle Connolly Medical Ltd. pub¬ 
lishes guides to the best doctors 
in the United States. 
Historical librarian 
appointed 
MELISSA J. CRAFE, PH.D., waS 
named the John R. Bumstead 
Librarian for Medical History at the 
Cushing/Whitney Medical Library 
last year. Grafe replaces Toby A. 
Appel, PH.D., M.L.S., who retired 
in 2010. Grafe, whose doctorate is 
in the history of medicine, comes 
to Yale from Lehigh University, 
where she was the humanities 
librarian. For her doctoral research 
at Johns Hopkins she specialized 
in 18th-century American medical 
practice, but she also worked with 
rare books and special collections 
at the Historical Collection for 
the Institute of the History 
of Medicine. 
Among her current projects is 
Yale’s participation in the Medical 
Heritage Library, an effort by 
leading medical libraries to make 
rare books accessible online. 
Collections from Yale, Columbia, 
Harvard, Johns Hopkins, the 
National Library of Medicine, 
the New York Public Library, and 
other institutions are being digi¬ 
tized and posted online. 
“I see my job as working with 
researchers, students, faculty, and 
anyone who is interested in the 
history of medicine and our collec¬ 
tions, and helping to bring forth 
new knowledge,” said Grafe, who 
oversees a staff of four full-time 
employees, one part-time employ¬ 
ee, and three part-time student 
hires. "We’re here to preserve the 
collection for future generations. 
We’re here to make it accessibie 
either through digital resources 
or blogs or the exhibitions and 
classes that we do. We’re here to 
help our patrons.” 
Two Yale scientists were among 
n to receive Laureate Awards in 
November from the Endocrine 
Society, the largest organiza¬ 
tion devoted to research on 
hormones and the practice of 
endocrinology. According to the 
society, the awards represent 
the pinnacle of achievement in 
the field of endocrinology. 
Tamas L. Horvath, d.v.m., 
PH.D., the Jean and David W. 
Wallace Professor of Compara¬ 
tive Medicine and professor of 
neurobiology and of obstetrics, 
gynecology and reproductive 
sciences, received the Ernst 
Oppenheimer Award. This 
award recognizes meritorious 
accomplishments by a young 
investigator in the field of basic 
or clinical endocrinology. 
Gerald I. Shulman, m.d., ph.d., 
the George R. Cowgill Professor of 
Physiological Chemistry, professor 
of medicine and of cellular and 
molecular physiology, and a How¬ 
ard Hughes Medical Institute in¬ 
vestigator, will deliver the Clinical 
Investigator Award Lecture at the 
society’s annual meeting in June. 
The award acknowledges major 
contributions to clinical research 
related to the pathogenesis, 
pathophysiology, and treatment 
of endocrine diseases. 
Daniel A. Colon-Ramos, ph.d., 
assistant professor of cell biol¬ 
ogy, received the Early Career 
Award for Public Engagement 
with Science at the annual 
meeting of the American As¬ 
sociation for the Advancement 
of Science in Vancouver in 
February. The award recognizes 
his work with the nonprofit or¬ 
ganization CienciaPR, a website 
for educators and professionals 
interested in science and Puerto 
Rico. The award, established in 
2010, is given once a year to an 
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sarly-career scientist or engineer 
vho demonstrates excellence in 
;ontributions to public engage- 
Tient with science activities. 
Guadalupe Carcia-Tsao, m.d., 
lorofessor of medicine (digestive 
itiseases), is the new president- 
plect of the American Asso- 
pation for the Study of Liver 
[Diseases. Garcia-Tsao is a staff 
jahysician at the VA Connecticut 
jrlealthcare System, where she is 
[:hief of the Section of Digestive 
[Diseases and program direc- 
jior of the Hepatitis C Resource 
Center. She is also director of the 
Clinical Core of the NiH-funded 
'.iver Center at Yale. Garcia-Tsao 
Earned her medical degree 
from the Universidad Nacional 
Autonoma de Mexico and 
i:ompleted her internal medicine 
'Residency and gastroenterology 
[fellowship at the Institute Na¬ 
tional de la Nutricion in Mexico 
City. She completed her training 
in hepatology at Yale and joined 
the faculty in 1989. 
Unda S. Godleski, m.d., associ¬ 
ate chief of staff for education 
at the VA Connecticut Health¬ 
care System in West Haven and 
associate professor in the De- 
!partment of Psychiatry, received 
the 2010 David M. Worthen 
Award for Career Achievement 
in Educational Excellence in 
bctober. The award recognizes 
[an employee of the Veterans 
Health Administration who has 
made contributions of national 
significance to education in the 
‘health professions. 
John H. Krystal, m.d. ’84, hs ’88, 
the Robert L. McNeil Jr. Profes¬ 
sor of Translational Research 
and chair of the Department 
of Psychiatry, was installed as 
president of the American Col¬ 
lege of Neuropsychopharmacol¬ 
ogy in December. He will serve 
a one-year term, studying the 
neurobiology and treatment of 
psychiatric disorders. Krystal 
is a pioneer in translational 
neuroscience, which is the effort 
to link concepts and approaches 
arising from basic brain research 
to the study of the neurobiology 
and treatment of psychiatric 
disorders. He has applied this 
strategy to develop and test new 
approaches to treating schizo¬ 
phrenia, PTSD, alcoholism, and 
depression. Krystal also directs 
Yale’s Center for the Translational 
Neuroscience of Alcoholism, 
which is funded by the National 
Institute on Alcohol Abuse and 
Alcoholism, and he is a member 
of the National Advisory Council 
on Alcohol Abuse and Alcohol¬ 
ism. He is also a member of the 
Institute of Medicine of the 
National Academies. 
Steven Marans, M.s.w., ph.d., 
Harris Professor of Child Psychia¬ 
try in the Child Study Center and 
director of the National Center 
for Children Exposed to Violence/ 
Childhood Violent Trauma Center 
at Yale, was appointed in Octo¬ 
ber to the U.S. Attorney General’s 
National Task Force on Children 
Exposed to Violence. The task 
force is part of the Defending 
Childhood Initiative, whose goals 
are prevention of children’s ex¬ 
posure to violence as victims and 
witnesses; reduction of negative 
aftereffects on children exposed 
to violence; and development 
of better understanding and 
increased awareness of this 
issue. The task force will identify 
promising practices, program 
implementation, and commu¬ 
nity strategies to prevent and 
respond to children’s exposure 
to violence. 
Steve Martino, ph.d., associate 
professor of psychiatry, was 
appointed chief of psychology 
for the VA Connecticut Health¬ 
care System in December. The 
VA’s Psychology Service has 49 
psychologists on staff; it com¬ 
prises two predoctoral training 
programs in West Haven and 
Newington; clinical and research 
postdoctoral training programs; 
and opportunities for research, 
education, and national service. 
Martino’s research interests 
include motivational interview¬ 
ing, clinician training strategies, 
the science of dissemination and 
implementation, technology- 
based approaches to therapy, 
and curriculum evaluation. 
Scott J. Miller, PH.D., chair and 
the Irenee du Pont Professor of 
Chemistry, was recognized as a 
fellow of the American Associa¬ 
tion for the Advancement of 
Science (aaas) in February. The 
AAAS cited Miller’s "visionary 
approach to catalysis that has 
resulted in new types of reactiv¬ 
ity and unprecedented selectiv¬ 
ity in asymmetric synthesis and 
natural product modification.’’ 
Michael H. Nathanson, ph.d., 
M.D., FW ’90, professor of 
medicine (digestive diseases), 
section chief (digestive diseases), 
and director of the Liver Research 
Center, began a five-year term as 
editor of the journal Hepatology. 
Stanley H. Rosenbaum, m.d., 
professor of anesthesiology, of 
medicine (pulmonary), and of 
surgery (trauma), received the 
Lifetime Achievement Award 
from the Society of Critical Care 
Anesthesiologists. The award 
presentation took place at the 
society’s annual meeting in 
Chicago in October. 
Elisabetta Ullu, ph.d., professor 
of medicine (infectious diseases) 
and of cell biology, was named 
the winner of the American 
Society for Biochemistry and 
Molecular Biology’s (asbmb) 
inaugural Alice and C.C. Wang 
award. Ullu received the award 
for her laboratory’s work with 
the protozoan parasite Try¬ 
panosoma brucei, which causes 
African sleeping sickness, to 
uncover a novel mechanism of 
gene silencing known as rna 
interference. The award honors 
Ching Chung ("C.C.’’) Wang, 
PH.D., professor of pharmaceuti¬ 
cal chemistry at the University 
of California, San Francisco. Ullu 
received her ph.d. from the 
University of Rome in 1973 and 
took a position at Yale in 1984. 
Ullu will receive her award in 
April duringthe Experimental 
Biology 2012 conference in San 
Diego, where she will deliver 
the award lecture. The award 
consists of $35,000 for use by the 
recipient’s research laboratory, a 
plaque, and travel expenses for 
the recipient to attend and speak 
at the ASBMB annual meeting. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
1 Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
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26 students 
Student health project 
offers blood screening 
Yale students provide tests, referrals, 
and advice on handling high blood 
pressure and blood glucose. 
On a cold Saturday morning in January, 
dozens of people gathered in the base¬ 
ment of the Episcopal Church of St. 
Paul and St. James, near New Haven’s 
Wooster Square. They came for 
warmth, companionship, free cloth¬ 
ing, and the weekly food pantry run by 
Loaves and Fishes. 
Some also came for free blood pres¬ 
sure and blood glucose screenings 
provided by Yale students in the health 
professions. Teams from the School 
of Medicine, the School of Nursing, 
and the School of Public Health have 
been coming to the church for about 
10 years as part of the Neighborhood 
Health Project (nhp). The mission 
of the NHP is simple—under the 
tutelage of volunteer physicians, the 
students offer screenings and advice 
about nutrition and exercise. “A lot of 
our patients have high blood sugar 
and high blood pressure,” said Sarah 
Aspinwall, a public health student 
who’s one of four clinic coordinators. 
“A lot of that is a diet and exercise 
issue.” Last year the clinic also gave 
free flu shots to almost 100 people, 
with vaccine provided by New Haven’s 
health department. 
The screenings are the easy part. 
If the tests reveal a problem, the stu¬ 
dents refer their patients to a source 
of free or low-cost health care in New 
Haven. That’s the hard part—many of 
their patients are unemployed or have 
limited resources. 
One of the patients that morning 
was 36 years old and recently arrived 
from Mexico. He hadn’t worked in two 
weeks; before that he had worked inter¬ 
mittently in remodeling. He was wor¬ 
ried about his frequent urination and 
recent weight loss. Carrie A. Redlich, 
M.D. ’82, HS ’86, FW ’87, M.P.H. ’88, 
professor of medicine (occupational 
medicine), and this week’s preceptor, 
had questions for the patient: When 
was the last time you saw a doctor.^ 
How much weight have you lost? Why 
are your pants so loose? Does anyone in 
your family have diabetes? 
First-year physician associate stu¬ 
dent Lauren Monoxelos had already 
done the screenings—the patient’s 
results were off the charts. Jessica 
Wang, a second-year medical student 
and one of the clinic coordinators, 
repeated the tests. Still off the charts. 
There’s only so much the staff can 
do at a screening clinic, so Redlich 
made an appointment for the patient 
at HAVEN, a student-run free clinic on 
Grand Avenue. 
This case offered a lesson beyond 
the mechanics of strapping a blood 
pressure cuff on a patient’s arm. 
“For me one of the biggest shockers 
in terms of interfacing with the 
medical system has been that when 
you’re studying it, you think the low- 
income population will just sign up 
for Medicaid and they’ll get care,” said 
Danielle Correia, a second-year public 
health student and clinic coordinator. 
“It seems very simple on paper, but 
when you’re actually in that context 
you realize the sheer complications of 
what signing up for Medicaid involves. 
What if they’re just above the poverty 
line but still very low-income?” 
Then there are the lessons in 
bedside manner. “The thing that we 
sometimes underestimate is how 
important it is to get comfortable with 
patients,” said nhp faculty advisor 
Jeffrey R. Bender, m.d., hs ’83, the 
Robert 1. Levy Professor of Medicine 
(Cardiology) and professor of immu¬ 
nobiology. “This is a great way for stu¬ 
dents to start getting a sense of how 
to talk to people, make them immedi¬ 
ately comfortable, and engender trust 
from the outset.” 
“It’s really rewarding,” said Wang. 
“We are helping people get access to 
health care who would otherwise have 
a very hard time doing so.” 
—John Curtis 
Maureen Wright, a student pursuing dual degrees 
in public health and the Physician Associate 
Program, took a patient’s blood pressure at the 
Neighborhood Health Project in January. Stu¬ 
dents in medicine, nursing, public health, and 
the PA program also do blood glucose screenings 
and offer advice about diet and exercise. 
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Salons bring faculty and 
students together for wine, 
books, and conversation 
A few days after their return from winter 
iirecess, 10 second-year students piled 
onto a bus in front of the Sterling Hall 
I of Medicine for the 20-minute trip to 
the Guilford home of Erol Fikrig, m.d., 
Waldemar Von Zedtwitz Professor of 
Medicine, Howard Hughes Medical 
Institute investigator, and professor of 
lepidemiology and public health and of 
microbial pathogenesis: and of Margaret 
'iFikrig, m.d., assistant professor of 
■medicine. Both specialize in infectious 
idiseases. They were joined by Gerald 
Triedland, m.d., former director of the 
I|aids Program at Yale and professor of 
imedicine (aids) and of epidemiology 
](microbial diseases). Friedland has served 
hn the front lines of three epidemics— 
jHiv/AiDS in New York City, hiv/aids 
jin South Africa, and extensively drug- 
resistant tuberculosis in South Africa. 
ii As the group sipped wine and beer 
j!in the Fikrigs’ living room, the talk 
[turned to the evening’s theme—The 
i Plague, Albert Camus’ 1947 novel 
! about an outbreak of bubonic plague 
lin an Algerian seaport, 
i The literary salon was the second in 
a series of four. In December Thomas 
P. Duffy, M.D., professor of medicine 
(hematology) led first-year students in a 
' discussion of Rebecca Skloot’s history 
i| of HeFa cells used widely in medical 
1 research. The Immortal Life of Henrietta 
Lacks. In January Warren A. Andiman, 
, M.D., Fw ’77, professor of pediatrics 
1 (infectious diseases) and of epidemiol¬ 
ogy (microbial diseases), hosted a dis- 
I cussion of Steven Johnson’s The Ghost 
Map—the story of John Snow, a pioneer 
epidemiologist who traced the source of 
a cholera epidemic in London in 1854. 
Michael F. Schwartz, ph.d., assistant 
dean for curriculum and associate pro¬ 
fessor of neurobiology, concluded the 
series in February with a discussion of 
Oliver Sacks’ The Man Who Mistook His 
Wife for a Hat. 
The salons came out of a discus¬ 
sion among faculty members about 
the relationship between literature and 
medicine. “Somebody said something 
and a light bulb went off” said Nancy 
Angoff M.p.H. ’81, M.D. ’go, hs ’93, 
associate dean for student affairs. “We 
started thinking about books that ht 
with certain courses. We started think¬ 
ing biochemistry, we started thinking 
anatomy, we started thinking cell bio. 
We put together a committee of students 
and faculty and came up with these 
choices.” Another impetus was a pro¬ 
gram launched this academic year—the 
medical school provided iPads to all stu¬ 
dents—which allows students to receive 
free electronic versions of the books. 
First- and second-year students were 
invited to sign up for the salons—the 
dual goals were to integrate the human¬ 
ities into students’ medical education 
and to provide a relaxed and informal 
way for students and faculty to interact. 
That night at the Fikrigs’ home, 
Friedland led the discussion of The 
Plague. “This is about death and dying, 
and the choices that we make at personal, 
professional, and community levels,” 
Friedland said. “To me it has been a 
textbook of the hiv/aids epidemic, bet¬ 
ter than any journal article I could read.” 
One student, Rebecca Vitale, said 
afterward that the discussion provided 
a link between the book and modern 
epidemics. “It talks about the medical 
profession in the way that it functions 
in a time of crisis,” she said. “That 
is a piece of medicine that you never 
talk about.” 
At the final session a few weeks later 
at Schwartz’s home in Guilford, the 
discussion veered from the Sacks book 
to discussions of neurology and to les¬ 
sons from the accumulated wisdom of 
TOP Gerald Friedland, who observed the 
hiv/aids epidemic firsthand, led the discussion 
of The Plague. 
BOTTOM In February Michael Schwartz (left) 
hosted a discussion of The Man Who Mistook His 
Wife for a Hat with first-year students and neurol¬ 
ogy professors David Greer and Serena Spudich. 
the faculty present. Schwartz and the 
students were joined by David M. Greer, 
M.D., vice chair of neurology and the 
inaugural Dr. Harry M. Zimmerman 
and Dr. Nicholas and Viola Spinelli 
Associate Professor of Neurology, and 
Serena Spudich, m.d., associate profes¬ 
sor of neurology. 
“Could this book have been written 
now.^” first-year Amanda Wallace asked 
of the book, written in 1985. 
“We thought this is the way medi¬ 
cine was at the time,” answered Spudich. 
“It’s a historical piece,” added Greer. 
“We have treatments now. Now we have 
a ton of stuff we can do. I don’t think 
you could write this now.” 
-f.C. 
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A neurologist inspired 
by his patients 
William Gaillard frees his pediatric 
patients from debilitating or life- 
threatening conditions. 
When Irving S. Cooper, m.d., was 
perfecting the stereotactic cryosurgery 
to treat Parkinson disease in the late 
1950S, William D. Gaillard, m.d. ’85, 
was spending summers down the 
block in Tannersville, N.Y. Developer 
of the first surgical procedures for 
Parkinson disease, a pioneer in cryo¬ 
surgery, stereotactic surgery, and func¬ 
tional neurosurgery, as well as a close 
family friend. Cooper invited Gaillard 
to spend a summer during college 
working with him. 
“He was bright and innovative, as 
well-versed in literature as he was in 
medicine. My interest in neuroscience 
stems from his influence,” said Gaillard, 
who chose pediatric neurology instead 
of surgery. Gaillard. chief of the Division 
of Epilepsy, Neurophysiology, and 
Critical Care Neurology at Children’s 
National Medical Center in Washington, 
D.C., felt surgery wouldn’t allow time 
for a family, which now includes his 
19-year-old son, i6-year-old daughter, 
and his wife, Adelaide S. Robb, M.D., 
a principal investigator at Children’s 
National Medical Center. Gaillard 
proudly describes Robb as “the best 
pediatric psychopharmacologist east of 
the Mississippi River. And west.” 
Gaillard’s work, like Cooper’s, helps 
free patients from debilitating or life- 
threatening neurological conditions. 
As director of the comprehensive pedi¬ 
atric epilepsy program at Children’s 
National, director of the Intellectual 
and Developmental Disabilities Re¬ 
search Center Imaging Core, associate 
director of the Center for Neuroscience 
Research at Children’s Research 
Institute, and professor of neurology at 
George Washington and Georgetown 
universities, Gaillard focuses on 
difflcult-to-control seizures. 
In a fleld that can take a heavy 
emotional toll, Gaillard draws inspi¬ 
ration from his patients and their 
parents. The pediatric neurologist 
tells the story of a 13-year-old patient 
with Rasmussen encephalitis, a rare 
inflammation of one hemisphere of 
the brain that causes severe seizures, 
cognitive disabilities, paralysis on one 
side of the body, and possibly death. If 
medications don’t control the seizures, 
the only cure is removal of the affected 
hemisphere of the brain. Typically 
surgery is not recommended if it will 
affect movement, memory, or lan¬ 
guage—functions Gaillard describes 
as “essential to being human.” But 
even after falling into a coma, the girl 
was seizing uncontrollably. 
“We didn’t have any options if we 
wished to save her life,” Gaillard said. 
So he recommended removal of the left 
hemisphere of the young girl’s brain. 
The surgery cured her seizures— 
but as expected, she couldn’t speak or 
understand. She was depressed, using 
a wheelchair, and taking numerous 
medications. A year after surgery, 
during which Gaillard managed the 
treatment of a movement disorder the 
surgery had caused, the once-bright 
and outgoing girl could speak only one 
word. “Six months later,” Gaillard said, 
trying to control his emotion, “she 
walked into my office and said, ‘Hello, 
Dr. Gaillard.’ ” 
Still Gaillard’s patient, the young 
woman now speaks and walks and is 
back in school; she no longer takes 
either seizure medications or anti¬ 
depressants. Gaillard gives all the 
credit to the patient and her mother, 
who encouraged her daughter when 
William Gaillard treats pediatric patients who 
have seizures that are difficult to control. His im¬ 
aging research allows physicians to determine, 
noninvasively, whether seizures are located in 
the areas of the brain that control language. 
even the girl’s schoolteachers said they 
lanticipated no further improvement. 
iShe worked tirelessly for her daugh- 
I. 
ter,” he said. 
Due in part to Gaillard’s imaging 
research, physicians can now deter- 
I imine noninvasively whether seizures 
are located in the areas of the brain 
that control language. Among the 
Imore than loo studies Gaillard has led 
or co-authored, many in collaboration 
1 with the National Institutes of Health, 
i he is most excited about his research 
Lon using functional magnetic reso- 
Inance imaging as a replacement for 
linvasive methods of brain mapping. 
[Imaging can reveal which portions of 
la patient’s brain control language to 
idetermine whether surgery is a viable 
option to cure seizures. 
Gaillard is quick to explain that he 
chose pediatrics because “it’s more fun.” 
He admires pediatricians’ willingness 
“to play in the sandbox” and “laugh at 
themselves.” For Gaillard, the ability to 
laugh at himself comes with the ability 
to “know what you don’t know.” 
I “If you really want to take care of 
•someone, it’s best if you work closely 
iwith others with the skill sets you 
jdon’t have,” he said. Gaillard’s own 
[playfulness, not to mention school 
spirit, is apparent in his bulldog- 
printed bowtie and e-mails occasion¬ 
ally signed “Boola Boola.” 
Drawn to medicine by an aunt who 
iwas forbidden to go to medical school 
i because “a lady did not take a man’s job,” 
[Gaillard pursued neurology after a spring 
[spent at University Gollege London’s 
{Institute of Neurology at Queen Square. 
[He credits Laura R. Ment, m.d., associ- 
jate dean of admissions and professor of 
pediatrics and of neurology, with encour¬ 
aging his interest in pediatrics and child 
"neurology, and Richard H. Mattson, m.d., 
professor emeritus of neurology, with 
encouraging his interest in epilepsy. 
“What’s really rewarding is to try 
[to help a child have a normal life,” 
Gaillard said. 
—Sonya Collins 
An alumnus’journey: doctor, 
inventor, and a founder of the 
UCSD medical school 
when Robert Hamburger, m.d. ’51, 
HS ’54, was a newly minted University 
of North Garolina graduate, he planned 
to become a journalist. Although his 
career took a very different path—one 
that led him to become a physician, 
inventor, and medical school founder— 
Hamburger never lost his ear for the 
telling anecdote or colorful quote. 
On the subject of deciding to 
become a doctor, he said, “I used to 
baby-sit for our family doctor’s two 
kids. I would sneak into his office to 
look at his books, mostly to look at 
the sex pictures, but it left me with a 
genuine interest in medicine.” 
On religion: “During my first inter¬ 
view at the medical school, the inter¬ 
viewer asked me about my religion, and 
I told him I was an atheist. Knowing 
I’d served in the war (Hamburger was 
a P-38 pilot during World War II), he 
said, ‘There are no atheists in foxholes.’ 
I told him that was a load of crap; I 
became an atheist when I saw what 
human beings do to each other.” 
And on the death of two of his 
three daughters from cancer: “It was 
very tough. I’ve saved a large number 
of very sick patients in my career, but 
I couldn’t save my own kids. I have 
quite a strong ego, but that gave me a 
good sense of humility.” 
Hamburger is best-known for dis¬ 
covering the relationship of allergy 
inheritance and IgE (one of the five 
immunoglobulins humans have in 
their bodies) in mothers and infants, 
inventing a high-efficiency particulate 
filter to aid children with asthma, and 
helping to launch the University of 
California School of Medicine in La 
Jolla. He credits his training at Yale, 
especially studying under the Yale 
system, for his success on all these 
fronts. The Yale approach, with its 
emphasis on research-based medicine 
in a noncompetitive environment, 
taught Hamburger the importance of 
questioning conventional wisdom and 
insisting on scientific evidence to sup¬ 
port one’s hunches and beliefs. 
“It became my model, the model 
that I operated on,” he said. “I would 
drive people crazy when I’d say, ‘That 
sounds kind of like hearsay. Is there 
any evidence to back it up?’ But that’s 
how I think; that was my training.” 
Hamburger applied to the School 
of Medicine at the urging of his sister 
Evelyn, who had been accepted by the 
Yale School of Nursing. Without the 
support of his wife, Sonia, to whom he’s 
been married for 67 years, he wouldn’t 
have made it through, he said. (Her 
support when he was missing in action 
during World War II also helped his 
parents get through that crisis.) After he 
completed his residency at Yale and at 
Strong Memorial Hospital in Rochester, 
N.Y., he became the chief of pediatrics 
at Milford Hospital in Connecticut. 
“I was broke. I owed everybody money, 
so I worked 16- to 18-hour days, seven 
days a week, to get out of debt.” After 
four years. Hamburger returned to Yale 
to become a postdoc in the microbiology 
department. Six months later, in 1964, 
he followed his division chief, David 
M. Bonner, ph.d., to the University 
of California, San Diego (ucsd). The 
timing was fortuitous, as ucsd was 
then launching a medical school and 
Hamburger was asked to sit on the advi¬ 
sory committee. 
(Yale connections to ucsd are 
strong and deep. Former Dean Gerard 
N. Burrow, m.d. ’58, HS ’66, served as 
dean of the medical school there from 
1986 to 1992. Nobel laureate George 
E. Palade, m.d., left Yale in 1990 to 
become the first dean of scientific 
affairs at ucsd. The current dean of 
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Robert Hamburger is best-known for discovering Ifl 
the relationship between allergy inheritance I 
and an immunoglobin in mothers and infants. ! tl 
He was also a founder of the medical school at Kf 
the University of California, San Diego. | 
■it 
w 
: jr 
(31 
’! 
: Jt 
■iC 
ii 
ill 
the medical school at ucsd is David A. 
Brenner, m.d. ’79, hs ’82. 
Drawing on his experience at Yale, 
Hamburger recommended the aspects 
of his Ivy League education he valued 
most, while rejecting “the stuffiness 
and formality.” That meant no compe¬ 
tition and no grades at the new school. 
The school should be small, and stu¬ 
dents should be required to complete 
a thesis based on original research in 
order to graduate. 
His suggestions were well-received, 
and Hamburger was encouraged to stay 
on, first as assistant dean for faculty and 
curriculum affairs, and later as head of 
the school’s Pediatric Immunology and 
Allergy Division and as assistant dean of 
the medical school. He became a profes¬ 
sor emeritus in 1990. 
Throughout his career Hamburger’s 
work has focused on allergic diseases 
and their impact on children’s health. 
In the late 1990s he developed an 
allergen detector system to help chil¬ 
dren with asthma sleep more soundly. 
“Sunbeam bought the rights, but then 
they went belly up,” he said. “I still 
have samples of that device in my 
closet. It was the one effort in my life 
to try to get rich.” 
More successful was his collabora¬ 
tion with Nestle, the Swiss food and 
confectionery company, which asked 
Hamburger to serve on its advisory 
board to help promote its baby formula. 
Hamburger said he would participate 
only if the company helped him spread 
the word about the benefits of breast 
feeding, which include later resistance 
to allergies. “Our message was ‘breast is 
best, but if you can’t nurse or you need to 
supplement, use Nestle baby formula.’ ” 
Now well into his retirement, 
Hamburger has returned to his first 
vocational love—writing. He and his 
I a 
granddaughter Toya are collaborat- ' 1* 
ing on a collection of short stories ' ■ 
that will constitute his autobiography. . 
Tentatively titled Autobiography: ^ 
A Long Life in Short Story, it is about 1 j| 
25 pages long, but promises to grow ' d 
much longer. ■ ™ 
—Jennifer Kaylin i 
' H' 
( 3 
Familiar Faces 
Do you have a colleague who is making ^ 
' of 
a difference in medicine or has followed ,, ■ In 
an unusual path since leaving Yale? We’d; 
like to hear about alumni of the School 0 ^ i( 
Medicine; Physician Associate Program; ' « 
and the medical school’s doctoral, fellow ** 
i i 
ship, and residency programs. Drop us a I 
line atymm@yale.edu or write to Faces, , ^ 
Yale Medicine, i Church Street, Suite 300, ’ ^ 
New Haven, CT 06510. j s 
vIOTES 
i970S , > - 
Norman Coleman, M.D.’70, 
eceived the 2011 Homeland 
I iecurity Medal, a Samuel J. Hey- 
j nan Service to America Medal 
' )resented annually by the Part- 
■ jnership for Public Service to 
i lonor excellence in federal civil 
'[iervice. This medal recognizes 
S 'ederal employees for signifi- 
i ;ant contributions to the nation 
n activities related to homeland 
'security. Coleman, associate di- 
I ector of the Radiation Research 
I Program at the National Cancer 
j nstitute of the NiH, developed 
3 blueprint for dealing with the 
aealth consequences of a radio- 
j ogical or nuclear incident. 
S 
iJ 
el 
.1 jHarry Romanowitz, m.d. ’73, 
I Clinical assistant professor in 
phe Department of Pediatrics, 
i-eceived Sacred Heart Univer¬ 
sity’s College of Health Profes- 
(i;ions 2011 Community Partner 
I Inward. The award is given in 
Recognition of “exceptional 
j collaboration to further the 
i educational goals and mission 
i of the college.” His teaching and 
j mentoring of nurse practitioner 
I iand nursing students through 
the first urgent care pediatric 
I practice in Fairfield County 
!j(which he founded in 2007) 
'provides outstanding clini- 
, ^cal training for students, 
pomanowitz served for 20 years 
■as Stamford Hospital's chair 
of pediatrics and maintains 
his consultation practice. 
If RossTonkens, m.d. ’74, has been 
,, appointed head of the American 
Heart Association’s (aha’s) new 
)ff ' 
Science and Technology Ac- 
* celerator division. He is charged 
t with identifying and vetting po- 
lO, itentialiy “game-changing” sci- 
; entitle innovations aligned with 
Ronald Vender Gerard Doherty Emma Webber 
Adam Kaye 
Philip Butler 
Carolyn Goldberg 
aha’s core mission—to foster 
healthier lives free of cardiovas¬ 
cular diseases and stroke—that 
are insufficiently developed to 
attract private equity funding, 
and with accelerating their 
translation into products that 
improve real-world cardiovascu¬ 
lar outcomes. 
Ronald J. Vender, m.d. ’77, hs ’80, 
FW ’82, chief medical officer of 
Yale Medical Croup and a nation¬ 
ally recognized gastroenterolo¬ 
gist specializing in therapeutic 
endoscopy and inflammatory 
bowel disease, was appointed 
vice president of the American 
College of Gastroenterology 
(acg). The mission of the ACC is 
to advance the medical treat¬ 
ment and scientific study of 
gastrointestinal disorders. 
1980s 
Gerard M. Doherty, m.d. ’86, 
has been appointed chair of 
the Department of Surgery at 
Boston University School of 
Medicine and chief of surgery 
at Boston Medical Center ef¬ 
fective January i. Doherty was 
previously at the University of 
Michigan, where he was N.W. 
Thompson Professor of Surgery, 
vice chair of the Department 
of Surgery, and section head 
of General Surgery. Doherty’s 
clinical focus is endocrine 
oncology; it comprises diseases 
of the thyroid, parathyroid, 
endocrine pancreas, and adrenal 
glands, as well as the surgi¬ 
cal management of multiple 
endocrine neoplasia syndromes. 
His research interests include 
a series of projects to regen¬ 
erate parathyroid cells for 
replacement of lost tissue in 
people who are permanently 
hypoparathyroid. 
1990s 
Joshua Broder, m.d. ’99, who 
published Diagnostic Imaging 
for the Emergency Physician 
(Elsevier 2011), was announced 
as the 2011 winner of the prose 
Award in Clinical Medicine. The 
PROSE Awards are the American 
Publishers Awards for Profes¬ 
sional and Scholarly Excellence. 
Broder is associate professor and 
residency director in emergency 
medicine at Duke University 
Medical Center. 
2000s 
Jeremy Allen, m.m.sc., pa-c ’07, 
and Maria Teresa Trigg, m.m.sc., 
PA-c ’09, were married on Octo¬ 
ber 22 in the Great Smoky Moun¬ 
tains of North Carolina. Allen 
works as a physician associate in 
emergency medicine and Trigg is 
in private practice in Connecticut. 
Eric Arzubi, m.d. ’08, hs ’11, 
received the Resident Physician 
Community Service Recognition 
Award (csra) from the Associa¬ 
tion of American Medical Colleges 
in November. The csra is given to 
one resident around the country 
each year and recognizes contri¬ 
butions that improve the commu¬ 
nities surrounding the resident’s 
training institution. Arzubi, a 
fellow in adult psychiatry at the 
School of Medicine, was honored 
for helping to organize and lead a 
mental health advocacy coalition 
in Connecticut, the Children’s 
Committee of the Keep the 
Promise Coalition. The coalition’s 
primary goal Is the expansion and 
enhancement of school-based 
mental health services. 
Adam H. Kaye, m.d. ’09, m.b.a. 
’09, and Emma J. Webber were 
married in Guilford, Conn., in 
September. Among the wedding 
party were Christopher Spock, 
M.D. ’09, and David Gimbel, 
M.D. ’10. Kaye is a radiology 
resident at the Hospital of the 
University of Pennsylvania. 
Webber is pursuing a career in 
environmental public policy. 
David LaBorde, m.d. ’04, m.b.a., 
is the co-founder and ceo of 
Iconic Data, which offers physi¬ 
cians a tool for managing patient 
data across facilities. Iconic Data 
was recently selected as a part of 
the inaugural class of Healthbox, 
a Sandbox Industries business 
incubator funded by Blue Cross 
and Blue Shield. LaBorde spent 
sixyears in neurosurgery and 
previously worked in manage¬ 
ment consulting at McKinsey & 
Co. and in health care investment 
banking at Goldman Sachs and 
Merrill Lynch. 
2010s 
Philip Butler, m.d. ’lo, and Carolyn 
Goldberg, m.d. ’10, were married 
in October in Anguilla in the 
British West Indies. The couple 
completed residencies at the Uni¬ 
versity of Wisconsin Hospital and 
Clinics in Madison—she in plastic 
and reconstructive surgery, he in 
diagnostic radiology. In Novem¬ 
ber Butler began a residency in ra¬ 
diology at Brigham and Women’s 
Hospital in Boston. 
send alumni news to 
Claire M. Bessinger, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
VISIT us ON THE WEB 
yalemedicine.yale.edu 
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32 in memoriam 
Malcolm Bagshaw, m.d. '50, one 
of the world’s foremost experts in 
radiation therapy, most notably 
in developing new applications 
of radiation therapy for prostate 
cancer, died on September 18 at 
home in Palo Alto, Calif., after 
an extended illness. He was 86. 
Bagshaw was the former chair of 
the departments of radiology and 
radiation oncology at Stanford 
University School of Medicine. 
He completed his residency in 
radiology at the University of 
Michigan and joined Stanford in 
1956. He was appointed head of 
the Division of Radiation Therapy 
in 1960 and became chair of 
the Department of Radiology 
in 1972. Bagshaw received the 
1996 Charles F. Kettering Prize, 
awarded by the General Motors 
Cancer Research Foundation, for 
his role in improving prostate 
cancer treatment. 
John D. Baxter, m.d. ’66, HS ’68, 
whose early work in cloning and 
recombinant protein produc¬ 
tion provided the basis of the 
biotechnology industry, died 
of canceron October 5 in San 
Francisco. A native of Lexington, 
Ky., he was 71. At the time of his 
death Baxter was director of the 
Genomic Medicine Program of 
the Methodist Hospital Research 
Institute in Houston. By cloning 
the growth hormone family of 
genes and through subsequent 
studies, Baxter made major con¬ 
tributions to the understanding 
of growth and development, and 
established a model for advances 
in developmental biology. That 
model led to the creation of the 
first synthetic drug to stimulate 
growth in children of abnormally 
short stature and the discovery 
of drugs to increase milk produc¬ 
tion in dairy cows. Baxter and a 
colleague then became the first 
to show what a nuclear receptor 
looks like when it is binding to a 
hormone—a breakthrough that 
led to new structures in drug 
design. Baxter was named to the 
National Academy of Sciences 
in 2003. He also received an 
Outstanding Investigator Award 
from the Howard Hughes Medi¬ 
cal Institute. 
|[« 
Harold O. Conn, m.d., fw ’53, 
HS ’56, a world-renowned 
hepatologist, author, and pioneer 
in the basic understanding and 
treatment of advanced liver 
disease, died on October 9 in 
Pompano Beach, Fla. He was 85. 
Conn, a 50-year faculty member 
at the School of Medicine, wrote 
more than 400 peer-reviewed 
articles about hepatic encepha¬ 
lopathy. One of Conn’s greatest 
professional accomplishments 
was The Histopathologyofthe 
Liver, published in 1993, which he 
wrote with Gerald Klatskin, m.d. 
It was his last major project until 
he contracted normal-pressure 
hydrocephalus (nph). Erroneously 
diagnosed for 10 years as Parkin¬ 
son disease, nph robbed him of 
his ability to walk or think clearly 
until the correct diagnosis was 
made. Following a remarkable re¬ 
mission after brain surgery at age 
78, Conn became a spokesperson 
for NPH awareness. 
We have also received word 
of the passing of the following 
alumni and faculty: 
Mary North Allen, MED ’45, a 
photographer, died on Novem¬ 
ber 26 at her home in Madison, 
Wis. Allen was 92. After her 
graduation from Mills College in 
1941, she attended Yale 5chool 
of Medicine for one year. 
Carl E. Andrews, m.d. ’44, died 
on 5eptember 12 in Fort Pierce, 
Fla. He was 91. Andrews was a 
retired general surgeon who 
had practiced in West Palm 
Beach for 33 years. 
Graeme C. Baker, m.d., hs ’76, a 
plastic surgeon, died on October 2 
in Erie, Pa. He was 73. 
Dennis P. Bekeny, m.d., hs ’72, of 
Hamden, Conn., died on October 6 
at 5milow Cancer Hospital at 
Yale after a brief illness. Bekeny 
was a pediatrician in the New 
Haven area for 36 years. 
Donald Smythe Childs Jr., m.d. ’42, 
a retired radiologist, died on 
December 10 in Rochester, Minn. 
He was 95. 
George M. Goza Jr., m.d., hs ’56, 
died at home on October 19 in 
Rice Lake, Wis. A retired internist 
and cardiologist, Goza was 85. 
Robert H. Groves Sr., m.d. ’56, 
died on October 31 in Rochester, 
Mich. He was 81. 
James W. Innes, m.d., hs ’63, 
FW ’64, died on August 29 in River¬ 
side, Conn. He was 79. Innes 
practiced internal medicine and 
gastroenterology. 
William H.O. Kiekhofer, m.d. ’51, 
a retired associate professor of 
obstetrics and gynecology at the 
University of Wisconsin Medical 
5chool, died on October 13 in 
Providence, R.l. He was 89. 
Ruth H. Kotler, pa-c ’88, a neuro¬ 
surgical physician associate at 
the University of Connecticut 
Medical Center, died at home in 
Avon, Conn, on November 5 of 
breast cancer. 5he was 47. 
Cheryl E. Lemmons, m.d., hs ’87, 
a surgeon and geriatric psychia¬ 
trist, died in Onset, Mass., on 
August 6 after a short illness. 
Francis B. Maraist, m.d., hs ’55, 
a retired general surgeon, died 
on November 1 in Tequesta, Fla. 
He was 85. 
Robert N. Margolis, m.d., hs ’65, 
associate clinical professor of 
orthopaedics and rehabilitation, 
died in Woodbridge, Conn., 
on 5eptember 21. He was 78. 
Margolis served as associate chief 
of orthopaedics at the Hospital of 
5aint Raphael, chief of orthopae¬ 
dics at the VA Connecticut Health¬ 
care 5ystem in West Haven. 
Nessan McCann, m.d., hs ’66, 
died on 5eptember 14 in 5t. 
Augustine, Fla. He was 88. 
K. Alvin Merendino, m.d. ’40, 
PH.D., a retired professor of 
surgery at the University of 
Washington Medical Center, died 
on 5eptember lo in 5eattle. He 
was 96. Merendino performed 
the first open-heart surgery 
on the West Coast and helped 
establish a renal transplantation 
program in 5eattle. 
Richard Neubauer, m.d. ’76, 
died on October 31 at his home 
in 5tuckagain, Alaska, from 
complications of primary amy¬ 
loidosis. Neubauer was 61. Born 
in Queens, N.Y., he served in the 
Indian Health 5ervice in Wyoming 
before moving to Alaska. 
John A. Ogden, m.d. ’68, hs ’73, 
died in Atlanta on August 31. He 
was 68. Ogden served as chair 
of orthopaedics at the 5chool 
of Medicine from 1978 to 1983 
and later as clinical profes¬ 
sor of orthopaedics at Emory 
University. 
Thomas R. Pellegrino, m.phil. ’71, 
M.D., HS ’77, died at home in 
Hampton Roads, Va., on Novem¬ 
ber 17 after a short illness. At the 
time of his death, Pellegrino was 
associate dean for education at 
Eastern Virginia Medical 5chool. 
Jeffrey Robbins, m.d., hs ’68, a 
retired otolaryngologist, died 
on July 13 at his home in Bristol, 
Tenn. He was 69. 
Ben A. Shaver Jr., m.d. ’56, a 
retired pediatrician, died on 
November 23 in Potomac, Md. 
He was 81. 
Don H. Smith, m.d. ’70, a prison 
psychiatrist, died on October 12 in ; 
Port Washington, Wis. He was 66. 
Smith was a junior research fel- : 
low in the Yale Arbovirus Research 
Unit during his years at the School 
of Medicine. 
Martin B. Vita, M.D.’50, a retired 1 
pediatrician, died on September 18 < 
in New York City. He was 83. 
DouglasA. Wegner, M.D., HS’94, | 
a hand surgeon, died suddenly of 
a heart attack on August 5 in Tuc¬ 
son, Ariz., while running in Sabino < 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine. 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail J 
to claire.bessinger@yale.edu 
nd note 33 
Second-yeari save the Yale system ! 
Egregious violations of the Yale system—mandatory class atten¬ 
dance and exams—drive a student to the breaking point in the Class 
of 2014’s Second Year Show, The iPocalypse, presented In February. 
The heroine, played by Juliet Fraser, finds her dreams of a career in 
neurosurgery thwarted on Match Day. ''Podiatry!?” she screams. 
All ends well, however, when students put an end to a scheme by 
an evil consultant played by Samantha Wang (who co-directed the 
show with Conor Grady), left to right, Alex Kula, Kelsey Loeliger, 
Grady, and Fraser appear in a scene from the show. 
I 
1 
Yale Medicine yale university, i church street, suite 300, new haven ct 06510 
yalemedlcine.yale.edu 
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2 Letters 
Tissue from the lab 
mends a broken heart 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or fewer) and 
news items to Yale Medicine, 
I Church Street, Suite 300. 
New Haven, CT 06510, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length, and content. 
VISIT US ON THE WEB 
Our new website is up and 
running—and the feedback has 
been wonderful! Visit us at yale- 
medicine.yale.edu and peruse 
the newest issue or issues going 
back to 1998. 
CORRECTION 
An alumni note in the Spring 
2012 issue incorrectly stated that 
Carolyn Goldberg, m.d. ’10, and 
Philip Butler, m.d. 'io, completed 
residencies at the University of 
Wisconsin. Goldberg completed 
an internship in plastic and recon¬ 
structive surgery there and will 
start an anesthesiology residency 
at Brigham and Women's Hospital 
next year. Butler is a resident in ra¬ 
diology at Brigham and Women’s 
Hospital in Boston. 
Tom Forbes remembered 
When I was in medical school 
one of our anatomy professors, 
Tom Forbes, taught an optional 
course about the history of 
anatomy. It was held once a 
week at lunch time. Professor 
Forbes would bring wonderful 
butter cookies that his wife had 
baked, and we would listen to 
him talk about Vesalius and the 
other great anatomists while 
eating cookies. He would pass 
around the original anatomy 
books from the Cushing 
Collection for us to examine 
during class. It was one of the 
real highlights of the first two 
years of medical school. 
Albert Ungricht, m.d. '82 
Salt Lake City 
Kudos for Yale Medicine 
Yale Medicine received four 
awards from the New England 
chapter of the American Medical 
Writers Association in January. 
Will Solimene Awards for 
Excellence went to Jenny Blair, 
M.D. ’04, for “From Cedar Street 
to Capitol Hill," Winter 2010; 
to Jill Max for "Improving the 
Lot of Women in Medicine,” 
Autumn 2010, and “Medicine 
and the Military,” Spring 2011; 
and to Colleen Shaddox, for 
“Is the Physician-Scientist an 
Endangered Species?,” Autumn 
2011. Congratulations to all three 
for their outstanding work. 
In search of... 
YSM class photos! 
The School of Medicine's Alumni 
Office and the Historical Library 
are hoping to fill gaps in our 
collection of class photos. If 
you have a Commencement or 
White Coat Ceremony photo for 
one of the classes listed below, 
please contact Melissa Grafe, 
PH.D., the John R. Bumstead j 
Librarian for Medical History, j 
Cushing/Whitney Medical 
Library, at 203-785-4354 or 
melissa.grafe@yale.edu. We will 
scan and return original photos. 
We are looking for images 
from these classes: 1962,1965, 
1981,1982,1983,1986,1987, 
1988, 2003, 2004, 2006, 2007, 
2008, and 2009. 
starting point 3 
A modest man remembered 
1 Arthur Ebbert Jr., m.d., would by all accounts be embarrassed by the issue of Yale Medicine 
I that you hold in your hands. His friends and colleagues remember Ebbert, who died on 
June 7, as unassuming, gracious, and modest—a man who preferred the background to the 
limelight. As our writer Natalie Villacorta interviewed people who knew Ebbert, time and 
again they cautioned that he would have eschewed such attention. We hope, however, that he 
would have appreciated this acknowledgement of his contributions to the School of Medicine 
and to this magazine, which he founded in 1953 as the Alumni Bulletin. 
People remember Arthur Ebbert for who he was as much as for what he did. He 
seemed to know everything about the school, and everyone knew him and knew they could 
|i count on him. “ ‘Ask Art’ was the motto,” recalled John E. Eenn, m.d. ’61, hs ’67, clinical pro- 
;( fessor of surgery (vascular). “Anybody could approach (him) with any kind of problem, and if 
i he didn’t solve it, he knew how to give you advice to go about seeking a solution.” 
Ebbert felt that the school needed a publication that would keep alumni informed of 
relevant events, including new buildings on campus, advances in medicine and science, and 
inew methods for teaching medical students. Erom 1953 until 1966 the magazine was an eight- 
page newsletter: then it adopted the magazine format you see today. In 1986, our current editor 
, in chief Michael Kashgarian, m.d. ’58, hs ’63, fw ’65, took on that post when Ebbert retired. 
(Although we hadn’t heard the motto “Ask Art,” over the years we did indeed turn to him many 
times to learn aspects of the history of the medical school. He will be missed. 
In this issue we also continue our series on alumni career paths with an article on 
ithose who have devoted significant portions of their careers to underserved communities 
I around the world. As it happens, our two alumni profiles in this issue also focus on people 
who have spent time abroad. 
We hope you enjoy our autumn issue. 
John Curtis 
Editor 
|SECOND OPINION BY SIDNEY HARRIS 
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4 chronicle news from cedar street 
Unleashing the immune 
system against cancer 
A multicenter trial finds a way to 
thwart cancer’s hijacking of a 
protective immune response. 
A multicenter team that included Yale 
scientists has reported one of the first 
significant successes in harnessing the 
immune system to fight cancer. In an 
early clinical trial of a new cancer drug, 
the scientists said in a report published 
on June 2 in the New England Journal 
of Medicine, tumors regressed signifi¬ 
cantly in between 20 and 33 percent of 
patients with non-small-cell lung can¬ 
cer, kidney cancer, or melanoma. 
The response in king cancer 
patients was remarkable, said Mario 
Sznol, M.D., professor of medicine, 
because immunotherapies had gener¬ 
ally been effective only in melanoma 
and kidney cancers. (For reasons that 
are not fully understood, the small 
number of patients with colorectal or 
prostate cancer in the trial—which 
had 296 patients—did not respond 
to the drug.) The patients in this trial 
had already received heavy doses of 
therapies that likely depleted their 
immune systems. If administered 
to patients with less prior treatment, 
the drug should be even more effec¬ 
tive, said Lieping Chen, m.d., ph.d., 
professor of immunobiology, of der¬ 
matology, and of medicine. The study, 
said Sznol, also found consistent, 
durable regression of cancers: 20 of 31 
responses that were tracked lasted for 
at least a year—a result rarely observed 
with traditional chemotherapy or 
forms of therapy that target specific 
characteristics of tumors. The drug. 
BMS-936558. which was developed by 
Bristol-Myers Squibb, acts by block¬ 
ing a protein that tumors use to dis¬ 
able the body’s immune system, and 
represents a new approach to cancer 
therapy. “We’re just at the beginning 
of a paradigm shift in the treatment of 
cancer," said Sznol. 
Since similar results were seen at 
all nine centers participating in the 
trial, Sznol considers it highly unlikely 
that the drug’s effectiveness is a fluke. 
Scott N. Gettinger, m.d., associate 
professor of medicine, who recruited 
lung cancer patients for the trial, said 
that the response in those patients 
“opens the door to looking at other 
solid tumors.” Most of his patients had 
few or none of the side effects often 
associated with chemotherapy—hair 
loss, drops in blood-cell counts, altered 
taste, and profound fatigue. “This is 
the best-tolerated drug I have ever 
given to patients with lung cancer," 
Gettinger said. 
The new drug has its roots in the 
labors of Ghen, who was training to 
be an oncologist in the 1980s. The 
lack of effective cancer treatments 
made it a depressing job. “That’s why 
I quit clinical practice,” Ghen said. He 
shifted to research, focusing on the 
role of the immune system in cancer. 
For decades scientists have sought 
to understand why the human immune 
system sits on the sidelines when 
cancer invades the body, and how to 
provoke it to attack cancer cells. Such 
an approach could target the disease 
while sparing normal cells, result¬ 
ing in greater effectiveness and fewer 
side effects. And because the immune 
system “remembers” invaders it has 
encountered, the response to immuno¬ 
therapy should be long-lasting. 
A decade’s research by Ghen and 
colleagues at other institutions found 
that the interactions of certain proteins 
and receptors allow tumor cells to 
disable T cells, the immune system’s 
main fighters. The tumor cells, Ghen 
said, take advantage of a mechanism 
that the body uses to prevent damage 
from prolonged immune responses. 
In 1991 Ghen, then at the Mayo Glinic, , 
discovered B7-HI, a protein that can i 
suppress T cells. Nine years later | 
researchers from Harvard Medical : 
School’s Dana-Farber Gancer Institute ■ 
and the University of Kyoto found that : 
By-HI binds to programmed death 1 . 
(PD-1), a receptor on the surface of T 
cells. Scientists renamed the B7-HI 
protein, calling it PD-Ll to reflect its 
role as a binding partner for PD-1. 
Tissues use PD-Ll to turn off the 
immune response when it’s gone on 
too long: and, Ghen found, PD-Ll is 
overexpressed in many human tumors, i 
“Gancer steals this mechanism,” 
said Ghen. Gancer triggers an immune) 
response, which sends T cells to attack : 
the tumor. The tumor, in response to 
signaling molecules from the T cells, 
expresses PD-Ll, which binds to PD-1 
and suppresses the T cells. BMS-936558: 
blocks the PD-1 binding site and keeps i 
PD-Ll at bay. 
Tests on tumor samples from the : 
recent trial revealed that tumors that i 
did not express PD-Ll did not respond I 
to treatment, while 36 percent of PD-L1-’| 
positive tumors showed a response. 1 
That suggests that PD-Ll may serve as ' 
a biomarker to identify patients who 
will benefit from anti-PD-1 drugs. i 
There are side effects of PD-1 block¬ 
age—in the current trial, three patients 
died of drug-related lung inflamma¬ 
tion—but Ghen thinks that adverse 
effects can be managed. 
Jedd D. Wolchok, m.d., ph.d., of 
Memorial Sloan-Kettering Gancer 
Genter, who was not involved in the 
current trial, said that the new results 
are encouraging for the potential of 
immunotherapy in the treatment of 
I 
W
tir
ill
-' 
III 
ACCESS TO FOOD IMPROVES 
i cancer. Following the success of the 
[drug ipilimumab, which also blocks 
j a molecule expressed on the surface 
ofT cells, the findings are the second 
; clear demonstration that unleash¬ 
ing the immune system can produce 
durable regressions in cancer. 
Although BMS-936558 was effective 
when used alone, the Yale researchers 
believe that it will be most useful 
when combined with other therapies. 
“I have patients who have benefited 
enormously from this drug,” Sznol said. 
And while current treatments prolong 
life for months or a couple of years, 
Sznol said, “these new therapies may 
I eventually offer the possibility of cure.” 
—Natalie Villacorta 
Mario Sznol, Scott Gettinger, Harriet Kluger, 
and Lieping Chen participated in a nine-center 
clinical trial of a drug that disarms a molecular 
defense mechanism mounted by tumors. 
Healthier foods are more available in neigh¬ 
borhood stores in underserved communi¬ 
ties since revisions in 2009 to the Special 
Supplemental Nutrition Program for Women, 
Infants, and Children (wic), according to a 
study by the Rudd Center for Food Policy 
and Obesity published in Vne Journal of the 
Academy of Nutrition and Dietetics in June. 
The researchers assessed the variety, 
quality, and prices of wic-approved foods 
in 252 convenience stores and non-chain 
grocery stores in Connecticut before and 
after the revisions. Access to whole-grain 
products and fresh produce improved, par¬ 
ticularly in low-income communities. 
“If the experience in Connecticut is typi¬ 
cal of other states,” said lead author Tatiana 
Andreyeva, ph.d., the center’s director of eco¬ 
nomic initiatives, “national food policy pro¬ 
grams that promote consumption of healthy 
foods but also require changes in stores can 
help to improve local food environments.” 
—John Curtis 
BLOCKING LUNG DISEASE 
A Yale-led team of scientists has uncovered 
a signaling pathway that promotes cell 
migration in certain forms of pulmonary 
fibrosis, a deadly lung disease, and may also 
be used by cancer cells in metastasis. The 
findings appeared in May’s advance online 
publication of Nature Cell Biology. 
There are no known cures or treatments 
for pulmonary fibrosis—^the development 
of excessive fibrous connective tissue in the 
lungs. The members of the Yale team found 
that by inhibiting certain proteins they could 
block signaling pathways that cancer cells and 
connective tissue cells need for migration. 
“Our ability to block the pathway pro¬ 
vides a potential therapeutic target for 
treating pulmonary fibrosis and other types 
of fibrosis,” said senior author Dianqing 
(Dan) Wu, ph.d., professor of pharmacol¬ 
ogy. “Because cancer cells, particularly 
melanoma and lung cancer cells containing 
activated braf genetic mutations, can use 
this signaling pathway to migrate, blocking 
this pathway could also prevent metastasis 
of these cancers.” 
—J.C. 
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6 chronicle news from cedar street 
Molecular profiling of tumors is 
cancer treatment of the future 
In May 2011, Marvin B. Brooks, M.D., 
HS '68, a urologist in Palm Springs, 
Calif., developed severe back pain while 
performing surgery. X-rays revealed 
lung cancer that had spread to his liver 
and vertebrae. He had never smoked. 
His oncologist told him that 10 per¬ 
cent of nonsmokers with lung cancer 
have a mutation in their epidermal 
growth factor receptor gene (EGFR). 
If Brooks fell within this category, he 
might be a candidate for an experimen¬ 
tal therapy. The top expert in this field, 
added the oncologist, is Roy S. Herbst, 
M.D., PH.D., professor of medicine 
(medical oncology) and of pharmacology, I 
chief of medical oncology, and associ¬ 
ate director for translational research at ; 
Yale. A week later Brooks was in New ■ 
Haven, and in the same hospital in i 
which he had previously operated and in i 
which his son was born, he had a liver : 
biopsy that went to Yale’s new Molecular I 
Tumor Profiling Laboratory. 
Confirming the oncologist’s sup- 1 
position, the lab detected one of the I 
EGFR mutations that seems to be a 
driver of many lung cancers. Instead 
of standard chemotherapy, Herbst ' 
recommended one daily pill of the 
experimental drug erlotinib (Tarceva), ' 
a reversible tyrosine-kinase inhibi- : 
tor that targeted the EGFR mutation i 
in Brooks’ tumor. In October 2011, 1 
in January 2012, and again in April i 
2012, Brooks tested free of cancer. ; 
Furthermore, Tarceva eliminated all 1 
detectable cancer without inflicting 
the debilitating side effects associated j 
with chemotherapy. ‘ 
“I went to Yale thinking I would be 1 
dead within a year,” said Brooks. ' 
That’s the sort of story Yale Cancer ' 
Center Director Thomas J. Lynch, 
M.D. ’86, envisioned when he pushed • 
for the profiling lab, which opened 
in the fall of 2010. “I think cancer i 
treatment in the future will be based j 
entirely on detailed molecular profil- | 
ing,” said Lynch. “This is what every¬ 
one will be doing.” | 
Analysis from the Profiling Lab 
often identifies patients as candidates ' 
for new drugs that foil known cancer- 
causing mutations, thereby changing 
the course of therapy. “In oncology, 
these drugs have been shockers,” said 
lab director Jeffrey L. Sklar, M.D. ’77, 1 
PH.D. ’77, professor of pathology and 
of laboratory medicine, “because they 
have had such a dramatic effect on 
^ tumors that have heretofore been 
j( highly resistant to therapy.” 
j “Right now, in about 20 percent 
i :of my patients with lung cancer,” said iHerbst, “I find some mutation that 
will let me give a patient a specific oral 
S drug that is much more effective and 
iless toxic than the standard of care. We 
are working hard to figure out some¬ 
thing new for the other 80 percent.” 
The Profiling Lab also identi¬ 
fies mutations associated with other 
j; cancers. About half of all melanoma I patients have a mutation in a gene 
|Called BRAF that responds to a new 
drug. Other mutations detected by 
the lab are associated with colon and 
breast cancer. The lab can currently 
screen for 66 mutations, each of 
I which requires its own test, all run in 
ja parallel and high-throughput fash- 
don. However, the profiling lab is about 
to shift to the so-called “next genera- 
jtion” of genomic sequencing, which 
'will detect all 66 mutations with one 
test. “Genomic sequencing will let 
tus look at many genes all at once and 
expand indefinitely the number of 
mutations for which we can routinely 
; screen,” said Sklar. “Very soon, we’re 
going to be profiling the full set of 
clinically relevant mutations within 
the tumor of every cancer patient who 
walks through the door of Smilow 
I Cancer Hospital.” 
The field is accelerating on all 
‘ fronts. New clinical research and faster 
sequencing require new developments 
in software and hardware to process, 
analyze, and store more and more infor¬ 
mation. Efforts to develop and utilize 
ACID MAKES BACTERIUM DEADLY 
Salmonella, which kills hundreds of thou¬ 
sands of people each year, turns virulent 
when it senses that its environment has 
turned acidic and triggered an increase in 
its energy level, according to a report in 
the June 13 issue of the journal Nature by 
researchers from the School of Medicine 
and the Yale Microbial Diversity Institute. 
This mechanism may present a novel target 
for drugs that can disarm Salmonella’s ability 
to cause disease, said Eduardo A. Groisman, 
PH.D., professor of microbial pathogenesis and 
a Howard Hughes Medical Institute investiga¬ 
tor. Groisman and associate research scientist 
Eun-Jin Lee, ph.d., tracked the signal transduc¬ 
tion cascade that enables Salmonella to survive 
within the host’s immune cells. Changes in the 
level of acidity raise atp levels in the bacterium 
and trigger a key virulence gene. 
“There will never be a world without 
Salmonella because it exists in many, many 
animal reservoirs,” Groisman said. “It is a 
major public health issue.” 
—John Curtis 
GENES AND HIGHER BRAIN FUNCTIONS 
A pattern of gene activity in the language and 
decision-making centers of the human brain is 
missing in Fragile X syndrome, a disorder asso¬ 
ciated with autism and learning disabilities, 
according to a study by Yale researchers pub¬ 
lished in the May n issue of the journal Cell. 
The researchers identified evolutionary 
changes that led the gene nosi to become 
active and produce a protein product in the 
parts of the developing brain that form the 
centers for those higher functions in adults. 
A protein that controls this activity is missing 
in Fragile X syndrome, the leading inherited 
form of intellectual disability among boys 
and the most common single-gene cause of 
autism. People with Fragile X syndrome have 
lower IQs, a high rate of attention-deficit/ 
hyperactivity disorder, and delays in speech 
and language development. 
“The same evolutionary mechanisms that 
may have gifted our species with amazing 
cognitive abilities have also made us more 
susceptible to psychiatric disorders such as 
autism,” said senior author Nenad Sestan, 
M.D., PH.D. ’99, professor of neurobiology. 
—J.C. 
these tools are under way at the Yale 
Center for Genome Analysis, located at 
West Campus. “Over the next 10 years,” 
said Richard R Lifton, M.D., PH.D., chair 
and Sterling Professor of Genetics, and a 
Howard Hughes Medical Institute inves¬ 
tigator, “we’ll understand the genetic 
landscape of all the major human can¬ 
cers, and we will increasingly be using 
molecular profiling to select treatment 
for individual patients. Five years ago 
we really did not imagine we would be 
capable of doing the things we’re doing 
routinely today.” 
—Steve Kemper 
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8 Books & ideas 
FIBROCYTES 
'.HEALTH M 
The 
Psychiatric Report 
erMptM riMik* •< r«>«ai(4 
AUC BUCHANAN and 
MtCHACt A.'nORKO 
A *^sick care” system 
A physician argues that the United States lacks a 
vision for providing health care. 
The United States makes a fundamental error in its manage¬ 
ment of health, argues Stephen C. Schimpff m.d., ’67, hs ’69. 
The nation leads the world in spending for medical care but 
lags in quality because it lacks a health care system. Instead, 
he writes, the United States has a “sick care” system, one “that 
waits until we become ill before it kicks into action.” 
In his new book. The Future of Health-Care Delivery, the 
former ceo of the University of Maryland Medical Center 
evaluates the American sys¬ 
tem of medical care, describes 
trends that will influence 
medicine in the coming 
decades, and explains why we 
spend so much. Then he sug¬ 
gests changes. 
Schimpff observes that 
our system is more adept at 
responding to acute illnesses 
than in undertaking the 
multifaceted care required 
to treat chronic disease. 
But chronic disease now 
dominates, and patients find 
themselves “shuttled” among 
specialists who rarely talk to 
one another. Patients are given too many drugs, devices, and 
procedures, each of which carries risks—preventable errors 
kill 100,000 Americans each year. 
Schimpff describes innovative systems in which spe¬ 
cialists work in teams to prevent duplication. He suggests 
changing insurance policies so that patients pay for rou¬ 
tine care and rely on insurance to cover catastrophic costs. 
President Obama’s Affordable Care Act, he argues, does 
little to change the way health care is delivered because it 
focuses on ways to finance care. Instead, writes Schimpff, 
“We first need to establish a vision for health care ... and 
then figure out how to pay for it.” 
For more details, visit www.medicalmegatrends.com. 
—Cathy Shufro 
THE FUTURE OF 
HEALTH-CARE 
DELIVERY 
j 
Stephen (1. Sehinipff. Ml) 
The Future of Health-Care 
Delivery 
Fibrocytes in Health 
and Disease 
edited by Richard Bucala, ph.d., 
M.D., professor of medicine 
(rheumatology), of epidemiol¬ 
ogy (microbial diseases), and of 
pathology (World Scientific Pub¬ 
lishing Co.) This volume pro¬ 
vides an overview of fibrocytes, 
precursor cells of fibroblasts. 
The contributors discuss the 
role of circulating fibrocytes in 
the etiopathogenesis of various 
fibrosing disorders, atheroscle¬ 
rosis, autoimmunity, and cancer. 
The Psychiatric Report: 
Principles and Practice of 
Forensic Writing 
edited by Alec Buchanan, ph.d., 
M.D., associate professor of psy¬ 
chiatry; and Michael A. Norko, 
M.D., FW '88, associate professor 
of psychiatry (Cambridge Univer¬ 
sity Press) Mental health profes¬ 
sionals acting as witnesses in 
criminal, civil, and child custody 
cases recognize that the written 
report is central in legal settings. 
This book addresses ethical 
concerns that include conflicts of 
interest, offers guidance for pre¬ 
paring various types of reports, 
and covers such issues as the 
detection of malingering and the 
use of psychological tests. 
How Vision Works: 
The Physiological Mechanisms 
Behind What We See 
by Nigel W. Daw, ph.d., professor 
emeritus of ophthalmology and 
neuroscience, and professor of 
neurobiology (Oxford University 
Press) This text, designed to 
offer a broad overview rather 
than detailed treatment of 
specialized topics, covers the 
psychology, anatomy, and physi¬ 
ology of all aspects of the visual 
system. Each chapter addresses 
a separate aspect of vision and 
includes illustrations. 
Assessment in Drama Therapy 
edited by David Read (ohnson, 
PH.D. ’80, associate clinical profes¬ 
sor of psychiatry: Susana Pendzik, 
PH.D.; and Stephen Snow, ph.d. 
(Charles C. Thomas Publisher) 
This book provides a comprehen¬ 
sive survey of assessment in the 
field of drama therapy, includ¬ 
ing its history, core philosophy 
and concepts, and practices. 
It explores various modes of 
assessment, including recently 
developed evaluation tools and 
assessment of adolescents. 
Manual of Skin Surgery: 
A Practical Guide to Dermato¬ 
logic Procedures, 2nd ed. 
by David J. Leffell, m.d., hs '86, 
FW ’87, the David P. Smith Profes¬ 
sor of Dermatology and professor 
of surgery (otolaryngology and 
plastic); and Marc D. Brown, 
M.D. (People’s Medical Publish¬ 
ing House—USA) This book 
presents the fundamentals of 
dermatologic surgery, from 
anatomy, diagnosis, and preop¬ 
erative preparation and assess¬ 
ment to operative technique 
and postoperative care. 
on campus 
( Health Insurance: 
Navigating Traps & Gaps 
by Maura Loughlin Carley, 
M.p.H. ’78, cic (Ampersand) 
This book provides insight into 
the complex and ever-changing 
: issues of health care coverage, 
' including advice on avoiding 
costly mistakes and navigating 
gaps in protection, 
j 
t Metabolism and Nutrition for 
I the Surgical Patient, Part II 
edited by Stanley J. Dudrick, 
; M.D., professor emeritus of sur- 
; gery (gastrointestinal); Juan A. 
Sanchez, m.d., mpa, hs ’93; and 
Ronald F. Martin, m.d. (Saun¬ 
ders) This book, part of The 
i ; Clinics: Surgery series, discusses 
:! nutrition and metabolism for 
^ the chronically ill patient. Topics 
II include nutritional management 
' of geriatric surgical patients and 
’: patients with acute and chronic 
! pancreatitis, surgical treatment 
of patients with diabetes melli- 
,: tus, immunologic functions and 
I, ° 
' aspects of the alimentary tract 
related to feeding, and enteral 
j! and parenteral feeding access 
I techniques. The book discusses 
I dietary, metabolic, and surgical 
ji management of obese patients 
I as well as nutritional support 
|: of patients with cardiovascular 
i disease, cancer, and inflamma- 
: tory bowel disorder. 
I 
l! 
I: 
Language Disorders from 
Infancy through Adolescence: 
Listening, Speaking, Reading, 
Writing, and Communicating, 
4th ed. 
by Rhea Paul, ph.d., ccc-slp, 
professor (adjunct) in the Child 
Study Center; Courtenay F. 
Norbury, d.phil. (Mosby) This 
text provides the information 
needed to assess childhood 
language disorders and to treat 
them appropriately. The book 
presents basic concepts and 
vocabulary, the scope of com¬ 
municative difficulties, updated 
information on best practices, 
and an overview of key issues 
and controversies. 
ACSM’s Guide to Exercise and 
Cancer Survivorship 
edited by Melinda L. Irwin, 
PH.D., M.p.H., associate profes¬ 
sor of epidemiology (chronic 
diseases) (Human Kinetics 
Publishers) This text describes 
applications of the science 
behind the benefits of exercise 
to the design or adaptation of 
exercise programs for cancer 
patients and survivors. The 
guide uses evidence-based 
information to assist health, fit¬ 
ness, and medical professionals 
in using exercise to help cancer 
survivors with recovery and as 
a strategy both for reducing the 
side effects of treatment and for 
enhancing overall quality of life. 
The descriptions above are based 
on information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via 
e-mail to cheryl.violante@yale.edu 
f ^ J 
A journal's 200-year history 
When the first issue of The New 
England Journal of Medicine 
and Surgery, and the Collateral 
Branches of Science appeared in 
January of 1812, New England 
was "a medical backwater,” 
said Jeffrey M. Drazen, m.d., at 
internal medicine grand rounds 
in May. 
Drazen, the journal’s present 
editor, said that founder and 
physician John Collins Warren 
felt that the new country needed 
a medical magazine. "Physicians 
in New England needed to know 
what was happening in the seats 
of learning in Berlin, London, 
and Paris,” Drazen said. The jour¬ 
nal would appear quarterly, be 
delivered on horseback, and cost 
$3 per year. 
Since then, it has assumed 
different forms until settling 
on its current name. The New 
England Journal of Medicine, in 
1928. This year it celebrates its 
bicentennial. 
The journal has continued to 
inform physicians throughout 
its history. In 1898 it reported 
on a new device called an X-ray. 
During World War II it explored 
the medical aspects of war. In 
1942 it reported on a new drug 
called penicillin, and in 1981 it 
published three articles on a 
little-understood disease called 
gay-related immune deficiency, 
or GRID, now called hiv/aids. 
“I firmly believe that physi¬ 
cians need the best and most 
up-to-date medical informa¬ 
tion," Drazen said, echoing the 
founding editor’s mission. 
—John Curtis 
Eliminating health disparities 
“Your zip code is a more powerful 
predictor of your health than your 
genetic code,” David R. Williams, 
PH.D., M.P.H., told psychiatry 
resident grand rounds in May. “In 
some states there is a 13-year dif¬ 
ference in life expectancy based 
on what county you live in.” 
Subway lines and even spe¬ 
cific train stations can be predic¬ 
tors of health in a society full of 
disparities based on factors that 
also include race, socioeconomic 
status, and education level, said 
Williams, the Florence Sprague 
Norman and Laura Smart 
Norman Professor of Public 
Health at Harvard. The United 
States, he said, ranks at the bot¬ 
tom of industrialized nations in 
such health indicators as infant 
mortality. Improving health, he 
continued, means addressing 
issues beyond health. 
"We need to invest in our 
schools, our sidewalks, school 
programs, produce markets, 
jobs—not traditional things to 
think about in terms of health, 
but these are the things that 
create opportunities for individ¬ 
uals to make healthy choices," 
Williams said. “The health of 
America depends on the health 
of all Americans. Improving 
Americans’ health will not only 
improve the economy, it will 
improve the quality of life.” 
—J.C. 
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Medicine in the time 
of Shakespeare 
An exhibit in the Historical Library explored medical 
theory and practice in 16th-century London. 
By Charles Gershman 
“A plague o’ both your houses,” the 
dying Mercutio cries in Romeo and 
Juliet. “Hysterica passio, down, thou 
climbing sorrow,” exclaims the mad 
king in King Lear, referring to an 
affliction of the womb. And in The 
Winter’s Tale, Camillo presents the 
visionary notion that a person can 
carry and spread a disease without 
showing signs of illness. 
Medical references are rife in the 
Bard’s oeuvre, garnering attention from 
literary scholars and medical historians 
alike. A recent exhibit organized by 
the Cushing/Whitney Medical Library 
highlighted themes from Shakespeare’s 
works, including plague, midwifery, 
domestic medicine, herbal remedies, 
astrological medicine, surgery, and other ■ 
medical topics from the period between 
1589 and 1613, when Shakespeare 
produced most of his known work. 
(Shakespeare lived from 1564 to 1616.) ' 
“Medicine in Shakespeare’s London,” ' 
curated by historical librarian Melissa 
Grafe, ph.d., was part of a university- ! 
wide Shakespeare festival and on display 
from March through June. 
In choosing relevant texts to display 1 
in the library’s rotunda, Grafe decided 
to paint a broad picture of medical I 
knowledge and practice at the time. “We ; 
wanted not only to discuss Shakespeare { 
but to go beyond what Shakespeare 
might say and write,” said Grafe, add- 
ing that the exhibit included works not 
directly connected to Shakespeare in i 
order to give a fuller picture of medicine 
in that time and place. i 
Among the texts displayed were 
The Byrth of Mankynde, otherwyse named ' 
the Womans Booke, published in 1545 i 
and one of the earliest books written j 
in English on pregnancy and child¬ 
birth; a 1633 edition of John Gerard’s J 
The Herball or Generali historie of plan- 
tes; plague orders issued by the Privy | 
Council under Queen Elizabeth I in i 
159^’ and a 1633 edition of The Workes \ 
of that famous chyrurgian, Mr. lohn I 
Banester, a compilation of the early i 
works of a surgeon who served the i 
Earl of Warwick. i 
“We chose selectively,” Grafe said. 
“Some texts were more important than 
others, but we wanted to show diversity. 
We wanted to talk about how people 
understood their bodies, health, and 
disease during Shakespeare’s time.” 
Indeed, some areas of medical 
knowledge saw significant advances 
in the Elizabethan Age—Andreas 
Vesalius laid the foundations for 
modern anatomy, and Ambroise Pare 
revolutionized battlefield medicine, 
pther fields, however, remained mired 
in ancient concepts. Not until the 
19th century did Western medicine 
abandon the notion, first proposed 
by Hippocrates, that there are four 
humors (blood, yellow bile, black bile, 
iand phlegm) corresponding to four 
human temperaments (sanguine, cho¬ 
leric, melancholic, and phlegmatic). 
iThe concept is described and illus- 
\trated in the 1664 edition of The Optick 
.Glasse of Humors, first published in 
I1607 by the cleric and writer Thomas 
Walkington. 
Also on display was a 1679 edition 
of John Hall’s Select observations on 
English bodies of eminent persons in des- 
Iperate diseases, in which the physician 
I describes a variety of diseases through 
jcase studies, including observations 
on melancholy and syphilis. Hall mar- 
I ried Shakespeare’s daughter Susanna 
I in 1607. Some historians have sug¬ 
gested that this connection explains 
Shakespeare’s medical fluency; how¬ 
ever, Shakespeare wrote many of his 
plays with medical references, like 
Macbeth and King Lear, before Hall’s 
relationship with the family. 
Although the exhibit included 
more than 25 texts, Grafe noted that 
the library’s early modern holdings are 
much more extensive. “This is just a 
small tip of the iceberg,” she said. “We 
have well over 1,000 books from that 
period.” Selections from the exhibit 
may be viewed online at exhibitions. 
shakespeare.yale.edu/exhibitions/ 
medicine-in-shakespeares-london/. 
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As part of a university-wide celebra¬ 
tion of William Shakespeare, the 
Cushing/Whitney Medical Library 
displayed medical literature from 
London in the Bard’s time. Among the 
items in the library’s collection are, 
on facing page, the 1633 edition of The 
Herball or Cenerall hiftorie ofplantes, 
by John Gerarde. On this page, from 
top; Select Observations on English 
Bodies, including observations on 
melancholy and syphilis, written by 
John Hall, who married Shakespeare’s 
daughter Susanna in 1607; a medical/ 
astrological manuscript from circa 
iSSSi including an image of an astro¬ 
labe, a device used by astronomers, 
navigators, and astrologers to plot the 
positions of the sun, moon, planets, 
and stars; A Description of the Body of 
Man Together With the Controversies 
Thereto Belonging, a collection of what 
were then considered the best works 
of anatomy and published in 1615; far 
right, A Treatise ofMelancholie, by 
Thomas Vautrollier; and near right. 
The Method of Curing Wounds Made 
by Cun-shot, also by Arrows and Darts, 
with their Accidents, by the surgeon 
Walter Hamond. 
MIKPOKOSMOrPA-HA.- 
DESCRIPTION 
of the Body of Man. 
Tooitbi> 
WITH THE CONTROVERSIES 
THERETO BELONGING. 
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Method of Curing Wounds 
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A . 
gentle 
man 
When Leon E. Rosenberg, m.d., hs ’63, became the dean 
in 1984, he immediately asked Arthur Ebbert Jr., m.d., to 
stay on as deputy dean. Ebbert, who had spent more than 
30 years in the School of Medicine’s administration, includ¬ 
ing 10 as deputy dean, had planned to take a sabbatical 
year and return to the university in a different role. But 
Rosenberg needed Ebbert’s help with the fundraising cam¬ 
paign, the construction of new buildings, and his state of 
the school address. Ebbert agreed to stay for two more years 
to help the new dean gain a foothold, beginning with pro¬ 
viding feedback on the draft of the address. 
“His advice was always measured and based on experi¬ 
ence, but always given with decency and politeness, with diplo¬ 
matic wording,” Rosenberg recalls. “1 told him I was going to 
count on him to tell me which doors to open and which to keep 
closed. He understood what that meant.” i 
Though Ebbert regularly reminded Rosenberg that the 
clock was ticking, he agreed when Rosenberg entreated him 1 
to stay an additional year. “But 1 think there was another thing 
going on,” Rosenberg joked at Ebbert’s retirement reception in I 
1987. “He was going to wait to be sure that I didn’t screw up ; 
what he’d been working 34 years to set up around here.” 
Ebbert died on June 7 in Hamden, Conn., where he 
had retired. He was 89. He left a brief obituary to share with 
the medical school community but requested that it not be 
submitted to the newspapers and that no memorial service 
be held in his honor. His friends and colleagues remembered 
him as an unassuming, modest man, who preferred to stay 
out of the limelight. 
n . Many roles in a time of change 
By Natalie Villacorta ’ ^ 
In his 34-year tenure, Ebbert filled a number of roles dur¬ 
ing a time of change around the country and at the School 
of Medicine. He arrived in 1953 at the invitation of Dean 
Vernon W. Lippard, m.d. ’29, with whom he had worked at 
the University of Virginia, where Ebbert had received his 
undergraduate and medical degrees and completed his resi¬ 
dency in medicine. He worked his way up the academic lad- ' 
der at Yale from instructor to professor to assistant dean of 
postgraduate education, then to associate and deputy dean, 
and served under three more deans—Erederick C. Redlich, 
M.D., Lewis Thomas, m.d., and Robert W. Berliner, m.d.— , 
before Rosenberg. Ebbert watched the faculty grow from 150 
to more than 700, and class size increase from 60 to 100 
.students. When Ebbert came to Yale, women made up only 
:io percent of each class but by the time of his retirement, 
their numbers were approaching 50 percent. 
“You could have been dean many times at many 
schools, but you chose to stay at Yale,” Berliner said at 
Ebbert’s retirement reception. “Eive deans! One dean is too 
jmuch for many of us. ... It’s my conviction that you, work¬ 
ing with five deans, have done more for this school than 
jany other person since Dean Winternitz made it a modern 
Imedical school.” 
Transformations across the country found their way 
to Yale as well during Ebbert’s time. In 1965 the implemen- 
itation of Medicare and Medicaid created a new source of 
revenue for doctors and hospitals as the government now 
paid for patients previously treated without charge. These 
[changes, along with increased understanding of the 
Icomplexity of science and medicine, prompted increased 
specialization—leading to the creation of several new depart¬ 
ments in the early 1970s, including anesthesiology, neurol¬ 
ogy, and laboratory medicine. In the same year that the 
Medicare program went into effect, the Grace-New Haven 
Community Hospital and the School of Medicine ratified a 
new affiliation agreement, and the hospital was renamed the 
Yale-New Haven Hospital (ynhh), reflecting its role as the 
University’s main teaching hospital. 
i New buildings rose on campus, including Harkness 
jHall in 1955, and a year after Ebbert’s retirement, the Yale 
Physicians Building. In 1981 the Yale Eaculty Practice Plan 
jWas created to coordinate the clinical activities of the full-time 
niedical faculty into one multispecialty group practice. 
As Ebbert rose through the ranks, however, he saw 
fewer and fewer patients. He spent his days in the dean’s 
office approving faculty promotions and appointments; over¬ 
seeing surveys of the school by the Association of American 
'Medical Colleges; interviewing prospective students; and 
ladvising students about their postgraduate plans. Ebbert also 
chaired the Student Advisory Council, established in 1963 to 
provide students with a faculty mentor who could guide them 
in understanding the relationship between basic science and 
clinical medicine, selecting elective courses, and starting 
research projects for their theses. 
But those who observed him in the clinic thought 
that a physician with such patience and perception, who had 
honed his skills in internal medicine as a captain in the U.S. 
Army Medical Corps in postwar Japan, should have been 
treating patients. In a letter to Ebbert upon his retirement, 
Donald S. Dock, m.d., hs ’57, wrote; 
“My first encounter with you was as the physician for 
a patient with suspected pheochromocytoma on one of the 
Winchester wards in the summer of 1955. I had just come 
up after an internship at Hopkins and recall clearly marvel¬ 
ing at the astute way you picked apart that case. For a while 
I thought it was a loss to the practicing world that you had 
taken a big job in the dean’s area, but I’ve quickly realized 
how important that move was to the medical school.” 
Indeed, Ebbert’s friends and colleagues recall not 
just the projects he oversaw or the administrative tasks he 
performed but also his way of making people feel that they 
could confide in him, and his calming, trustworthy effect. 
He understood the challenges that the faculty faced—fund¬ 
ing, personality incompatibilities, career decisions. He 
would listen to these dilemmas patiently, always offering 
fair and wise counsel. Ebbert was “a vital link between the 
faculty and the administration,” said Dorothy Horstmann, 
M.D., Fw ’43, a close friend, at his retirement reception. 
(Horstmann, a researcher whose key finding about polio led 
to the development of a vaccine, was the first woman to be 
named a full professor at the medical school.) 
“If you had a question about where to turn next, ‘Ask 
Art’ was the motto,” recalls John E. Fenn, m.d. ’61, hs ’67, 
clinical professor of surgery (vascular). “Anybody could 
approach [him] with any kind of problem, and if he didn’t 
solve it, he knew how to give you advice to go about seeking 
a solution.” As chief of staff of ynhh from 1982 to 1993, 
Fenn himself often turned to Ebbert for advice, finding in 
Ebbert a comforting ally at the School of Medicine. Whether 
it was a problematic student, a lost key, or a widow who 
needed an escort to a university function, Ebbert could be 
relied upon to help. 
Friendships maintained 
Ebbert, who was born in Wheeling, W.Va., in 1922, was 
an only child and never married. “His family was Yale,” 
said Sharon McManus, major gifts officer for the School 
of Medicine, who knew Ebbert when she was director of 
alumni affairs. 
Many of the students he interviewed for the admissions 
process during his early years at Yale went on to become faculty 
members and colleagues, including Fenn; Gerard N. Burrow, 
M.D. ’58, professor emeritus of medicine, who became dean 
of the medical school; and Michael Kashgarian, m.d. ’58, hs 
’63, FW ’65, professor emeritus of pathology. (At the time, the 
admissions committee consisted of Ebbert and his friend and 
colleague Thomas R. Forbes, ph.d., the Ebenezer K. Hunt 
Professor of Anatomy and an associate dean of the medi¬ 
cal school.) Ebbert formed friendships through this role that 
endured long after the students had graduated. To maintain 
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14 A gentle man 
those friendships he founded the Alumni Bulletin, the precur¬ 
sor of Yale Medicine, in 1953. The early issues were simple 
eight-page newsletters, the editorial staff consisting of Ebbert 
and his assistant, Guldane Mahakian. 
The first issue entreated its alumni readers to act as 
both “field correspondents and literary critics,” and to wel¬ 
come the Bulletin as “the expression of a real desire on the 
part of the new School administration to strengthen the loyal¬ 
ties of our Yale family.” “Alumni looked to him as a personal 
link to the school,” remembers Kashgarian, who succeeded 
Ebbert as editor in chief of the publication in 1986, a position 
he still holds. 
The Bulletin reported on everything from the meet¬ 
ings of the Association of Yale Alumni in Medicine (ayam) 
and the recipients of awards and appointments to student 
performance on board examinations. The Bulletin was also a 
forum for such news as the School of Medicine’s adoption of 
a coat of arms, reported in the October 1963 issue. 
As the school grew, so did the publication, with con¬ 
tributions from other members of the medical school com¬ 
munity; in 1966, its name was changed to Yale Medicine. 
Long after Ebbert had stepped down as editor in chief he 
continued to send newspaper and magazine clippings about 
alumni achievements to include in the next issue. 
He also served as the medical school’s delegate to the 
AYAM, always returning with impeccable reports of their 
meetings, McManus recalls, for his dedication, Ebbert was 
made an honorary member of the association. 
His long-term friendships and his institutional 
memory made him “the library of the place,” Rosenberg says, 
fittingly, he loved the Medical Library and “thought it was 
one of the jewels in the crown of Yale School of Medicine,” 
remembers library director Kenny Marone, m.l.s. 
A longtime friend and member of the Associates 
of the Medical Library, Ebbert served as its membership 
chair. Ebbert made sure that the collections and the staff 
were appreciated and protected, Marone says. He established 
a memorial fund in honor of his parents in 1977. He was 
also a devoted member of both the Nathan Smith Club for 
faculty and students interested in the history of medicine 
and the Beaumont Medical Club for physicians in the com¬ 
munity and at Yale. At the club’s monthly meetings, members 
would drink sherry and listen to a presentation given by one 
of their fellow members, followed by dinner in the Beaumont 
Room. They would toast the anonymous donor of the wine— 
who was Ebbert, Burrow recalls. 
Merle Waxman, m.a., director of the Office for Women 
in Medicine, has several books that were gifts from Ebbert, 
including The Trauma of Moving: Psychological Issues for Women 
and The Handbook of Nonsexist Writing, both written by 
friends of his. Inside the books are labels on which Ebbert had 
recorded the date in his clear, precise handwriting. She remem¬ 
bers that when she became director of the Office for Women 
in Medicine, which Ebbert and Berliner were instrumental in 
establishing in 1975, he offered to sponsor her membership at 
Mory’s, a private club for alumni, faculty, students, and oth¬ 
ers affiliated with Yale. “But Dr. Ebbert, isn’t that a club for 
men.^” Waxman asked. “Oh, no, my dear,” Ebbert responded, 
explaining that the club had been open to women since 1972. 
Waxman ended up becoming a member. 
Ebbert, she said, “was willing to speak and to defend 
fairness,” when it came to gender disparities at the School of 
Medicine. Ebbert advised the office, which seeks to increase 
the visibility and accomplishments of women in medicine 
and to provide them with social and professional support. He 
supported revisions to Yale’s tenure system that would allow I 
tenure-track women to work half time, giving them more time 
to achieve tenure, as many of them were simultaneously start¬ 
ing families. Ebbert also helped in the creation of the Phyllis 
Bodel Childcare Center, which has provided on-site care for the 
children of faculty, students, and staff since 1979. 
Christmas cards, sailboats, and lunches at AAory’s 
“Art looks like Mister Rogers, he sounds like Mister Rogers, 
and he behaves like Mister Rogers!” Rosenberg’s wife, Diane- 
Drobnis, and daughter, Alexa, used to say. 
Like Mister Rogers, whom Ebbert portrayed in a second- i 
year show, he was everybody’s favorite neighbor. Ebbert’s 
friends and colleagues recall that he always asked after their 
family’s welfare and sent handwritten Christmas cards every 
year. He maintained an extensive social network and always 
kept in touch with people—catching up with friends over 
lunch at Mory’s. His guests would arrive to find him sitting 
at his favorite table dressed in a jacket and striped, regimental 
tie—his uniform no matter the occasion. “I’m sure he didn’t 
go skiing in a tie—but it’s hard to picture—I’ve only ever seen 
him in ties,” says Waxman. 
Ebbert loved to ski and sail. He was a member of the 
Sachem’s Head Yacht Club in nearby Cuilford and owned 
a 24-foot-long Pearson Ensign sailboat named Coose. He 
purchased the Ensign from a family who named their boats 
after birds with a double 0 in their names (another of the 
family’s boats was named Loon). Though Ebbert didn’t 
particularly like the name, he kept it since it is bad luck to 
change a boat’s name. 
“He was a consummate sailor,” recalls Erancis M. 
Lobo, M.D. ’92, who met Ebbert through the Nathan Smith 
15 
(club and crewed on Goose during races. On the downwind 
|leg, when there was nothing to do but relax, Ebbert would 
break out gingersnap cookies and iced tea, while most other 
trews would be drinking something harder. 
\ This kind of old-fashioned gentlemanly behavior was 
. iiypical of Ebbert—he always opened the door for women 
ivith a smile on his face, never raised his voice, and was par- 
[icular in his speech—when he dictated to his assistant, he 
mcluded punctuation marks. When his mother’s health was 
failing he would visit her almost daily, reading aloud to her 
after the print became too small for her to make out. Ebbert 
also looked after Helen Forbes, the widow of his long-time 
friend and colleague, with the same devotion. 
This loyalty extended from his friendships into his 
!■ personal habits. He didn’t own a television, preferring to 
keep informed about current events through newspapers, 
[magazines, and the radio. He didn’t have an e-mail address 
^nd wrote all his notes by hand. He drove only American 
cars, with a preference for Oldsmobiles and Chevrolets. 
I “He was an extraordinary, comforting, gentle man. 
Not gentleman; gentle man. And a gentleman as well. Clearly 
a gentleman as well,” Fenn says. 
Before Art and After Art 
' “This is really the end of an era at the Yale School of Medicine 
I j—it is the Ebbert era,” Rosenberg announced at Ebbert’s retire- 
' ment—or “commencement,” if you asked Ebbert—reception 
i, in 1987, where Ebbert’s admirers overflowed the courtyard 
outside of Harkness Dormitory. “ ‘B.A.’ may mean something 
to some of you concerning this time of year, but to us it means 
! ‘Before Art.’ And ‘A.A.’ may have signiflcance to you, but to me 
1 it will always mean ‘After Art.’ ” 
[ On that pleasant June day, Ebbert’s devotion to the 
i' school was recognized, to his surprise, with the naming of 
I ;the third-floor lounge of the Hope Building in his honor. His 
Icolleagues could not think of a more appropriate place, as 
the lounge was “a gathering point” for students, faculty, and 
alumni, representing Ebbert’s relationships with all. 
i True to character, Ebbert spoke only a few words of 
thanks at the ceremony, wanting his guests to get back to 
[enjoying the party. “I know you probably would have preferred 
[ to go golfing or play tennis or sail or do your gardening,” he 
I said. While the speakers before him had lauded his service to 
; the students, faculty, and alumni, Ebbert paid tribute to the 
In 1953 Arthur Ebbert, then the 
medical school’s deputy dean, 
launched the Alumni Bulletin, 
an eight-page newsletter that 
evolved into the current format of 
Yale Medicine. Ebbert felt that the 
school needed a publication that 
would keep alumni informed of 
happenings on campus. 
Staff—the business managers and the secretaries. “They’re the 
people that know how to get things done around here,” he said. 
He asked Mahakian, his administrative assistant of 22 years, to 
stand, and presented her with a bouquet of flowers. She wrote 
in a thank-you note to Ebbert, “As a number of people have told 
me since, they know of no one else who would have honored 
their secretary as you did.... It was a party for you but I’m so 
happy you included me!” 
Ebbert received a stack of letters from former col¬ 
leagues, students, and friends who could not attend the recep¬ 
tion but wanted to add to the chorus of congratulations and 
words of thanks. The letters came from as far away as Los 
Angeles and Miami and as close as the School of Nursing. 
Many wrote that they had learned of his retirement from an 
article in Yale Medicine, reaffirming the importance of the 
publication he had founded. 
From the wall in the Hope Building where his por¬ 
trait, painted by William F. Draper, hangs today, Ebbert will 
continue to be in the background, where he felt most com¬ 
fortable—wearing a jacket and tie, as always, ym 
—Natalie Villacorta is a student at Brown University and was Yale Medicine’s 
2012 summer writing intern. 
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Yale doctors 
around 
the world 
Since the days of Peter Parker, alumni 
have brought health care to underserved 
regions of the world. 
By Jenny Blair 
As a medical student in South India in the mid-1980s, Unni 
Karunakara, m.p.h. ’95, dr.ph., read a magazine article that he 
remembers still. It was about Medecins Sans Frontieres (msf, 
also known as Doctors Without Borders), a medical humani¬ 
tarian organization famed for rushing medical aid to disaster 
areas and war zones. Karunakara wrote to msf saying he would 
like to work with them. 
He never received a reply. But 10 years later, as a Yale 
public health student on his way home from a fellowship in 
South Africa, Karunakara met an msf representative in the 
Brussels airport. Soon he was offered a job. “It was never 
meant to be a lifetime engagement,” he recalled. “Now it’s been 
about 15,16 years.” After managing viral hemorrhagic fever 
outbreaks in Africa and caring for Bangladeshi cyclone vic¬ 
tims—among other responsibilities—Karunakara is now msf’s 
international president. Based in Geneva, he chairs their inter¬ 
national board and represents the organization to the interna¬ 
tional community and national governments between travels to 
field projects all over the world. 
Like Karunakara, Yale medical students and gradu¬ 
ates routinely cross borders to work in what are usually low- 
resource medical settings. The tradition of service abroad 
dates to the 19th century, when such medical school alumni 
as Peter Parker and Moses C. White traveled to China as 
medical missionaries; it experienced a resurgence in the 
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Yale doctors around the world 
PREVIOUS PACE Unni Karunakara, 
international president of Medecins 
Sans Frontieres, at a malnutrition 
screening in a mobile clinic at a camp 
for internally displaced persons 
in Mogadishu in 2on. 
1990S with a renewed interest in global health, once known 
as tropical medicine or international health. Some alumni 
began training overseas as students, while others have incor¬ 
porated overseas work into their practice, made international 
health a career focus, or even moved abroad permanently. 
The work forces them not only to recall fundamental skills 
but also to confront medicine’s intersections with policy, the 
environment, religion and culture, economics, and poverty. 
And for those willing to forgo fast diagnostics and advanced 
medications, working abroad can provide satisfaction that 
practice in the United States may not. 
“There’s almost never a day that goes by when you 
don’t think, ‘Boy, I really saved that patient’s life or limb,’ ’’ 
said Kinari Webb, m.d. ’02, who started a clinic in rural 
Borneo and has made Indonesia her home. By contrast, she 
said, as a family practice resident in the United States, “I felt 
like my major successes as a physician were getting people 
off 15 meds and down to four.” 
“You’re getting to the heart of why we go into medicine,” 
said Anna Gibb Hallemeier, m.d. ’02, hs ’06, who has worked 
in Kenya and New Zealand. “The impact that you can make 
is a lot more visible, I think, than doing primary care in the 
States.” And, she said, international medicine can put the vaga¬ 
ries of American practice, from its prescriptions for wrinkles to 
its constant threat of lawsuits, into perspective. 
Travels abroad and medicine 
It was an international experience that led Hallemeier to 
medicine. As an undergraduate she studied chimpanzees 
in Uganda, and that’s where she changed her career plans. 
Webb had had a similar epiphany after studying orangutans in 
Borneo. “When Kinari and I met in medical school, we com¬ 
pared our admissions essays, and they were essentially identi¬ 
cal,” Hallemeier said. “We both went to the forest and decided 
we preferred the human primate to the other primates.” Her 
change of heart occurred as she watched her local guides and 
hosts falling victim to diseases like hiv/aids and malaria. 
“It was just so unavoidable—how important public health was, 
how important prevention was,” said Hallemeier. “I realized I’d 
rather be working to do something about these diseases than 
observing chimpanzees in the forest and trying to pretend that 
these problems weren’t there.” 
For Ellis L. Webster, m.d. ’91, an ent and head and 
neck surgeon, the road to international medicine was the 
road—or rather the flight—home. In addition to a busy 
practice in West Palm Beach, Fla., he spent years caring for 
poorer patients 30 miles west in Belle Glade, many of whom 
paid him in mangoes and lettuce; and he provides free surgi¬ 
cal care for patients from Haiti, some of them victims of the 
2010 earthquake. Now, he works on the Caribbean island of 
Anguilla every month. “The reason why I wanted to do medi¬ 
cine was to help people,” he said. “It seems like a cliche.” 
Webster grew up on the island, a British overseas ter¬ 
ritory that is home to about 13,500. Urged by his mother, who 
had six other children, to avoid his fisherman father’s path 
and get an education, Webster began his health care career 
as a i6-year-old studying dentistry in Trinidad; attended the 
University of the Virgin Islands; completed medical school at 
Yale; and trained in otolaryngology at the University of Iowa. 
As he made a career in the United States, the knowledge that 
his own people lacked ent care weighed on him. “It’s like a 
Third World country in terms of the medical care that’s pro¬ 
vided,” he said. The territory’s few primary care physicians are 
sent by the British Foreign and Commonwealth Office to serve 
one-year terms fresh out of medical school. 
So Webster started a part-time practice on the 35-square- 
mile island in 2010. He set up an office, shipped equipment 
(the Anguillan government waived some import duties), and 
opened his doors that September. One week a month he cares 
for Anguillans’ nasal polyps, sinusitis, mastoiditis, and goiters, 
as well as an occasional tongue cancer. He sees patients with 
long-neglected chronic conditions like draining ears or goiters; 
the latter can leave people short of breath for years, but after 
surgery they may return to their usual way of life. The grati¬ 
tude his patients show, said Webster, makes the monthly trip 
to his home island deeply satisfying. It was something he had 
always wanted to do, he said; “something I needed to do to give 
back. Now my people do not have to travel abroad for routine 
ENT care and I can treat head and neck diseases before they 
become debilitating or unresectable.” 
Low-resource medicine 
Medical practice is challenging at the best of times, but it can 
be much more so in a low-resource setting. Emergency physi¬ 
cians may have to manage long-term diabetes care without 
access to benchmark blood tests. Gastroenterologists may 
have to guess whether a patient is having a heart attack. A 
coughing patient’s diagnosis may require a therapeutic trial 
of antibiotics—if those don’t work, maybe it’s TB. Maybe. “It 
requires comfort with uncertainty, which many Western phy¬ 
sicians can’t handle,” said Webb, who has worked with dozens 
of American students and physicians at her clinic. And 
though the cost of treatment is an issue in the United States, 
it can be a deal-breaker abroad: A family without a safety net 
may risk starvation if they sell their rice fields or cow to pay 
for treatment. “You are treating the whole community and 
you are treating the whole family,” said Webb. “Sometimes 
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LEFT In Zanzibar, Tanzania, 
Alison Norris conducted a 
focus group discussion about 
contraception and pregnancy 
for a group of married men in 
a rural district in 2010. 
BELOW While walking to a 
field site at a sugar plantation in 
northern Tanzania, Alison Norris 
and two of her children were 
joined by a cheerful group of chil¬ 
dren who live on the plantation. 
Norris carried out her doctoral 
research there in 2004. 
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20 Yale doctors around the world 
TOP Kinari Webb launched a 
clinic in 2007 with the dual goals 
of providing health care to an 
underserved population and 
preserving the nearby rainforests, 
which are threatened by logging. 
ABOVE Rachel Bronzan spent 
several years in Malawi, treating 
malaria and conducting research. 
She and her husband, Frank, 
took time out for a walk with 
their daughter, Alexis, near 
Mt. Mulanje. 
that means you’ve got to tell them that they shouldn’t spend 
any more money on care.” 
Even providing basic care may not be simple. To get the 
right medication to some Anguillan patients, Webster often 
brings drug reps’ free samples to the island because staples 
like nasal steroid sprays and advanced antihistamines aren’t 
available there. “I find that 1 am writing for meds that are anti¬ 
quated by U.S. standards,” he said. Diagnostic tools are simi¬ 
larly scarce, he added, which means he sometimes relies on 
“intuition and gut feelings. This is where you really put what 
you learned in medical school and residency to work. It takes 
up to three months to get pathology reports; therefore I have 
to make intraoperative and treatment decisions based on prior 
experience. I also often see patients with non-ENT conditions, 
who show up to get medical attention.” 
A veteran of many field hospitals, Karunakara is 
intimately aware of the challenge of simplifying Western 
medicine for the field without sacrificing quality. For sleep¬ 
ing sickness, he said, msf found a way to cut the usual 
four-times-a-day infusions to twice a day and then finish the 
treatment with oral medications. And msf pushed drug com¬ 
panies to create fixed-dose combinations of hiv drugs, which 
have made it much easier for patients to adhere to treatment. 
“These are common-sense innovations,” he said. But making 
fixed-dose combinations possible, however, required the inge¬ 
nuity of generic drug companies in India and taking on some 
of the most powerful corporations in the world. 
The big picture in medicine 
Indeed, working in developing countries often means physi¬ 
cians must think about the big picture in a way they may 
never have to do at home. The effects on medical practice of 
politicians, polluters, corporations, and cultures can be clearer 
when viewed from a foreign, low-resource perspective, perhaps 
because one’s patients tend to be poorer and more vulnerable. 
The ways in which such forces interact with medicine were 
a topic of intense discussion during medical school among 
four students who matriculated in the class of 2002: Webb; 
Hallemeier; Alison Norris, m.phil. ’04, ph.d. ’06, m.d. ’08; 
and Margaret Bourdeaux, m.d. ’03. All went on to make such 
questions a part of their professional lives, and they remain 
connected to one another today through Webb’s Borneo work. 
“We were systemic thinkers,” Webb recalled. “We were inter¬ 
ested in how medicine fit into the whole world.” 
In the years since, Webb quite literally saw the forest 
for the trees. She began an ngo called Health in Harmony 
and opened a clinic near a rainforest in Indonesia. It combines 
clinical practice, public health, and rain forest conservation, 
which suits the physician who hasn’t stopped caring about 
orangutans and their habitat. “I know that the conservation and 
academic part are incredibly important for the long term, but 
1 also need to combine it for myself with the short-term satis¬ 
faction” of patient care, Webb said. 
Norris traveled to Kenya as an undergraduate to study 
a new drug for trypanosomiasis, a disease caused by parasitic 
protozoa; though the drug killed more lab mice than trypano¬ 
somes, she found herself enamored of East Africa. “I [was] 
excited by how much one can do with so little,” she said. She 
returned to the region before medical school and again as a 
Downs Fellow, then wrote her ph.d. thesis on sexually trans¬ 
mitted diseases on a sugar plantation in Tanzania—this time 
with two small children in tow. Norris is now an assistant 
professor of epidemiology at Ohio State University’s College of 
Public Health: she is also president of Health in Harmony’s 
board of directors. 
I Bourdeaux and Hallemeier are also involved with inter¬ 
national work from the United States while remaining clini¬ 
cally active. Hallemeier combines a Cape Cod practice with 
iHealth in Harmony work. Though she spent two months in 
,Kenya’s Maua Methodist Hospital as a medical student “gain- 
jing hands-on experience on the inpatient wards,” then six 
'weeks in New Zealand as a Yale/Johnson & Johnson scholar, 
family obligations have kept her stateside while she continues 
her international medical involvement. Hallemeier has served 
las both board president and a board member of Health in 
Harmony, where she talks with potential donors and volun¬ 
teers and helps coordinate their complex trips to Borneo. 
“I couldn’t be in Borneo myself, so I wanted to do what I 
could from this end,” Hallemeier said. 
Bourdeaux studies global health policy and humanitar¬ 
ian aid at Boston’s Brigham and Women’s Hospital while car¬ 
ing for neonates there. She grew interested in the mechanics 
I of humanitarian aid during two stints in Kosovo shortly after 
'the war there had ended. For her m.d. thesis, she did an eth¬ 
nography of the health system there that made her rethink her 
assumptions about the effectiveness of humanitarian interven- 
I tion when an ngo doesn’t understand local culture. Albanian 
physicians who had fled as refugees were often hired by ngos 
i to staff postwar hospitals, but because they had fled, those 
:! same physicians had lost the trust of the population. “Nobody 
I wanted to go to the publicly run clinics or hospitals because 
! there was such a huge trust deficit,” said Bourdeaux. “The 
international community didn’t recognize this at all.” 
The situation on the ground 
Such confusion is familiar to Rachel Bronzan, m.d. ’95, m.p.h., 
a veteran of the Centers for Disease Control and Prevention’s 
Epidemiology Intelligence Service who studied malaria and 
provided clinical care in Malawi for several years. She now 
serves as an advisor to the government of Togo from her home 
in Seattle. Rural women in Malawi, Bronzan recalled, some¬ 
times knelt before asking her a question. Such things “[make] 
it clear that you just don’t understand or know where [people 
are] coming from.” 
Not fully understanding the cultural situation on the 
ground is a problem for many ngos attempting to provide aid. 
In fact, the last 15 years or so have seen an intense international 
effort to better delineate aid organizations’ responsibilities. 
It’s human nature to want to rush to the scene of a disaster 
to try to help—an impulse that may be especially strong in 
people like physicians who have specialized skills. Yet, as the 
flawed hires in Kosovo demonstrate, there are too many ways 
to go wrong. In the aftermath of the 2010 Haiti earthquake, 
responders ranging from teenage Scientologists to pediatric 
icu specialists descended upon the island, while stacks of 
boxes containing old clothes mailed by American churches 
accumulated under tarps at the airport. This shower of unorga¬ 
nized labor and supplies is what experts sometimes refer to as 
the second disaster. Not all personnel and supplies are needed, 
yet they will have to be dealt with somehow, sometimes at great 
cost to other responders. 
This “second disaster” points to the disturbing idea 
that humanitarian aid can do more harm than good. To help 
requires more than good will and a black bag. 
“We have so many people going out there with a 
trunk full of albuterol and thinking that’s going to help,” said 
Bourdeaux. “There needs to be some recognition that humani¬ 
tarian response requires some training and some thought.” 
She compared the world’s checkered and disorganized disaster 
responses to the way that a town without a fire department 
might respond to a house blaze. “What you have is a bunch 
of neighbors ... with fire hoses. Some of the people who own 
them have experience putting out fires, some don’t. We need a 
fire department.” 
Bourdeaux now studies military approaches to 
humanitarian aid, including those initiated by the United 
States military and NATO. “There’s lots of potential for 
improvement in how the international community responds 
to things,” she said. “I find it to be one of the most fascinat¬ 
ing stories of our generation.” 
A new interest in global health 
Whatever overseas commitment Yale medical students and 
alumni are making, they are doing so these days in increas¬ 
ing numbers. When Bronzan graduated in 1995, interna¬ 
tional work didn’t strike her as a prominent option at Yale. 
Such faculty members as polio expert Dorothy Horstmann, 
M.D., FW ’43, infectious disease specialist Robert E. Shope, 
M.D., HS ’58, and virologist Wilbur G. Downs, m.d., m.p.h., 
routinely worked in the developing world; and the Wilbur 
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22 Yale doctors around the world 
Ellis Webster, an ENT and head 
and neck surgeon, has a practice 
in Florida, but once a month he 
returns to his home island of 
Anguilla to provide care to the 
islanders. 
Downs International Health Travel Fellowship Program 
for student research abroad has been available since 1966, 
but foreign opportunities were still “more of a curiosity” in 
Bronzan’s time. “People would be encouraging,” she said, 
“but there was not a big culture of it at all.” 
One of the people who changed that state of affairs 
and helped put Yale on the international medicine map is 
Frank Bia, m.d., m.p.h., fw ’79, professor emeritus of inter¬ 
nal medicine. Bia graduated from medical school at Cornell 
in 1971: his yen to work abroad [chronic pruritus pedis] was 
so unusual that it invited ribbing. “You seem to think we’re 
running a travel agency rather than a medical school,” his 
dean told him. After medical school, Bia worked at the Albert 
Schweitzer Hospital in Haiti. Along with Michele Barry, m.d., 
HS ’77, he co-founded Yale’s international health program in 
1981. Twenty years later, the program received funding from 
Johnson & Johnson. Between 1981 and 2011, what is now called 
the Yale/Stanford Johnson & Johnson Global Health Scholars 
Program had funded overseas rotations for some 600 physi¬ 
cians. Residents and career physicians can apply to work in 
one of five sites in South Africa, Uganda, Liberia, Indonesia, 
and Rwanda; many of the slots come with funding for travel 
and expenses. 
Information, said Bia, is behind the explosion of inter¬ 
est in international medicine, in part because the Internet 
has made disparities so obvious. “Medical students are com¬ 
ing to medical school with a sense of global citizenship,” he 
said. Technology is also easing interactions across borders 
in an unprecedented way. A few decades ago, physicians 
serving in remote areas might not have had access to a tele¬ 
phone, much less an Internet connection. Now Bia can co¬ 
author a manuscript with someone in Eritrea. 
Bia left Yale in 2008 to serve as the full-time medical 
director of the ngo AmeriCares. By that time, overseas rota¬ 
tions were already a highly sought-after option among medi¬ 
cal students. The school’s 2006 establishment of an Office of 
International Medical Student Education, headed by Robert 
Rohrbaugh, m.d. ’82, hs ’86, fw ’88, professor of psychiatry, 
formalized this development, providing funding and super¬ 
vised international electives as well as hosting foreign stu¬ 
dents in a bilateral exchange. Under its auspices, three Yale 
medical students went abroad in 2007, the program’s first 
year. Last year, 30 did. 
Yale is not alone in providing international opportu¬ 
nities for its students. Carol A. Aschenbrener, m.d., chief 
medical education officer at the Association of American 
Medical Colleges, said that as of 2010, two-thirds of the 
130 medical schools that responded to a survey said that they 
had integrated global health into their curricula. “Things 
that happen here affect health elsewhere in the world and 
conditions in other countries affect our health,” she said. 
“Understanding the major issues in global health is really 
critical for future physicians.” 
23 
No single approach 
How can physicians and students be sure they’ll be useful? 
Webb’s clinic is designed to be a permanent presence in its com¬ 
munity and effect long-term change. By contrast, Karunakara 
thinks MSF and other humanitarian aid organizations should 
stick to rapid relief and not take on capacity-building. “You’re 
there to help people and not to help systems,” he said; the goal of 
aid is to alleviate suffering rather than to alleviate poverty, which 
is the role of long-term development programs, msf’s long-term 
effects arise, he said, when the organization provides a model 
that can be scaled up by domestic authorities. “Very often, these 
demonstrations get taken up by other agencies, and they try it 
on, and they improve on it.” 
Whether doctors sign up for a one-week mission trip or 
join an organization like Health in Harmony or msf with an 
aim to live abroad for months or years, there are some things to 
look out for. “Going with an organization that has been there 
for a long time in-country is important,” said Bourdeaux. “Not 
just ones that are famous. Get a sense of their authenticity and 
street cred.” She also recommended that physicians consider 
deploying not in the immediate wake of an acute emergency, 
but some time later, when world interest has receded. 
However carefully chosen the organization, alumni say 
that whether a doctor will find international work satisfying 
may depend on the doctor. Bronzan recalls how one Western 
physician in Malawi reacted to the death of a child from 
severe meningitis. “He just lost it,” she said, and recalled the 
man saying, “ ‘This is outrageous—in my entire career, no 
child has ever died of meningitis.’... He went ballistic and 
wanted to change everything.” What he didn’t appreciate was 
that children in that clinical setting had underlying medical 
and social conditions that sometimes made meningitis all but 
impossible to treat. 
Webb echoes many international physicians who advise 
doctors to think past the altruistic satisfaction of a short trip. 
“Western physicians should only ever be going to teach and 
learn from their local colleagues,” she said. “I think that the 
whole point is capacity building. It’s not about tourism; it’s not 
about getting your own experiences. It’s about improving care 
for people in the long run.” ym 
—^Jenny Blair, m.d. ’04, is a freelance writer based in Austin, Texas. She spent 
a year at the Health in Harmony clinic in Borneo. 
Bibhav Acharya m.d. ’11, Jason Andrews m.d. ’06, Sanjay Basu, m.d. ’09, 
PH.D. ’09, Duncan Smith-Rohrberg Wlaru, m.d. ’09, ph.d. ’09, and Ryan 
Schwarz m.d. ’n, m.b.a. ’11, while still in medical school, formed Nyaya, a 
clinic and hospital in a remote region of western Nepal. The hospital was 
founded with support from the Nepalese government and is completely 
staffed by local Nepalese health care providers. 
Kyeen Mesesan Andersson, m.d. ’07, ph.d. ’07, uses mathematical models 
to study epidemics of infectious disease. Much of her research has focused 
on HIV prevention in South Africa. She is a senior modeler and policy analyst 
at the Futures Institute, a global health organization based in Glastonbury, 
Conn., that specializes in the design and implementation of public health 
and social programs for developing countries. She is also a member of the 
Clinical and Health Services Research Core at Yale’s Center for Interdisciplinary 
Research on aids. 
Dagan Coppock, m.d. ’04, a poet and primary care physician who practiced 
near Boston, is spending two years in Botswana as a preceptor for Beth Israel 
Deaconness Medical Center’s training program. He previously studied the 
poetry of traditional healers in Nigeria. 
Kebba Jobarteh, m.d. ’02, m.p.h., heads the Hiv care and treatment program 
in Mozambique for the U.S. Centers for Disease Control and Prevention. He is 
a co-founder of Speak Up Young Africa, which has produced a documentary 
film highlighting the positive responses of young people to the hiv/aids 
epidemic in Uganda, Zambia, Zimbabwe, Nigeria, and Burkina Faso. Jobarteh, 
who has worked in a number of African countries, served as a Pediatric aids 
Corps physician in Malawi, where he also worked with Partners in Health as 
director of pediatrics and pediatric infectious diseases. 
Eric Krakauer, ph.d. ’91, m.d. ’92, assistant professor of medicine, and of 
global health and social medicine at Harvard Medical School, and a practicing 
internist and palliative medicine specialist at Massachusetts General Hospital, 
has been working in Vietnam since 2001, when he founded the Vietnam-CDC- 
Harvard Medical School aids Partnership to provide training and technical 
assistance in hiv/aids treatment to physicians and nurses in partnership with 
the Ministry of Health. As director of international programs at the Harvard 
Medical School Center for Palliative Care since 2005, Krakauer has assisted 
Vietnam’s Ministry of Health and major cancer centers and general hospitals 
to integrate parn relief and palliative care into the country’s health care sys¬ 
tem. Recently, Krakauer began working with Partners In Health to integrate 
pain relief and palliative care into cancer, hiv, and non-communicable disease 
treatment programs in Rwanda and Malawi. 
Roger Mason, m.d. ’70, a vascular surgeon, worked in Trinidad and Tobago 
from 2004 to 2009 as a vascular surgeon, founding Caribbean Healing Arts, 
Ltd (cha) in 2006 to improve the quality of health care in Caribbean emerg¬ 
ing nations, cha accomplishes its mission by building medical centers of 
excellence in Caribbean islands, recruiting "top docs” from North America 
and England who offer medical care to medical tourists as well as nationals. 
Profits from medical tourism operations subsidize care for nationals. Yale phy¬ 
sicians and public health graduates who would like to participate in this effort 
are invited to contact Mason at shaman212@gmail.com. 
Sarah Tishkoff, ph.d. ’96, the David and Lyn Silfen Associate Professor 
in the departments of genetics and biology at the University of 
Pennsylvania’s Perelman School of Medicine, studies the genetic history 
of Africa and has found greater genetic diversity among Africans than 
in any other ethnic group. 
Are you a physician who writes or works in another of the fields we’ll 
be profiling in our "Alumni Career Paths" series? Do you know medical 
school alumni, former Yale house staff, or fellows who are? Send us 
the names and then check the Web edition of Yale Medicine to view an 
expanding list of alumni with similar interests. You can write to us at 
ymm@yale.edu and view the list atyalemedicine.yale.edu. 
“Alumni Career Paths” future topics: 
• The front lines of clinical practice 
• Academic medicine 
• Sports medicine 
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Faculty 
Arthur Norwich George Lister Jorge Galan John Carlson 
Shaw prize for protein 
folding studies 
ARTHUR NORWICH, M.D., HS ’78, 
Sterling Professor of Genetics, pro¬ 
fessor of pediatrics, and a Howard 
Hughes Medical Institute investi¬ 
gator, received the Shaw Prize in 
Life Science and Medicine in May. 
Norwich is a co-winner, with his 
longtime collaborator Franz-Ulrich 
HartI, M.D., PH.D., of the Max 
Planck Institute of Biochemistry, 
for their research on how proteins 
fold Into their functional state. 
The award, which comes with a 
$1 million prize, was announced 
by the Shaw Prize Foundation in 
Hong Kong. 
Norwich and HartI found that 
specialized proteins called chap- 
eronins help proteins fold correct¬ 
ly within the cell. Their findings 
have implications for treating 
several diseases, because improp¬ 
erly folded proteins can clump 
together and are implicated in 
such neurodegenerative illnesses 
as Parkinson disease, Alzheimer 
disease, Huntington disease, mad 
cow disease, and amyotrophic lat¬ 
eral sclerosis, also known as Lou 
Gehrig’s disease. 
The Shaw Prizes, three annual 
awards in astronomy, life science 
and medicine, and mathematical 
sciences, honor living individuals 
who have achieved breakthroughs 
in academic and scientific research. 
The prizes are dedicated to fur¬ 
thering societal progress, enhanc¬ 
ing quality of life, and enriching 
humanity’s spiritual civilization. 
Pediatric chair named 
after national search 
GEORGE LISTER, M.D. ’73, HS ’75, has 
been named chair of pediatrics, 
chief of pediatrics at Yale-New 
Haven Hospital (ynhh), and physi¬ 
cian in chief at Yale-New Haven 
Children’s Hospital, marking his 
return to the school where he 
studied medicine, completed his 
residency, and served on the fac¬ 
ulty for more than 20 years. Lister 
comes from the University of Texas 
Southwestern Medical School, 
where he is the Robert L. Moore 
Chair of Pediatrics. He is also pedia¬ 
trician in chief at Children’s Medical 
Center Dallas. He replaces Clifford 
BOGUE, M.D., who has served as 
interim chair since 2010. 
After completing his residency 
and fellowships. Lister joined 
the faculty at the University of 
California, San Francisco, in 1977. 
He returned to Yale and YNHH in 
1978, where he became professor 
of pediatrics and of anesthesiol¬ 
ogy. He founded the Section 
of Critical Care and Applied 
Physiology and was its chief for 
more than 20 years. In 2003 he 
moved to UT Southwestern. 
In 1992 Lister was appointed 
by the National Institute of Child 
Health and Human Development 
to chair the steering commit¬ 
tee of a national study of the 
Collaborative Home Infant 
Monitoring Evaluation, a program 
intended to test the rationale 
for home monitoring of infants 
at risk for SIDS. He has been an 
active member of the American 
Pediatric Society and the Society 
for Pediatric Research. 
Two named to National 
Academy of Sciences 
Two Yale professors were elected 
to the National Academy of 
Sciences (NAS) in May. jorge 
GALAN, PH.D., D.V.M., the Lucille 
P. Markey Professor of Microbial 
Pathogenesis, professor of cell 
biology, and chair of the Section 
of Microbial Pathogenesis, and 
JOHN CARLSON, PH.D., the Higgins 
Professor of Molecular, Cellular, 
and Developmental Biology, were 
among 84 new members and 21 for¬ 
eign associates elected this year. 
Galan is renowned for his 
research on the cell biology, bio¬ 
chemistry, immunobiology, and 
structural biology of the bacte¬ 
rial pathogens Salmonella and 
Campylobacter, which together 
cause most of the world’s food- 
borne illness. His lab discovered 
novel molecular mechanisms that 
lead to infection and illness and 
represent potential targets for a 
new class of antimicrobials. Galan 
was recruited to Yale in 1998 to 
launch the section, and has since 
expanded it into a team of eight 
scientists who bring a variety of 
research methods to bear on infec¬ 
tious diseases ranging from tuber¬ 
culosis and Legionnaires’ disease 
to tropical parasitic diseases. 
Carlson’s work has advanced 
the fight against infectious dis¬ 
eases like malaria that are spread 
by insects. Carlson is one of the 
world’s experts in insect olfaction. 
His group discovered a family of 
60 genes that encode odorant 
receptors in Drosophila. In one 
experiment, Carlson’s lab acti¬ 
vated mosquito olfaction genes in 
a fruit fly, enabling researchers to 
identify chemicals in human sweat 
that attract mosquitoes. 
Two faculty members 
take jobs in Washington 
MIRIAM DELPHIN-RITTMON, PH.D., 
assistant professor of psychiatry, 
has accepted a political appoint¬ 
ment in the administration of 
President Barack Obama as senior 
advisor to the administrator in 
the Substance Abuse and Mental 
Health Services Administration 
office of Policy, Planning, and 
Innovation. Delphin-Rittmon will 
work on policy issues including 
the elimination of disparities; data, 
quality and evaluation efforts; and 
behavioral health service defini¬ 
tions. She has served as the direc¬ 
tor of the Office of Multicultural 
Affairs in Connecticut’s Department 
of Mental Health and Addiction 
Services and as director of Cultural 
Competence and Health Disparities 
Research and Consultation in 
Yale’s Program for Recovery and 
Community Health. 
PHILIP RUBIN, PH.D., CEO of 
Haskins Laboratories and adjunct 
professor in the Department of 
Surgery (Otolaryngology), was 
appointed to key roles at the White 
House and the National Science 
Foundation in March. Rubin was 
named assistant director for social, 
behavioral, and economic sci¬ 
ences in the Executive Office of 
the President’s Office of Science 
and Technology Policy. He will 
also serve as a senior advisor in 
the National Science Foundation’s 
Social, Behavioral, and Economic 
Sciences directorate. 
NOTES 25 
Diane Krause Melinda Peter Cresswell Jonathan Demb John Jack Elias Myron Genel Valentina 
Pettigrew Elefteriades Greco 
Diane Krause, m.d., ph.d., profes¬ 
sor of laboratory medicine, of 
cell biology, and of pathology, 
and associate director of the Yale 
Stem Cell Center, and Melinda M. 
Pettigrew, ph.d., associate pro¬ 
fessor of epidemiology (microbial 
diseases), and associate dean for 
academic affairs in the School of 
Public Health, have been selected 
I to participate in Executive Lead¬ 
ership in Academic Medicine, 
a year-long leadership training 
program for women in medicine. 
Fifteen Yale faculty members, 
including n from the School of 
Medicine, were inducted into the 
Connecticut Academy of Science 
and Engineering in May at the 
lacademy’s annual meeting. The 
inductees from the School of Med¬ 
icine are Susan J. Baserga, m.d. 
'88, PH.D. '88, professor of molecu- 
'lar biophysics and biochemistry, 
of genetics, and of therapeutic 
radiology; Linda K. Bockenstedt, 
M.D., Harold W. Jockers Profes¬ 
sor of Medicine (rheumatology); 
Sharon W. Cui, ph.d., senior re¬ 
search scientist; Pietro De Camilli, 
M.D., FW ’79, the Eugene Higgins 
Professor of Cell Biology, professor 
of neurobiology, and a Howard 
Hughes Medical Institute inves¬ 
tigator; Ronald S. Duman, ph.d., 
the Elizabeth Mears and House 
Jameson Professor of Psychiatry 
and professor of neurobiology and 
of pharmacology; Jo Handelsman, 
PH.D., the Frederick Phineas Rose 
Professor of Molecular, Cellular 
and Developmental Biology; 
Kevan C. Herold, m.d., professor 
of immunobiology and medicine 
(endocrinology); William L. Jor¬ 
genson, PH.D., Sterling Professor 
of Chemistry and director of the 
Division of Physical Sciences and 
Engineering; Nancy A. Moran, 
PH.D., the William H. Fleming, 
M.D. Professor of Ecology and 
Evolutionary Biology; W. Mark 
Saltzman, ph.d., the Goizueta 
Foundation Professor of Biomedi¬ 
cal Engineering and professor of 
cellular and molecular physiology 
and of chemical engineering; and 
Scott A. Strobel, ph.d., the Henry 
Ford II Professor of Molecular 
Biophysics and Biochemistry, 
professor of chemistry, and How¬ 
ard Hughes Medical Institute 
investigator. 
Henry Binder, m.d., fw ’65, senior 
research scientist and professor 
emeritus of medicine, received 
the Solomon A. Berson Medical 
Alumni Achievement Award in 
Clinical Science from the nyu 
School of Medicine in May. The 
award goes to a graduate of the 
NYU School of Medicine who has 
distinguished himself or herself 
by major accomplishments in 
clinical medical research. Binder 
has studied the regulation of 
colonic electrolyte transport, 
yielding knowledge of the 
pathophysiology of and improved 
treatment for diarrheal disorders, 
which has directly helped rural 
and developing peoples. 
Peter Cresswell, ph.d., Eugene 
Higgins Professor of Immunobi¬ 
ology, professor of cell biology 
and of dermatology, and a How¬ 
ard Hughes Medical Institute In¬ 
vestigator, received the AAi-Life 
Technologies Meritorious Career 
Award in May from the American 
Association of Immunologists for 
his contributions in the area of anti¬ 
gen processing and presentation. 
Jonathan Demb, ph.d., associate 
professor of ophthalmology and 
visual science and of cellular and 
molecular physiology, received 
the Cogan Award in May from the 
Association for Research in Vision 
and Ophthalmology. The award 
recognizes a researcher who is 40 
or younger who has made impor¬ 
tant contributions to research in 
ophthalmology or visual science. 
John A. Elefteriades, m.d. ’76, 
HS ’83, the William W.L. Glenn 
Professor of Cardiothoracic Sur¬ 
gery, was elected to the Interna¬ 
tional Academy of Cardiovascular 
Sciences. The academy provides 
the organizational structure for 
worldwide sharing of research 
and educational information in 
the field of heart health. 
Jack Elias, m.d., professor of 
medicine and chair of the De¬ 
partment of Internal Medicine, 
delivered the J. Burns Amberson 
Lecture at this year’s American 
Thoracic Society 2012 Interna¬ 
tional Conference in San Fran¬ 
cisco in May. This lecture honors 
individuals who have made 
major lifetime contributions 
to clinical or basic pulmonary 
research and/or clinical practice. 
Myron Genel, m.d., professor 
emeritus and senior research sci¬ 
entist in pediatrics, has received 
the 2012 Stepping Up for Children 
Award from the Stepping Stones 
Museum for Children in Norwalk, 
Conn. The award recognizes indi¬ 
viduals, nonprofit organizations, 
or companies that demonstrate 
a commitment to improving and 
enriching the lives of children 
and families. 
Valentina Greco, ph.d., assistant 
professor of genetics, is the re¬ 
cipient of a 2012 Research Scholar 
Grant from the American Cancer 
Society to support her project, 
“Stem Cell Deregulation during 
Tumor Regression.” 
Tamas Horvath, d.v.m., ph.d., 
chairofthe Section of Comparative 
Medicine and director of the Yale 
Program in Integrative Cell 
Signaling and Neurobiology of 
Metabolism, received the 2012 
Ernst Oppenheimer Award in 
June, one of the Endocrine Soci¬ 
ety’s Laureate Awards. Horvath’s 
work over the last 15 years has 
played a key role in the develop¬ 
ment of the currently accepted 
model of neuroendocrine regula¬ 
tion of energy balance. 
Joan A. Steitz, ph.d.. Sterling 
Professor of Molecular Biophysics 
and Biochemistry, received the 
degree of doctor of science honoris 
causa from Rockefeller University 
in June. Steitz is best known for 
discovering and defining the func¬ 
tion of small nuclear ribonucleo- 
proteins, cellular complexes that 
play a key role in the splicing of 
pre-messenger rna, the earliest 
product of DNA transcription. 
Hugh Taylor, m.d., professor of 
obstetrics, gynecology, and re¬ 
productive sciences, and director 
of the Division of Reproductive 
Endocrinology and Infertility, was 
selected by the Endometriosis 
Foundation of America as its 2012 
honoree in March. 
Howard Zonana, m.d., profes¬ 
sor of psychiatry, received the 
2012 Isaac Ray Award from the 
American Psychiatric Association 
and the American Academy of 
Psychiatry and the Law in May. 
This honor was awarded for 
Zonana’s decades of leadership 
and outstanding achievements in 
forensic psychiatry. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
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26 students 
Medical care and human 
rights in Uganda 
Doctors' practice of detaining 
patients who can’t pay their bills is 
focus of a student's documentary. 
Esther sits outside her mud hut home 
in front of a rust-red tree framed by 
the lush vegetation of the central 
Ugandan countryside and tells her 
shocking story. For more than two 
months her doctor had imprisoned 
her behind a locked gate and barbed 
wire-topped fence. She received no 
food, relying for sustenance on visi¬ 
tors and her son, whom the doctor also 
detained and compelled to work as a 
guard and laborer. 
The reason for the detention: Esther 
owed $65 of $200 for an operation 
that cured her of a crippling disease. 
But Esther is reluctant to condemn the 
doctor too harshly. Efe operated on her 
when no one else would. 
“I just pray that God forgives him 
for what he has done,” she said. 
Esther plays a pivotal role in a docu¬ 
mentary by Michael Otremba, m.d. ’12, 
which explores the detention of 
Ugandan patients unable to pay their 
bills. The movie is titled Twero, which 
means “right to health” in Luo, the lan¬ 
guage of that part of Uganda. Otremba, 
who devoted his fifth year at the School 
of Medicine to the project, wanted to 
combine his interests in human rights 
and the visual arts. He paints, and 
as a first-year student he organized a 
Christo-like art project that involved 
wrapping anatomy tables in pink [“End 
Note,” Yale Medicine, Autumn 2008]. 
Although Otremba had been to Uganda 
twice, he knew nothing about film. 
In stepped Gretchen K. Borland, 
M.D., associate professor of medicine, 
an accomplished documentary film¬ 
maker, and recipient of a MacArthur 
“genius” grant, whose work includes 
the award-winning Rolling about 
wheelchair users. Borland schooled 
Otremba in moviemaking, provided 
weekly advice by phone during six 
months of filming in Uganda, and 
helped edit 50 hours of raw footage. 
She was careful to ensure that the film 
remained Otremba’s. “It’s very easy 
for the mentor, as someone with more 
experience, to take over,” Borland said. 
Borland’s assistance was crucial, 
Otremba said. Her most valuable 
insight: interviewing documentary 
subjects is like interviewing patients. 
In both cases, you are asking them 
to open up and tell truths. Borland 
also helped Otremba with an ethical 
dilemma when he filmed a father who 
could afford malaria medication for j 
only one of his two daughters. Otremba i 
arranged treatment for both girls. 
What appears to be a black-and- 
white story isn’t; and conveying that 1 
reality is the film’s biggest challenge. , 
“In some ways, there’s an understand- j 
ing of the doctors’ plight,” Otremba I 
said. “Only 60 percent of Ugandan j 
physicians stay in the country, and ! 
not many are willing to work in these ( 
rural areas. I don’t think in any way 1 
it’s okay. But it is difficult when you j 
meet a bunch of physicians. They '8 
make so little money, and they are the 
only ones around.” | 
A doctor who detains patients—not 5 
the one who treated Esther—justified 
the practice, saying he needs to pay his ^ j 
bills. He added that he always treats . ■ 
first even though he knows that 30 to 
40 percent of patients can’t pay the full 
fee. “It’s a controversial and disturbing 
practice,” Berland said. “Patient deten- 
tion is part of a larger set of responses ' 
to an inadequate health system.” 
Patient detentions are a symptom ' j 
of larger systemic problems, including ■ 
corruption, funding shortages, and a j 
culture maimed by years of civil war, ,i 
Otremba said. He hopes to enter his ; 
30-minute movie in human rights film j 
festivals and plans to show it to policy 
makers in human rights, but isn’t 
about to give up his stethoscope. “This 
reinforced that I want to be a doctor,” 
he said. “I like being able to help.” 
In August Otremba learned that he 
had received one of six awards conferred 
in 2012 by the international consortium. 
Networked Digital Library of Theses and ' 
Dissertations, for his film. The awards 
recognize students who have written 
exemplary electronic theses and disser¬ 
tations. Twero: The Road to Health can 
be viewed at vimeo.com/47748677. The I 
password is twerofilm. ( 
—Christopher Hoffman 
Gretchen Berland, a physician and award-winning 
documentary filmmaker, served as a mentor to 
medical student Michael Otremba as he made a 
film about the provision of medical care and hu- : 
man rights in Uganda. 
FDA review process faster than 
in other countries, med student 
reports in nejm 
Somewhere between his board exami¬ 
nations and his wedding this spring, 
medical student Nicholas Downing 
found time to be the lead author on a 
paper published in a prestigious clinical 
journal. The paper, published online 
in May and in print in June in The 
New England Journal of Medicine, chal¬ 
lenges criticism that the Food and Drug 
lAdministration’s (fda) drug review pro¬ 
cess is too slow. According to the paper, 
[the FDA approved drugs faster on aver¬ 
age than peer agencies in Europe and 
Canada between 2001 and 2010. 
“It’s a huge accomplishment,” said 
Joseph Ross, m.d., m.h.s. ’06, assis¬ 
tant professor of medicine and senior 
author of the paper. 
And it’s not Downing’s first publica¬ 
tion. He also published a paper in April 
'in Archives of Internal Medicine describ¬ 
ing how a pharmaceutical company 
used reformulations to dominate the 
market for fenofibrate, a drug given to 
treat high cholesterol levels, for over a 
decade despite numerous generic for¬ 
mulations of the drug. 
Downing, an American citizen, grew 
up in London and attended Harvard, 
graduating in 2007 with a degree in 
chemistry. He then worked for three 
years at McKinsey & Company, an inter¬ 
national management consulting firm. 
As a business analyst and engagement 
manager. Downing worked mostly with 
pharmaceutical companies and, to a 
lesser extent, with hospitals. “I didn’t 
really understand the clinical and 
human side of medicine,” he said, 
“and that was kind of a stimulus that 
got me interested in exploring what a 
medical career could look like. 
“Medicine is not immune to mar¬ 
ket forces,” he said, but added that few 
people understand both “the realities 
of business ... (and) the nuances and 
human side of clinical medicine.” 
During his first year at Yale, 
Downing approached Ross and Harlan 
Krumholz, m.d., the Harold H. Hines 
Jr. Professor of Medicine (cardiology) 
and professor of investigative medicine 
and of public health (health policy), 
and the director of the Robert Wood 
Johnson Foundation Clinical Scholars 
Program, about a summer research 
project. Ross and Krumholz were 
interested in research about the phar¬ 
maceutical industry, and Downing had 
business experience in pharmaceuti¬ 
cals—the perfect partnership. 
The idea for the fda study emerged 
from the impending reauthorization 
of the Prescription Drug User Fee Act 
(pdufa), which was first enacted in 
1992 to allow the fda to collect fees 
from drug companies to fund the pro¬ 
cess of new drug approval. In addition, 
there had been “a lot of noise about 
the FDA being slow” in the media. 
Downing said. 
But this need for speed must be bal¬ 
anced by quality assurance. Downing 
added. As a result, it wasn’t clear what 
the appropriate speed might be, so the 
team decided to compare the fda with 
peer agencies in Europe and Canada. 
The team found that the fda 
reviewed applications for new molecu¬ 
lar entities or biologic drugs more 
rapidly on average than the European 
Medicines Agency and Health Canada 
from 2001 to 2010. Downing’s team 
found that the fda completed its ini¬ 
tial reviews 50 to 60 days ahead of the 
other two agencies, with its median 
time for completion being 303 days. 
And for 72 drugs that were approved 
by all three agencies, the fda’s first 
review time was about 100 days faster. 
Eor those drugs approved in at least 
two regions, two-thirds were first 
approved in the United States. 
Nicholas Downing’s research into how long 
it takes the fda to approve novel therapies 
was published in The New England Journal 
of Medicine. 
The report concludes that given the 
fda’s lead over its peer institutions, 
criticisms about the inefficiency of 
the agency’s review process for novel 
drugs may be unfounded. 
The study is important because 
“it injected some objective informa¬ 
tion into what had become a relatively 
subjective debate,” Downing said. 
PDUFA V, the fourth reauthorization of 
the 1992 act, was signed into law by 
President Barack Obama on July 9. 
Downing said the team’s next step 
is to examine the quality of the fda’s 
drug reviews. “I think it’s the responsi¬ 
bility of every physician to understand 
the safety and efficacy profile of every 
single drug that they use,” he said. 
—Natalie Villacorta 
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28 Alumni FACES 
Seeking a continent’s 
history in its DNA 
A Yale alumna finds clues to agricul¬ 
ture, malaria, lactose tolerance, and 
pygmies’ stature in Africans’ genes. 
Sarah Tishkoff, ph.d. ’96, has lost 
count of the trips she’s made to Africa 
since 2001 to study the continent’s 
genetic history. “By looking at your 
blood,” she explains to sub-Saharan 
villagers, “we can learn something 
about your mother, your father, your 
grandparents.” 
Through the villagers’ dna, Tishkoff 
has traced the history of malaria and 
dairy farming. She’s suggested a 
link between pygmies’ stature and a 
genetic mutation that strengthens their 
immune systems. She’s found the com¬ 
mon ancestors of East Africa’s only two 
click-speaking populations. And her 
studies reveal greater genetic diversity 
among Africans than in any other eth¬ 
nic group and suggest that all humans 
came from Africa more recently than 
previously believed. 
Her most recent research, featured 
on the cover of the August 3 issue of 
the journal Cell, analyzed the fully 
sequenced genomes of 15 Africans 
from three hunter-gatherer groups. The 
study—which she described as the first 
high-coverage whole-genome popula¬ 
tion genomics study in humans and the 
most extensive in Africa—identihes sev¬ 
eral million previously unknown genetic 
mutations in humans, finds evidence 
that the direct ancestors of modern 
humans may have interbred with mem¬ 
bers of an unknown ancestral group of 
hominins, and suggests that different 
groups evolved distinctly in order to reap 
nutrition from local foods and defend 
against infectious disease. “Our analy¬ 
sis sheds light on human evolution, 
because the individuals we sampled 
are descended from groups that may 
have been ancestral to all other modern 
humans,” Tishkoff said. “A message 
we’re seeing is that even though all 
the individuals we sampled are hunter- 
gatherers, natural selection has acted 
differently in these different groups.” 
Her work has attracted attention 
from Scientific American, National 
Geographic, and pbs’s Nova. But none 
have been more interested than the 
villagers themselves. “In one village, 
a man had a copy of the Jehovah’s 
Witnesses’ magazine Watchtower with 
a picture of a double helix in it. He 
asked me, ‘That’s what you’re study¬ 
ing, right.^’ I said, ‘That’s right.’ And 
he said, ‘So could you trace where the 
blacks in the U.S. are from.^’ ” 
Studies of Africans were scarce 
when Tishkoff came to Yale in 1989. 
Her advisor, Kenneth K. Kidd, ph.d., 
professor of genetics, of ecology and 
evolutionary biology and of psychia¬ 
try, had DNA samples from just two 
African populations in his lab. “The 
Mbuti and Biaka Pygmies from 
Central Africa are probably the least 
representative of African populations, ^ 
but nobody knew that at the time,” 
said Tishkoff, the David and Lyn Silferi 
University Professor in the depart- | 
ments of genetics and biology at the ^ 
University of Pennsylvania Perelman -Ij 
School of Medicine. 
Tishkoff found more than she 
expected in those samples, specifically 
in a stretch of dna on chromosome 12. 
“All Europeans looked similar to each 
other. All Asians looked similar to each 
other. But I wasn’t seeing anything 
similar in these African groups,” she 
said. “So I looked through the literature,Ijj 
contacted the people who were studying fi 
Africans, asked if they’d like to collabo- 
rate; they sent some dna, and we ended || 
up publishing in Science in 1996.” t 
In the study, Tishkoff, Kidd, and 'rii 
their collaborators revealed more 
genetic diversity among sub-Saharan -i 
Africans than among Northern 
Africans or non-Africans and sug- 
gested that humans came from Africa 
about 100,000 years ago. While j 
researchers already favored the Out- \ 
of-Africa theory over a multi regional j 
theory, Tishkoff’s study was the first 
to support it by using the same type ) 
of DNA used in forensics—nuclear J 
DNA, which reveals more about an 
29 
Sarah Tishkoff is seeking clues to Africa’s genetic 
history and, through dna samples, has traced 
the history of malaria and dairy farming and 
found a possible clue to pygmies’ stature. In 
Tanzania in 2001 she collected blood samples 
from villagers. 
I individual’s evolutionary history than 
idoes mitochondrial dna. 
When scrutiny of other genes 
continued to suggest that Africans dif¬ 
fered more widely from one another 
than from anyone else, Tishkoff 
wanted to know the continent’s entire 
I genetic history. She started in South 
lAfrica in 1997, where, as a postdoc 
iiat the University of Witwatersrand, 
[she first heard about the Hadza and 
ii Sandawe of Tanzania. Though the two 
i] groups are the only click-speakers in 
1 : East Africa, no one knew whether they 
Ifi'are related. Tishkoff had to find out. 
i- While waiting for local permissions 
» j for studies in Tanzania and Ethiopia 
in (it took years), she continued her post¬ 
doctoral work at Pennsylvania State 
University, studying a gene related 
ly I i to malaria resistance. By determin- 
2 i ^ ing when the gene first appeared in 
j j African populations, Tishkoff and 
idifj her colleagues provided support for a 
long-held theory that malaria became 
endemic only after agriculture had 
been introduced. 
Tishkoff was a professor at the 
University of Maryland when she and 
her team finally got permission to 
conduct her studies in Tanzania in 
2001. She traveled the country in a 
Land Rover whose floor had almost 
completely rusted out. The vehicle, 
however, proved its worth—the team 
connected their centrifuge to that 
rusty Land Rover to process blood 
samples. The Bush Lab, as they 
dubbed the vehicle, helped Tishkoff, 
students, and collaborators learn that 
the click-speakers’ last common ances¬ 
tors had lived 15,000 years ago. The 
languages and the people were barely 
related. The team also linked the gene 
responsible for lactose tolerance in 
Africans to the beginning of African 
dairy farming 7,000 years ago. 
African collaborators, including 
researchers, nurses, and schoolteach¬ 
ers, are a major key to Tishkoff’s suc¬ 
cess. Through a study of 121 African 
populations, four African American, 
and 60 non-African populations, 
Tishkoff and her collaborators have 
shown that Africans have the highest 
level of intrapopulation genetic diver¬ 
sity. The knowledge that Africans are 
more diverse than other populations 
will affect future study designs and 
biomedical research and—^Tishkoff 
hopes—encourage further study. 
Throughout her work, Tishkoff has 
trained numerous African scientists 
from high school to the postdoctoral 
level to carry on research in Africa 
themselves. “That’s one of the things 
I am most proud of” 
—Sonya Collins 
Africa beckons two Yale 
practitioners after long careers 
in medicine 
Three years ago, an unexpected post¬ 
card arrived in the Denver mailbox of 
Christopher (Kip) Doran, m.d. ’73, and 
Maureen O’Keefe Doran, m.s.n. ’71. 
It was an invitation to a reception for 
potential Peace Corps volunteers over 
the age of 50. Intrigued, they went. 
As they walked out Kip recalled, “We 
looked at each other and said, ‘We 
could do that.’ ’’ 
The Dorans had spent 30 years in 
Denver, where they lived, worked, and 
raised two daughters. Both taught at 
the University of Colorado, both were 
heavily involved in community organi¬ 
zations, and both had private practices 
—Kip in psychiatry and Maureen as 
a mental health nurse practitioner. It 
wasn’t easy to disengage, and yet the 
prospect of such an adventure felt like 
“a second breath of life.” 
So they signed up and as they wound 
down their practices, they learned they 
would be sent to Botswana. They flew 
to Africa, where a three-month home 
stay with a Botswana family immersed 
the Dorans in language, culture, and 
HIV issues (a quarter of young adults in 
Botswana are Hiv-positive). They settled 
into Ramotswa, a town of 28,000 about 
45 minutes from the capital. There 
they served from April 2009 to June 
2011 as teachers and mentors. Though 
neither Doran was permitted to work 
clinically with patients, they used their 
teaching skills in medicine. Kip planned 
and implemented educational activities 
at the district aids coordinator’s office 
while Maureen taught high school guid¬ 
ance classes, helping students build 
self-esteem and leadership skills with 
an eye to hiv prevention. They wrote a 
textbook teaching parents how to talk to 
children about sex, sexuality, and hiv. 
And they taught a mental health course 
at the newly opened national medical 
school, encouraging students to study 
medicine in “the American way” of 
learning, group discussion, role-playing. 
30 Alumni FACES 
Kip and Maureen Doran put their private 
practices in Denver on hold to join the Peace 
Corps and work as teachers and mentors in 
Botswana for two years. They also found time to 
visit the Mokolodi Nature Reserve, a protected 
environmental and conservation area outside 
the capital, Gaborone. 
and interview practice. It went over well 
with the students, who gave the class 
top satisfaction ratings. All in all, said 
Maureen, Botswana “was a wonderful 
match for us.” 
Far from being a hindrance, the 
Dorans’ age worked in their favor. “Age 
is respected in Botswana culture,” said 
Kip—he was 63 and his wife 62 when 
they began their service. “I was male, I 
was older, and I was a physician. When I 
talked, people listened.” Maureen agreed, 
recalling that when villagers greeted 
them in Setswana with “Dumela mogolo” 
(Hello, old people!), it was “the highest 
compliment you could get.” 
Maureen noted that being older 
allows Peace Corps volunteers to stay 
focused and keep the long view dur¬ 
ing difficult moments. Taking time off 
to work abroad may also be easier for 
older people than for those in midlife 
who are still establishing careers. Since 
the early 2000s, the Peace Corps has 
actively recruited older volunteers, in 
part by reaching out to aarp members. 
By 2005, 6 percent of Peace Corps 
volunteers were older than 50, up from 
I percent in previous decades. 
Regardless of volunteers’ ages, 
though, the Peace Corps is no vacation. 
The Dorans commuted on foot and 
brought groceries home in backpacks; 
their house was unheated, and they 
were often cold. There were disturbing 
incidents, like a student death from 
HIV-related meningitis. Hardest was 
refraining from meeting problems with 
culturally unworkable solutions. When 
faced with a problem, said Maureen, 
“You have to be able to be quiet with I 
yourself to look and see how the locals 
are doing it. ... Things get done, but not 
with the speed or efficiency we would 
sometimes have wished for.” 
“One of the things that impressed 
me is [that] it’s hard to help,” said Kip. 
Even with funding from large organi¬ 
zations like the Gates Foundation or 
PEPFAR, he said, “It’s hard to use that 
money wisely and intelligently.” 
The Dorans’ Peace Corps service 
continues in a new way. One of the , 
organization’s goals is promoting 
Americans’ understanding of other cul-, 
tures; Kip and Maureen have taken that 
to heart, giving frequent presentations 
about their two years in Botswana. 
They’ve come a long way from their 
first uncertain days as foreign volun¬ 
teers. “I kept saying to Kip, ‘I don’t like • 
change! Why am I doing this.^ I like 
stability!”’ Maureen recalled. “But I’m 
very, very glad that we did. 
“It’s something to do for America,” she, 
added, “for your country. I don’t think 
it’s ever too late to consider doing that.” 
—Jenny Blair, M.D. ’04 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or has followed 
an unusual path since leaving Yale? We’d 1 
like to hear about alumni of the School o ij 
Medicine; Physician Associate Program; 
and the medical school’s doctoral, fellow ^ 
ship, and residency programs. Drop us a 
line at ymm@yale.edu or write to Faces, 
Yale Medicine, 1 Church Street, Suite 300, 
New Haven, CT 06510. 
NOTES 
Philip Di Saia Edward 
Halperin 
C.Seth John Patti Kenneth Jeffrey Carpenter Cynthia Lord Robin Smith 
Landefeld Andreoni 
1950s 1970s 
Robert J.T. Joy, m.d. ’54, received 
the 2012 Lifetime Achievement 
Award from the American 
Association for the History of 
Medicine. The Lifetime Achieve¬ 
ment Award is given annually 
to a member of the association 
who has retired from regular 
institutional affiliation or prac¬ 
tice with a distinguished record 
of support for the history of 
medicine and has made continu¬ 
ing scholarly contributions of a 
distinguished nature. 
1960s 
I 
A chair has been established 
at the University of California, 
Irvine, in recognition of Philip 
I j. Di Saia, m.d., hs ’67, and his 
|i more than 30 years of service to 
fthe Department of Obstetrics 
jjand Gynecology’s Division of 
[ Gynecologic Oncology. Di Saia, 
I the former chief of the division, 
helped the school become a 
j leader in women’s cancer care. 
t Robert Bristow, m.d., was named 
'the inaugural holder of the Philip 
‘ J. Di Saia Prestigious Chair in 
Gynecologic Oncology in January. 
i' Arthur I. Eidelman, m.d., hs ’67, 
Fw ’67, has been elected presi- 
; dent of the Academy of Breast- 
ji feeding Medicine. As chair of the 
!' policy committee of the section 
, of breastfeeding of the American 
Academy of Pediatrics (aap), he 
: is the lead author of the new aap 
* policy statement on breastfeed- 
i ing, published in Pediatrics in 
, March 2012. 
j David J. McConnell, m.d. ’62, has 
I been named clinical professor 
I emeritus of medicine at Columbia 
University College of Physicians 
'and Surgeons. 
Edward C. Halperin, m.d. ’79, has 
been named chancellor for health 
affairs, chief executive officer, 
and professor of radiation oncol¬ 
ogy, pediatrics, and history at 
New York Medical College in Val¬ 
halla, N.Y. He was also named vice 
provost for biomedical affairs of 
the Touro College and University 
System. Halperin was previously 
dean of the school of medicine 
and vice provost of the University 
of Louisville in Kentucky. 
C. Seth Landefeld, m.d. ’79, has 
been named chair of the Depart¬ 
ment of Medicine at the University 
of Alabama at Birmingham. Lande¬ 
feld, an internationally known cli¬ 
nician and researcher in geriatrics, 
epidemiology, and biostatistics, 
previously served as chief of the 
Division of Geriatrics and associate 
chair for strategic planning and 
implementation of the Depart¬ 
ment of Medicine at the University 
of California, San Francisco. 
John A. Patti, m.d. ’71, was 
elected president of the Ameri¬ 
can College of Radiology (acr) in 
May. Patti, the immediate past 
chair of the ACR Board of Chan¬ 
cellors, is a thoracic radiologist at 
Massachusetts General Hospital 
and a member of the faculty of 
Harvard Medical School. 
1980s 
Kenneth Andreoni, m.d. ’88, was 
elected vice president/president¬ 
elect of the United Network for 
Organ Sharing, which manages 
the nation’s organ transplant 
network under federal contract. 
Jeffrey P. Carpenter, m.d. ’86, has 
been named the inaugural chair 
of the Department of Surgery at 
the newly formed Cooper Medical 
School of Rowan University in 
Camden, N.J. He was previously 
professor of surgery at the Uni¬ 
versity of Pennsylvania. 
Barbara G. Fallon, m.d. ’80, has 
been named medical director of 
the breast program at the Hospi¬ 
tal of Central Connecticut in New 
Britain. Fallon, a hematologist- 
oncologist, was previously in 
private practice. 
1990s 
Cynthia B. Lord, m.h.s., pa-c 
’91, a clinical associate profes¬ 
sor in Quinnipiac University’s 
PA program, received the 2012 
Outstanding pa of the Year 
Award from the American Acad¬ 
emy of Physician Assistants at 
its annual conference in Toronto 
in May. 
Robin L. Smith, m.d. ’92, m.b.a., 
has been chair of the advisory 
board of NeoStem, a leader in the 
development and manufacturing 
of cellulartherapies, since 2005, 
and in 2006 became the chief 
executive officer and chair of the 
board. She is the president and 
serves on the board of the Stem 
for Life Foundation, a nonprofit 
and nonpartisan organization. 
2000s 
Phillip P. Chan, m.d. ’00, ph.d. 
’00, CEO of CytoSorbents Corpo¬ 
ration, was named a finalist in 
the Ernst & Young Entrepreneur 
of The Year® 2012 program in the 
New Jersey region. The award 
recognizes entrepreneurs who 
have demonstrated success in 
such areas as innovation, finan¬ 
cial performance, and personal 
commitment to their businesses 
and communities. Chan has 
been CEO and president of the 
company since 2009. 
Garth N. Graham, m.d. ’01, 
M.P.H. ’01, has been named to 
the advisory board of LodgeNet 
Healthcare, a company that de¬ 
velops evidence-based, customiz¬ 
able tools that enable hospitals to 
engage patients and their families 
before, during, and after hospital¬ 
ization. Graham is the assistant 
dean for health policy and the 
chief of the Section of Health Ser¬ 
vices Research at the University of 
Florida College of Medicine. 
2010s 
Elliot J. Rapp, M.D. ’11, received 
the 2012 Massachusetts Medical 
Society’s Information Technology 
Award in June for his project Cube 
Knowledge, a software-based 
learning platform for self-testing 
and spaced repetition suited to 
the study of medical information. 
Rapp began a diagnostic radiol¬ 
ogy residency at the University of 
Washington in July. 
SEND ALUMNI NEWS TO 
Claire M. Bessinger, Yale Medicine, 
1 Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
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in memoriam 
Arthur Edward Baue, m.d„ the 
former chair of the Department 
of Surgery at Yale, died at home 
in Hamden, Conn., on Decem¬ 
ber 28,2011. He was 82. Baue 
devoted much of his career to the 
study of shock following trauma 
and is credited with defining the 
concept of posttraumatic mul¬ 
tiple organ failure in the care 
and study of injured patients. 
A graduate of Harvard Medical 
School, he performed his general 
surgery training at Massachu¬ 
setts General Hospital before 
pursuing advanced thoracic 
surgical training in 1962 at the 
Frenchay Hospital in North Bristol, 
England. He then returned to the 
United States; after a year at the 
University of Missouri School of 
Medicine, he was recruited by the 
University of Pennsylvania in 1963. 
Baue returned to Missouri in 1967 
as the surgeon in chief and Edison 
Professor of Surgery at the Jew¬ 
ish Hospital of St. Louis. In 1975 
he was recruited to Yale as the 
Guthrie Professor and chair of the 
Department of Surgery as well 
as surgeon in chief of Yale-New 
Haven Hospital. He returned to St. 
Louis University Medical Center 
as a professor of surgery im985 
and retired in 1997. 
James J. Fischer, m.d., ph.d., 
HS ’65, chair of the Department 
of Therapeutic Radiology at the 
School of Medicine from 1972 
to 2002, died while running 
on the beach near his home in 
Madison, Conn., on February 22. 
He was 75. Fischer received his 
undergraduate degree from Yale 
in 1957. hi5 medical degree from 
Harvard in 1961, and his ph.d. in 
1964. He conducted pioneering 
studies on the use of nuclear 
magnetic resonance to study 
enzyme complexes, publishing 
a seminal paper on the topic in 
Nature in 1963. He returned to 
Yale in 1964 for an internship 
in internal medicine under Paul 
Beeson, m.d., then trained as a 
clinical and research fellow in 
the Department of Radiology. 
Fischer was named the Robert E. 
Hunter Professor when radiation 
therapy became a free-standing 
department in 1972. He was 
also appointed chair of the new 
department, a position he held 
until 2002. 
Gilbert H. Glaser, m.d., the 
founding chair of the Depart¬ 
ment of Neurology, died on 
January 21, 2012, at the Hospital 
of Saint Raphael in New Haven. 
He was 91. Glaser was a professor 
emeritus at the School of Medi¬ 
cine and considered an interna¬ 
tional authority on epilepsy. He 
is widely acknowledged as one of 
the founders of neurology as an 
independent discipline. 
Glaser received his under¬ 
graduate and medical degrees 
from Columbia University and 
trained at the Neurological 
Institute of Columbia Univer¬ 
sity. From 1946 through 1948, 
he served as director of the 
electroencephalography labora¬ 
tory at Brooke Army Medical 
Center in Texas. Glaser was an 
assistant attending and chief 
of the neurology clinic at the 
Neurology Institute in New York 
before moving to Yale in 1952 as 
assistant professor and head of 
the Section of Neurology, then a 
division within the Department 
of Medicine. He was appointed 
a full professor in 1963. Neurol¬ 
ogy became a free-standing 
department in 1971, with Glaser 
serving as its chair until his 
semiretirement in 1986. He 
retired fully in 1991. 
John P. Hayslett, m.d., hs ’66, 
FW ’67, professor emeritus of 
medicine and founding chief of 
the Section of Nephrology, died 
at Connecticut Hospice on April 
15. He was 77. Hayslett earned 
his medical degree in i960 from 
Cornell University Medical Col¬ 
lege. He came to Yale in 1960 and 
served in administrative roles, 
including director of the Dana 
Medical Clinic, president of the 
medical staff of Yale-New Haven 
Hospital, and medical director of 
the Yale Physician Associate (pa) 
Program. A tireless advocate of 
the PA profession, he revised the 
curriculum to allow the program 
to confer the master of medical 
sciences degree and advised 
students and faculty on their 
research projects. An inpatient 
medicine team at the VA Con¬ 
necticut Healthcare System’s 
West Haven campus was named 
in his honor in 2011 in recogni¬ 
tion of his outstanding service 
as a clinician and educator at 
that institution. 
Howard M. Spiro, m.d., the 
founding section chief of gastro¬ 
enterology in the Department of 
Internal Medicine and founding 
director of the Yale Program for 
Humanities in Medicine, died on 
March 11 in Branford, Conn., after 
a brief illness. He was 87. 
Spiro graduated from Har¬ 
vard College in 1944 and received 
his medical degree from Harvard 
in 1947. After completing an 
internship at the Peter Bent 
Brigham Hospital (now Brigham 
and Women’s Hospital), he re¬ 
mained there to pursue research, 
primarily on gastrointestinal 
physiology. After serving for two 
years in the military as chief of 
gastroenterology at Madigan 
Army Hospital in Tacoma, Wash., 
he returned to Boston to spend 
two years in research at Massa¬ 
chusetts General Hospital. 
Spiro was recruited to Yale 
in 1955 by Paul Beeson, m.d., 
to establish the first full-time 
academic gastroenterology 
section at Yale. His ambition 
was to establish a nationally 
recognized academic research 
section of gastroenterology and 
to incorporate both medical and 
psychological concerns in the 
teaching and provision of patient 
care. Spiro was well-known for 
his strong dedication to patients 
and bedside teaching. 
In 1965 he established the 
Yale-Affiliated Gastroenterology 
Program, an educational col¬ 
laboration among fellowship 
training programs in south- 
central Connecticut. He was a 
prolific writer, with publications 
ranging from his textbook Clinical 
Gastroenterology and scien¬ 
tific peer-reviewed papers to the 
popular books Doctors, Patients 
and Placebos; When Doctors Get 
Sick; and Facing Death. Spiro, 
along with Enid Peschel, ph.d., a 
medical researcher and educator, 
established the Yale Program for 
Humanities in Medicine in 1982. 
Students, faculty, and members 
of the public would gather weekly 
to sip sherry and listen to speak¬ 
ers address topics breaching the 
boundaries between medicine 
and the humanities, including art’ 
history, music, and politics. 
Raymond S. Yesner, m.d., pro¬ 
fessor emeritus of pathology, 
former associate dean of the 
School of Medicine, and senior 
research scientist, died at his 
home in Woodbridge, Conn., on 
February 8. He was 97. 
Yesner’s education began 
in a one-room schoolhouse 
in Wellington, Maine; he later 
attended P.S. 19 in New York Cit} 
before high school at Boston 
Latin. At i6, he graduated with 
an academic scholarship to Har¬ 
vard College. He chose Tufts for' 
his medical education and com¬ 
pleted his internship and resi¬ 
dency at the Beth Israel Hospital 
in Boston. Yesner joined the 
School of Medicine in 1947 as am 
assistant professor and became; 
chief of laboratory medicine at 
the VA Hospital in West Haven 
in 1953. He served as associate 
dean of the School of Medicine 
from 1968 to 1974. In 1969 he 
was promoted to chief of staff 
of the VA. He served as director 
of the electron microscope labo 
ratory there until he became the 
director of the autopsy service 
at Yale. Yesner made significant 
contributions to the under¬ 
standing of lung tumors and 
their pathology. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine 
I Church Street, Suite 300, 
New Flaven, CT 06510, or via e-mai 
to claire.bessinger@yale.edu 
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2 Letters 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or fewer) and 
news items to Yale Medicine, 
1 Church Street, Suite 300, 
New Haven, CT 06510, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length and content. 
VISIT US ON THE WEB 
Our new website is up and 
running—and the feedback has 
been wonderful! Visit us 
at yalemedicine.yale.edu and 
peruse the newest issue or 
issues going back to 1998. 
How words can give 
comfort 
It’s Day Two of the Hospital of 
Saint Raphael becoming part of 
Yale-New Haven Hospital. Since 
I came to the United States of 
America five years ago, New 
Haven has been my home and 
Saint Raphael’s, my family. I walk 
in—it’s the same building, mostly 
the same people, the same rou¬ 
tine, but also there is a distinct 
difference. New id badges, new 
e-mail ids, and new policies; 
the familiar place is suddenly a 
bit alien. I am on the medicine 
consult service; and in between 
doing a preoperative evaluation 
and placing an ng tube in an 
anorexic patient, I find myself 
wandering toward the library. 
There are a myriad of things to 
read, especially in the journal 
section. My eyes fall on a colorful 
Journal on the lowermost shelf 
of the rack. I pick it up—it’s Yale 
Medicine, Winter 2012.1 had never 
noticed it before. As I browsed 
through its 33 pages, I found 
myself reading every page of it 
and actually enjoying it. 
The article that caught my 
attention was "Doctors Who 
Write,” by Cathy Shufro. That 
article struck a chord with me, 
made me happy, and somehow 
made me feel like I belong. It is 
amazing to see how words can 
give comfort. In this time of tran¬ 
sition from the Hospital of Saint 
Raphael to Yale, where there was 
a sense of unfamiliarity, this arti¬ 
cle made me feel that there are 
people at Yale who enjoy what I 
enjoy—writing! I felt like some 
of the things said by Richard 
Selzer and Dagan Coppock came 
right out of my head—I had 
thought them but never said 
them. It felt calming. This is 
exactly what I needed today. I 
wanted to share my experience 
with you and thank you, for you 
have made me feel excited and 
hopeful about my Day Two—and 
my upcoming days as a part of 
Yale-New Haven Hospital. 
Sofia Siddiqui, m.d. 
Clinician-educator 
Department of Medicine 
Yale-New Haven Hospital 
Tribute to Arthur Ebbert 
rekindles memories 
What a wonderful tribute to 
Arthur Ebbert in the Autumn 
2012 edition of Yale Medicine] 
["A gentle man,” Yale Medicine, 
Autumn 2012] Art was very spe¬ 
cial. I met him prior to my arrival 
at Yale for my surgical resi¬ 
dency in July 1970. As did Art, I 
graduated from the University 
of Virginia (uva) undergradu¬ 
ate and medical schools, and 
had met Art at uva alumni 
events while still a student 
in Charlottesville. His love for 
uva and his adopted Yale were 
pervasive, and I enjoyed seeing 
him throughout my six years as 
a house officer in New Haven. 
The article in Yale Medicine por¬ 
trayed him beautifully and cap¬ 
tured his humility and grace. 
I also want to thank you for 
the cover picture showing the 
aerial view of the Medical School 
campus. While I was a house 
officer, my wife and I lived in a 
house at 796 Howard Avenue 
and our “Memorial Unit” new¬ 
born daughter spent the first 
six months in that house. When 
these buildings were torn down 
in later years to make room for 
new construction, I was sad¬ 
dened that I had no pictorial 
remembrance of that old neigh¬ 
borhood on Howard Avenue. 
How wonderful it was to look at 
the cover honoring Art Ebbert 
and to view that house that 
was so important to me and my 
family in the mid-1970s. You see, 
having Art Ebbert at Yale and 
in my life continues to give me 
such rich memories. 
Frederick L "Rick” 
Creene, m.d., hs ’76 
Clinical Professor of Surgery 
UNC School of Medicine 
Chapel Hill, N.C. 
Great cover and great story 
about a great man!! I have keen 
memories of Dr. Ebbert’s arrival 
at Yale in 1953 during my sec¬ 
ond year. My wife Rose was a 
secretary in the Yale Diagnostic 
Clinic for Dr. Beeson and she 
met Dr. Ebbert before I did. Her 
initial comment was "What 
a charming man!” He indeed 
was a charm for the School of 
Medicine with his 34 years of 
devoted service. 
William Narva, m.d. 's6 
Rear Admiral, U.S. Navy (Ret.) 
Los Angeles, Calif. 
Photo dating incorrect 
As usual, Yale Medicine is splen¬ 
did. I well recall Arthur Ebbert, 
M.D., and you have nicely and 
aptly summarized his key role at 
the school. 
I might point out the incor¬ 
rect dating of the full-page 
spread aerial photograph of the 
medical school campus on the 
second and third pages. It shows 
the medical school on Cedar 
Street, the hospital, and a bit of 
what was then named Grace- 
New Haven Hospital. However, 
Harkness Hall, the residence 
for medical students, is missing 
from the photograph—which 
shows a large empty field next 
to the pediatric section of the 
school. I lived in Harkness for 
four years beginning in 1956, 
the first year it opened. Since 
the caption says, “as it appeared 
during the 1960s,” that is incor¬ 
rect. Harkness was in place in 
the 1960s and there was no 
empty field between Grace- 
New Haven Hospital and the 
medical school. 
Thank you for publishing the 
photograph, which reminded 
me of a glorious four years—the 
most important time of my life. 
Malin Dollinger, m.d. ’60 
Rancho Palos Verdes, Calif. 
FROM THE EDITOR 
Many alumni wrote to point out 
the incorrect dating of the photo¬ 
graph mentioned above. As best 
we can determine, the photo¬ 
graph was taken about 1954. 
CORRECTION 
The End Note in the Autumn 
2012 issue of Yale Medicine 
incorrectly identified the student 
in the photograph. Her correct 
name is Lara Rosenbaum. 
We regret these errors. 
i 
starting point 3 
No shortage of breaking news 
People often ask how we come up with ideas for the articles that appear in Yale Medicine. 
There’s no easy answer to that question. Ideas might come from a chance conversation, a tip 
from a scientist or clinician, or a writer’s familiarity with a beat. We observe, discern patterns, 
develop a hypothesis, then look for information to confirm or deny that hypothesis—like scien¬ 
tists, we sometimes find ourselves following a path that leads nowhere. For this issue we had 
an abundance of important breaking news stories with significance not just for the medical 
school, but for the university and New Haven. 
In August we learned that President Richard C. Levin would be stepping down after 
20 years at the helm of the University. Two months later the Yale Corporation unanimously 
chose Provost Peter Salovey as his successor. 
In September came the news, long anticipated, of Yale-New Haven Hospital’s acquisi¬ 
tion of the Hospital of Saint Raphael. Over the years we’ve covered the history of medical 
care in New Haven and the evolution of the city’s various hospitals through mergers and 
acquisitions. Now only one hospital remains in the city. 
And both feature stories attest to a new age in medicine. The encode project, in which 
Yale faculty played a key role, has advanced knowledge of those regions of the genome deri¬ 
sively called junk dna, even though it’s been known for years that they are vibrant and active 
areas of the genome. And the School of Medicine and Yale-New Haven Hospital have begun 
to implement an electronic medical record (emr) format that is expected to revolutionize not 
just the practice of medicine but medical research as well. 
Finally, in our student pages we explore a phenomenon we’ve been observing for a few 
years now—more and more students are opting to stay on for a fifth year at the School of 
Medicine. The reasons why may surprise you. 
John Curtis 
Editor 
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4 chronicle news from cedar street 
Levin’s legacy endures 
at the School of 
Medicine 
President Richard C. Levin steps down 
after 20 years. Provost Peter Salovey 
will take the helm in June. 
When Richard C. Levin took office as 
president of Yale in 1993, the univer¬ 
sity faced several challenges. Among 
them were an infrastructure desper¬ 
ately in need of repairs and renova¬ 
tions, high crime rates in New Haven 
that made it hard to recruit students 
and faculty, and talk of eliminating 
entire departments because of a bud¬ 
get crisis. While these pressing issues 
needed to be addressed. Levin also 
held a vision of Yale as a truly global 
institution. And preeminence in sci¬ 
ence and medicine was essential to 
reaching that goal. 
“We are among the handful of cen¬ 
ters in the nation and the world that 
have assumed leadership in the basic 
biological sciences, the understand¬ 
ing of human health, the treatment of 
human disease, and the education of 
scientists and medical practitioners,” 
Levin said in a 1996 speech. “As our 
fourth century begins, we must aspire 
to continuing leadership in the life sci¬ 
ences, which hold so much promise 
for human health and our nation’s 
future prosperity.” 
In August 2012 Levin announced 
that after 20 years of leading the 
university, he would step down at the 
end of the current academic year. (In 
November, the Yale Corporation, in a 
unanimous vote, named Provost Peter 
Salovey, ph.d. ’86, to succeed him.) 
Levin noted in a message to the Yale 
community that the time is right for a 
change in leadership. The university, 
he said, is in a much stronger posi¬ 
tion than it was 20 years ago. Many 
institutional goals—the five-year Yale 
Tomorrow campaign; renovations of 
the residential colleges; managing the 
2008 financial crisis; funding for the 
new School of Management campus; 
achieving critical mass on the West 
Campus; and launching Yale-NUS 
College in Singapore—have been 
reached or are close to realization. 
At the School of Medicine Levin 
has left a legacy of investments in 
new research buildings as well as 
recruitments of leading scientists and 
physicians that have strengthened its 
clinical, educational, and research mis¬ 
sions. In January 2000 Yale announced 
an unprecedented $500 million invest¬ 
ment in science and engineering. Less 
than a month later Levin announced an 
additional $500 million for the School 
of Medicine over the coming decade. 
“He had a very clear vision that 
science was critical to the future of 
Yale University,” said Dean Robert 
J. Alpern, m.d.. Ensign Professor of 
5 
OPPOSITE Richard Levin (right) announced in 
August that he would step down after 20 years 
as president of Yale. Peter Salovey (left) was 
named to succeed him. 
Medicine, who came to Yale in 2004. 
“Rick felt that medicine was already 
strong and that with the right invest¬ 
ments it could become really strong. 
He was committed to having a great 
medical school and was very good at 
tying his decisions to that vision.” 
Those investments created the 
infrastructure for modern biomedi¬ 
cal science—new laboratories, core 
technology facilities, and high-tech 
teaching centers. The opening of two 
new buildings—the 457,000-square- 
foot Anlyan Center for Medical 
Research and Education and the 
i20,ooo-square-foot Amistad Street 
Building—freed older spaces for new 
uses, and permitted reorganization 
and renovation across the medical 
campus. New space led to an increase 
in medical school faculty, which in 
turn led to an increase in the school’s 
annual grant funding over the same 
time period, from about $140 mil¬ 
lion to about $540 million. Support 
of medical research has had a spinoff 
effect, nurturing a biotech industry 
in New Haven, which is now home to 
several companies formed on the basis 
of discoveries made in Yale labs. 
In another advance for scientific 
and medical research, the university 
in 2007 purchased the former Bayer 
Healthcare North American pharma¬ 
ceutical headquarters, now known as 
West Campus, adding more than 1.5 
million square feet of building space 
to the university, including 450,000 
square feet of laboratory space. Rather 
than use these facilities as spillover 
space for existing programs. Levin 
believed that the campus should pro¬ 
vide opportunities for innovative bio¬ 
medical and clinical science programs 
that cross disciplinary boundaries. “I 
remember him saying that this should 
not be just more of the same,” Alpern 
said. “It should allow us to do some¬ 
thing different and distinctive.” The 
West Campus is now home to new 
biomedical research centers as well as 
core technology facilities. “This has 
transformative potential, frankly, only 
some of which we can envision today,” 
Levin reflected when planning began 
for the West Campus. “We’ve given our 
successors an opportunity to dream in 
ways we can’t imagine today.” 
In selecting Salovey to succeed 
Levin, members of the Yale Corporation 
cited his leadership skills and his knowl¬ 
edge of Yale, as well as his own scholarly 
accomplishments. Salovey, the Chris 
Argyris Professor of Psychology, has also 
served as chair of psychology, dean of 
Yale College, and dean of the Graduate 
School of Arts and Sciences; and has 
longstanding links to the schools of 
medicine and public health. In 1997 he 
became the first deputy director of the 
Center for Interdisciplinary Research on 
AIDS. He is well known for his research 
on the concept of emotional intel¬ 
ligence and studies of effective health 
communications. 
“While Rick Levin will be missed 
greatly, Peter Salovey will be an excel¬ 
lent successor,” Alpern said. “I am 
confident that he will continue Rick’s 
commitment to science and medicine, 
while defining his own specific agenda 
and implementation plan.” 
—Marc Wortman and John Curtis 
GENDER BIAS PERSISTS 
“Whenever I give a talk that mentions past 
findings of implicit gender bias in hiring, 
inevitably a scientist will say, ‘That can’t hap¬ 
pen in our labs because we are trained to be 
objective,”’ said Jo Handelsman, ph.d., the 
Frederick Phineas Rose Professor of Molecular, 
Cellular and Developmental Biology, and a 
Howard Hughes Medical Institute professor. 
She tested that belief among colleagues 
at several research-intensive institutions 
who received the same application—osten¬ 
sibly from an undergraduate applying for a 
job as lab manager—which was randomly 
assigned a male or female name. Scientists 
of either sex were more likely to hire the 
man than the woman, more willing to men¬ 
tor him, and willing to pay him $4,000 more. 
Handelsman published her findings on 
Sept. 24 in the Proceedings of the National 
Academy of Sciences. 
Regarding her colleagues’ insistence that 
gender bias couldn’t happen in their labs, 
said Handelsman, “I had hoped that they 
were right.” 
—John Curtis 
LOTTERY TICKETS MAY POSE RISK 
Youngsters who receive instant lottery tickets 
as gifts tend to start gambling earlier in life, 
perhaps putting them at risk for gambling dis¬ 
orders as adults, Yale researchers reported on 
Sept. 19 in the journal Adolescent Health. 
A survey of about 2,000 Connecticut high 
school students found that children and ado¬ 
lescents who received scratch lottery tickets 
tend to have more permissive attitudes 
about gambling than those who did not re¬ 
ceive such gifts. Researchers also reported 
an association between the age of gambling 
onset and the severity of problem gambling 
among those who received lottery tickets. 
"Our research suggests that family mem¬ 
bers and friends should consider the possible 
negative impact of giving children or ado¬ 
lescents lottery tickets as gifts,” said Marc 
Potenza, ph.d.’93, m.d. ’94, HS ’98, fw ’99, 
professor of psychiatry, neurobiology and 
child study, and senior author of the research. 
—J.C. 
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6 chronicle NEWS FROM CEDAR STREET 
Hospital of Saint Raphael 
becomes a new campus of 
Yale-New Haven Hospital 
About three years ago Mama 
Borgstrom, m.p.h. ’79, president and 
CEO of Yale-New Haven Hospital 
(ynhh), and Christopher O’Connor, 
then the newly appointed president of 
the Hospital of Saint Raphael (hsr), 
began meeting over lunch to explore 
synergies that would allow the two 
hospitals to provide the best possible 
health care to the New Haven commu¬ 
nity. Both executives saw advantages 
in collaboration over competition. 
“We talked about ways we could work 
together,” Borgstrom said. 
Both CEOS, however, had other con¬ 
cerns on their minds. More than 90 per¬ 
cent of ynhh’s beds were occupied, 
straining its capacity. The only place to 
build was upward, but a new patient 
tower would cost about $650 million 
and take up to seven years to construct. 
Six blocks away, hsr was spending more 
than it was taking in—about 70 per¬ 
cent of its patients were on Medicaid or 
Medicare. Over time the two ceos came 
to recognize that a partnership made 
sense for both institutions. 
On September ii, O’Connor and 
Borgstrom, surrounded by staff from 
both hospitals, elected officials, New 
Haven’s mayor, and representatives of 
the Sisters of Charity of St. Elizabeth, 
signed a document that made official 
ynhh’s purchase of Saint Raphael’s. 
At one minute after midnight the next 
day, HSR became the Saint Raphael 
Campus (SRC) of ynhh, which 
absorbed 3,400 of its employees. 
The solution for hsr, said 
O’Connor, “was to partner with a 
hospital that was already well known 
to our staff and physicians. It will 
drive efficiency and effective use of 
medical resources. It will address 
financial challenges we face while 
providing an innovative opportunity 
to invest in services right here in 
New Haven.” 
“We believe that as one unified hos¬ 
pital, we’ll be able to enhance access to 
high-quality health care resources in a 
more cost-effective manner,” Borgstrom 
said. “This integration will be critical to 
meeting the extraordinary health care 
challenges that lie ahead.” 
To judge by those present at the 
ceremony in a ynhh auditorium, the 
acquisition is a win-win for all. Under 
the terms of the agreement ynhh paid 
$160 million for hsr. With only 300 
of hsr’s 511 beds occupied, ynhh has 
more room for patients. Most jobs at 
HSR will be preserved—though about 
200 layoffs, mostly in administration, 
are expected. The agreement main¬ 
tains hsr’s Catholic values and tradi¬ 
tions, which have been in place since it 
was founded by the Sisters of Charity 
in 1907. The transaction turned ynhh 
into one of the largest hospitals in the 
country, with 1,519 beds. 
“As we conducted our delibera¬ 
tions as a board, it became clear that 
the integration of these two hospitals 
would provide a unique chance to 
reshape the delivery of health care in 
the state,” said Joseph Crespo, chair 
of the board of ynhh. “Not only that, 
with the wave of health care reform 
that is sweeping our nation, we felt 
that this could serve as a model for the 
nation as well.” 
Mayor John DeStefano Jr. cited the 
importance of the two hospitals and the 
School of Medicine to the city—New 
Haven has 11,600 jobs in medicine as 
well as 42 bioscience companies. “The 
combination of medical school and 
clinical practice of the hospital is essen¬ 
tial to not just the city’s economic well¬ 
being, but to the state,” he said. 
But for the staffs of both hospi¬ 
tals, the heavy lifting was just begin¬ 
ning as they integrated two hospitals 
with different ways of doing things. 
Decisions to be made ranged from the 
mundane—where to find bed linens 
and cafeteria trays—to such complex 
topics as new reporting relationships 
for medical staff, media policies for 
communications officers, and senior¬ 
ity and job descriptions. Also on the 
agenda is expanding the planned 
implementation of an electronic medi¬ 
cal records system at ynhh to cover 
HSR. In the runup to the acquisition 
more than 1,300 policies and proce¬ 
dures were standardized. 
At the time of the signing it was 
not yet clear which departments would 
be headquartered in which hospital, 
though emergency departments and 
intensive care units will remain open 
in both. A command center was set 
up at SRC to answer questions that 
might arise. The center also ensured 
that such essential services as patient 
care, admissions, medical records, 
purchasing and supplies, support 
services, information technology and 
telephones, and payroll and billing will 
continue without interruption. 
Aiding in the transition, noted 
O’Connor, who became executive vice 
president and coo of the Yale New 
Haven Health System, are strong ties 
between the two hospitals. About 
80 percent of hsr’s physicians were 
SMOKING BANS AND ALCOHOL 
already accredited at ynhh. The chief of 
staff and senior vice president for medi¬ 
cal affairs at ynhh, Peter N. Herbert, 
M.D. ’67, had previously served as chair 
of the department of medicine at hsr. 
Alan Kliger, m.d., a senior vice presi¬ 
dent at Saint Raphael, has also worked 
Mama Borgstrom and Christopher O’Connor 
signed the agreement that sealed Yale-New 
Haven Hospital’s purchase of the Hospital of 
Saint Raphael. 
at Yale, where he served on the clinical 
faculty and is now a vice president and 
chief quality officer of the Yale New 
Haven Health System. 
—John Curtis 
Banning smoking in bars and restaurants 
can cut down not only on tobacco-related 
illnesses but also on alcohol abuse, accord¬ 
ing to a study by Yale researchers. 
Using data from a national alcohol sur¬ 
vey, the Yale researchers compared remis¬ 
sion rates of individuals with alcohol use 
disorder (aud) in states that enacted smok¬ 
ing bans in establishments that serve alco¬ 
hol with rates in states without such bans. 
In the states where smoking bans were in 
effect, there was an n percent increase in 
remission of aud. States with public drink¬ 
ing bans also had a lower rate of new cases 
of AUD—7 percent versus n percent in 
states without bans. These changes seemed 
to be most pronounced in men and young 
people as well as in smokers. 
“We wanted to see if separating smok¬ 
ing and drinking in public drinking venues 
changed drinking behavior,’’ said Sherry 
McKee, PH.D., associate professor of psy¬ 
chiatry and senior author of the study pub¬ 
lished in September in the journal Drug and 
Alcohol Dependence. “It does.” 
—John Curtis 
ENZYMES AT WORK 
Yale scientists have captured views of an 
enzyme’s working parts that show the opera¬ 
tion of its chemical mechanisms. 
“We caught the intron in action,” said 
principal investigator Anna Pyle, ph.d., the 
William Edward Gilbert Professor of Molecular, 
Cellular, and Developmental Biology and pro¬ 
fessor of chemistry. Pyle’s lab reported in 
the October 26 issue of the Journal Cell on 
14 crystal structures that appear at different 
stages of catalysis in a group II intron—a ribo- 
zyme involved in rna splicing. 
One of rna’s major functions is to copy 
genetic information so that ribosomes, 
the cellular protein factories, can decode 
it. An early step in that process is splicing— 
breaking rna apart and recombining its 
pieces to produce a protein. 
“Whenever splicing gets messed up, you’ll 
find a disease that results,” said Pyle, a 
Howard Hughes Medical Institute investiga¬ 
tor. “Until now we haven’t really understood 
the splicing reaction chemically.” 
—J.C. 
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8 Books & ideas 
Return to poetry 
Cardiologist Barry Zaret composes poems about a life in 
medicine, dusk in the Berkshires, and his late wife. 
Every time he updates Clinical Nuclear Cardiology, the text¬ 
book he co-wrote, Barry L. Zaret, m.d., adds new material. 
But when he sits down to revise a poem, he does the opposite. 
“You start big and you get smaller and smaller,” says 
Zaret, the Robert W. Berliner Professor Emeritus of Medicine, 
who was Yale’s long¬ 
time chief of cardiovas¬ 
cular medicine until 
2004. “It has to have 
the right cadence, and 
there’s got to be an 
economy of words. It’s 
amazing, the time you 
can spend on simple 
changes.” He reworks 
the poem over time. 
“You need to let the 
poem mature.” 
Zaret’s first book 
of poetry. Journeys, 
touches on themes 
from the writer’s 
Jewish heritage and 
a life in medicine, and on the beauty of Massachusetts’ 
Berkshires. Nine poems in a section titled “In the Land of 
Cancer” tell the story of his wife Myrna’s illness and death 
from cancer in 2010, and of the grief and renewal that fol¬ 
lowed. Among Zaret’s favorite poems in the collection are 
“My father’s Kosher Butcher Shop”; a description of dusk 
called “Berkshire Light”; and “Paper Plate Pesach,” about his 
first Passover without Myrna after 47 years of marriage. 
Until Zaret returned to poetry eight years ago, he had 
not written a poem since contributing to his Far Rockaway 
High School yearbook in 1958. In recent years, he’s been set¬ 
ting his alarm for 4:30 a.m. so he can write before heading 
down to the School of Medicine. Weekends, he paints at his 
house in the Berkshires. His oil painting, “The Road from 
St. Remy to Arles,” appears on the cover of Journeys. 
—Cathy Shufro 
The Great Manchurian Plague 
of 1910-1911: The Geopolitics of 
an Epidemic Disease 
by William C. Summers, m.d., 
PH.D., professor of therapeutic 
radiology, of history of medicine 
and science, and of molecular 
biophysics and biochemistry 
(Yale University Press) In this 
case study, the author first sets 
the scene in Manchuria, then 
describes the epidemic that 
began in 1910 when plague was 
transmitted from marmots to 
humans and killed as many as 
60,000 people in less than a 
year. Summers examines the 
actions and interactions of 
the multinational doctors, the 
politicians from three countries, 
and the ordinary citizens who 
confronted the outbreak. 
Casebook of Interpersonal 
Psychotherapy 
edited by John C. Markowitz, 
M.D., and Myrna M. Weissman, 
PH.D. ’74 (Oxford University 
Press) This book addresses the 
use of interpersonal psycho¬ 
therapy (ipt), a modality that 
has been developed to build 
social skills as well as relieve 
psychiatric symptoms on the un¬ 
derstanding that interpersonal 
problems contribute to many 
mental disorders. The authors 
provide detailed case studies 
that illustrate how psychothera¬ 
pists use IPT to treat patients 
with a range of conditions and 
complications that include 
mood, anxiety, eating, and 
personality disorders. The book 
examines different contexts for 
practicing ipt, including group 
therapy, inpatient settings, and 
telephone therapy. 
Becoming a Consummate 
Clinician: What Every Student, 
House Officer and Hospital 
Practitioner Needs to Know 
edited by Ary L. Goldberger, 
M.D. ’74, HS ’77, and Zachary D. 
Goldberger, m.d. ’04 (Wiley- 
Blackwell) In an era in which 
the learning curve in medicine 
is increasingly steep, this text 
features real-world examples 
in hospital-based medicine to 
help both practitioners and 
students improve their clinical 
skills and learn to communicate 
more effectively as they assess, 
integrate, and present clinical 
information. The authors offer 
strategies for attending physi¬ 
cians to help their trainees de¬ 
velop critical thinking skills. The 
book is available in an online 
edition as well as in print. 
A Diffident Doctor 
by Hugh L. Moffet, m.d. '57 
(Two Harbors Press) The 
author’s personal story presents 
a snapshot of history, culture, 
politics, and major events during 
the time span from his early 
childhood in Illinois in the 1930s 
to medical school at Yale, a pedi¬ 
atrics practice in Wisconsin, and 
retirement in Nevada beginning 
in 1998. The author’s presentation 
of American medical practice over 
the past 50-plus years reveals 
changes in diagnostic methods 
and medications—as well as in 
infectious diseases themselves. 
Biomental Child Development: 
Perspectives on Psychology and 
Parenting 
by Frank John Ninivaggi, m.d., 
Fw ’77, assistant clinical profes¬ 
sor in the Child Study Center 
and of psychiatry (Rowman 
& Littlefield Publishers) The 
biomental perspective provides 
on campus 9 
and_ 
FORTUNE 
Cultural Competency 
for the Health 
Professional 
\ a holistic view of child develop- 
^ merit that incorporates biologi- 
t cal and emotional dimensions, 
i The book provides parents 
■ with a basic understanding of 
j normal psychological develop¬ 
ment based on current findings 
from psychology, psychiatry, 
and neuroscience. The author 
maintains that positive parent¬ 
ing encompasses diverse styles 
arising from differences among 
both children and caregivers. 
Parents, grandparents, and 
other caregivers can use this 
'guide to achieve a working 
i understanding of child develop¬ 
ment at each stage in the young 
person’s life. 
2ist Century Global Mental Health 
by Eliot Sorel, m.d., fw ’75 
(Jones & Bartlett Learning) This 
textbook examines the subject 
of global mental health, its inte¬ 
gration with public health and 
primary care, the progress to date, 
and the challenges that remain. 
The book addresses the increasing 
prevalence of mental disorders, 
the fragmentation of health 
systems, the pervasive stigma of 
mental illness, and the persis¬ 
tence of worldwide discrimina¬ 
tion against the mentally ill. 
Lifetime and Fortune: A 20th 
Century Neurosurgeon’s Journey 
by Edward R. Lang, m.d. ’60 
(Xlibris Corporation) Lang is a 
retired neurosurgeon born in the 
Hyde Park neighborhood of Chi¬ 
cago’s South Side. In this auto¬ 
biography, the author describes 
his childhood, college years, his 
medical education and residency, 
and his later career. He also gives 
an account of extensive travels 
to the British isles, Europe, Scan¬ 
dinavia, and China. 
Cultural Competency for the 
Health Professional 
by Patti R. Rose, m.p.h. ’85 
(Jones & Bartlett Learning) This 
text underlines the importance 
of cultural competency for 
allied health professionals, and 
describes the process of assess¬ 
ment, training, and evaluation, 
it provides students in the 
health professions with impor¬ 
tant information about cultural 
competency as well as practical 
insights in applying this knowl¬ 
edge in day-to-day work with 
patients from different cultural 
backgrounds. 
Smith's Patient-Centered 
Interviewing: An Evidence- 
Based Method, 3rd ed. 
by Auguste H. Fortin, m.d., 
associate professor of medicine; 
Francesca C. Dwamena, m.d.; 
Richard M. Frankel, ph.d.; and 
Robert C. Smith, m.d. (McGraw- 
Hill Professional) This text has 
been updated and expanded 
by a multidisciplinary team of 
medical experts, and presents 
a step-by-step method for 
mastering every aspect of the 
medical interview. The book dis¬ 
cusses ways to obtain accurate 
biomedical facts from patients 
as well as critical personal, so¬ 
cial, and emotional information. 
The descriptions above are based 
on information from the publishers. 
SEND NOTICES OF NEW BOOKS TO 
Cheryl Violante, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via 
e-mail to cheryl.violante(a)yale.edu 
The mystery of Hiv 
Only five men were listed in the 
first official recognition of what 
would become a worldwide 
pandemic: five gay men from 
Los Angeles with a rare pneu¬ 
monia who were described in 
the Centers for Disease Control 
and Prevention’s (CDC) Morbidity 
and Mortality Weekly Report 
of June 5,1981. The first cause 
suspected was "poppers,” nitrite 
inhalants popular with gay men. 
Harold W. Jaffe, m.d., told 
the story of solving the “medi¬ 
cal mystery” that was hiv at the 
Beaumont Medical Club Lecture 
on October 26. The associate 
director of science at the CDC 
described working as an epidemic 
intelligence officer on a disorder 
that did not yet have a name. 
Through detective work 
that included tracing webs of 
sexual partners, Jaffe and his 
colleagues recognized that the 
illness was spread through sex¬ 
ual contact and contaminated 
blood products. 
"Sometimes we think of pub¬ 
lic health as kind of mechanical 
and dry, but it isn’t,” said Jaffe, 
who also screened depictions of 
himself in And the Band Played 
On, a 1993 movie about the aids 
crisis. The story of aids, Jaffe said, 
shows the "power of the epide¬ 
miological method to understand 
and control a disease even before 
we knew the cause.” 
—Cathy Shufro 
Evidence in our language 
Evidence of individual identity 
almost as incriminating as a 
fingerprint can be gleaned from 
how we use language. 
"A lot of us litter our writ¬ 
ings, our texts, our e-mails, 
and our letters with a little bit 
of ourselves,” said author and 
storyteller Jack Hitt. As forensic 
linguistics has become more 
accepted in American court¬ 
rooms, he said, testimony from 
linguists has sealed both convic¬ 
tions and acquittals. Hitt, who 
gave the James Kenney Lecture 
in September for the Program 
for Humanities in Medicine, 
wrote an article about the topic 
for The New Yorker in July. 
In one case, although the 
physical evidence was not over¬ 
whelming, a Jury found a man 
guilty of killing his family based 
largely on the linguistic con¬ 
structions in anonymous threat¬ 
ening e-mails sent before the 
murders. Consistently misplaced 
apostrophes and fused spellings 
(“goodtime”) were identical to 
material that the suspect was 
known to have written. 
Forensic linguists look "for 
any kind of unconscious pat¬ 
tern,” Hitt said. They also listen 
to voice recordings for "the 
beats in that sentence and the 
pause in that comma.” 
Experts have delivered a 
split verdict. "Half the body of 
forensic linguists doesn’t think 
that forensic linguistics should 
be involved in criminal cases,” 
Hitt said. 
—John Dillon 
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The Civil War Wounded 
in Photographs 
By Natalie Villacorta 
In this 1864 photo of a ward at Harewood Army 
Hospital in Washington, D.C., wounded soldiers 
lie under mosquito nets over their beds. Reed 
Bontecou, M.D., the hospital’s head surgeon, 
commissioned photographs of his patients to 
document surgical practices. Ninety-eight of those 
photographs found their way to the School of 
Medicine’s Medical/Historical Library. 
0 
i 
i’l 
ri.i 
Seated in profile, the young men pose 
as they would for family portraits. On 
closer inspection of the oval gold-lined 
frames, the serene faces are scarred, bald 
spots divided by deep canyon-like cuts, 
shoulders swollen around bullet craters. 
These are the “after” photos, taken 
after the men had left their homes to 
fight for the Union or the Confederacy, 
and after they were wounded, carrying 
the scars of the American Civil War 
for the rest of their lives. 
“This is one moment in this person’s 
life,” said Heidi Knoblauch, a doctoral 
candidate in the History of Medicine 
program, who is examining Yale’s col¬ 
lection of 98 photographs taken during 
the Civil War at Harewood Army 
Hospital in Washington, D.C. “To 
piece together what happens after this 
moment, how people live with their 
wounds afterwards, how that patient 
experience either carries with them or 
doesn’t carry with them, has been a 
motivating factor for me.” 
Knoblauch’s photo analysis will 
comprise one chapter in her dissertation 
on the use of photography in American 
medical practice from 1839 to the eve of 
World War II. 
Locked away in the stacks of the 
Cushing/Whitney Medical Library, 
these Civil War photographs are 
one of four collections of enlarged 
photographs commissioned by the 
head surgeon at Harewood, Reed 
Bontecou, m.d., a pioneer in the art 
of clinical photography. Yale’s collec¬ 
tion is now used as a teaching tool 
in several classes, including “Photo 
Memory in the U.S.,” taught by Laura 
Wexler, ph.d., professor of American 
Studies and Women’s, Gender, and 
Sexuality Studies. 
Knoblauch noticed that most of 
the scholarship on the photos focuses 
on Bontecou and the practice of sur¬ 
gery rather than on the patients he 
photographed. “By focusing on him, 
we’ve kind of lost the patients’ narra¬ 
tives,” Knoblauch said. Investigating 
the lives of the men in Bontecou’s 
photos is a way for Knoblauch to enter 
into that patient experience, she said. 
“Being wounded gave them a record; it 
attached a visual image to their name, 
something that a lot of Civil War sol¬ 
diers did not get,” she said. 
On the backs of the photos are short 
biographies of the soldiers—both Union 
and Confederate—containing personal 
and medical information. Knoblauch 
also searched census data and military 
and pension records; she will use the 
individual stories to tell the larger story 
of what it was like to be a wounded Civil 
War veteran. 
Robert A. Butcher, a 21-year-old 
laborer from Philadelphia who served 
in an infantry company, suffered two 
saber cuts to his skull during a battle 
at Burke’s Station, Va., in April 1865. 
He complained of severe headache and 
sensitivity to light and noise, but left 
Harewood at his own request and lived 
for 68 more years, moving among vet¬ 
erans’ homes across the country from 
Milwaukee to the Chesapeake Bay. 
Aaron Detweiler, an i8-year-old 
corporal in a Pennsylvania infantry 
company, was shot in his upper right 
arm during the battle of Hatcher’s 
Run, Va., in March 1865. He went on 
to become a doctor and later drowned 
in a place called Devil’s Hole. 
“It’s a different story because it 
shows not only the tragedies of the 
war, but also the resilience. A lot of 
these people live until 1910, 1930— 
and just thinking about how they 
go on has been interesting for me,” 
Knoblauch said. 
The photographs will be part of an 
exhibit curated by Knoblauch titled 
“Portraits of Wounded Bodies.” They 
will be on display in the rotunda of the 
Medical Library from January through 
April 2013. The cases in the foyer of 
Sterling Hall will provide background 
on medicine during the Civil War, 
including maps of and information 
about Harewood Hospital as well as a 
biography of Bontecou. 
Natalie Villacorta is a student at Brown 
University and was Yale Medicine’s 2012 
writing intern. 
ABOVE Although the photographs documented 
surgical practices, they also included information 
about the patients. From left: Judson Spofford, 
a private in the 10th Vermont Regiment, was al¬ 
most killed by a Minie ball at Fort Stedman, near 
Petersburg, Va.; Robert A. Butcher, 21, a private 
in the 82nd Pennsylvania, was wounded in April 
1865 when Confederate cavalrymen struck his 
head with sabers; CpI. Aaron Detweiler served in 
the 198th Pennsylvania Regiment, Co. G, and was 
wounded in the arm in battle in Virginia in 1865; 
far right, an unidentified soldier. 
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Yale scientists played a leading role in an international 
effort to map the 99 percent of the human genome that 
doesn't produce proteins—perhaps ending the notion 
that those regions are “junk." 
By Colleen Shaddox 
Junk no more 
R.I.P., junk dna: not the dna as such, but the moniker that 
has described it in a misleading fashion for years. Scientists 
have long known that vast swatches of the human genome 
don’t produce proteins. They have also known that these 
sections are nonetheless active. How much of the genome 
produces proteins was not known until the first draft of 
the Human Genome Project, released in 2000, tallied 
the coding regions of the genome. Only about i percent— 
roughly 21,000 genes—codes for proteins. And the other 
99 percent.^ 
The National Human Genome Research Institute 
(nhgri) began a follow-up to the Human Genome Project 
in 2003. With a budget of $288 million, the Encyclopedia 
of DNA Elements (encode) would map that 99 percent and 
catalogue its functional elements for a better understanding 
of the genome and its role in human biology and disease. 
ENCODE enlisted 440 researchers at 32 institutions in the 
United States, the United Kingdom, Spain, Singapore, and 
Japan, who communicated via wikis, Google docs, and two 
face-to-face meetings each year. The researchers began with 
a pilot project that would study just i percent of the genome 
while gauging research methods and technologies. Their 
findings, published in Nature and Genome Research in 2007, 
showed that the project could identify and characterize func¬ 
tional elements in the genome. In the next phase, the con¬ 
sortium went beyond the initial i percent and covered the 
whole genome by studying 147 cell types and performing 
more than 1,600 experiments. 
In September the findings from those experiments 
were published in such journals as Nature, Genome Research, 
and Genome Biology. This research announced all encode, 
“gives the first holistic view of how the human genome actu¬ 
ally does its job.” 
The consortium found biological activity in 80 percent 
of the genome and identified about 4 million sites that play 
a role in regulating genes. Some noncoding sections, as had 
long been known, regulate genes. Some noncoding regions 
bind regulatory proteins, while others code for strands of rna 
that regulate gene expression. Yale scientists, who played a 
key role in this project, also found “fossils," genes that date 
to our nonhuman ancestors and may still have a function. 
Mark B. Gerstein, ph.d., the Albert L. Williams Professor of 
Biomedical Informatics and professor of molecular biophys¬ 
ics and biochemistry, and computer science, led a team that 
unraveled the network of connections between coding and 
noncoding sections of the genome. 
Arguably the project’s greatest achievement is the 
repository of new information that will give scientists a 
stronger grasp of human biology and disease, and pave the 
way for novel medical treatments. Once verified for accu¬ 
racy, the data sets generated by the project are posted on 
the Internet, available to anyone. Even before the project’s 
September announcement, more than 150 scientists not con¬ 
nected to ENCODE had used its data in their research. 
“We’ve come a long way,” said Ewan Birney, ph.d., 
of the European Bioinformatics Institute (ebi) in the United 
Kingdom, lead analysis coordinator for encode. “By care¬ 
fully piecing together a simply staggering variety of data, 
we’ve shown that the human genome is simply alive with 
switches, turning our genes on and off and controlling 
when and where proteins are produced, encode has taken 
our knowledge of the genome to the next level, and all of 
that knowledge is being shared openly.” 
Big data, big questions 
The day in September that the news embargo on the encode 
project’s findings was lifted, Gerstein saw an article about 
the project in The New York Times on his smartphone. There 
was a problem. A graphic hadn’t been reproduced accurately. 
“I was just so panicked,” he recalled. “I was literally walking 
around Sterling Hall of Medicine between meetings talking 
with The Times on the phone.” He finally reached a graphics 
editor who fixed it. 
An academic whose scholarly and personal interests 
focus on information and how we make sense of it, Gerstein 
had run up against the juggernaut of the 24-hour news 
cycle. But in the end, he helped The New York Times get it 
right, just as he’d played a role in helping the international 
consortium of encode scientists interpret the vast expanse 
of data that they uncovered. The concept of “big data,” an 
amount of information so large that it challenges efforts to 
store and use it, is key to encode and to Gerstein’s work 
generally. “It’s really a very transformative idea in terms of 
how people approach experiments and how people think 
about analyzing things,” he said. He likened a rich data 
resource to a great piece of literature, “something that’s 
kind of transcendent and speaks to many different people.” 
It can inspire and answer many questions. “I do think that 
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14 Junk no more 
particularly for genomic data sets,” he said, “the value of the 
data set goes beyond the initial question.” 
Given the new availability of incredibly large data sets, 
a scientific supergroup with high levels of collegiality and 
collaboration was essential to the success of encode. Having 
one group carry out the project allowed for a uniformity of 
method and reporting that was critical, said Michael Pazin, 
PH.D., program director in functional genomics at nhgri. 
Imagine the confusion caused by a map where thick blue 
lines sometimes represent interstate highways and other 
times rivers. But there is ample room for small projects to 
emerge based on the availability of the new resource, added 
Elise Feingold, ph.d. ’86, program director in genome 
analysis at nhgri. “I don’t think (consortia are) ever going 
to substitute for the individual researcher and these small 
collaborations,” she said. 
Gerstein took to the collaborative process, according 
to Birney. “Mark likes to find a scenario where everyone gets 
along without compromising the science. This is not always 
as easy as it sounds, and takes some effort talking to people. 
Like all of us, Mark has some characteristic phrases, and I 
would always know that Mark didn’t quite agree on some¬ 
thing when he would start, ‘Wouldn’t you say, Ewan, that ...’, 
and then he’d be into some point,” Birney said. 
New technology paves the way 
ENCODE would have been unthinkable without the technology 
and methodology to gather, store, and analyze enormous data 
sets. When Gerstein began his career things were different. 
He’d majored in physics and wanted to pursue a science that 
was driven by advances in computer technology. But there 
was no clear pathway to do that. He completed his doctorate 
at Gambridge, which is now home to the ebi. “There was no 
EBi,” recalled Gerstein. “There was no program in bioinfor¬ 
matics. I did a program in chemistry.” He wondered whether 
he’d stay in academia because most universities did not have 
even a single bioinformatics position. 
In 1996, however, Donald Engelman, ph.d., the Eugene 
Higgins Professor of Molecular Biophysics and Biochemistry, 
saw the need for computational expertise at Yale and recruited 
Gerstein. “I and others in the department were concerned 
about computation and its role in research,” remembered 
Engelman, who was not involved in encode. “There would be 
an enormous explosion of information to deal with as genetic 
information became available and more structural informa¬ 
tion became available. Someone who can use those enormous 
databases is key.” 
In those days, though, the tools for uncovering those 
data were still being discovered. When Valerie Reinke, ph.d., 
associate professor of genetics, was in college, she’d often 
draw diagrams of cells on cocktail napkins to illustrate points 
to her friends who were not science majors. “It always amazes 
me that there are people who don’t want to know how their 
bodies work,” she said. Reinke was part of the modENCODE 
project, which focused on functional element identifica¬ 
tion similar to encode, only in such model organisms as 
the fruit fly Drosophila melanogaster and the roundworm 
Caenorhabditis elegans. Reinke specializes in roundworm, 
which shares many genes with humans. About a fifth of the 
worm’s genome codes for proteins, making it easy to identify 
noncoding functional elements. The tools for discovering 
the fine details of what was happening in those sketches she 
drew in college were still evolving when she was a student. By 
2000, when she joined the Yale faculty, microarray technol¬ 
ogy, which allows scientists to analyze expression of multiple 
genes in a single experiment, was brand-new. As with per¬ 
sonal computing, dna sequencing technology has rapidly 
grown more powerful, faster, and cheaper. 
In 2007, as the encode pilot project was ending and 
the next phase was getting started, next-generation sequenc¬ 
ing technology became available. “That was really a remark¬ 
able confluence of events that we were able to take advantage 
of and was really a game changer for the project,” remem¬ 
bered Feingold. 
The evolution of the technology is making it practical 
to look at genetics on an individual level, said Reinke, where 
information could be used to formulate treatments tailored 
to a particular patient. “We haven’t even begun to scratch 
the surface,” she said. “There are so many questions.” 
One thing is clear, encode will have profound impli¬ 
cations for personal genomics. Each of us gets a double set 
of genes, with one copy, or allele, coming from each parent. I 
Being able to determine allele-specific expression “brought 
home the idea of what you might call a personal annota¬ 
tion,” Gerstein said. “We think that this personal annotation 
is the next phase for genomics.” 
This personal annotation, notes Gerstein, can raise 
ethical issues. Would you want an employer or health 
insurer to know about your susceptibility to a degenerative 
illness? These kinds of questions don’t stop at the molecu¬ 
lar level, when Foursquare lets the world know in which 
Starbucks you’re enjoying a coffee and a friend can share on 
! Facebook a picture from the office holiday party that you’d 
rather never saw the light of day. “I do think a big aspect 
j of information technology, both big data and computing, is 
I this erosion of privacy,” said Gerstein. 
The myth of junk DMA 
Some early press coverage credited encode with discover¬ 
ing that so-called junk dna has a function, but that was old 
news. The term had been floating around since the 1990s 
and suggested that the bulk of noncoding dna serves no 
purpose: however, articles in scholarly journals had reported 
for decades that dna in these “junk” regions does play a reg¬ 
ulatory role. In a 2007 issue of Genome Research, Gerstein 
had suggested that the encode project might prompt a 
new definition of what a gene is, based on “the discrepancy 
between our previous protein-centric view of the gene and 
one that is revealed by the extensive transcriptional activ¬ 
ity of the genome.” Researchers had known for some time 
that the noncoding regions are alive with activity, encode 
demonstrated just how much action there is and defined 
what is happening in 80 percent of the genome. That is not 
to say that 80 percent was found to have a regulatory func¬ 
tion, only that some biochemical activity is going on. The 
space between genes was also found to contain sites where 
DNA transcription into rna begins and areas that encode rna 
transcripts that might have regulatory roles even though they 
are not translated into proteins. 
But helping people grasp the massive import of 
ENCODE proved a challenge. “People don’t think that creat¬ 
ing a resource is a sexy endeavor,” said Feingold. 
“It’s so easy to either overpromise or undersell,” 
J agreed Pazin. On the one hand, he did not want to make 
claims that encode would quickly lead to cures for diseases 
like cancer. On the other, he didn’t want the public to ignore 
the discovery because it was too technical to understand. 
That’s why the “useful shorthand” of junk dna so often 
came up in coverage, said Feingold. 
Hopefully, encode will help put an end to the notion 
of junk DNA. The project not only assigned general classes 
of functions to areas of the genome but also showed the 
complexity of how those areas interact. The project revealed 
the genome’s organizational hierarchy, with top-level regula¬ 
tors wielding vast influence while “middle managers” often 
have to collaborate to regulate genes. 
There was no “Eureka!” moment, said Gerstein, who 
called the findings “the opposite of a discovery.” Instead, 
there were years of gathering and interrogating data to 
create a map of the vast majority of the genome. As many 
researchers have found, these noncoding regions are alive 
with regulatory activity that plays a critical role in human 
disease, though some of the functioning that was docu¬ 
mented did not have such obvious applications. 
His team, Gerstein said, took a different path from 
those of others involved in the project. 
“Most of the project is more oriented on annotating 
elements,” he said. “Our unique perspective was to make 
it a network.” 
If it were simply a genetic encyclopedia, encode 
would catalogue its entries in isolation from one another. 
The Abaco Islands reside next to abacus in a conventional 
encyclopedia because that’s how the words fall alphabeti¬ 
cally—not because the topics identified by the words have 
any intrinsic relationship. Knowing how different parts 
of the genome work together is far more powerful than sim¬ 
ply compiling a parts list. 
Through computational analysis, Gerstein’s lab broke 
apart the “hairball” of the regulatory networks to find work¬ 
ing relationships. He developed statistical models that 
identified regulators located far away from the genes they 
influence. He found that the way the human genome is 
organized is not so different from the way humans organize 
themselves. Gerstein likens transcription factors that have 
considerable regulatory influence to top-level managers. As 
might be the case with their human analogues, these elite 
transcription factors tend to be conservative. 
“What does conservative mean? Conservative means 
they’re more preserved. There’s less variation,” said 
Gerstein. “It’s sort of natural that in that kind of context, 
you don’t want them to change as much.” 
The less influential transcription factors, which he 
terms “middle managers,” are less conservative and more likely 
to work cooperatively than their peers. Often these middle 
managers will co-regulate a gene, easing the flow of informa¬ 
tion in what would otherwise be “a bottleneck.” 
Junk no more 
Valerie Reinke studies the round- 
worm C. elegans and focuses on 
functional element identifica¬ 
tion in that organism. Advances 
in technology made the encode 
project possible, she says, and 
are making it practical to look at 
genetics on an individual level. 
“We haven’t even begun to 
scratch the surface,” she says. 
During his long career, geneticist 
Sherman Weissman has focused 
on genome-wide mapping of 
gene activity and chromosome 
structure in humans. “We have 
so much data, and a very large 
part of it hasn’t been fully 
exploited,” he says. 
Mark Gerstein played a key role 
in an international project that 
elucidated many of the functions 
of the 99 percent of the human 
genome that does not code for 
proteins. Gerstein and his team 
unraveled the complex network i 
of working relationships among | 
genes and their regulators. 
There is less interaction between the top-level tran¬ 
scription factors and the bottom-level, least influential 
transcription factors than one would expect to happen by 
chance. The human genome is not egalitarian. 
Gerstein and colleagues at the Sanger Center, the 
University of California at Santa Cruz, and Cold Spring 
Harbor Laboratory on Long Island also found about 
12,000 pseudogenes—fossil genes dating back to our non¬ 
human ancestors—which at first glance appear to be dead. 
But it turns out that some pseudogenes, while they no 
longer code for proteins, are quite animated. “They’re very 
much on the edge between living and dead,” said Gerstein. 
In some people, these pseudogenes are turned into 
actual genes. “What’s going on here? Is this a gene that’s 
being born?” he asked. Pseudogenes open a window on the 
history of our species. Some of these fossil genes may still 
be players in the regulatory network. 
The impact on medicine 
What will ENCODE mean for human health, and how soon 
will this genomic encyclopedia inform treatment? There is no 
easy answer to that critical question, according to Sherman 
Weissman, m.d.. Sterling Professor of Genetics. 
“I grew up with the held,” said Weissman, whose 
research interests include genome-wide mapping of gene 
activity and chromosome structure in humans. Weissman 
contributed to encode through collaborations with former 
Yale professor Michael Snyder, ph.d., a leader in the held of 
functional genomics who is now at Stanford. 
Knowing the molecular basis of a disease carries no 
guarantee that a cure is imminent. Linus Pauling, ph.d., 
linked sickle cell disease to an abnormal protein in 1949, 
making it the first genetic disease for which the molecular 
basis was known. But, Weissman noted, there is still no 
cure for it. On the other hand, survival rates for chronic 
myelogenous leukemia are improving thanks to Gleevec, a 
drug based on oncogene study that received fda approval in 
2001. Weissman is optimistic that genetic information could 
lead to effective treatments for Alzheimer disease, which he 
terms “simpler than cancer.” 
“We have so much data, and a very large part of it 
hasn’t been fully exploited,” he said. “We’re really bumping 
up against the ceiling in some practical ways.” 
One of the project’s findings is that genetic changes 
linked to disease occur between genes in places where 
ENCODE has identified regulatory sites. It’s still not clear 
how variations in these areas contribute to disease. “Some 
people were surprised,” said Pazin, “that disease-linked 
genetic variants are not usually in protein-coding regions. 
We expect to find that many genetic changes causing a 
disorder are within regulatory regions, or switches, that 
affect how much protein is produced or when the protein is 
produced, rather than affecting the structure of the protein 
itself The medical condition will occur because the gene is 
aberrantly turned on or turned off or abnormal amounts of 
the protein are made. Far from being junk dna, this regula¬ 
tory DNA clearly makes important contributions to human 
health and disease.” 
“It’s important to realize that these findings won’t 
be taken forward by people like Mark or myself—rather we 
have to empower clinical researchers to use this data,” said 
Birney of the ebi. “I think encode will have a big impact on 
medical research—in particular, genome-wide association 
studies have a really remarkable overlap with encode data 
outside of protein-coding genes, and this is leading to all 
sorts of new hypotheses of how these diseases operate.” ym 
—Colleen Shaddox is a freelance writer in Hamden, Conn. 
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Yale’s Epic 
challenge 
The health care system embraces electronic 
medical records and takes on a monumental task. 
By Bruce Fellman 
In early October, Gary E. Friedlaender, m.d., a specialist in 
musculoskeletal oncology who chairs the Department of 
Orthopaedics and Rehabilitation, was in Australia for meet¬ 
ings. Yet even 9,000 miles away from his office in New 
Haven, Friedlaender could stay in touch with his Yale Medical 
Group (ymg) practice and access information about his 
patients, including charts, notes, and X-rays. 
“I was able to take out my laptop, receive information, 
generate orders, and talk to other providers about patient 
care,” said Friedlaender, the Wayne O. Southwick Professor 
of Orthopaedics and Rehabilitation and professor of pathol¬ 
ogy. “Everything I needed was at my fingertips, and I can 
now connect wherever I happen to be.” 
The reason is Epic, a suite of electronic medical 
record (emr) applications that is being implemented 
throughout the Yale New Haven Health System (ynhhs): 
at Greenwich, Bridgeport, and Yale-New Haven hospitals, 
as well as at ymg and the Northeast Medical Group (nemg) 
community practices. 
“Epic will transform the way we teach and practice 
medicine, both at Yale and around the country and the 
world,” said Dean Robert J. Alpern, m.d.. Ensign Professor 
of Medicine. “The Epic emr will help us achieve a higher 
quality of care than ever before.” 
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20 Yale’s Epic challenge 
PREVIOUS PACE Onaralnyday 
in October 2011. Yale Internal 
Medicine Associates became the 
first practice in the Yale Medical 
Croup to implement the Epic elec¬ 
tronic medical records system. 
Marie Folio (seated), director of 
practice management, worked 
with staff on that first day. 
The implementation process began in July 2010 when 
senior ynhhs, ymg, and School of Medicine administrators 
met with officials from Epic Systems, a Wisconsin-based 
software company, to sign a $250 million contract that 
would transform health care delivery throughout the medi¬ 
cal center. The emr has been in use since October 2011, 
when Yale Internal Medicine Associates (yima) became the 
first YMG practice to start using the Epic ambulatory appli¬ 
cation. As of December, 388 providers in 76 practices were 
up and running on Epic with the numbers increasing each 
week. Yale-New Haven Hospital (ynhh) is scheduled to 
go live in early Eebruary and the entire rollout will be com¬ 
pleted by September 2013. 
Orthopaedics went live in March 2012, so Eriedlaender 
can log onto Epic, even from “down under,” and have all the 
information he needs in one place. “We were drowning in 
paper,” he admits, “and all too often, we couldn’t find what 
we needed in a timely way. The Epic emr corrects all that. It’s 
indispensable to improving the health care of the future.” 
Enough people, from doctors to front-desk profession¬ 
als, have incorporated the emr into their workflows to cor¬ 
roborate these assessments. One key observer and present 
Epic user is David J. Leffell, m.d., deputy dean for clinical 
affairs, and the David P. Smith Professor of Dermatology 
and professor of surgery. When the contract was signed, 
Leffell was ymg’s geo and played an instrumental role in 
the selection of Epic. His practice went live with the soft¬ 
ware in July—but as he and countless others have discov¬ 
ered, the process is easier said than done. 
“The implementation was painful,” Leffell admitted. 
“There’s a steep learning curve. It’s not as customizable as 
we’d like, and it’s clear that our aspiration for a totally paper¬ 
less world is not achievable. But even now—this early in the 
project—the pluses outweigh the minuses.” 
Those advantages are considerable. There’s immedi¬ 
ate secure electronic access to a patient’s medical history, 
including vital signs, medications, allergies, lab test results, 
and X-rays. Then there’s the ease and speed of the emr 
system’s interactions with providers and patients alike, 
along with such “smart” features as warnings about drug 
interactions and information about treatment protocols. 
Pharmacies, thanks to an e-prescribing provision, no longer 
puzzle over a physician’s handwriting, and staffers don’t 
have to hunt down errant charts. Through MyChart, an 
application that ynhhs included as part of its Epic imple¬ 
mentation, patients can log into their own account to view 
their records and test results, interact with their providers, 
schedule appointments, and even pay bills. (More than 
7,000 patients had signed up for MyChart by December.) 
And the wealth of data in the system will provide a mother 
lode of digital information to find more cost-effective ways 
to improve care. 
As if these reasons aren’t compelling enough, there’s 
also a financial incentive. Within the American Reinvestment 
and Recovery Act, the $789 billion federal stimulus legisla¬ 
tion of 2009, was a provision called the Health Information 
Technology for Economic and Clinical Health (hitech) Act. 
HITECH makes available up to $20 billion to doctors and 
hospitals that institute emrs and demonstrate what federal 
officials term “meaningful use” of the new technology. These 
benchmarks include using the emr for a certain percentage 
of medication orders, entering demographic information, 
recording vital signs, noting smoking status, and maintain¬ 
ing an active medication allergy list, among other things. By 
meeting these requirements, physicians can become eligible 
to receive up to $44,000 in Medicare money over five years. 
But to garner the full $44,000 payment, each physician has 
to be using a certified emr like Epic and hitting meaningful 
use targets by no later than this year. 
An increasing number of ynhhs providers have done 
just that, and there is another powerful reason not to wait. 
Providers who choose to sit on the emr sidelines or don’t 
achieve meaningful use by the end of 2015—and don’t qualify 
for a waiver—will be hit with a noncompliance penalty that 
amounts to i percent of Medicare payments in 2016, to rise to 
5 percent in 2020. (There are Medicare penalties for hospitals, 
but no Medicaid penalties for either providers or hospitals.) 
With the federal government encouraging and sup¬ 
porting the use of electronic medical records, it was time 
for all parts of ynhhs to act. ynhh, which was using 
separate emr systems in the inpatient and outpatient clinic 
areas, was looking for a single integrated system, ymg, 
which still lived largely in the paper-records universe, 
wanted to go electronic. 
After lengthy reviews and consideration of several 
candidate systems, a due-diligence committee chose the emr 
software developed by Epic Systems, whose product is rated 
tops in evaluations by independent consultants. The integrated 
suite of software for both inpatient and ambulatory services 
is used by around 270 health care organizations worldwide, 
including Kaiser Permanente, the Cleveland Clinic, and Weill 
Cornell Physicians. Many academic medical centers, from the 
University of Wisconsin Hospital and Clinics to Dartmouth- 
Hitchcock, are also part of the Epic community. When a 
plethora of implementations currently under way are complete, 
about 250,000 physicians—one in every four in this country— 
will be working in an Epic system. 
21 
Yale’s “Manhattan Project” 
Epic was chosen, and thus began what Leffell called “our 
equivalent of the Manhattan Project—an incredibly compli¬ 
cated process that exceeds anything we’ve ever attempted 
by orders of magnitude.” 
The entire Epic model system, as the company calls 
it, consists of 19 separate but fully integrated components, 
from billing and scheduling modules to inpatient and 
ambulatory applications. But Epic is not simply plug-and- 
play software. It has to be built, or “personalized,” to fit the 
needs of each organization. 
Over the summer and fall of 2010, ynhhs hired nearly 
200 staffers and sent them to Epic’s campus in Wisconsin for 
training and certification. Then Team Epic, led by project direc¬ 
tor Lisa Stump; Steven Schlossberg, m.d., ymg’s chief medi¬ 
cal information officer; and Daniel Barchi, chief information 
officer at the School of Medicine, settled into headquarters in 
Stratford, Conn., and began working nonstop on what became 
known as the “collaborative build.” Meeting regularly with a 
YNHHS Providers Advisory Group and subject matter experts 
well-versed in every conceivable aspect of the health care sys¬ 
tem from billing to bed planning, pharmacy consultation to 
patient care data, the team reviewed all aspects of the software 
' with the people who’d be using it. At various points in the 
process, it was time for a “stoplight” vote on each part of the 
proposed Epic workflow. The vote was taken by a show of cards: 
I green for “Okay, this will work for us,” and red for “Let’s stop 
" and think about this.” 
, There were thousands of votes as everyone involved 
j in the project weighed in and shaped the end result. In addi¬ 
tion to creating a system that seemed to meet the workflow 
needs of its users, the collaborative build had another critical 
result. It brought people, many of whom had never worked 
together, out of their silos. “We’re building an emr, but the 
true power of the Epic project may lie in helping us to form 
better teams that will transform our health care culture,” 
said Edmund E. Funai, m.d., former professor (adjunct) of 
obstetrics, gynecology, and reproductive sciences, and then a 
member of the Epic project’s interim leadership committee. 
Their efforts were showcased in May 2011 at an event 
called the Work Flow Walk Through. This preview of the 
ambulatory application—there was a separate walk-through 
for the inpatient hospital side—attracted hundreds of 
future Epic users and left many favorably impressed by the 
TOP When the orthopaedics 
department launched its emr in 
March 2012, it benefited from the 
lessons learned by other depart¬ 
ments. Chair Gary Friedlaender 
discussed the system with staff. 
ABOVE Implementation of the 
systems was challenging as staff 
adapted to a new way of keeping 
records and had to create patient 
files by transferring paper records 
to computers. 
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22 Yale's Epic challenge 
A new electronic medical record 
will replace paper files that now 
hold patients’ medical histories. 
Trevor Lewis, a senior administra 
tive assistant in orthopaedics, 
looked over patient records. 
potential power of the system, yima, the pioneer practice, 
prepared to go live that fall. 
While Epic team members met with practice represen¬ 
tatives and hne-tuned the software, there was hardware to be 
installed and there were extensive training sessions for every¬ 
one who’d be using the application. In addition, before the 
switch was flipped and the Epic login appeared on computer 
screens, staffers began what for many is an ongoing effort 
to abstract pertinent data from paper records and enter the 
information into a patient’s emr. 
A steep learning curve 
The Epic era began on a rainy Wednesday morning, October 
19, 2011, at YIMA headquarters on the third floor of the Yale 
Physicians Building. There were festive balloons, coffee and 
pastries, and enough Epic systems specialists in place to 
make the transition smooth and seamless. 
It didn’t work out quite that way. As Leffell noted, the 
learning curve was steep. For example, right after go-live, 
productivity at yima dropped by about 50 percent. This was 
anticipated and factored into the implementation timetable. 
But the goal of returning to normal within a month or so 
eluded many yima physicians, nurses, medical assistants, 
and other staffers, as it would do in other practices. 
In part, the decline in productivity was due to the sheer 
complexity of the software, which allows different ways to 
accomplish the same task. “As the very first Yale practice to 
go live, our transition to Epic was a struggle,” said Matthew 
Ellman, m.d., yima’s practice director. “But although some 
challenges remain a year later, we are now reaping the ben¬ 
efits of immediate and easy access to clinical results, rapid 
communication among staff and with patients, and the con- I 
venience and improved safety of e-prescribing.” 
To be sure, working electronically and having to enter 
data via a keyboard on a computer screen rather than by hand ■ 
in a notebook (or dictated into a tape recorder) is such a mas- i 
sive change in how a practice does business that slowdowns 
and snafus are inevitable. But some practices had easier 
23 
transitions than others. Epic’s debut last March in orthopae¬ 
dics was certainly not pain-free. “We walked through the fire,” 
said practice manager Connie Rinaldi. But the flames were 
more a simmer than a conflagration, and they didn’t burn for 
long because, Rinaldi continued, “We reached out to other 
departments to learn what worked, and we decided that we’d 
find solutions of our own to pass along.” 
The strategy was a success, and almost all the provid¬ 
ers were able to get back up to lOO percent of their pre-Epic 
productivity levels within a month. But there was a cost, 
noted Maureen Carey, r.n., who manages the nursing staff: 
someone had to enter all the new data that Epic requires, and 
the process could add as much as 15 minutes to each appoint¬ 
ment. The extra work, Rinaldi explained, is being managed by 
shifting the responsibilities of the existing medical assistants. 
Sending now-superfluous file cabinets to an off-site storage 
facility has had an unexpected benefit. “Everyone now has 
I adequate desk space,” she said. Moreover, Rinaldi and Carey 
expect the extra work to be temporary; as increasing numbers 
of patient records become part of the Epic system, the time- 
I consuming data entries will no longer be necessary. 
I And computer makes three 
Adding a computer to the doctor-patient encounter has not 
j proven as disruptive as many providers had feared, said 
I orthopaedic surgeon Jonathan Grauer, m.d. ’97, a self- 
. confessed Epic partisan. “Everybody in the beginning was 
j nervous that having to work on a computer while the patient 
was in the examining room would compromise the quality 
of the interaction, and it felt a little strange and awkward at 
first,” Grauer confessed. 
But there are ways to blunt the oft-stated worry that 
the physician is taking care of a computer rather than a 
person, such as taking notes on paper and then transferring 
the data into Epic when the office visit is complete. In fact, 
there’s research about ways to minimize computer intrusive- 
ness; yima was able to incorporate such findings into the 
design of its examination rooms because the practice was 
moving to new offices in advance of going live. The trick lies 
in maintaining a triangular setup, with the computer equip¬ 
ment set off to one side so that the monitor doesn’t get in 
the way of eye contact between doctor and patient. 
Dickerman Hollister, m.d., a Greenwich oncologist, 
may even be taking a cue from sports bars by hanging a 
large monitor on a wall where everyone in the room can see 
what’s on the screen. “I can type pretty fast, and I can be on 
the keyboard and facing patients at the same time,” he said. 
“They can see what I’m doing and work with me. Epic defi¬ 
nitely enhances our communication and better informs my 
patients about their care.” 
The ability of the system to quickly generate office- 
visit summaries for patients, as well as useful health care 
information about a particular concern, has helped change 
doubters into fans. “The presence of a computer in the room 
is part of the price we pay for the portability of health care 
information,” said Grauer. “We’re all trying to find ways to 
deal with it.” 
Indeed, there’s no longer any real choice, “emr use 
is mandated by federal authorities for everyone who’s in the 
Medicare and Medicaid arena,” said Friedlaender, “so emrs are 
going to be a part of our professional life. The real question we 
should be asking—and trying to answer—is how do we use 
them to maximize the quality of care we’re providing?” 
There are a number of ways to address this concern: 
some of them local, others more global. The Epic implemen¬ 
tation required everyone involved in the process to take a 
hard look at workflow. Working in Epic means following the 
application’s workflow and entering office visit data in a cer¬ 
tain predetermined order. 
“Epic imposes a discipline on a doctor’s daily activi¬ 
ties that’s very beneficial, in both the short and long run,” 
said Leffell. Using the emr has already resulted in improve¬ 
ments in such areas as the way calls from patients are 
received, routed, and acted upon; the thoroughness of docu¬ 
mentation; and the turnaround time for notes. “We’re now 
able to get our notes into everyone’s hands the next day—it 
used to take a week or two,” said Grauer. “With Epic, the 
retrievability of all that information is just fantastic.” 
Hollister, who logs in from home over morning cof¬ 
fee, explained that the emr “makes me more efficient. It 
brings me up to speed before rounds and makes it less likely 
I’ll get surprised.” 
And Eriedlaender, besides touting Epic’s ability to 
provide 24/7 access to complete patient care information, 
offers perhaps the most compelling reasons of all to make 
the electronic leap. “Epic reminds us that we’re creating an 
electronic medical record that belongs to the patient—it’s 
not a private, inaccessible dossier,” he explained. “And the 
EMR allows us to keep track of how well we’re doing for our 
patients. If this transparency is threatening, then the anxi¬ 
ety is well deserved. As providers, we need feedback; and if 
Epic provides a nudge, so be it. In the end, we’ll be glad we 
have this powerful tool available to us.” ym 
—Bruce Fellman is a writer in North Stonington, Conn. 
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Faculty 
Marina Picciotto 
Neurobiologist elected 
to IOA/\ 
MARINA PICCIOTTO, PH.D., the 
Charles B.C. Murphy Professor 
of Psychiatry and professor of 
neurobiology and of pharmacol¬ 
ogy, has been elected a member 
of the Institute of Medicine, the 
branch of the National Academies 
charged with providing science- 
based advice on medicine and 
health to policymakers, profes¬ 
sionals, and the public at large. 
Picciotto is an authority on 
the molecular underpinnings 
of tobacco and alcohol abuse, 
depression, and eating behaviors, 
with a particular interest in the 
role of nicotinic acetylcholine 
receptors (nAChRs). In addition to 
playing a role in tobacco addic¬ 
tion, nAChRs have been impli¬ 
cated in Alzheimer disease and 
in the dysfunctional sensory pro¬ 
cessing characteristic of schizo¬ 
phrenia. Picciotto has also studied 
the effects of nicotine exposure 
during gestation and adolescence 
on learning and memory and 
on the neuropeptide galanin. 
Calanin modulates Ach release 
and may exert a protective effect 
against addiction to such drugs 
as cocaine, amphetamines, 
and opiates. 
Picciotto graduated from 
Stanford University in 1985 
with a degree in biological sci¬ 
ences and received a ph.d. in 
molecular neurobiology from The 
Rockefeller University in New 
York City in 1992. She joined the 
Yale faculty in 1995 after complet¬ 
ing a postdoctoral fellowship at 
the Institut Pasteur in Paris. 
Picciotto, who is vice chair 
for basic science research in the 
Department of Psychiatry and 
associate director of the School 
of Medicine’s m.d./ph.d. pro¬ 
gram, also serves on the National 
Advisory Council of the National 
Institute on Drug Abuse. 
Yale professor honored 
with two awards 
JOAN A. STEiTZ, PH.D., Sterling 
Professor of Molecular Biophysics 
and Biochemistry and a Howard 
Hughes Medical Institute inves¬ 
tigator, has received the 2012 
Pearl Meister Creengard Prize 
of Rockefeller University, which 
recognizes outstanding achieve¬ 
ments of women scientists; 
and the 2012 Vanderbilt Prize in 
Biomedical Science. The latter 
prize, established by Vanderbilt 
University School of Medicine 
in 2006, honors nationally and 
internationally known women sci¬ 
entists who have “a stellar record 
of research accomplishments” 
and who have contributed signifi¬ 
cantly to the mentorship of other 
women in science. Prize winners 
receive a $25,000 honorarium; 
visit Vanderbilt to meet with 
faculty and deliver a Discovery 
Lecture; and serve as mentors to 
women who are pursuing gradu¬ 
ate studies in the biomedical sci¬ 
ences at the Vanderbilt School of 
Medicine. Steitz will receive the 
prize in May. 
The Pearl Meister Creengard 
Prize, created by Nobel laureate 
and Rockefeller professor Paul 
Creengard, ph.d., includes a 
$100,000 honorarium. 
Steitz earned her doctorate 
in biochemistry and molecular 
biology from Harvard in 1967. 
Following a postdoctoral fel¬ 
lowship in Cambridge, England, 
she joined the Department 
of Molecular Biophysics and 
Biochemistry at Yale. Steitz is 
perhaps best known for discover¬ 
ing and defining the function of 
small nuclear ribonucleoproteins 
(snRNPs), cellular complexes 
that play a key role in splicing 
and processing pre-messenger 
RNA—the earliest product of 
DNA transcription. 
Hugh Taylor 
School of Medicine names 
new chair of ob/gyn 
HUGH S. TAYLOR, M.D., HS ’92, 
FW ’98, was named chair of 
the Department of Obstetrics, 
Cynecology, and Reproductive 
Sciences at the School of 
Medicine, and chief of obstet¬ 
rics and gynecology at Yale- 
New Haven Hospital, effective 
October i, 2012. Taylor has served 
as professor and vice chair of 
obstetrics, gynecology, and 
reproductive sciences, and as 
chief of reproductive endocri¬ 
nology and infertility. Taylor’s 
research has been funded by 
the NiH for more than 20 years. 
He is the editor in chief of the 
journal Reproductive Sciences as 
well as editor of Endocrinology. 
He serves on the board of direc¬ 
tors of the American Society for 
Reproductive Medicine (asrm), 
where he is president-elect of the 
endometriosis interest group; 
he also serves on the govern¬ 
ing council of the Society for 
Gynecologic Investigation (sci). 
Taylor received the President’s 
Achievement Award from the 
SCI in 2008. 
As chief of reproductive 
endocrinology and infertility, 
Taylor has expanded the clinical 
capability and geographic reach 
of this critical service. Under 
his leadership, the section has 
established itself as a national 
leader, reflected in Taylor’s 
role as clinical director of the 
Society for Assisted Reproductive 
Technology, the organization that 
governs in vitro fertilization prac¬ 
tice in the United States. He has 
been recognized as Mentor of the 
Year by the American Congress of 
Obstetricians and Gynecologists 
and as Honoree of the Year by 
the Endometriosis Foundation 
of America. He has received 
multiple research awards from 
the ASRM, the sci, and the Endo¬ 
crine Society. 
Henry Binder JudyCho 
Chair endowed for Gl 
studies 
HENRY J. BINDER, M.D., profeSSOr 
emeritus of gastroenterology, 
and his wife, Joan W. Binder, have 
endowed a full professorship for 
a physician-scientist in the field 
of gastroenterology, judy h. cho, 
M.D., was named the first Henry J. 
and Joan W. Binder Professor of 
Gastroenterology. 
Binder has devoted his career 
to studying gastrointestinal dis¬ 
orders and diarrheal diseases—a 
major problem in many develop¬ 
ing countries. He came to Yale as 
a postdoctoral fellow in gastro¬ 
enterology in 1963. He had devel¬ 
oped an interest in the field while 
a student at New York University 
School of Medicine, where he 
stayed on as an internal medicine 
resident at Bellevue Hospital. 
Binder was director of the 
General Clinical Research Center 
at Yale-New Haven Hospital for 
21 years and established two nih- 
supported training programs. 
Binder maintains an active clinical 
practice at the School of Medicine 
that focuses on patients with 
inflammatory bowel diseases and 
unexplained chronic diarrhea. In 
recent years, with support from 
the Gates Foundation, Binder has 
worked to reformulate oral rehy¬ 
dration solution—a recipe that 
combines salt, sugar, and water 
in the proper ratio—for the treat¬ 
ment of diarrhea in children. 
Cho, professor of medicine 
(digestive diseases) and of 
genetics, is the director of the 
Inflammatory Bowel Disease 
Center. Her research seeks to 
identify genetic variations that 
affect susceptibility to and 
expression of inflammatory 
bowel disease. 
NOTES 
Andrew 
Goodman 
Gil Mor Jamie Morano Thomas Gill Valentina Greco 
Daniel C. DiMaio, m.d., ph.d., 
the Waldemar Von Zedtwitz 
Professor of Genetics and scien¬ 
tific director and deputy director 
of Yale Cancer Center, has been 
appointed to a five-year term on 
the Board of Scientific Advisors 
of the National Cancer institute 
(nci). The board assists and 
advises the director of the in¬ 
stitute, with a primary focus on 
oversight of the full portfolio of 
the Net’s extramural programs. 
The board also provides advice 
on scientific policies and reviews 
concepts for research and 
related activities supported by 
the NCI. 
David S. Fischer, m.d., clinical 
professor of medicine (oncol¬ 
ogy), received the Richard Blu- 
menthal Patient Advocate for 
Life Award from the Connecticut 
Hospice during its Legacy Cer¬ 
emony on September 23. Fischer 
helped to found Connecticut 
Hospice, the first hospice in the 
country, in 1974. 
Thomas M. Gill, m.d., Hu¬ 
mana Professor of Medicine 
(Geriatrics) and professor of 
epidemiology and of investiga¬ 
tive medicine, received the 2012 
Joseph T. Freeman Award from 
the Gerontological Society of 
America. The award, a lecture¬ 
ship in geriatrics, is conferred on 
a physician prominent in both 
research and practice in the field 
of aging. The award was pre¬ 
sented at the society’s annual 
meeting in San Diego 
in November. 
Andrew L. Goodman, ph.d., 
assistant professor in the 
Department of Microbial 
Pathogenesis and at the Yale 
Microbial Diversity Institute on 
the West Campus, has received 
a 2012 NIH Director’s New 
Innovator Award. Presented 
by the National Institutes of 
Health, the honor is intended to 
encourage new laboratories to 
launch innovative biomedical 
and behavioral research. The 
$1.5 million, five-year award will 
enable Goodman and his team 
to develop new approaches to 
understand the effects of the 
body’s resident bacteria on 
human health. Goodman’s team 
will use mice raised without 
any intestinal microbes of their 
own to investigate whether 
differences in the composition 
of bacterial communities in the 
gut—as well as differences in 
human genome sequences— 
affect drug metabolism. 
Valentina Greco, ph.d., assistant 
professor of genetics and of der¬ 
matology, received an Roi grant 
from the National Institutes of 
Health for her project, "Live Im¬ 
aging of Skin Regeneration.” The 
five-year grant for $1.9 million 
will fund high-resolution live 
imaging studies of the cellular 
and signaling mechanisms that 
govern tissue regeneration in 
hairfollicle stem cells. Greco is a 
member of the Signal Transduc¬ 
tion Research Program at Yale 
Cancer Center. 
Valerie Horsley, ph.d., the 
Maxine F. Singer, ph.d. ’57 As¬ 
sistant Professor of Molecular, 
Cellular, and Developmental 
Biology, has received a Presi¬ 
dential Early Career Award for 
Scientists and Engineers, the 
highest honor bestowed by the 
U.S. government on outstand¬ 
ing scientists and engineers 
beginning their independent ca¬ 
reers. Horsley received the honor 
for her studies of the extrinsic 
regulation of epidermal homeo¬ 
stasis. She is one of 20 scientists 
to receive the award in 2012. 
Gil G. Mor, m.d., ph.d., professor 
of obstetrics, gynecology, and 
reproductive sciences, received 
the 2012 American Journal of 
Reproductive Immunology 
Award for outstanding contribu¬ 
tions to reproductive immunol¬ 
ogy. The award was conferred 
by the American Society for 
Reproductive Immunology at a 
Joint international conference in 
Hamburg, Germany, in May. 
Jamie P. Morano, m.d., m.p.h., 
a third-year fellow in the 
program of infectious diseases 
in the Department of Internal 
Medicine, was selected as a New 
England Journal of Medicine 
Cold Award Winner for her es¬ 
say on technology and medicine 
titled "hiv/aids 2.0,” as part of 
the journal’s 200th anniversary. 
Morano works with Frederick 
L. Altice, M.D., HS ’89, on issues 
of identification, screening, and 
treatment of Hiv, hepatitis C, 
and latent tuberculosis among 
immigrant groups and other 
underserved populations. 
Morano also served as the elect¬ 
ed representative of the infec¬ 
tious disease section on the 
School of Medicine’s Graduate 
Medical Education Committee 
for 2011-2012. 
Clarence Sasaki 
Don Nguyen, ph.d., assistant 
professor of pathology, received 
an Roi grant from the National 
Cancer Institute for his project, 
"A Novel Lineage Specific Metas¬ 
tasis Suppressor Pathway in Lung 
Cancer.” The five-year grant for 
$1.1 million will fund research into 
the ways in which fundamental 
molecular circuits that control 
airway development are rewired 
during lung adenocarcinoma me¬ 
tastasis. Nguyen is a member of 
the Signal Transduction Research 
Program at Yale Cancer Center. 
John D. Roberts, m.d., director of 
the Adult Sickle Cell Program at 
Yale-New Haven Hospital, received 
the Harry Hynes Award from the 
Community Clinical Oncology 
Program (ccop), in the Com¬ 
munity Oncology and Prevention 
Trials Research Group, a program 
within the NCi’s Division of Cancer 
Prevention. The ccop is a network 
for testing and validating medical 
interventions against cancer and 
for delivering the benefits of sci¬ 
entific discovery to the public and 
community physicians. The award 
honors excellence in research 
related to community clinical 
oncology programs. 
ClarenceT. Sasaki, m.d. ’66, HS ’73, 
the Charles W. Ohse Professor of 
Surgery (Otolaryngology), has 
been named president of the 
American Laryngological Associa¬ 
tion (ala). The ALA is one of the 
premier organizations in otolaryn¬ 
gology and is a major supporter of 
research, education, and academic 
issues related to laryngology. 
SEND FACULTY NEWS TO 
Claire M. Bessinger, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
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26 students 
Med school on the 
five-year plan 
At a time when some are calling 
to shorten medical school, many 
Yale students are extending it. 
Like most of his classmates, Julius 
Oatts is staying on at the School of 
Medicine for a fifth year of study. 
This option, available for more than 
20 years, has become increasingly 
Julius Oatts stayed 
on for a fifth year at 
the medical school, 
an increasingly 
popular option for 
medical students. 
Oatts spent the 
year working with a 
mentor in ophthal¬ 
mology and getting 
a feel for the life of a 
physician-scientist. 
popular, with as many as two-thirds of 
each class adding a year to their medi¬ 
cal studies, primarily to do research. 
For Oatts, an extra year gives him the 
chance to try on the lifestyle of a 
physician-scientist. “It’s easy to say 
you’re interested in patient care and 
research in the beginning of med 
school, but this is the first time that 
I have seen what the day-to-day of that 
is like, both the challenges and the ben¬ 
efits,” Oatts said, who’s doing research 
in ophthalmology. “You take a project 
and it’s yours for the year.” 
At a time when some are calling 
to shorten medical training, more 
than half of Yale students are choos¬ 
ing to extend it. A March 21 article in 
The Journal of the American Medical 
Association called for a reduction in 
medical training by 30 percent by 
2020, arguing that the lengthy and 
expensive training is a driver of high 
health care costs. Other articles call 
for accelerating medical education to 
address physician shortages, citing 
lack of evidence that longer train¬ 
ing makes a better doctor. Dozens of 
schools are putting this theory to the 
test with six- to seven-year combined 
bs/m.d. programs. Some medical 
schools are offering students a three- 
year plan. Yale students are sticking 
around, however, to carry out research, 
bolster residency applications, explore 
career options—or maybe take one 
last year to focus on things other than 
medicine. While some other medical 
schools offer additional time for 
predefined research projects, Yale 
is unique in the absolute freedom 
it gives students. 
The first students to take a fifth year 
to do research did so in the 1980s. For 
many years the number held steady at 
about half the class. In 2007, however, 
three-quarters of the class stayed 
on for a fifth year. About half the 
next year’s class took a fifth year; in 
subsequent years the number of stu¬ 
dents staying on has hovered between 
two-thirds and three-quarters of each 
class—65 students who started with the 
class of 2011, and 57 who began their 
studies with the Class of 2012. 
Originally devoted to a year of 
full-time research, the hfth year was 
born out of a recognized decline in 
physician-scientists, said John Forrest, 
M.D., HS ’67, professor of medicine 
and director of the Office of Student 
Research. Meanwhile, the months 
I available for research in the four-year 
I curriculum had slipped over the years 
I from about ii to five and a half as new 
requirements were added. 
“Students who conduct 12 months 
of full-time research receive full fel¬ 
lowships of $24,000 to $28,000 per 
year. These fellowships are supported 
by grants from the Howard Hughes 
Medical Institute, our nih ctsa-tl 
I grant, the Doris Duke Charitable 
Foundation, the American Societv 
of Nephrology, the American Heart 
Association, and Yale-endowed one- 
year research fellowships,” Forrest said. 
“Many funding agencies supporting 
research are alarmed at the national 
decline in physician-scientists and have 
stepped up to the plate. They recognize 
that careers as physician-scientists 
often begin in medical school, particu¬ 
larly at research-intensive institutions 
such as ours.” 
About half the students taking a 
fifth year spend only part of the time 
i doing research in what’s called a par¬ 
tially funded or “flexible” fifth year. 
Their months of full-time research are 
funded at the nih predoctoral rate. 
The year might include research and 
rotations abroad. Students also audit 
undergraduate classes and do elective 
rotations—two went to culinary school 
1 and wrote a nutrition curriculum for 
the medical school. Others take the 
year, or more, to earn a joint degree in 
public health, public policy, business 
administration, or theology. 
“If there’s 70 people that do it, 
there’s 70 different things that they’ll 
get out of it and put into it,” said 
Michael Soule, m.d. ’12, who spent his 
fifth year researching substance abuse 
treatment in correctional facilities, 
serving on the admissions commit¬ 
tee, and taking a class on his favorite 
poet, Wallace Stevens. “Literature and 
writing keep me afloat as a person.” 
said Soule, who began his residency in 
psychiatry at Massachusetts General 
Hospital last summer. 
Zahir Kanjee, m.d. ’ii, studied art 
history, Spanish, European literature, 
and kept up with The New England 
Journal of Medicine. He also squeezed 
in workouts, time with friends, and 
three months in South Africa research¬ 
ing drug-resistant TB. Kanjee, now an 
internal medicine resident at Brigham 
and Women’s Hospital in Boston, said 
students have dubbed the four-year 
route at Yale “the accelerated track.” 
The fifth year at Yale is tuition-free, 
though some students may need addi¬ 
tional loans to cover living expenses. 
The payoff they said, is immeasurable. 
It’s been called the best year of medi¬ 
cal school by many. “It’s a wonderful 
opportunity that most med students 
don’t get,” Kanjee said. “It made me a 
better person, a better doctor, a happier 
and more complete person.” 
But with more than half the class 
adding a year to already lengthy train¬ 
ing, is there simply too much to do 
in four years at Yale? For some stu¬ 
dents, the four-year track is too over¬ 
scheduled to make a career decision, 
conduct in-depth research, and take 
advantage of what Yale offers outside 
the med school. 
“One of the biggest things that 
I think drives our students to take a 
fifth year is that there isn’t enough 
time in the third year to make a career 
decision,” said Nancy Angoff, m.p.h. 
’81, M.D. ’90, HS ’93, associate dean of 
student affairs. The third year, with its 
required clerkships in the core areas of 
medicine, has a tight schedule. 
That’s one reason Mei Elansary, 
M.D. ’12, who started a residency 
in pediatrics at Children’s Hospital 
Boston after graduation, took a fifth 
year. “My third-year exposure wasn’t 
quite enough to decide if [pediatrics] 
was for me,” so an elective in pediatric 
emergency medicine during her fifth 
year helped finalize the decision. 
Students who take a fifth year also 
tend to finish medical school with 
numerous publications and national 
meeting presentations on their 
resumes. “They’ve heard it will help 
their residency applications, especially 
in fields where there is a lot of pres¬ 
sure to do research in that area and 
publish,” Angoff said. 
A framework for overhauling the 
curriculum is now under way and will 
likely give students additional time for 
research and electives. Opinions are 
mixed among faculty and students as 
to whether this change will affect the 
number of students who stay on for an 
extra year. Some insist that the fifth 
year, symbolic of the medical school’s 
culture of independent research and a 
thesis, isn’t going to change. 
“Treating students with the under¬ 
standing that we are going to be profes¬ 
sionals who are all interested in different 
things, and putting the resources 
behind us to pursue our interests at the 
depth that we want—that trust and com¬ 
mitment to the students is reflected in 
the fifth year,” Soule said. “I think it’s 
really a reflection of the greater ethos of 
the school.” 
—Sonya Collins 
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Kyeen Mesesan Andersson uses 
mathematical models to predict the 
paths of infectious disease. 
Doing the math to fight 
infectious disease 
An infectious disease specialist applies 
mathematical modeling to predict the 
paths of deadly viruses. 
Kyeen Mesesan Andersson, m.d. ’07, 
PH.D. ’07, has always liked math. She 
knew from childhood, too, that she 
wanted to be a scientist. At Brown 
University she began her undergradu¬ 
ate studies with physics and switched 
to molecular biology. Then, just before 
graduation, a “life-changing” class in 
vaccine development set her on a path 
that led through infectious disease 
research and medicine before returning 
her full circle to math. 
First stop: two years as an emerg¬ 
ing infectious diseases fellow with 
the Centers for Disease Control and 
Prevention, where Andersson worked as 
a virologist on the dengue fever vaccine 
development team, devising mutant 
clones that might weaken the virus 
and be incorporated into a vaccine. At 
a conference, she met an official in the 
U.S. Army Medical Research Institute of 
Infectious Diseases who offered to send 
her to Peru so she could gain clinical 
experience with the disease. 
She spent a month in the Amazon 
port of Iquitos, where she saw many 
people infected by the virus she knew 
so well from the lab. Seeing the clini¬ 
cal picture, she became fascinated 
by the possibility of bridging the gap 
between science and medicine. That 
clinched her decision to apply to m.d./ 
PH.D. programs. 
Andersson entered the School of 
Medicine in 1999. At an aids con¬ 
ference during medical school she 
discovered a third approach to infec¬ 
tious disease: one of the speakers was 
Sir Roy Anderson, ph.d., a British 
epidemiologist known for his predictive 
mathematical models of Creutzfeldt- 
Jakob disease and aids. “I remember 
being absolutely amazed that you could 
use math to forecast disease growth 
and disease processes,” Andersson said. 
She was hooked. 
Under faculty advisors David A. 
Paltiel, PH.D., professor of public health, 
and Linda M. Niccolai, ph.d., associate 
professor of epidemiology, Andersson 
spent three years in South Africa creat¬ 
ing a mathematical model of the hiv 
epidemic in Soweto as well as surveying 
adults on their sexual risk-taking behav¬ 
iors. Her aim was to predict whether | 
changes in behaviors that resulted from 
taking an hiv vaccine would have an 
effect on the hiv epidemic. 
Policymakers deciding on new dis¬ 
ease interventions can’t wait the years 1 
that it takes to collect and analyze data, ' 
so they may rely instead on mathemati- ! 
cal simulations, Andersson explained. |i 
No one knows, for instance, whether j 
people who have received a partially j 
effective hiv vaccine would take more 011 
fewer precautions, nor the effects their ! 
post-vaccination behaviors might have 
on the virus’ spread. Andersson’s ph.d. . 
thesis created a model to answer just 
such questions. A vaccine that’s merely 
30 percent effective, she found, could 
still save lives. Three large clinical 
trials in Africa had shown that male 
circumcision could reduce transmission 1 
of HIV from women to men. Intrigued 
by those findings, she also modeled 
male circumcision and hiv transmis¬ 
sion in Soweto, and found that an adult 
male circumcision program could ' 
greatly reduce the expected number i 
of new infections. Those results made I 
world headlines after she presented , | 
them at the i6th International aids 
Conference in Toronto in 2006. 
After graduating from Yale she 
signed on as a postdoctoral fellow at the' 
School of Public Health and explored 
the gender dynamics of Hiv-preventive 
29 
, circumcision programs. Her new model 
showed that while widespread male cir¬ 
cumcision could reduce new infections, 
it could also increase new infections 
among Soweto women. The reason.^ 
Circumcised men may skip condoms— 
and women there may lack the power to 
demand their use. 
Since 2010, Andersson has continued 
developing mathematical models at the 
Futures Institute in Glastonbury, Conn., 
for clients like the Gates Foundation, 
UNAIDS, and health ministries overseas. 
She and her husband Richard, a South 
African engineer who works at Yale’s 
Office of Cooperative Research, are the 
parents of 2-year-old Amelia and i-year- 
old Alexis. 
Partly because of her four-year 
delay between college and medical 
, school, Andersson, 39, decided to forgo 
i residency training. “In an ideal world, 
I would have done both clinical medi- 
j cine and research,” she said. “I chose to 
do what was closest to my heart.” She 
j had once asked her mentor at Brown, 
I Anne De Groot, m.d., how she juggled 
research, family, and a medical practice. 
“That’s when I discovered that she 
had an ex-pro-hockey-player husband 
who was raising both kids and keeping 
house,” Andersson recalled, laughing. 
Though she misses clinical care, 
Andersson loves the power of math¬ 
ematical modeling. A recent question 
from one of the institute’s clients under¬ 
scored that for her. 
“When Bill Gates comes and asks 
you, ‘How much is it going to cost to 
treat everyone in the world [who has 
Hiv]?’ ” she noted, “it’s probably for a 
good reason.” 
—Jenny Blair 
An alumnus’ singular calling to 
medicine and ministry 
“Go to church this Sunday” was the 
prescription that Benjamin R. Doolittle, 
M.Div. ’94, M.D. ’97, wrote for a 
patient addicted to heroin. “Bring the 
church bulletin to our next appoint¬ 
ment,” he said. 
The patient had wanted to attend 
church but feared that the congregation 
would judge her. So Doolittle gave her 
the little push he knew she needed. 
She came to the next appointment, bul¬ 
letin in hand, glad she had gone. “The 
cure for addiction is never a pill,” said 
Doolittle, associate professor of medi¬ 
cine and of pediatrics at the School of 
Medicine. A person’s spirit must be 
renewed, their self-esteem rebuilt, and 
their shame released. “Medicine is 
this fusion of science and emotion and 
spirituality. As physicians we are more 
than technicians.” 
Though he wears a white coat 
on weekdays and a black robe on 
Sundays, he sees these two roles as 
“one singular call.” 
“I don’t see myself as a physician 
during the week and a minister on the 
weekend—there’s just me,” he said. 
Ever since Doolittle felt “the call” in 
his senior year at Yale College, where 
he studied biology and philosophy, he 
knew he wanted to pursue both medi¬ 
cine and the ministry. He was attracted 
to the “fix-it mentality” in medicine, 
but his volunteer work at a New Haven 
soup kitchen and a children’s theater 
program led to a love for community 
outreach that he could harness as a 
minister. “What’s so great about medi¬ 
cine is the stories and the relationship 
building that happen, and that very 
much feels like a ministry,” he said. 
He enrolled in divinity school first 
to get his “spiritual life squared away,” 
knowing that once he began medi¬ 
cal school it would be tough to take 
a break. The seeds of his spirituality 
had been planted while growing up 
in Schenectady, N.Y.. where he had 
attended a Protestant church; but it had 
been truly awakened during a gap year 
in Paris between high school and col¬ 
lege. Doolittle spent many lonely after¬ 
noons wandering the streets and sitting 
inside beautiful cathedrals. “I realized 
that I needed other emotional and 
spiritual resources for a sense of peace 
and happiness because I didn’t have the 
familiar anchors of my home,” he said. 
“Slowly, a sense of faith and prayer life 
became real to me.” 
In Doolittle’s first year of divinity 
school, one of the deans asked him to 
preach a few sermons for an inner-city 
church that was between ministers. 
He had no prior preaching experi¬ 
ence; however, Pilgrim Congregational 
Church was on the verge of closing 
and couldn’t afford a pastor. Why else 
would they take a medical student for 
a minister? Doolittle joked. Or even 
worse; a resident. 
The night before that first Sunday 
he borrowed a black robe and drank 
nearly a gallon of coffee to stay up writ¬ 
ing the sermon. He took a scene from 
Butch Cassidy and the Sundance Kid in 
which the title characters are shooting 
at a target, and related it to faith: “If you 
follow your instincts and heart, instead 
of overthinking, you will hit the target.” 
The congregation asked him to preach 
the next Sunday, and every Sunday 
all through his medical school days. 
“I would have to write my sermons on 
hospital note paper,” he said. 
Doolittle often told the stories of 
the wards from the pulpit; conversely, 
in the hospital he offers his patients 
spiritual counsel. And theological and 
medical problems may overlap and 
become indistinguishable. A patient 
with HIV, certain she was going to 
die, turned to faith. When her health 
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Alumni FACES 
started to improve, she stopped taking 
her medications, convinced that God 
iiad healed her. Her viral load crept up 
and her T-cell population diminished. 
Doolittle urged her to resume her medi¬ 
cations, and now she sees medicine not 
as separate from her faith but as “a gift 
from God.” 
Doolittle continues in his dual roles. 
On the medical school faculty he is 
the program director of the Gombined 
Internal Medicine and Pediatrics 
residency program. As the minister of 
social action at South Ghurch in New 
Britain, he provides support for the 
church’s outreach programs, much like 
the work he did as president of the cabi¬ 
net of Dwight Hall as an undergradu¬ 
ate. He also officiates at the weddings 
of students and faculty. This August he 
officiated at the wedding of two recent 
graduates, Matthew Vestal, m.d. ’ii, and 
Heather Speller, m.d. ’ii, at a vineyard 
in Stonington, Gonn. 
—Natalie Villacorta 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or has followed 
an unusual path since leaving Yale? We’d 
like to hear about alumni of the School of 
Medicine; Physician Associate Program; 
and the medical school’s doctoral, fellow¬ 
ship, and residency programs. Drop us a 
line at ymm@yale.edu or write to Faces, 
Yale Medicine, 1 Church Street, Suite 300, 
New Haven, CT 06510. 
With degrees in both theology and medicine, 
Benjamin Doolittle offers spiritual counseling 
and medical care. 
NOTES 31 
Howard Ozer Steven 
Scheinman 
1970s 
C. Norman Coleman, m.d. ’70, 
was honored with a University 
of Vermont Alumni Achievement 
Award at the annual Reunion 
& Homecoming weekend on 
October 5. Coleman graduated 
from the University of Vermont 
, imgSe with a bachelor of arts in 
' mathematics. He trained in in¬ 
ternal medicine at the University 
|i of California, San Francisco; in 
medical oncology at the National 
Cancer Institute; and in radiation 
oncology at Stanford University. 
Coleman is associate direc¬ 
tor of the Radiation Research 
Program in the Division of Cancer 
Treatment and Diagnosis and 
i special advisor to the director of 
j the National Cancer Institute. 
Howard Ozer, m.d. ’75, ph.d. ’75, 
has been named director of the 
University of Illinois Cancer Cen¬ 
ter. Ozer joined the faculty there 
in 2010 as the Eileen Lindsay 
Heidrick Professor in Oncology 
and chief of hematology/ 
oncology, and has served as 
interim director of the cancer 
center since January 2011. Ozer 
is internationally known for 
research in the development of 
hematopoietic growth factors 
and cytokines and for clinical 
trials of biological therapies for 
leukemia and lymphoma. 
Steven J. Scheinman, m.d. ’77, 
HS ’80, FW ’84, was named 
president and dean of The Com¬ 
monwealth Medical College in 
Scranton, Pa., as of September 10. 
Scheinman had been professor 
of medicine and pharmacology 
Douglas Paul Rothman 
Wallace 
Rahn Bailey Jeffrey Lyness Sara Nayeem 
and George Bell 
at SUNY Upstate Medical Uni¬ 
versity and served as its senior 
vice president and dean of the 
College of Medicine from 2004 
to 2011. 
Douglas C. Wallace, ph.d. ’75, a 
genetics researcher who founded 
the field of mitochondrial 
genetics in humans, received the 
2012 Genetics Prize of the Gruber 
Foundation in November. Wallace 
was honored for his groundbreak¬ 
ing achievements in helping 
scientists understand the role 
of mitochondria in the develop¬ 
ment of disease and as markers 
of human evolution. He received 
the award in New Orleans at the 
annual meeting of the American 
Society of Human Genetics. 
1980s 
Paul B. Rothman, m.d. ’84, was 
appointed in December 2011 
as the 14th dean of the Johns 
Hopkins University School of 
Medicine and second chief 
executive officer of Johns 
Hopkins Medicine, a combina¬ 
tion of an academic medical 
center and a health system 
with a global reach. Rothman, a 
rheumatologist and molecular 
immunologist, previously served 
as dean of the Carver College 
of Medicine at the University of 
Iowa and as leader of that uni¬ 
versity’s clinical practice plan. 
He succeeds Edward D. Miller, 
M.D., who retired after 15 years 
as both dean and the first CEO of 
Johns Hopkins Medicine. 
1990s 
Rahn K. Bailey, m.d., fw '95, as¬ 
sociate professor and chair of the 
Department of Psychiatry and 
Behavioral Sciences at Meharry 
Medical College, was installed 
as president of the National 
Medical Association (nma) on 
July 31 at the association’s 2012 
Annual Convention and Scientific 
Assembly in New Orleans, nma 
is the largest and oldest na¬ 
tional organization representing 
African-American physicians and 
the patients they serve. A gradu¬ 
ate of Morehouse College, Bailey 
received his medical degree from 
the University of Texas Medical 
Branch in Galveston, Texas. He 
completed his residency in psy¬ 
chiatry at the University of Texas 
at Houston and completed a 
fellowship in forensic psychiatry 
in the Department of Psychiatry 
at the School of Medicine. 
Jeffrey M. Lyness, m.d., hs ’90, 
professor of psychiatry, became 
the senior associate dean for aca¬ 
demic affairs at the University 
of Rochester School of Medicine 
and Dentistry on July 1. Lyness, 
who was appointed associate 
dean for academic affairs a year 
ago, has been director of cur¬ 
riculum for medical student edu¬ 
cation since 2008 and medical 
director of continuing medical 
education since 2010. He is past 
president of the American Asso¬ 
ciation for Geriatric Psychiatry. 
William Pao, ph.d. ’97, m.d. ’98, 
was honored for his leadership 
in lung cancer research by Joan’s 
Legacy: Uniting Against Lung 
Cancer at its “Strolling Supper 
with Blues and News” gala in 
New York City in November. 
Pao is director of the Division 
of Hematology and Oncology, 
director of Personalized Cancer 
Medicine, and professor of 
medicine, cancer biology, and 
pathology/ microbiology/immu- 
noiogy at Vanderbilt University. 
2000s 
Sara M. Nayeem, m.d. ’06, 
M.B.A. ’06, and George W. Bell IV, 
M.D., were married on August 11 
in Alexandria, Va. Nayeem works 
at New Enterprise Associates, 
a venture capital firm in Chevy 
Chase, Md., where she directs the 
firm’s investments in biophar- 
maceutical companies. Bell is 
a cardiologist at CardioCare, a 
clinic in Chevy Chase. 
2010s 
Alisse K. Hauspurg, m.d. ’12, 
and Adam J. Janicki, m.d., were 
married on June 2 in Stonington, 
Conn. The couple met as under¬ 
graduates at the University of 
Pennsylvania. Hauspurg is a resi¬ 
dent in ob/gyn at Women and 
Infants Hospital of Rhode Island 
in Providence. Janicki received 
his medical degree from Tufts 
and is a resident in emergency 
medicine at Rhode Island Hospi¬ 
tal in Providence. 
SEND ALUMNI NEWS TO 
Claire M. Bessinger, Yale Medicine, 
I Church Street. Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
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32 in memoriam 
Festus Olumiywa Adebonojo, 
M.D. ’60, HS ’63, professor 
emeritus of pediatrics at Eastern 
Tennessee State University, died 
in Johnson City, Tenn., on June 25. 
He was 81, Adebonojo was the 
first Nigerian to graduate from 
Yale University and the first Ni¬ 
gerian to complete an m.d. and 
residency training at Yale. 
Richard J. Apell, doctor of 
optometry, died on May 30 
in Madison, Conn. He was 90. 
Apell was head of the Optomet- 
ric Department of the Gesell 
Institute of Human Develop¬ 
ment in New Haven between 
1950 and 1960. 
Edith M. Beck, M.D. ’48, died on 
August 17 in Greenwich, Conn. 
She was 91. Beck was chair of the 
general medical section at Green¬ 
wich Hospital for many years and 
had been a clinical instructor at 
the School of Medicine. 
Allan A. Brandt, m.d. ’51, died in 
Milford, Conn., on May 1. He was 
89. As director of Emergency 
Medical Services at Milford 
Hospital, Brandt was instrumen¬ 
tal in establishing the city’s first 
Emergency Medical Services 
Council whose efforts allowed 
Milford to be a pioneer partici¬ 
pant in the national 911 system. 
Jane B. Cadbury, m.d. ’43, one 
of the first women to juggle 
a career as a physician with 
raising children, died on July 7 in 
Framingham, Mass. She was 94. 
Cadbury was one of only three 
women in her medical school 
class and became the first woman 
to be promoted to district direc¬ 
tor of the Saint Louis County 
Health Department in the early 
1960s. After moving into public 
health she spent more than 
20 years as a physician in the 
health service at the University 
of Wisconsin-Milwaukee. 
Anthony P. Cipriano, m.d., hs ’69, 
died on May 25 at his home in 
Branford, Conn. He was 96. As 
a captain in the Army Medi¬ 
cal Corps during World War II, 
Cipriano landed on the beaches 
of Normandy on D-Day, wit¬ 
nessed the liberation of Paris, 
and was wounded in the Battle 
of the Bulge. On his return to 
New Haven, he became one of 
the first specialists in internal 
medicine. In 1969 he completed 
a residency in dermatology at 
Yale and practiced in New Haven 
and East Haven until he retired 
in 2003 at the age of 87. 
John Dana Clark, m.d., died on 
June 30 in Madison, Conn. He 
was 79. Clark had been chief 
of anesthesiology at Yale-New 
Haven Hospital and an assistant 
clinical professor of anesthesiol¬ 
ogy at the School of Medicine. 
John P. Ferguson Jr., m.d. ’39, a 
retired obstetrician/gynecolo¬ 
gist, died on June 30 in Spring- 
field, Mo. He was 97. 
Edward J. Gerety, m.d. ’54, a re¬ 
tired thoracic and cardiovascular 
surgeon, died on September 7 
in Albuquerque, N.M. Afighter 
pilot in the Marine Corps during 
World War II, he was 93. 
George W. Greenman, m.d., 
FW ’59, HS ’65, died on May i6 
in Tucson, Ariz. He was 85. 
A retired psychoanalyst. Green- 
man began his career as a pe¬ 
diatrician but later completed a 
medical residency in psychiatry 
at Yale-New Haven Hospital. 
Henry H. Jones, m.d. ’43, hs '46, 
professor emeritus of radiology 
at the Stanford University School 
of Medicine, died at his home on 
campus on August 11. He was 95. 
Jones was a key member of the 
team that built the department 
into a powerhouse in the field. 
He was the first chief of the 
radiology service at the Palo Alto 
Veterans Administration Hospi¬ 
tal, now the Veterans Affairs 
Palo Alto Health Care System. 
Jones was a founding member 
of Physicians for Social Respon¬ 
sibility and a leader in the move¬ 
ment to eliminate the threat 
of nuclear war and weapons of 
mass destruction. 
Edith M. Jurka, M.D. ’44, died on 
May 19 in Clearwater, Fla. She 
was 96. A longtime resident of 
Croton-on Hudson, N.Y., Jurka had 
a private practice in psychiatry. 
Jerome "Jerry” Kaye, m.d. ’44, 
a retired pediatrician, died on 
May 28, in Boulder, Colo. 
He was 93. Kaye practiced pe¬ 
diatrics in Phoenix from 1947 to 
2002 and was part of a group of 
doctors who helped make Phoe¬ 
nix Children's Hospital a reality. 
Frederick Martin Lane, m.d. ’53, 
HS ’59, a former clinical professor 
of psychiatry at the Columbia 
University College of Physicians 
and Surgeons, died on June 12 in 
New York City. He was 84. 
Walter E. Needham, ph.d., who 
served in the departments of 
psychiatry, psychology, and neu¬ 
rology at the School of Medicine, 
died on June 6 at his home in 
Madison, Conn., after a long 
battle with cancer. He was 76. 
Eveline B. Omwake, m.a., died 
in Black Mountain, N.C., on Au¬ 
gust 19. She was 100. Omwake 
was assistant professor in the 
Child Study Center from 1952 to 
1964 and also served as the di¬ 
rector of the center’s Laboratory 
Nursery School. 
Fitzhugh C. Pannill Jr, m.d. ’45, 
died on June 30 in New Braunfels, 
Texas, after a brief illness. He 
was 90. In 1965 Pannill was 
named dean of the new Univer¬ 
sity of Texas Medical School at 
San Antonio, where he recruited 
faculty, students, and staff to 
establish what was soon recog¬ 
nized as a world-class medi¬ 
cal institution. In 1973 he was 
recruited to the State University 
of New York at Buffalo, where he 
served as vice president of health 
affairs, acting dean, and profes¬ 
sor of medicine. 
William L. Roberts, m.d., ph.d., 
HS ’91, FW ’95, medical director 
at ARUP Laboratories and a pro¬ 
fessor at the University of Utah 
School of Medicine, died in Salt 
Lake City on July 26 following a 
year-long battle with brain can¬ 
cer. He was 52. In 1998, Roberts 
joined the University of Utah 
and ARUP as assistant profes¬ 
sor in clinical chemistry, and he 
became a full professor in 2007. 
Richard H. Saunders Jr, m.d., hs ’49, 
a retired professor of medicine, 
died at his home in Middlebury, 
Vt., on August 12. He was 93. 
Saunders helped to create the 
University of Massachusetts 
Medical School in Worcester, 
Mass., where he was professor 
of medicine and associate dean 
from 1969 to 1982. 
Paul H. Seton, m.d. ’52, hs ’53, 
a retired psychoanalyst, died 
of pneumonia in Northamp¬ 
ton, Mass., on May 22. He was 
88. Seton had been director of 
counseling services at Smith 
College, taught at the Smith Col¬ 
lege School of Social Work, and 
maintained a private psychoana¬ 
lytic practice. 
Roy B. Sherman, m.d. ’58, hs ’61, 
of Winsted, Conn., died on June 13, 
his 83rd birthday. Sherman had 
been chief of anesthesiology at 
Winsted Memorial Hospital. 
Bernard Snow, m.d., hs ’61, a re¬ 
tired psychiatrist who practiced I 
in New Haven for many years, 
died at Yale-New Haven Hospi¬ 
tal on September 10. He was 81. 
Marc J. Taylor, m.d., hs ’66, 
FW ’68, of Southbury, Conn., died 
on June 5 at Smilow Cancer Hos¬ 
pital in New Haven. He was 75. 
Taylor was head of the liver 
study unit at the VA Connecti¬ 
cut Healthcare System in West 
Haven. He had been a clinical 
associate professor of medicine 
at Yale and attending physician 
at Waterbury Hospital. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-maii 
to claire.bessinger@yale.edu 
Art exhibit honors anatomy lab donors 
Unused cubbyholes outside the anatomy labs in The Aniyan Center have become 
home to student works of art that honor the donors who contributed their remains for 
medical training. Students who completed anatomy studies in 2012 worked in teams 
to create small boxes that reflect their feelings about their work with the donors. 
vale Medicine yale university, i church street, suite 300, new haven ct 06510 
yalemedicine.yale.edu 
winter 2013 
i'i 
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U.S. Postage 1 
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Burlington, VT 05401 
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PERIODICAL ROOM 
Cushing-Whitney Medical Library 
Historic medical 
texts online 
spring 2013 YSM'S unsung 
heroes 
New leader 
atYMG 
cancer 
While some Yale scientists, ^ 
partner with industry to develop 
new cancer drugs, others want 
to know whether stem cells are 
to blame for cancer. 
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Letters 
HOW TO REACH US 
Yale Medicine welcomes news 
and commentary. Please send 
letters (350 words or fewer) and 
news items to Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via 
e-mail to ymm@yale.edu, and 
include a telephone number. 
Submissions may be edited for 
length and content. 
Visit us on 
the Web 
Our new website is up and 
running—and the feedback has 
been wonderful! Visit us 
at yalemedicine.yale.edu and 
peruse the newest issue or 
issues going back to 1998. 
Meeting alumni on the 
residency trail 
One of the highlights of my 
residency interview season 
was meeting alumni of our 
school. These encounters were 
among the most pleasant on 
the interview trail because the 
conversations would frequently 
turn to the Yale system. Having 
represented my colleagues on 
the school-wide Educational 
Policy Committee during medical 
school, I had the special privilege 
of helping carry out the commit¬ 
tee’s charge to interpret the phi¬ 
losophy of the Yale system and 
articulate Its manifestation amid 
the challenges of modern medical 
education. With a certain pride 
and responsibility, I assured my 
alumni interviewers that indeed, 
there are still no class rankings 
or attendance lists; and yes, the 
thesis requirement still runs the 
graduating class a bit ragged 
around this time of year. 
The unexpected reward from 
these interviews was discovering 
what happens after Yale. On 
the cusp of my own graduation 
I have wondered whether the 
Yale system and Its pillars of self- 
motivated learning and innova¬ 
tion will still matter a few months 
from now. The answer, from 
the experiences of those who 
have come through the Sterling 
Hall of Medicine before me, is 
a remarkable 'yes.’ One inter¬ 
viewer demonstrated the iPhone 
app he had designed to help 
patients track their lab results 
over time. Another described the 
fruitful collaborations she has 
made with faculty across her 
university to improve health out¬ 
reach in the community. Another 
showed me pictures from her 
recent exhibition of paintings—a 
hobby she developed during an 
elective course at the Yale School 
of Art. What binds their stories 
together is not that Yale taught 
them howto program software, 
or find collaborators, or apply 
oil to canvas. These alumni sug¬ 
gested to me that the Yale system 
fostered an environment that 
encourages lifelong opportunities 
to augment their learning. They 
became physicians alongside the 
exploration of complementary 
interests, not in spite of it. 
As I prepare to retire my short 
white coat, I recognize now that 
the three words emblazoned 
across the left pocket—Yale 
Medical Student—represent 
much more than the position I 
have held for four years. I have 
been deeply Inspired by the 
stories of these former students 
of medicine at Yale, and I am 
hopeful that my career as a physi¬ 
cian will continue to be shaped 
by the Yale system, which has 
distinguished the school for over 
80 years—and, as I have come to 
understand, finds new meaning 
in the lives of its graduates. 
Kevin Koo, m.d. ’75 
New Haven, Conn. 
Writing and medicine 
The Internal Medicine Writers’ 
Workshop was a big draw for 
me when I was interviewing for 
residency [“Writers’ Workshop 
Celebrates 10 Years,” Yale 
Medicine Online, Winter 2013]. 
I was an English major in college 
and I started to write stories 
about my experiences with 
patients during my third year of 
medical school. I began writing, 
and still do so, primarily as an 
outlet for the stresses of life in 
medicine. The first story I wrote 
was about an experience I had in 
med school taking care of a young 
woman who lost a baby dur¬ 
ing her second trimester. I write 
because the patients that we see 
every day—and their stories—are 
important. The Writers’ Workshop 
has been the perfect outlet for 
me to share these stories. In the 
workshop, I have seen emotions 
and passions in my coworkers and 
friends that I had not witnessed 
while working side-by-side with 
them for 80 hours a week for 
the past few years. It’s a safe 
environment where we can share 
thoughts and feelings without 
the pressured constraints of daily 
clinical life. Through my participa¬ 
tion in the Writers’ Workshop, 
I have been reminded of why I 
went into medicine—the inter¬ 
personal relationships, the ability 
to help heal others, sometimes 
simply by listening. 
I am so thankful that we 
have the Writers’ Workshop. It 
has helped to make me a more 
empathetic and well-rounded 
physician, and has made a major 
impact on me during these for¬ 
mative years in my training. 
Paul Florilli, m.d. 
Department of Medicine 
Yale-New Haven Hospital 
The complexities of emrs 
I enjoyed reading "Yale’s Epic 
Challenge” in the Winter 2013 
Yale Medicine. As a former CMio 
who trained in medical informat¬ 
ics and clinical computing at Yale, 
I know the challenges of emr 
implementation are considerable, j 
especially for an organization as 
large and complex as the Yale 
Health System. In fact, the term 
"ehr” is an anachronism; what 
Yale and others are now imple- j 
menting are not simply electronic ■; 
filing systems but enterprise¬ 
wide clinical resource and clini- j 
dan control systems, with all the 1 
complexity that implies. 
I do hope that Yale has 
learned well from the trials 
and tribulations of others’ prior 
efforts. I still note many dif¬ 
ficulties with commercial ehrs, . 
resulting in unintended con- 1 
sequences up to and including j 
patient injury and death. , 
Finally, I note that the state¬ 
ment [by one of the physicians 
quoted in the article] that J 
"emr use is mandated by fed- j 
eral authorities for everyone 
who’s in the Medicare and 
Medicaid arena” is not accurate . 
While there are reimbursement 
penalties for non-adopters 
of HHS-’’certified” ehrs in those 
programs, there are no federal 
or state requirements for 
their use. ! 
Responsibility for the choice ' 
of ehr adoption and liability for j 
patient safety problems that ma; 1 
result falls fully on the adopters. ! 
Health care leadership should 
remain ever mindful of this. 
Scot Silverstein, m.d., fw ’g4 
Philadelphia, Pa. 
starting point 3 
A new look for Yale Medicine 
As it happens both of this issue’s feature stories are about cancer. Marc Wortman reports on 
a controversial theory that holds that certain stem cells underlie cancer and that identifying 
I these cells can lead to new possibilities for treatment. Kara Nyberg reports on a partnership 
between the School of Medicine and Gilead Sciences in which the pharmaceutical company 
underwrites research at Yale that could lead to new targets for drugs to fight cancer. Having 
two articles on a related topic in this issue owes more to serendipity than our editorial pre¬ 
science, but starting with our autumn issue, the features in Yale Medicine will all be linked 
by a theme in science or medicine. This focus will allow us to explore in depth advances in 
science and medicine not just at Yale but around the world. 
This thematic approach is part of a new vision for the magazine as we embark on a 
redesign to give the print edition of Yale Medicine a livelier and more modern look. We will 
expand our news and feature section and some sections that have traditionally appeared in 
our print issue—faculty, alumni, and student news—will appear online only. As part of our 
redesign we’ll expand our online edition with regular postings in between print issues. Our 
print issue will continue to appear three times a year, in winter, spring, and autumn. 
We hope that you will enjoy the new format of the magazine as we continue to bring you 
news of the School of Medicine community. 
John Curtis 
Editor 
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chronicle news from cedar street 
I 
Paul Taheri began his new post as ceo of Yale 
Medical Group in March. He came to Yale from 
the University of Vermont, where he prepared 
the medical practice for the future of health 
care reform. 
As health reform looms, 
a new leader at ymg 
Paul Taheri sees centralization, stan¬ 
dardization, and primary care as keys 
to the practice’s success. 
In March Paul Taheri, m.d., m.b.a., left 
Shelburne, Vt., a suburb of Burlington, 
for a new job in New Haven. Taheri, 
who had led the University of Vermont 
Medical Group since 2007, arrived to 
take over as ceo of Yale Medical Group 
(ymg). He moved from overseeing a 
500-physiciatr multispecialty group to ! 
leading one that has more than 1,000 I 
physicians, mostly specialists. ; 
“Yale is a bigger enterprise,” said 
Taheri, who will also serve as deputy : 
dean at the School of Medicine. ■ 
Yale’s location on an axis that includes I 
such powerhouse medical centers as 
New York City and Boston places it, 
Taheri said, in the “hotbed of innova¬ 
tion and delivery.” ; 
That said, Taheri’s move to New i 
Haven comes at a time of imminent 
change in medicine both nationally i 
and locally. President Obama’s health 
care reform takes effect next year, 
with anticipated cuts in reimburse¬ 
ment from Medicaid and Medicare as 
well as other changes in the financial 
model of medical practice. Many in 
medicine foresee a shortage of physi¬ 
cians at the same time that thousands 
of new patients are expected to enroll 
in Medicare. The shortage of primary 
care doctors is of particular concern, 
Taheri said. “The general trend in 
American health care is placing a 
greater emphasis on primary care,” 
he said. “We have to figure out how to 
either integrate or build relationships 
with primary care providers. I suspect 
that is where the practice will grow.” 
The clinical practice at Yale has 
seen major expansion over the past 
decade—the size of the clinical fac¬ 
ulty has grown; clinical revenues have 
nearly doubled; and clinical programs 
have expanded in breadth and depth— 
but leadership at the medical school 
and within ymg see a need for a more 
centralized and unified physician 
group practice. 
Taheri agrees, and achieving that 
is among his immediate priorities. 
“Figuring out how we govern our¬ 
selves will be a very big issue,” he 
said. “Ultimately things need to come 
to some pinnacle and have decisions 
made by the group.” 
He’s also hoping to continue 
the move toward standardized cus¬ 
tomer service throughout the medi¬ 
cal group’s practices. “How does 
registration work? How are patients 
brought to the room? What person 
is doing what in the clinic?” he said. 
“Whether they go to New London 
or Bridgeport, it should be the same 
experience. There are huge benefits 
to standardization.” 
Taheri was credited with prepar¬ 
ing the medical practice at uvm for 
the future of health care reform both 
I financially and operationally. He 
[established the Fletcher Allen Center 
[for Health Care Management to pro¬ 
vide business training for physicians. 
HEALTH AND FAT’S EXCESS ENERGY 
Yale scientists have found that excess energy 
is packaged into fundamentally different fat 
deposits, which are associated with many 
health problems linked to being overweight. 
“The cell’s inability to process all the 
excess energy—not the accumulation of 
fat itself—is what causes most health prob¬ 
lems,’’ said Tobias Walther, ph.d., associate 
professor of cell biology and senior author 
of the study published online February 13 
in the journal Developmental Cell. Health 
problems start when molecules linked to fat 
synthesis overwhelm cells, rendering them 
unable to store energy as fat. That storage 
failure leads to inflammation, insulin resis¬ 
tance, fatty liver, and other problems associ¬ 
ated with obesity. 
Exploring ways to prevent failure of the 
cells’ ability to accommodate excess energy 
may be a more effective way to tackle the 
health problems associated with obesity than 
simply trying to get rid of fat itself, Walther 
said. “Historically, concentrating on just burn¬ 
ing fat has not worked too well,” he said. 
—John Curtis 
PREDICTOR FOR INPATIENT CARE 
Though elderly people with heart failure 
often enter the hospital over and over, 
it’s hard to estimate a specific individual’s 
risk of landing there. One low-tech way 
may be to check gait speed. 
Sarwat Chaudhry, m.d., associate pro¬ 
fessor of medicine, isolated health factors 
in elderly heart failure patients that were 
likely to precede hospital admission. Weak 
grip strength and slow gait, she found, 
were comparable to chronic kidney disease 
and diabetes for predicting admission. 
The results appeared in the Journal of the 
American College of Cardiology in January. 
Her predictors make sense, says Chaudhry: 
Gait speed requires the smooth function of 
several organ systems, and is also the single 
best measure of frailty in the elderly. While 
it’s important to keep track of chronic dis¬ 
eases, she added that measuring an elderly 
person’s general functioning is also impor¬ 
tant: “Physical function turns out to be a sim¬ 
ple and accessible marker of overall health.” 
—Jenny Blair 
nurses, and administrators; and he 
led the uvm Medical Group Revenue 
Department to achieve national rank¬ 
ing among its peers. 
YMG, he said, is well positioned to 
weather coming storms, Taheri said. 
“You have world-class faculty,” he said. 
“You have a great brand. You still have 
leverage with the payers. As long as we 
are data-driven, thoughtful, methodical, 
we can manage the changes and balance 
all the missions of the enterprise, and 
come out more able to bear risk.” 
Taheri succeeds David J. Leffell, m.d., 
director and later ceo of ymg, who led 
the transformation of ymg over the past 
15 years while continuing to direct the 
Section of Dermatologic Surgery and 
Cutaneous Oncology. Leffell’s leader¬ 
ship has advanced ymg’s reputation 
for quality of care and service, and he 
spearheaded many initiatives, includ¬ 
ing the branding of the clinical practice 
under the name Yale Medical Group; 
establishing first-rate billing, collec¬ 
tions, and compliance functions; and 
selecting Epic as the medical center’s 
first integrated electronic health record. 
Michael Berman, m.d., who directed 
the initial restructuring of the practice, 
oversaw its operations as interim direc¬ 
tor and CEO during the past year. 
—John Curtis 
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6 chronicle news from cedar street 
When viewing their own 
possessions, hoarders’ brains 
light up under fMRi 
In the spring of 1947, two brothers 
named Homer and Langley Collyer were 
discovered dead in their Harlem brown- 
stone. To reach them, police had to make 
their way through a barricade of 140 tons 
of treasure and garbage—including 
dress dummies, bales of newspapers, 
and the chassis of a Model T—that 
Langley had collected over decades. 
Compidsive hoarding is a behavior 
both fascinating and tragic. Hoarders’ 
penchant for accumulating innumer¬ 
able but often worthless objects can 
disrupt careers, break up families, 
and even kill. And there are countless 
cases less famous than the Collyers’. 
In the reality television show Hoarders, 
people display blithe indifference to 
the mounds of belongings in their 
houses—yet grow panicky when faced 
with discarding them. 
That peculiar combination of non¬ 
chalance and anxiety about possessions, 
which David Tolin, ph.d., adjunct asso¬ 
ciate professor of psychiatry, calls the 
“two basic head-scratchers” of hoarding 
disorder (HD), has now been captured 
on functional magnetic resonance 
imaging (fiURi) of the brain. 
Tolin and his colleagues asked 
three groups of people—HD patients, 
obsessive-compulsive disorder (ocd) 
patients, and healthy controls—to bring 
in a pile of junk mail from home. Each 
piece was photographed, as were pieces 
of mail supplied by the lab. As the 
subjects lay in an mri machine, they 
viewed photos of their own and the 
lab’s mail, then decided whether each 
item should be kept or shredded. 
Compared with the other groups, 
HD patients experienced abnormally 
low brain activation in the insula (a 
structure within the cerebral cortex) 
and in the anterior cingulate cortex 
(ACC) when they assessed the experi¬ 
menters’ possessions. By contrast, 
those same brain regions lit up in 
a hyperactive pattern when the HD 
patients assessed their own posses¬ 
sions. (Perhaps unsurprisingly, the 
HD patients chose to shred fewer per¬ 
sonal items than did members of the 
other groups.) The results were pub¬ 
lished in the August 2012 issue of the 
Archives of General Psychiatry. 
“That biphasic abnormality 
maps on really well to some of the 
clinical puzzles that we have in 
hoarding,” said Tolin, who works 
with HD patients as director of the 
Anxiety Disorders Center at Hartford 
Hospital’s Institute of Living, and who 
has appeared as a guest expert on 
Hoarders. “You can see that flip-flop 
occurring even clinically.” 
While HD has long been consid¬ 
ered a type of ocd, Tolin’s results add 
to a growing body of evidence that it is 
a distinct disorder. “The more people 
we talked to who had hoarding prob¬ 
lems,” Tolin said, “the more skeptical 
we became that this had anything to 
do with OCD." In a previous study, 
he found that fewer than one in five 
hoarders meet the Diagnostic and 
The world’s best-known hoarders were the ec¬ 
centric and reclusive Collyer brothers, Langley 
and Homer. When they were found dead in 
their New York City brownstone in 1947, they 
were buried amid 140 tons of junk. Yale scien¬ 
tists have captured on fMRi some of the brain 
activity associated with hoarding. 
Statistical Manual of Mental Disorders 
(dsm) criteria for ocd. 
In fact, HD may bear some relation 
to autism and anxiety disorders. The 
insula and acc help a person decide 
whether an object is relevant to him or 
her; and HD patients’ low level of acti¬ 
vation in these regions while viewing 
experimenters’ possessions is similar 
to the reaction of autistic patients to 
human faces. On the other hand, the 
hyperactive response echoes patterns 
seen in anxiety disorders. That, too, 
makes clinical sense: If every item 
seems relevant, then trying to decide 
which ones to throw away can be 
overwhelming. 
HD will be included as a separate 
disorder in the upcoming fifth edition of 
the DSM, psychiatry’s bible. In the mean¬ 
time, Tolin cautions that abnormalities 
in brain mris don’t mean that HD is 
untreatable. “Regardless of what’s going 
on in the brain,” he said, with appropri¬ 
ate treatment “people can overcome 
hoarding. They can get better.” 
—Jenny Blair 
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Two key genetic mutations 
open new pathways to 
treating meningioma 
Murat Giinel, m.d., hs ’98, can now 
look at the mri of a patient with 
meningioma and tell with almost com¬ 
plete certainty which genetic mutation 
is causing the tumor, based solely 
on the tumor’s location in the brain. 
Moreover, in time he may be able to 
cure the tumor without ever wielding 
a surgical blade. 
Whereas most tumors contain a 
dizzying array of garbled dna and 
broken chromosomes, making it dif¬ 
ficult to target any single molecular 
abnormality for therapy, Giinel’s group 
found that meningiomas—which arise 
from the membranes covering the 
brain and are the most common form 
of primary brain tumor—feature only 
one or sometimes two key mutations 
in just five genes. What’s more, these 
mutations are closely tied to the biology 
of the tumors, including their location 
and malignant potential, as reported 
' in the March i issue of Science. These 
' findings, said Giinel, the Nixdorff- 
I German Professor of Neurosurgery 
and professor of neurobiology and of 
genetics, can point the way to more 
straightforward treatment for menin¬ 
giomas, which presently affect about 
170,000 people in the United States. 
Although 90 percent of these 
tumors are histologically benign, they 
sometimes require surgical treatment 
because they can invade such critical 
neurovascular structures as the optic 
canal. The 10 percent of meningiomas 
that are malignant also require surgi¬ 
cal removal, as no medical therapies 
are currently available. 
The culprits in about half of all 
meningiomas are mutations in the 
i tumor suppressor gene neurofibro- 
min 2, or NF2. Until now, however, the 
; mutational causes of the other half of 
meningiomas remained a mystery. 
; To crack the case, Giinel and 
his colleagues scoured menin¬ 
gioma exomes using whole-exome 
sequencing technology developed at 
Yale. Their search turned up four new 
genetic culprits. Two of the mutated 
genes, SMO and akti, have been 
implicated in other cancers, including 
basal cell carcinoma and medulloblas¬ 
toma. Another gene, KLF4, maintains 
embryonic stem cells and can prevent 
their differentiation, trafj, the fourth 
gene identified, occurs in about a 
quarter of all meningiomas but had 
not been previously linked to cancer. 
The scientists found that these 
genetic defects do not run in the same 
circles. Rather, they are mutually 
exclusive of NF2, the suppressor gene, 
and sometimes even of one another. 
In about a third of the defects, the 
researchers found, TRAFy mutations 
worked in tandem with either KLF4 or 
AKTi mutations. 
Giinel’s group also discovered that 
these distinct mutational groups can 
predict where the meningioma will 
appear and how it will affect the brain. 
For example, tumors with NFi muta¬ 
tions border the brain’s hemispheres 
and feature genomic instability that 
can lead to malignancy. In contrast, 
tumors with SMO mutations arise from 
the skull base near the midline where 
surgery is difficult, but they show a 
stable genetic profile that suggests they 
will remain benign. “One of the next 
steps is to perform clinical trials to see 
if we can cure these meningiomas with 
targeted therapies,” said Giinel. 
These findings represent a break¬ 
through in treating meningiomas and 
also malignant brain cancers. Giinel 
believes that malignant tumors are 
basically conglomerations of the differ¬ 
ent individual types of cells that form 
benign tumors. “If we have the drugs to 
attack all of those subpopulations, then 
curing a malignant tumor is not going 
to be different than curing a benign 
tumor. The problem is that we didn’t 
have the tools until recently to under¬ 
stand the complex genomic nature of 
these cancers and how we would attack 
all of the cancer at the same time.” 
—Kara Nyberg 
WHY HEAVY DRINKERS CAN’T QUIT 
The brains of heavy drinkers, Yale scien¬ 
tists reported in the Journal of Clinical 
Investigation in March, are more receptive 
to a chemical byproduct of alcohol con¬ 
sumption that may make it hard to quit. 
Fourteen drinkers—half had had at least 
eight drinks a week, including four drinks 
per occasion once a week, and half had 
had fewer than two per week—were given 
acetate. The liver normally converts alcohol 
to acetate, which the brain uses for fuel and 
may come to prefer over blood sugar. That 
in turn may promote dependence, because 
people who stop heavy drinking lose not 
only the alcohol itself but also the acetate. 
“There may be ways to support early 
sobriety with acetate or drugs that mimic 
some effects of acetate, and we need to 
investigate that with respect to effective¬ 
ness, safety, cost, and practicality,” said 
senior author Graeme Mason, ph.d., profes¬ 
sor of diagnostic radiology and psychiatry. 
—John Curtis 
MAKING AN OLD BRAIN YOUNG 
Yale scientists have reversed a molecular 
switch that helps the brain make the transi¬ 
tion from teenager to adult. They reported 
on March 6 in the journal Neuron making 
an adult mouse brain youthful, which pro¬ 
moted learning and healing. 
Scientists have long known that adoles¬ 
cent brains are more malleable—youngsters 
learn languages more quickly and recover 
faster from brain injuries. The Yale team 
found that without this molecular switch— 
the Nogo Receptor 1 gene—^juvenile levels of 
brain plasticity lasted into adulthood. When 
researchers blocked this gene in adult mice, 
they found that the mice recovered from 
injury as quickly as adolescents and mas¬ 
tered complex motor tasks more quickly than 
adults with the receptor gene. 
“It suggests we can turn back the clock 
in the adult brain and recover from trauma 
the way kids recover,” said senior author 
Stephen Strittmatter, m.d., ph.d., the 
Vincent Coates Professor of Neurology and 
professor of neurobiology. 
—J.C. 
Y
al
e 
M
e
d
ic
in
e
 
s
p
ri
ng
 
20
13
 
8 Books & ideas 
How to bounce back from trauma 
Two psychiatrists explore why some people are better able 
to endure trauma than others. 
Rear Admiral Robert Shumaker survived eight years in 
North Vietnamese prisons by helping to develop a secret 
communication lifeline among his fellow prisoners. While 
most people undergo some form of trauma during their 
lifetime—though not always as harrowing as Shumaker’s— 
some bounce back more easily than others. 
For 20 years, Steven M. 
Southwick, M.D., and Dennis 
S. Charney, m.d., hs ’81, 
have been studying the 
biology and psychology of 
post-traumatic stress disor¬ 
der and depression. In their 
book Resilience: The Science 
of Mastering Life’s Greatest 
Challenges, Southwick, 
the Glenn H. Greenberg 
Professor of Psychiatry and 
professor in the Ghild Study 
Center; and Charney, a 
former member of the Yale 
faculty who is now the Anne and Joel Ehrenkranz Dean of the 
Icahn School of Medicine at Mount Sinai in New York City, 
explore how some people are better able to cope with stress. 
The authors interviewed Vietnam-era POWs, Special 
Forces instructors, and civilians who have led productive 
lives after severe psychological trauma. “... the resilient peo¬ 
ple we interviewed,” they write, “tended to use the same or 
similar coping strategies when confronted with high levels 
of stress.” The authors identify 10 resilience factors includ¬ 
ing optimism and strong social connections; delve into the 
scientific and genetic underpinnings of these factors; and 
offer practical advice on ways to foster resilience in everyday 
life. While acknowledging that human resilience is a com¬ 
plex and dynamic phenomenon, the authors maintain that " 
people can improve their resiliency. “Ultimately, resilience is 
about understanding the difference between fate and free¬ 
dom, and learning to take responsibility for one’s own life.” 
—Jill Max 
t 
Classics of Community 
Psychiatry: Fifty Years 
of Public Mental Health 
Outside the Hospital 
by Michael Rowe, ph.d., associate 
professor of psychiatry; Martha 
Lawless; Kenneth Thompson, 
M.D.; and Larry Davidson, ph,d„ 
professor of psychiatry (Oxford 
University Press) This collection, 
which focuses on the American 
experience, contains 45 texts 
exploring the history of deinstitu¬ 
tionalization and the community 
mental health center movement; 
the community support model; 
and current conceptualizations of 
recovery from mental illness. 
Health Policies and Ethics: 
A Critical Examination of Values 
from a Global Perspective 
by Roger Worthington, ph.d., 
M.A., assistant professor (adjunct) 
of medicine (general medicine); 
and Robert Rohrbaugh, m.d. ’82, 
HS ’86. Fw ’88, professor of 
psychiatry (Radcliffe Health) 
The authors compare and 
contrast ethical and policy issues 
from countries around the world, 
with a focus on the United States 
and countries in Africa and Asia. 
Worthington and Rohrbaugh 
address such issues as conflicts 
of interest; the balance between 
health care quality and cost; and 
the effects of geography and 
demographics on access to care. 
Practical Social Skills for Autism 
Spectrum Disorders: Designing 
Child-Specific Interventions 
by Kathleen Koenig, m.s,n., aprn, 
associate research scientist in the 
Child Study Center (W.W. Norton 
& Company) Koenig addresses | 
ways to help children with autism ij 
spectrum disorders develop | 
“social repertoires” that they can fi 
call upon in a range of day-to-day I 
situations, from the classroom 
to the lunchroom to the family i 
dinnertable.Theauthoruses I 
case vignettes to illustrate the 1 
application of each interven¬ 
tion, suggests what to do when i 
a child’s response is inadequate, ; 
and offers a helpful guide to mea- ■ 
suringthe child’s progress. 
Foot and Ankle Sports Medicine 
Edited by David W. Altchek, m.d.; ; 
Christopher W. DiGiovanni, m.d.; | 
Joshua S. Dines, m,d.; and 
Rock G, Positano, m,p,h. ’89 
(Wolters Kluwer/Lippincott 
Williams & Wilkins) This book 
covers pediatric sports injuries, 
sport-specific injury prevention, 
rehabilitation, and shoe selec¬ 
tion, in addition to such adult 
sports-related injuries as tendon 
disorders, trauma, and injuries 
to the hindfoot, midfoot, fore¬ 
foot, and lower leg. More than 
40 specialists contributed to 
this guide, including physicians, 
physical therapists, and trainers 
for major sports teams. 
Principles and Practice of 
Geriatric Surgery, 2nd ed. 
edited by Ronnie Ann Rosen¬ 
thal, M.D., professor of surgery; 
Michael E. Zenilman, m,d.; 
and Mark R, Katlic, m,d. 
(Springer) The editors provide 
an overview of geriatric care 
in an evidence-based textbook 
that covers special issues which 
confront surgeons treating 
elderly patients, ranging from 
anesthesia complications to 
minimally invasive surgery. 
This updated edition presents 
new procedures, methods. 
loor wdanki I- 
SPORTS 
MEDICINE 
and information required to 
keep up with developments 
in the rapidly evolving field 
of geriatric surgery. 
Centers for Ending: The Coming 
Crisis in the Care of Aged People 
by the late Seymour B. Sarason, 
PH.D., professor emeritus of psy¬ 
chology (Springer) The author 
used his firsthand experience 
as both practitioner and patient 
in senior facilities to reveal 
professional and moral failings. 
Sarason discusses such issues as 
insensitive medical personnel, 
poorly trained nurses and aides, 
indifferent administrators, 
and a prevailing culture that is 
content with treating "bodies” 
instead of complete human 
beings. He argues that such 
deficiencies engender feelings 
of loneliness, isolation, depres¬ 
sion, and dependency among 
residents of these facilities; and 
he recommends the formation 
of a presidential commission to 
iconfrontthe crisis. 
Goldberger’s Clinical 
I Electrocardiography; 
lA Simplified Approach, 8th ed. 
by Ary L. Goldberger, m.d. ’74; 
Zachary D. Goldberger, m.d. ’04; 
(and Alexei Shvilkin, m.d. (Saun- 
’ders) The authors provide the 
fundamentals of ecg interpreta¬ 
tion and analysis in this cardiol- 
jogy reference text, which offers 
guidance on understanding 
I rhythm disorders and their clinical 
outcomes; broadens mastery of 
jthe material with online-only 
self-assessment ecgs and review 
(questions; expands clinical skills 
via online clinical highlights and 
review questions; and includes 
diagnosis and management tips 
as well as extended coverage of 
difhcult-to-classify heart rhythms. 
Seldin & Giebisch’s 
The Kidney; Physiology and 
Pathophysiology, 5th ed. 
edited by Robert J. Alpern, m.d., 
dean and Ensign Professor of 
Medicine; Michael J. Caplan, 
M.D. ’87. PH.D. ’87, C.N.H. Long 
Professor of Cellular and Mo¬ 
lecular Physiology; Orson 
W. Moe, M.D. (Academic Press) 
In this edition, previous chapters 
have been updated and new 
chapters have been added. The 
role of stem cells, the signifi¬ 
cance of cilia, and expansion of 
the section on pathophysiology 
are some of the updates incor¬ 
porated in this text. 
Meditations on the Good News; 
Reading the Bible for Today 
by Rev. Debra W. Haffner, 
M.p.H. ’79 (Religious Institute 
Inc.) This book of 40 essays on 
Biblical verses is designed to 
introduce readers to positive 
messages in the Bible. The au¬ 
thor highlights passages with in¬ 
spirational and practical lessons 
to help lead a joyful life. 
Madness & Glory: A Novel 
by Albert Rothenberg, m.d., hs ’60 
(Pegasus Publishers) This book 
follows Philippe Pinel, a French 
physician who pioneered the hu¬ 
mane treatment of the mentally 
ill, and his patient in the Bicetre 
asylum who learns of a plot 
against the leaders of the French 
Revolution—which puts both 
their lives in danger. 
on campus 
The neurobiology behind 
our choices 
When Ray Dolan, m.d., had to 
run an errand, he took a risk, did 
not feed the parking meter, and 
got a ticket for $200. If he paid 
the ticket within 14 days, the 
fine print on the ticket informed 
him, he could cut the fine in 
half. Still he did nothing. 
The parking ticket, said 
Dolan, the Mary Kinross 
Professor of Neuropsychiatry 
and director of the Wellcome 
Trust Centre for Neuroimaging 
at University College London 
(ucl), triggered a negative 
Pavlovian response associated 
with a hard-wired disposition 
not to act. Dolan’s handling of 
the ticket was a case in point 
in his talk at the Yale/uci 
Senior Scientist Lecture Series 
in March. The talk centered on 
his research into values, choice, 
decision making, and action. 
Dolan described in neurobio- 
logical detail the interactions 
that occur in such regions of the 
brain as the orbital prefrontal 
cortex and the striatum when 
people are engaged in values- 
based decision making. “We 
have multiple systems control¬ 
ling our behavior, and most of 
the time they are in alignment,” 
he said. "So it’s striking when 
they come into opposition. This, 
I believe, accounts for lots of 
everyday behaviors in which 
people react suboptimally.” 
—Jennifer Kaylin 
Proposing new politics 
of medicine 
The United States, said Helena 
Hansen, m.d. ’05, ph.d. ’04, 
spends more on medicine 
than any developed country 
yet has poorer outcomes. 
Meanwhile, low-income 
countries like Cuba and India 
are improving health care. 
"What’s missing?” asked 
Hansen, an assistant profes¬ 
sor of psychiatry and assistant 
professor of anthropology at 
New York University, speak¬ 
ing to members of the Yale 
Global Mental Health Program 
in March. “We have technol¬ 
ogy that practitioners in other 
countries can only dream about. 
But we focus on eradicating the 
patient’s acute symptoms, not 
on the social or institutional fac¬ 
tors that led to them.” 
Calling for a “new politics 
of medicine,” Hansen said that 
American clinicians need to look 
beyond the patient and focus 
on where patients live as well 
as their level of education, diet, 
and income level. Clinicians also 
need to engage in interdisciplin¬ 
ary collaborations with such 
community partners as urban 
planners, educators, and crimi¬ 
nal Justice leaders. 
“Doctors need to prescribe 
structural interventions, so 
that ailing systems become the 
patient, not only the individual,” 
Hansen said. “We need to push 
clinical professionals to think of 
themselves as agents for insti¬ 
tutional change, social change, 
and policy change.” 
—J.K. 
The descriptions above are based 
on information from the publishers. 
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The world’s 
medical 
heritage 
goes digital 
The world’s leading medical 
libraries make historic texts 
available online. 
By Christopher Hoffman 
It’s 1909 and your child has diarrhea. 
The cure, according to that year’s edition 
of the Guide to the Clinical Examination 
and Treatment of Sick Children, is opium. 
“Opium is a valuable remedy in 
childhood,” author John Thomson, 
M.D., writes. “It is chiefly of use in 
relieving pain and quieting the actions 
of the bowels.” 
Until recently, this window into 
early 20th-century pediatric medicine 
sat on a shelf deep in the stacks of the 
Cushing/Whitney Medical Library. 
Now the book is Just a mouse click 
away through the online Medical 
Heritage Library, one of nearly 6,000 
Cushing/Whitney rare books uploaded 
onto the site as of June 2012. 
The Medical Heritage Library is 
part of an effort by Open Knowledge 
Commons, a digital curation col¬ 
laborative—a network of librarians, 
universities, students, lawyers, and 
technologists—to create free digital 
libraries. The organization, founded 
in 2008, invited Cushing/Whitney 
and other leading medical libraries, 
including those at Harvard, Columbia, 
and the U.S. National Library of 
Medicine, to upload works into the 
site. The works will be available to his-1 
torians, amateur scholars, laypeople, 
and anyone interested in the history 
of medicine. As of this spring, more 
than 40,000 works had been stored ir 
the library’s virtual stacks, with more 
going online every day. 
To avoid duplication, each library 
is assigned certain subjects. Cushing/ 
Whitney’s topics include surgery, pedi¬ 
atric medicine, gynecology, obstetrics, 
homeopathy, and phrenology, said 
Sarah McGlynn, m.l.s., the library’s 
former preservation and collections 
management librarian. The eclectic 
collection includes textbooks, manu¬ 
als, government pamphlets, self-help 
books, treatises on social issues, even 
novels and nonfiction—anything with 
a connection to medicine from the 
19th and 20th centuries. 
Yale’s contributions include: The 
Nightless City, an 1899 “expose” of 
Tokyo’s then-red light district that could 
have doubled as a guidebook; The Rules 
of Aseptic and Antiseptic Surgery, by 
Arpad Gerster, m.d., a seminal work 
from 1888; and the 1877 How to Teach 
According to Temperament in the School- 
Room and the Family, which applies 
phrenology—the belief that head 
bumps can be used as measures of per¬ 
sonality and intelligence—to the hiring 
of teachers and instruction of children. 
As the 19th century progressed, 
scientific medicine supplanted home 
remedies, quackery, and superstition. 
Melissa Grafe, ph.d., librarian for medi¬ 
cal history, said that while the practices 
of yesteryear may repel, they were on the 
cutting edge at the time. “You look back 
and say, ‘Oh, my God, that’s crazy,’ ” 
Grafe said. “But, perhaps 100 years from 
now, people are going to look at us and 
say, ‘Oh, my God, that’s a little crazy.’ ” 
Grafe’s favorite Yale contributions 
are 19th-century “sexual hygiene” 
books offering women and girls 
advice on everything from improv¬ 
ing the complexion to contraception. 
McGlynn’s best finds include a novel 
called The Lunatic at Large, with a 
whimsically beautiful cover; and a 
self-help book titled Talks with Homely 
Girls on Health and Beauty. 
Scholars are experimenting with 
data mining and other mass informa¬ 
tion extraction techniques to determine 
how best to use the trove, said John 
Gallagher, m.l.s., deputy director of pub¬ 
lic services for Cushing/Whitney. 
Digitizing the books is a laborious 
process, he said. “The scanning is the 
easy part.” A variety of library staff 
is involved in the project, reviewing, 
selecting, and cataloguing books as 
well as proofreading scanned texts. 
Volumes must be in good condition for 
the digitization machine, which auto¬ 
matically turns and photographs their 
pages. Because 19th-century works 
were often poorly made and are disin¬ 
tegrating due to the high acid content 
of their paper, they are given priority. 
An exhibit on display at the Cushing/Whitney 
Medical Library focuses on the digitization 
process and displays discoveries from the work. 
To visit the Medical Heritage Library, go to 
medicalheritage.org. 
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OPPOSITE Anomalies and curiosities of medicine: 
i being an encyclopedic collection of rare and ex¬ 
traordinary cases, and ofthe most striking instances 
of abnormality in all branches of medicine and 
surgery, derived from an exhaustive research of 
i medical literature from its origin to the present day, 
abstracted, classified, annotated, and indexed, by 
' George M. Gouid, M.D., and Walter L. Pyle, M.D. 
> Published in 1898 the book catalogued medical 
? cases including this case of universal dermatitis. 
THIS PACE Left, a page from The homeopathic 
practice of surgery, together with operative surgery, 
by Benjamin Hill, M.D., and Jason Hunt, M.D., pub¬ 
lished in Cleveland, Ohio in 1855. This image illus¬ 
trated the case of a woman with a tumor. Hill was 
a professor of obstetrics and diseases of females, 
and professor of surgery at Western Homeopathic 
College, which he founded in Cleveland in 1850. 
From the same book, third from left, a chapter 
offered instructions on amputations. 
Second from left, early in the 20th century, 
Charles Lentz & Sons of Philadelphia published 
a price list for surgical instruments, hospital 
supplies, orthopedic apparatus, and trusses, 
among other items. Right, a page from The 
rules of aseptic and antiseptic surgery, a practi¬ 
cal treatise for the use of students and the 
general practitioner, by Arpad G. Gerster, M.O., 
published in 1892. 
t 
A controversial theory focuses on identifying and treating so-called 
cancer stem cells within solid tumors. While doubters abound, some at 
Yale believe a revolution in cancer care may be in the offing. 
By Marc Wortman 
Illustrations by Sophie Casson 
Hope crushed can be a terrible thing. Oncologist Alessandro 
D. Santin, m.d., sees that despair all too often. Santin, pro¬ 
fessor of obstetrics, gynecology, and reproductive sciences, 
typically treats ovarian cancer patients when their tumors 
have grown dangerously large and spread to other parts of 
their bodies. Most of these women undergo surgery first, 
then chemotherapy. After they have endured these compli¬ 
cated and painful treatments, though, often the most he can 
offer is a small measure of good news. 
Nearly four out of five patients have no detectable dis¬ 
ease left in their body; however, cancer will return in nearly 
90 percent of the apparently “cured” women—the second 
time with a vengeance—and chemotherapy will no longer 
work. “There is very little we can do for them at that time,” 
Santin says. 
Sitting in his School of Medicine office almost swal¬ 
lowed by the stacks of papers and journals that surround 
him, Santin speaks of the deceptively malevolent power 
of ovarian cancer cells to re-erupt after treatment. He has 
been studying the source of that power and thinks emerg¬ 
ing insights reveal new possibilities for stopping it from 
killing women. “I’m targeting the cells that are resistant to 
treatment and therefore responsible for the cancer’s recur¬ 
rence and the death of my patients,” he says. He has come to 
believe a very specific type of killer lies deep within tumors: 
cells that are not ordinary tumor cells. 
“We are trying to identify a subset of cells that looks 
different, acts different, and reacts differently among cancer 
cells. These are the cells you try to kill with anything,” but 
cannot, at least so far. 
Santin’s research is among the most advanced efforts 
to translate the complicated biology of what some observers 
term “cancer stem cells” into novel treatments for one of the 
most aggressive and lethal forms of cancer. According to a 
controversial theory that is gaining wider acceptance among 
oncologists and cancer researchers, certain cells have a 
unique set of developmental differentiation and self-renewal 
powers—akin to stem cells that form tissues during embry¬ 
onic development—needed to initiate tumors. According to 
this theory, tumors need these “cancer seeds” in order to 
spread through the body. Santin and a growing number of 
cancer biologists are also convinced that among the mass of 
tumor cells in an individual cancer, only a subset of tumor 
cells have the genetic endowment to resist treatment. 
The idea that a separate type of tumor cell lies at the 
root of cancer completely reworks existing dogma about how 
cancers form, gain structure, and spread. The notion of a 
separate subset of cells within tumors, says Gil G. Mor, m.d., 
PH.D., professor of obstetrics, gynecology, and reproductive 
sciences, who shares an office suite with Santin and also stud¬ 
ies the role of ovarian cancer stem cells, marks “a big change 
in the concept we learned in biology as medical students. We 
were taught that tumors are a mass of identical cells.” 
“This,” says Haifan Lin, ph.d., professor of cell biol¬ 
ogy and of genetics, and director of the Yale Stem Cell 
Center, “is a paradigm-shifting idea.” He explains, “A small 
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number of cells are much more important within a tumor 
than others. These are seeding cells—cancer cells that are 
different from other cancer cells.” But Lin added, “cancer 
stem cells may not be responsible for all types of cancers." 
Thomas J. Lynch Jr., m.d. ’86, the Richard Sackler 
and Jonathan Sackler Professor of Medicine (Medical 
Oncology); director of Yale Cancer Center; and a specialist 
in lung cancer, considers that notion controversial but says, 
“There is no doubt that a population of cells is responsible 
for propagating metastases. There is no doubt we have to 
target them to halt the process.” Lynch questions their des¬ 
ignation as cancer stem cells, but he is convinced that “for 
therapy to be successful, you have to target that population.” 
While oncologists almost universally acknowledge 
that only genetically aberrant hematopoietic stem cells can 
generate blood cancers, including most leukemias, there 
is no definitive way to distinguish cancer stem cells in 
solid-tumor cancers. Some say that’s because the cells are 
not there. But Santin and Mor say that they have character¬ 
ized traits of these cells, including unique surface proteins, 
in certain cancers that distinguish them from other cells 
within solid tumors. That characterization may provide tar¬ 
gets for the development of new anticancer agents. Several 
efforts are now under way at Yale and elsewhere to find 
therapies that attack those so-called stem cells. 
If the researchers succeed, a revolution in the way 
oncologists view—and more importantly—treat cancer may 
be in the offing. 
Cancer’s seeds 
Recent decades have brought enormous advances in knowl¬ 
edge of cancer’s often baffling biology. But despite huge 
investments in treatment that have drawn on those insights, 
including the introduction more than 30 years ago of com¬ 
monly used platinum-based chemotherapeutic agents, the 
odds and length of survival for most patients newly diagnosed 
with advanced solid-tumor cancers have barely increased. 
Eventually, in most cases of ovarian cancer—as well as lung, 
colorectal, breast, pancreatic, brain, and other solid organ- 
tissue cancers—the malignancy recurs after treatment, and 
that very often presages death. 
Mainstream cancer biology points to tumor cells that 
escape even the most powerful targeted treatments as the 
culprits in cancer recurrence. Most oncologists believe that 
cure rates would rise if it were possible to improve the newer 
agents’ targeting accuracy or increase the potency of chemo¬ 
therapy agents without putting the patient’s life at risk. But 
the cancer stem cell theory puts treatment resistance and 
cancer recurrence in a very different light. It isn’t that a few 
cells hide out only to proliferate anew; it’s that certain cells 
have a genetic endowment that resists chemotherapy and 
enables them to regenerate tumors and spread the cancer. 
“There are definitely cancer cell types that can initi¬ 
ate tumors and some that do not,” says Don Nguyen, ph.d., 
assistant professor of pathology, who studies how lung can¬ 
cer metastasizes, “and the cells that form tumors may be 
unique or more frequent depending on the cancer type.” 
That opinion contrasts with traditional models of cancer 
biology. According to the most widely held view, malignant 
cells have mutations that make them genetically unstable. They 
accumulate further mutations and evolve into tumors that 
grow rapidly, encourage blood vessel formation, discourage 
immune responses, metastasize, and resist treatment. 
Mor finds this model of malignancy “oversimplified.” 
The cancer stem cell model posits that rather than being 
made up of identical cells, the tumor is composed of geneti¬ 
cally and functionally different cell types. Furthermore, 
within the tumor there is a hierarchy. “Only these mother 
cells can give origin to cancer cells and all the cells in the 
tumor, including the blood vessels to nourish the tumor,” 
Mor says. “We have isolated the cancer stem cells and we can 
recreate the complexity of the human tumors in the mouse. 
That only happens with the cancer stem cells.” He hopes 
to test therapeutic agents designed to treat recurrent forms 
of the disease in ovarian cancer patients. These advanced 
tumors appear, he says, “to be a different monster altogether” 
from the primary untreated cancer; and require “a completely 
different approach” to target resistant cancer stem cells as 
well as the other non-stem cells that make up a tumor. 
Lin agrees. He expects that new drugs specifically 
engineered to seek out and kill cancer’s seeds will stop at 
least some aggressive chemotherapy-resistant cancers. “The 
key is to find what is specific and different in cancer stem 
cells. That becomes their Achilles’ heel,” he says. 
But the most basic questions about the biology of 
cancer stem cells await answers because the existence of 
uniquely potent tumor-initiating cells with stem cell-like 
characteristics remains unproven. 
15 
Where cancer comes from 
The cancer stem cell theory arose out of a paradox observed in 
certain cancers in laboratory studies. Tumor cells—even large 
numbers of them—may fail to generate new tumors when 
transplanted into immunodeficient laboratory mice. At the 
same time, other tumor cells—sometimes just single cells— 
can generate new tumors physiologically identical to the parent 
cancer, and also spontaneously generate metastases. 
In 1994 cancer biologists at the University of Toronto 
found that very specific human acute myeloid leukemia (aml) 
cells were needed to transmit the disease into immunocom¬ 
promised mice. “In leukemia you can take out cancer stem 
cells and transplant them and create the cancer again,” says 
Lin. “Lots of leukemia cells cannot do that. Only leukemia 
stem cells can.” Evidence for the role of stem cells in other 
hematological malignancies followed. To cure aml patients, 
treatments require total destruction and replacement of the 
patients’ bone marrow to eliminate the cancer-causing stem 
cell component. Nine years after the Toronto discovery, how¬ 
ever, the research focus began to shift from cancers of the 
blood to solid-tumor cancers. In 2003, University of Michigan 
researchers separated populations of what they said were rare 
stem cell-like cells from other cancer cells within specimens 
from human breast cancer tumors. 
Since then scientists say they have characterized popu¬ 
lations of cells resembling stem cells in many types of solid 
tumors through elevated levels of proteins typically found 
only on the surface of stem cell membranes. “There is a semi¬ 
consensus in certain cancers, probably not all of them, that 
stem cells exist,” says Joseph Schlessinger, ph.d., chair and 
the William LL. Prusoff Professor of Pharmacology. 
The presence of such stem cells may explain a can¬ 
cer’s ability to survive treatment. “A lot of drugs can kill 
regular cancer cells but not cancer stem cells,” says Lin. 
“They can evade every insult we throw at them.” Cancer 
stem cells, he believes, possess dna repair mechanisms 
that allow them to resist chemotherapy. They also divide 
much more slowly than most cancer cells, making them 
less vulnerable to chemotherapeutic agents that attack fast- 
dividing cells. (Speed of division underlies the death of hair, 
nail, and certain blood cells during chemotherapy as well 
as the development of unbearably itchy skin and other che¬ 
motherapy-related side effects.) Moreover, studies indicate 
:hat when tumor cells die during treatment, they release 
signaling proteins that may stimulate surviving stem cells 
to reproduce and differentiate into a new tumor. In effect, 
treatment may actually increase the proportion of the highly 
aggressive and resistant cancer stem cells within tumors, 
perhaps explaining why fast-growing deadly malignancies 
often follow therapy. 
What matters then is not just how many tumor cells 
a cancer therapy eliminates, but also its capacity to kill the 
cancer at its source. 
Attacking cancer at the root 
Lin studies genes that he calls the master regulators—they 
control other genes in the genome and decide whether a cell 
becomes a neuron or a heart, kidney, or skin cell. Genetic 
switches normally turn off stem cells once they have com¬ 
pleted these tasks—except for small numbers involved in 
renewing and repairing blood, skin, bone, certain cells in 
the brain, and membranes in the lung and gastrointesti¬ 
nal tract. Lin believes that the stem cell genes may mutate 
through environmental insults like exposure to sun, tobacco 
smoke, and carcinogenic chemicals, or through genetic 
machinery gone awry; become overactive; and reawaken 
their self-renewing powers. This time, though, they lead to 
cancerous overgrowth. The parent cells that gave life trans¬ 
form into killers. 
In the lab Lin’s team can manipulate genes in a nor¬ 
mal stem cell to turn it into a cancer cell. In humans, he 
says, no one knows exactly how a stem cell becomes cancer¬ 
ous. Despite limited insights into how cancer stem cells 
develop, he contends that it is possible to develop drugs 
against them. 
However, some cancer investigators question the 
notion of targeting cells that are so poorly understood. Scott 
Kern, m.d., associate professor of oncology and pathology 
at Johns Hopkins University School of Medicine, argues 
that alternate theories could explain the distinct class of 
treatment-resistant, tumorigenic cells under study. Says 
Kern, who studies cancer genetics, “We all know that the 
cancer stem cell theory explains at least some leukemias and 
teratocarcinomas [germ cell tumors, mainly cancers of the 
testes]. Nobody has debated that, to my knowledge. It is the 
extension of the idea to the common solid tumors ... that we 
find worthy of debate.” Existing theories, Kern argues, could 
explain the stem cell-like characteristics scientists claim to 
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see in certain cell populations within tumors. He thinks 
that methods being used to identify cancer stem cells in a 
tumor represent “fuzzy math” that weights statistical results 
of studies to conform to a stem cell theory. And what some 
call a distinct class of treatment-resistant tumor-initiating 
cells could in his view just as likely result from cancer- 
causing genetic and environmental factors and physiological 
processes that encourage tumor growth. “Instead of chasing 
stem cell-ness,” he says, “you’re chasing an unknown.” 
Definitive ways to distinguish cancer stem cells from 
normal ones have yet to emerge. That has not stopped can¬ 
cer researchers from trying to identify biological markers 
by studying the differences between tumors that respond 
to therapy and those that resist. Patients with those mark¬ 
ers that suggest a large population of cancer stem cells may 
benefit from more aggressive treatment. “The key,” says 
lung cancer biologist Nguyen, “is to identify these patients 
and get treatment to them as quickly as possible.” 
For some cancers, skin cancer among them, the role 
of stem cells is a bit different. Douglas E. Brash, ph.d., 
clinical professor and senior research scientist in therapeu¬ 
tic radiology, and professor of dermatology and of genetics, 
has found large clones of mutant progenitor cells, or skin 
stem cells, on the order of 30 per square centimeter in sun- 
exposed adult skin. These cells possess a mutation in the 
P53 tumor suppressor gene, which Brash showed came from 
sun exposure. When later exposed to beach-trip levels of 
ultraviolet radiation, the mutated stem cells produce more 
of themselves. In skin and other solid tissues, these pro¬ 
genitors are not professional stem cells: when they divide, 
they choose randomly between acting like a stem cell or 
acting like a differentiating cell. Brash theorizes that these 
mutated cells lead to a form of cancer known as squamous 
cell carcinoma. He is trying to create a mouse model in 
which the mutated skin stem cells can be observed while 
they are progressing to cancer. Shrinking a tumor 99 per¬ 
cent with a hammer may not be as effective as altering the 
stem cell’s choices with a screwdriver. 
Santin does not claim certainty that a subpopulation 
of tumor-initiating cells exist in all or even most cancers, 
but he does believe that they exist in therapy-resistant ovar¬ 
ian cancer. 
Much of Santin’s workday is spent either with patients 
or down the hall from his office in the laboratory where he 
and his colleagues are studying ways to kill ovarian tumor 
specimens enriched in chemotherapy-resistant cancer cells. 
During the past few years his laboratory team has published 
findings that Clostridium perfringens enterotoxin (cpe), a type 
of bacterial poison found in the intestine and responsible for 
foodborne illness and diarrhea in humans, may attack and 
kill only cancer cells possessing a specific protein called 
claudin-4 on their surface. Santin showed that the same 
protein can also be found on the surface of chemotherapy- 
resistant tumor cells. 
When exposed to the bacterial toxin, the previously 
resistant cells die within minutes. “It’s hard to believe 
how effective the toxin can be against these biologically 
aggressive tumor cells,” he declares. Santin is now working 
with W. Mark Saltzman, ph.d., the Goizueta Foundation 
Professor of Biomedical Engineering and professor of cellu¬ 
lar and molecular physiology and of chemical engineering, 
and chair of the Department of Biomedical Engineering, 
to engineer a small section of that bacterial toxin into a 
nontoxic form suitable for use as a drug and as a diagnostic 
tool. The researchers are infusing a fragment of cpe linked 
to a fluorescent dye that lights up when it binds to a cancer 
cell. Santin hopes that within the next two or three years he 
can test the modified enterotoxin as a diagnostic method for 
chemotherapy-resistant ovarian cancer and then also be able 
to use it to treat patients with resistant ovarian cancer. 
His departmental colleague Mor is looking for unique 
variants of the stem cell surface marker protein known as 
CD44 that may allow him to differentiate normal stem cells 
from the stem cells of ovarian cancer. Mor has already iden¬ 
tified markers he believes may be present only in therapy- 
resistant ovarian cancer cells and has begun using the 
markers to look for compounds that might kill the cancer 
cells. “In recurrent disease,” he says, “you need to treat the 
cancer with a completely different approach. We have been 
successful in killing the fast-dividing cells. In the next 10 
years, the challenge will be getting at the roots of cancer.” 
Even those who have raised doubts about the existence of 
cancer stem cells can agree with Mor about that. 
Marc Wortman, ph.d., is a freelance writer in New Haven. 
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Pharma and academia 
partner for better health 
Yale joins forces with the pharmaceutical company Gilead Sciences 
to search for targets for new and improved cancer therapies. 
By Kara Nyberg 
Illustrations by Sophie Casson 
In 2008 Ruth Halaban, ph.d., began searching the dna of 
melanomas in a quest for genetic clues to skin cancer. The 
obvious connection between sunlight, ultraviolet rays, and 
cancer, she said, had been determined through population 
studies. The genetic causal link remained to be discerned. 
Halaban hoped—naively, as it turned out—that with about 
20 samples she could find a genetic anomaly that would pro¬ 
vide that link. 
But with the sequencing of each sample then costing 
$2,500—and she also had to sequence a normal sample for 
comparison—the experiment grew costly. Funding from pri¬ 
vate foundations helped her launch the project, but Halaban, 
a senior research scientist in dermatology, soon realized 
she’d need far more than 20 samples. In the end, the cost 
of sequencing fell to about $1,400 per sample, and Halaban 
sequenced almost 150 samples. Her findings led her to a gene 
called RACi, which appears mutated in about 9 percent of 
melanoma tumors. She completed the research in 2012 thanks 
to a collaboration with Gilead Sciences, and her findings were 
published online in Nature Genetics in July of that year. 
“We discovered that raci is a sunlight signature 
mutation," said Halaban. “You can say that this is the cul¬ 
prit. This is directly related to sunlight.” 
Halaban’s findings are the fruit of a collaboration 
between Gilead and the School of Medicine that began in 
2011. By studying the genetic and molecular mechanisms 
underlying different forms of cancer, Yale and Gilead sci¬ 
entists work together to pinpoint new molecular targets 
implicated in cancer pathogenesis, and to develop agents 
designed to put a halt to the molecules’ rogue activities. 
Under an agreement with the School of Medicine, 
Gilead agreed to provide $40 million over four years to sup¬ 
port research to identify novel targets and new drugs for can- ;i 
cer therapy. The collaboration will continue, with evaluations 1 
after the fourth and seventh years, through 2021 with a total j 
of up to $100 million in funding over 10 years—the largest . 
corporate commitment in Yale’s history. As part of the agree¬ 
ment, Gilead has the option to license potential cancer thera¬ 
pies that result from the collaboration. ,t 
Although such collaborations are decades old, in 
recent years academia has sought new funding sources as the : 
pharmaceutical industry seeks new research collaborators. i 
The industry needs new drugs in its development pipeline, i 
and researchers across the country worry about years of flat ) 
spending from the National Institutes of Health, sequestra¬ 
tion—which mandates across-the-board federal spending cuts 
of 8 percent—and declines in funding of research from ven¬ 
ture capital. Partnerships between universities and pharma 
also allow each party to leverage their respective strengths in 
research and drug development. 
Tapping into the best minds 
The Yale-Gilead collaboration relies on some of Yale’s top sci 
entiflc minds, technology investments at the West Gampus, 
and the resources of Yale Gancer Center, the Cancer Biology 
Institute, and Smilow Cancer Hospital. “Through this 
i 
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20 Pharma and academia partner for better health 
collaboration,” says Howard Jaffe, m.d. ’82, president and 
chair of the board of the Gilead Foundation, and a member 
of the Yale-Gilead joint steering committee, “we’re tapping 
into some of the best minds on the planet who’ve done it 
before and are scientifically, technologically, and instinc¬ 
tively better than just about anybody else.” 
Indeed, the joint steering committee brings some of 
Yale’s leading scientists and clinicians to the table to help 
select and nurture the Yale research projects that receive 
Gilead funding. Joseph Schlessinger, ph.d., chair and the 
William H. Prusoff Professor of Pharmacology, and director 
of the Gancer Biology Institute on the West Gampus, chairs 
the six-member committee. 
“When we find cancer targets that are new, we will 
work with Gilead on designing drugs, which they can then test 
in the clinic,” said Schlessinger, whose studies of molecules 
involved in cell signaling led to the development of many can¬ 
cer drugs, including two developed by his biotech companies. 
“This is a tremendous opportunity for Yale and Gilead.” 
The Yale half of the steering committee also includes 
Richard P. Lifton, m.d., ph.d., chair and Sterling Professor 
of Genetics, head of the Yale Genter for Genome Analysis, 
and a Howard Hughes Medical Institute investigator: and 
Thomas J. Lynch Jr., m.d. ’86, the Richard Sackler and 
Jonathan Sackler Professor of Medicine (medical oncology), 
director of the Yale Gancer Genter, and physician-in-chief of 
the Smilow Gancer Hospital at Yale-New Haven Hospital. 
Three accomplished Gilead scientists round out the 
steering committee—Jaffe; William A. Lee, ph.d., senior 
vice president of research; and Linda Slanec Higgins, ph.d., 
vice president of biology. 
An old trend revived 
The past two years have seen an increase in multimillion- 
dollar pharma-academia collaborations that focus on discov¬ 
ering drug targets. Notable partnerships include Pfizer and 
the University of Galifornia at San Diego; Sanofi-Aventis 
and Golumbia University Medical Genter; and Novartis and 
AstraZeneca and the University of Pennsylvania. 
Since signing with Gilead in 2011, Yale has part¬ 
nered with several other companies. December 2011 
brought news of a collaboration with the Johnson & 
Johnson Gorporate Office of Science and Technology to 
jointly fund activities at the Yale Molecular Discovery 
Genter on Yale’s West Gampus. In May 2012, Yale 
announced a new partnership with GlaxoSmithKline to 
identify promising protein-destroying drug candidates 
in a variety of therapeutic areas. And in February, Yale 
and AbbVie announced a new collaboration. AbbVie will 
provide $14.5 million over five years to support research 
into the molecular, cellular, and genetic underpinnings of 
autoimmune and inflammatory diseases. In return AbbVie 
has an option to negotiate a license for any invention made 
through the collaboration. 
In 2002 Yale and Pfizer began a collaboration that led 
to the creation of Yale’s pet Genter in 2007. 
“The proximity of the clinical research unit Pfizer 
was building in New Haven made it ideal for Pfizer to part¬ 
ner with the Yale pet Genter to achieve its goal of finding 
out whether the drugs they were developing were hitting the 
targets in clinical trials,” said Roopashree Narasimhaiah, 
deputy director of corporate and foundation relations in the 
medical school’s development office. Pfizer, the pharmaceu¬ 
tical company, contributed $5 million to establish the center 
and provides $2 million annually to support pet imaging 
studies of mutual research interest. In these studies Yale 
and Pfizer scientists have worked together to determine 
whether to pursue the development of certain com¬ 
pounds to drugs. “It was not a discovery partnership,” said 
Narasimhaiah. “The aim was not to discover, but to validate 
compounds that Pfizer was making.” 
Such alliances between industry and universities 
may suggest a new trend; but as Jonathan Soderstrom, ph.d., 
managing director of the Yale University Office of Go- 
operative Research, explains, industrial sponsorship of 
academic research is not new. In fact, it is decades old. 
In 1982, Soderstrom said, Yale was already receiving almost 
$4 million in industry-sponsored research. By 1994, that 
figure had swelled to almost $18 million; the figures held 
steady between 2001 and 2009, with Yale averaging more 
than $15 million per year in industrial funding. 
Gilead, a company rooted in hiv and hepatitis research, 
also points to a long history of ties to academia. “We just cel¬ 
ebrated the 25th anniversary of an interaction we’ve had with 
two universities in Europe that was basically the genesis of the 
HIV drugs we developed,” says Jaffe. “We’ve always been of the 
mantra that Gilead itself is only capable of a very minuscule 
fraction of the potential for innovation in the world, and that 
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we can expand dramatically on that by partnering with the 
right academic institutions.” 
This recent spate of corporate agreements reflects a 
convergence of factors—advances in technology and a need 
to tap into academic research—that have opened the flood¬ 
gates for academia-pharma partnerships. The prime force 
driving both academia and pharma to partner, however, is 
shrinking funding. 
Creative solutions in tough times 
Although the nih budget doubled from 1999 to 2003, it 
has remained stagnant for nearly 10 years, topping out at 
$30.6 billion for flscal year 2012. Early this year the U.S. 
Congress passed a continuing resolution that maintained 
NIH spending at that level. As a result, Roi research grants 
from the nih have failed to keep pace with biomedical 
research costs. Despite these years of flat funding overall, 
however, nih grants to Yale have been increasing. In the 
flscal year that ended in June 2011, Yale received almost 
$340 million in nih funding. While Yale in general has ben- 
efltted, some labs at Yale have lost funding, causing worry 
among scientists. 
The outlook for 2013 is one of uncertainty. When 
Republicans and Democrats in Washington failed to reach a 
budget agreement early this year, sequestration took effect, 
with an 8 percent reduction in federal spending. A White 
House report issued last September projected an 8 percent 
cut in funding for science. 
The pharmaceutical industry is likewise going 
through a difficult time. The cost of drug discovery keeps 
rising, while many of the blockbuster drugs sustaining 
big pharma are about to go off patent, with few potential 
all-stars waiting in the wings. The floundering economy 
means less venture capital for startup biotech companies, 
which big pharma has recently relied on to identify drug tar¬ 
gets and jumpstart the development of therapeutic agents. 
Pharma’s wellspring of research and development money is 
also beginning to slow to a trickle due to waning revenue 
growth, forcing the drug companies to look elsewhere for 
leads on drug candidates. Out of the search for potential 
Axes, academia and pharma have looked to each other’s 
complementary strengths, recognizing that together they 
have the potential for much greater research capacity. 
Schlessinger cautioned, however, that the collabora¬ 
tion should not be seen as a replacement for the nih. Much 
of the cancer-related research typically supported by nih 
grants, he emphasized, “do not fit the goals of the Yale- 
Gilead collaboration. The collaboration’s goals are to identify 
genetic changes or other molecular alterations that take 
place in human cancers that can be used to develop novel 
targeted therapies, including small molecules, therapeutic 
monoclonal antibodies, or biologicals that selectively block 
cancer cell proliferation and/or stimulate programmed can¬ 
cer cell death.” 
Although the monetary perks of academia-pharma 
collaborations are obvious—academia gets money for 
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22 Pharma and academia partner for better health 
health-related research and pharma has the chance to identify 
a blockbuster drug that stands to turn a handsome profit— 
there are other benefits. The two sides need each other. 
“The reason taxpayers in this country support $30 bil¬ 
lion in biomedical research every year is because of the 
expectation that it is going to lead to an ability to improve 
human health,” says Lifton. However, there is a catch-22. 
“We have almost no ability to make new drugs and pharma¬ 
ceuticals in academia. We rely almost entirely on that 
happening in the private sector.” Toward that end, he says, 
there needs to be a translation from basic science to clini¬ 
cal development of a drug. 
“I have long felt that there’s tremendous talent and 
depth of understanding of biology in academia, and tremen¬ 
dous talent and depth in chemistry in the pharmaceutical 
industry, and a very inefficient bridge between those two 
bodies of expertise that is necessary to translate basic discov¬ 
eries into new therapies,” says Lifton. “Unless we have really 
effective pipelines for communication between academia 
and industry, we’re not going to achieve the realization of 
turning basic science discoveries into new treatments that 
are going to benefit the people who are funding the basic 
research—the taxpayers.” 
To facilitate new research—rapidly—the Yale-Gilead 
steering committee has streamlined the funding process. “If 
someone has an idea, they can bring it to the steering commit¬ 
tee and it can be funded two or three days later,” says Lynch. 
“Even in the best scenario, the nih funds projects nine months 
later from when you have your idea. So this really allows us to 
put resources to problems very quickly.” 
Another beauty of the Gilead partnership and others 
like it is that they not only foster collaboration between 
academia and pharma, they also encourage collaboration 
among different medical disciplines on the Yale campus. 
Under standard operating procedures, an individual inves¬ 
tigator receives an Roi grant to locate one small piece of the 
bigger cancer puzzle. For example, after a geneticist identi¬ 
fies a mutation underlying a particular cancer, advancing 
that information—and securing the funding to do so— 
sometimes gets a bit fuzzy. 
“One of the real strengths for Yale has been the ability 
to build teams among clinical investigators who have access to 
patients and tissue samples; genomics investigators who know 
how to use those samples to discover genes that underlie spe¬ 
cific forms of cancer; and biochemists and cell biologists who 
know how to go from specific genes and their mutations to 
assays to determine the consequences of the mutation that has 
been identified,” says Lifton. “It’s been really catalytic in terms 
of team-building across disciplines at Yale.” 
Halaban concurs. Every Thursday morning, she 
attends a melanoma board meeting with surgeons, patholo¬ 
gists, medical oncologists, radiologists, and researchers, 
where the discussion may turn to her Gilead-funded mela¬ 
noma sequencing project. “To hear clinicians talking about 
genes, asking me, ‘What did you find out about this gene or 
that gene?’ is amazing,” says Halaban. “These things were 
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not previously part of routine discussions. But now, the 
genetics of melanoma, currently mostly braf mutation sta¬ 
tus, changed it all.” 
Yet another advantage is that the flow of cash pro¬ 
motes other non-Gilead-funded research. “They’ve infused 
resources that we may not otherwise be able to get, both to 
expand Yale’s genomic capability and to build other aspects 
of our infrastructure,” says Patricia Pedersen, ph.d., associ¬ 
ate vice president for development and director of corporate 
and foundation relations, who played a key role in negotiat¬ 
ing the collaboration. “Overall, the Gilead investment has 
increased our capacity, which was necessary to enable us 
to deliver results to them. In doing so, it has increased our 
ability to do more research, apply for more nih grants, and 
get other funding.” 
Finding the right partner 
j Although academia-pharma collaborations create synergy 
through aligned interests and can be highly productive, 
negotiating the terms of the relationship can be difficult. 
Each stakeholder holds different core values. Academia prizes 
1 public pursuit of knowledge, research grant funding, and 
intellectual freedom. “We all have academic calendars that we 
live on, meaning that we want to get promoted, and for our 
careers to advance so that we get more grants. That’s why we 
have a never-ending desire to publish,” says Lynch. 
Both sides are working to eliminate such potential 
sources of conflict as restrictions on publication, problems 
with licensing rights, and conflict over control of the intel¬ 
lectual property. “You have to pick your partner well,” says 
Lynch. “It’s like a marriage. It’s really important that you 
select a company that fits the university.” 
“Indeed, Yale and Gilead have established strong 
links, productive collaboration, and common goals, and 
function as a harmonious couple,” Schlessinger said. Jaffe 
is an alumnus of the medical school; Gilead Sciences has 
previously funded faculty research projects; and the Gilead 
Foundation has supported a needle-exchange program 
and a mobile health care van in New Haven, so there is a 
history of camaraderie and collegiality. Adds Pedersen, “The 
company’s leadership is very academically minded.” For 
example, Gilead respects Yale’s mission to educate and dis¬ 
seminate information, placing few restrictions on the ability 
of Yale researchers to publish. 
“I think that Yale can feel confident based on our 
long-standing relationship and Gilead’s track record of social 
responsibility. We have pioneered worldwide access to our 
HIV drugs, signing deals with 13 different generic manufac¬ 
turers in India and having a no-profit cost,” says Jaffe. “We’re 
different. The major reason is that the people who created 
the value are still here. We’re all scientists or m.d.s. The core 
senior management of the company has been together over 
20 years. We’ve been able to maintain a certain culture here, 
and I think that’s of benefit for the Yale group.” 
Given the pressures on both pharma and academia, 
such alliances seem inevitable. 
“I believe that there is great beauty in science, and 
that’s one of the compelling things about being a scientist,” 
said Lifton. “But in addition, there is the expectation that 
our research will ultimately contribute to improvement 
in human health. Today, that is almost always going to go 
through an industry partner. We need to recognize that 
that’s how our system works.” 
Schlessinger agrees. “Many colleagues from other 
universities, as well as senior executives of major drug com¬ 
panies, emphasized to me the visionary aspects and the 
forward looking approach taken by the Yale-Gilead collabora¬ 
tion,” he said. “Moreover, as I believe that we are now in 
a golden age of drug discovery for cancer therapy and treat¬ 
ments for other diseases, we must come up with creative 
solutions to merge the best that academia and drug compa¬ 
nies offer in order to develop new treatments that reduce 
the suffering caused by such devastating human diseases 
as cancer.” 
Kara Nyberg, ph.d., is a freelance writer in Boulder, Colo. 
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Faculty 
Benjamin Polak 
New university provost 
named 
BENJAMIN POLAK, PH.O., chair of 
the Department of Economics, the 
William C. Brainard Professor of 
Economics, and professor of man¬ 
agement, was appointed provost 
of the university in December. He 
replaces Peter Salovey, ph.d., who 
can now focus on preparing for his 
next assignment as president—the 
role that he assumes on June 30. 
Salovey replaces Richard C. Levin, 
who is retiring after 20 years as 
president of Yale. 
Polak Joined the Yale faculty 
in 1994 and has made important 
contributions to decision theory, 
game theory, and economic his¬ 
tory. He received the William Clyde 
DeVane Medal for undergraduate 
teaching and scholarship in Yale 
College in 2005 and the Lex Hixon 
’63 Prize for Teaching Excellence in 
the Social Sciences in Yale College 
in 2006. In 1998 Polak won both 
the Graduate Teaching Prize and 
the Graduate Advising Prize in the 
Department of Economics; he was 
honored again with the Graduate 
Teaching Prize in 2005. 
Polak was appointed the inau¬ 
gural William C. Brainard Professor 
of Economics in 2008, and two 
years later was appointed chair of 
the Department of Economics. A 
member of the University Budget 
Committee, Polak has a strong 
grasp of the university’s budgetary 
and financial conditions. He has 
also served on the executive com¬ 
mittees of the MacMillan Center 
and the Institution for Social and 
Policy Studies and as a fellow of 
the Whitney Humanities Center 
and a visiting instructor at the Yale 
Law School. 
Richard Flavell 
Researchers honored for 
immune system research 
Two Yale School of Medicine 
researchers who study the immune 
system will share a 2013 Vilcek 
Prize for their long-standing and 
influential work on the innate 
immune system, the body’s first 
line of defense against infec¬ 
tion by bacteria and viruses. 
The prize went to Richard a. 
FLAVELL, PH.D., chair and Sterling 
Professor of Immunobiology; and 
RUSLAN M. MEDZHITOV, PH.D., 
the David A. Wallace Professor 
of Immunobiology. 
Flavell, a native of England, 
and his Yale colleagues have 
discovered several important 
receptors responsible for innate 
immunity, and he has made major 
contributions to our understand¬ 
ing of how activation of the 
innate immune system triggers 
the adaptive system’s more 
specialized immune response. 
Medzhitov, a native of Tashkent, 
Uzbekistan, immigrated to the 
United States in the early 1990s, 
having been inspired by the then- 
controversial theories of innate 
immunity championed by the late 
Yale immunobiologist Charles 
A. Janeway Jr., m.d. At the time, 
innate immunity was deemed 
unimportant and received scant 
scientific attention, but by 1997 
Medzhitov, Janeway, and col¬ 
leagues had identified a receptor of 
the human innate immune system 
that acts as a pathogen-detecting 
sentinel and activates adaptive 
immunity. In the wake of these 
findings, the study of innate immu¬ 
nity has seen explosive growth, 
and Medzhitov’s work continues 
to have significant implications for 
autoimmune diseases, cancer, and 
other illnesses. 
Immunologist receives 
inaugural prize 
RUSLAN MEDZHITOV, PH.D., the 
David A. Wallace Professor of 
Immunobiology and a Howard 
Hughes Medical Institute investi¬ 
gator, has been awarded the inau¬ 
gural Lurie Prize in the Biomedical 
Sciences from the Foundation for 
the National Institutes of Health. 
The award, which honors early- 
career researchers whose findings 
have advanced basic biomedical 
science, was given to Medzhitov 
for his groundbreaking discover¬ 
ies about the workings of the 
innate immune system. A jury 
of scientists selected Medzhitov 
from a group of 154 nominees. 
The award, which carries an 
honorarium of $100,000, will be 
presented to Medzhitov at a cer¬ 
emony in Chicago on May 14. 
Medzhitov came to Yale in 
1994 as a postdoctoral fellow in 
the lab of Charles A. Janeway Jr., 
M.D. The two researchers made 
the breakthrough discovery that 
a human fo/Mike receptor, a 
component of the innate immune 
system, provides the adaptive 
immune system with the nec¬ 
essary information to create 
custom-made B and T cells that 
target specific bacterial or viral 
invaders through recognition of 
basic molecular patterns shared 
by microbial pathogens. Since 
then, fo//-like receptors have 
become the subject of intense 
research activity in laboratories 
around the world. 
NOTES 
Lynn Cooley David 
McCormick 
Three faculty members received 
the distinction of Fellow from the 
American Association for the Ad¬ 
vancement of Science (aaas) in 
February for their efforts toward 
advancing science applications 
that are deemed scientifically 
or socially distinguished. Lynn 
Cooley, PH.D., the C.N.H. Long 
Professor of Genetics and profes¬ 
sor of cell biology and of molecu¬ 
lar, cellular, and developmental 
biology; Residential College 
Associate Fellow in the Faculty of 
Arts and Sciences; and director 
of the Combined Program in 
the Biological and Biomedical 
Sciences, was honored for her 
contributions to developmental 
cell biology, particularly for her 
analysis of oocyte growth during 
Drosophila oogenesis. Pietro De 
Camilli, m.d., fw ’79, the Eugene 
Higgins Professor of Cell Biology 
and professor of neurobiology, 
was honored for contributions to 
the cell biology of the synapse, 
and the discovery of the role of 
phosphoinositide metabolism in 
the control of endocytosis. David 
A. McCormick, ph.d., the Dorys 
McConnell Duberg Professor of 
Neurobiology and vice director 
of the Yale Kavli Institute for 
Neuroscience, was honored for 
contributions to the understand¬ 
ing of the cellular mechanisms 
by which the central nervous 
system generates states of activ¬ 
ity; how these states are related 
to behavior; and how they are 
determined by the actions of 
neuromodulatory transmitters. 
Three Yale faculty members re¬ 
ceived awards for distinguished 
service from the Connecticut 
Chapter of the American College 
of Physicians (acp) at its annual 
meeting in Southington, Conn., - 
in November, acp represents 
more than 2,300 physicians, 
1 
j 
25 
Cyrus Kapadia Paul Barash 
medical students, and resi¬ 
dents practicing internal 
medicine and its subspecialties 
across the state. 
The George F. Thornton Teach¬ 
ing Award, given annually to phy¬ 
sicians in recognition of contribu¬ 
tions to medical education and 
excellence in clinical teaching and 
motivational impact on students, 
residents, and colleagues, went to 
Auguste H. Fortin VI, m.d., m.p.h., 
associate professor of medicine; 
and Cyrus Kapadia, m.d., profes¬ 
sor of internal medicine (digestive 
diseases). Fortin is director of the 
psychosocial curriculum for the 
Primary Care Internal Medicine 
Residency Program and director 
of communication skills educa¬ 
tion. He has a special interest in 
doctor-patient communication, 
the humanities in medicine, 
the psychosocial aspects of 
j primary care, and professional 
burnout prevention. 
As a gastroenterologist, 
! Kapadia was instrumental in the 
i development of techniques to 
I identify precancerous changes 
in the colon. Kapadia directed 
I the Internal Medicine Residency 
Program at Yale-New Haven Hos- 
I pital from 1998 through 2011. 
The 2012 Laureate Award 
j was presented to Stephen P. 
O’Mahony, m.d., assistant clini¬ 
cal professor of medicine, who 
launched one of the state’s first 
hospitalist programs at Norwalk 
1 Hospital in 1999. He also began 
‘ to use his expertise in computer 
' engineering to integrate best 
j practices and patient safety into 
i clinical care through intelligent 
technology, decision support, 
I and education. 
Richard Kimberly Davis 
Belitsky 
Anne Eichmann Jordan Pober 
Paul Barash, m.d., professor of 
anesthesiology, received the 
Ralph M. Waters Award from 
the Midwest Anesthesia Confer¬ 
ence at its annual meeting in 
Chicago in November. Barash 
was recognized for his contribu¬ 
tions to the development of 
anesthesia in learning, practice, 
teaching, and research. 
Richard Belitsky, m.d., hs ’82, 
FW ’83, deputy dean for education, 
the Harold W. Jockers Associate 
Professor of Medical Educa¬ 
tion, and associate professor of 
psychiatry, was inducted into 
the University of Florida College 
of Medicine’s Wall of Fame in 
October. The Wall of Fame award 
and recognition ceremony were 
introduced in 1991 to recognize 
outstanding alumni who have 
made contributions to medicine, 
government, education, and 
the community. 
Michael G. Caty, m.d., recently 
named the Robert Pritzker Pro¬ 
fessor of Pediatric Surgery, is a 
noted pediatric surgeon whose 
clinical interests include neo¬ 
natal surgery, thoracic surgery, 
intestinal motility disorders, 
pediatric surgical oncology, 
pediatric laparoscopy, and mini¬ 
mally invasive thoracic surgery. 
He joined the Yale faculty in 
January 2012, when he was also 
named the chief of pediatric 
surgery at Yale-New Haven 
Children’s Hospital. 
Kimberly A. Davis, m.d., is the 
president-elect of east (Eastern 
Association for the Surgery of 
Trauma), the largest trauma 
organization in the country. 
Davis will be installed as presi¬ 
dent in January 2014. Her term 
as president-elect began in 
January of this year. 
Anne Eichmann, ph.d., has been 
appointed Ensign Professor of 
Cardiology. She is noted for her 
research exploring the factors 
that determine the location of 
cell growth in blood vessels and 
lymphatic vessels, as well as 
understanding how the vascular 
and nervous systems influence 
each other’s growth and func¬ 
tion. Eichmann came to Yale in 
2010 as a professor in the Yale 
Cardiovascular Research Center 
at the School of Medicine. 
T. Rob Goodman, m.d., vice chair 
of the Department of Diagnostic 
Radiology, was appointed the 
department’s interim chair in 
January. Goodman will also fill 
the role of interim chief of di¬ 
agnostic radiology at Yale-New 
Haven Hospital. His appoint¬ 
ment follows the departure of 
James A. Brink, M.D., who will 
lead the department of radiol¬ 
ogy at the Massachusetts Gen¬ 
eral Hospital. Goodman received 
his undergraduate degree from 
Dundee University in the United 
Kingdom and his medical degree 
from Cambridge University. He 
Joined the School of Medicine 
faculty in 2003. 
Jordan Pober, m.d. ’77, ph.d. ’77, 
FW ’78, whose research focuses 
on the functions of vascular 
endothelial cells in inflamma¬ 
tory and immune responses 
and how inflammation and 
immunity affect vascular health 
and function, has been named 
the inaugural Bayer Professor 
of Translational Medicine. Bayer 
has established this professor¬ 
ship in recognition of the goals it 
Deborah Martin 
Proctor Schwartz 
shares with the School of Medi¬ 
cine to improve the translation 
and delivery of fundamental 
scientific discoveries in human 
health. Pober serves as director 
of the Human and Translational 
Immunology Program and is vice 
chair of the Department of Im¬ 
munology’s Section of Human 
and Translational Immunology. 
Deborah Proctor, m.d., profes¬ 
sor of medicine (digestive 
diseases) and medical director 
of the Inflammatory Bowel 
Disease Program, received the 
Angel Among Us Award from 
the Middletown (Conn.) Elks at 
a meeting in November. Proctor 
donates much of her time to 
helping patients pro bono. She 
started the Free Flex-Sig screen¬ 
ing program, and she and her 
husband have made more than 
10 trips to Honduras, where 
they have sponsored more than 
40 children in an orphanage. 
Martin A. Schwartz, ph.d., re¬ 
cently named the Robert Berlin¬ 
er Professor of Cardiology, is a 
noted cardiovascular researcher 
whose studies of cell adhesion 
and behavior have led to new 
insights into atherosclerosis 
and heart disease. A professor 
of medicine (cardiology) and 
of cell biology, he is affiliated 
with the Vascular Biology and 
Therapeutics Program and is a 
member of the Yale Cardiovas¬ 
cular Research Center. 
send faculty news to 
Claire M. Bessinger, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
26 students 
Seeing the unsung 
people “who care for us” 
Medical students tell the stories of 
people who make their own lives better 
—a custodian, a bus driver, and a cook. 
Anyone who’s taken the Yale Shuttle to 
the VA Connecticut Healthcare System 
in West Haven has likely crossed paths 
with Chris Ferguson, one of the drivers 
on that route. What passengers may 
not know is that Ferguson is a graduate 
of Hamden’s Paier College of Art who 
juggles his work schedule so he can 
indulge his passion for painting. Diners 
at Marigolds have probably encountered 
kitchen worker Lhamu Bhutia, with¬ 
out knowing that she’s a refugee from 
Tibet whose family once owned a res¬ 
taurant in Nepal. Pearl Murphy, known 
to all as “Ms. Pearl,” is hard to miss. 
More than 6 feet tall, with an outsize 
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personality to match, she works nights 
as a custodian at the medical school— 
one of the two full-time jobs the single 
mother has held for 30 years. 
Their stories, as told by three medi¬ 
cal students, were the focus of an 
inaugural narrative project sponsored 
by the Program for the Humanities 
in Medicine with the aim of draw¬ 
ing attention to unsung heroes of the 
medical school. The students’ narra¬ 
tives were published in a book titled 
The Art of Caring, and the students 
read from their narratives at a lecture 
in March. Ferguson and Murphy, 
along with friends and family, were in 
the audience for the lecture. 
“We never pay attention to those 
individuals who care for us in envi¬ 
ronments such as this,” said Thomas 
P. Duffy, M.D., professor of medicine 
(hematology) and director of the 
humanities program, at the lecture 
in the Cohen Auditorium. “It is those 
individuals who allow us to live the 
privileged lives that we live.” 
Over the course of three months 
first-years Matt Meizlish and Lorenzo 
Sewanan, and second-year Christine 
Sunu interviewed Murphy, Bhutia, and 
Ferguson and used their subjects’ own 
words to describe their lives—from 
TOP At a session in January, Alisa Anderson 
met with the students and described how the 
writing workshop would proceed. “One of the 
central focuses is that we interview people who 
often go unnoticed,” she said. 
MIDDLE Under the guidance of Alisa Anderson 
(second from left) medical students Lorenzo 
Sewanan, Christine Sunu, and Matt Meizlish 
gathered the life stories of three medical school 
workers and published the oral histories in a 
book. The Art of Caring, in March. The students 
read from their stories at a Humanities in Medi¬ 
cine lecture in the Cohen Auditorium. 
BOTTOM Matt Meizlish (back row, far right) 
told the story, in her own words, of Pearl 
Murphy, a custodian who’s worked at Yale for 
30 years. At the humanities lecture in March, 
Murphy (seated, far right) was joined by her 
daughter Tennille Murphy, granddaughter 
lyana Liburd, and (back row) George Keen, and 
Marquis McGraw. 
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Ferguson’s passion not only for art, but 
for the religion that anchors him spiri¬ 
tually, to Murphy’s amusement at her 
granddaughter’s attempts to teach her 
how to text, to Bhutia’s family’s odys¬ 
sey from Tibet to India to Nepal to the 
United States. Guiding the students 
through the process was Alita Anderson, 
M.D. ’oi, who impressed classmates 
and faculty in her student days with her 
portrayals of the workers and patients 
whose life stories she had gathered. At 
i her first meeting with the students in 
January, Anderson described the process 
i that would unfold, starting with decid¬ 
ing whom to interview. 
, “In this project one of the central 
focuses is that we interview people who 
I often go unnoticed and are doing the 
! work of caring for this community— 
; people who are custodians, grounds- 
i keepers, security guards—and play 
; a big role in creating the community 
that you live in every day,’’ Anderson 
told the students. Over the next weeks 
I Anderson, who lives in Atlanta, dis- 
I cussed the projects with the students 
i during weekly conference calls. 
The narrative project was the 
i brainchild of Duffy; Nancy R. Angoff, 
1 M.p.H. ’8i, M.D. ’90, HS ’93, associate 
dean for student affairs; and Forrester 
A. Lee, m.d. ’79, hs ’83, associate 
dean for multicultural affairs. “It was 
decided that we would call on Alita 
Anderson to be an artist and writer in 
residence,” Duffy recalled. “Out of that 
has come this remarkable manuscript.” 
—John Curtis 
From faltering English 
to leadership of a medical 
student group 
One Saturday when he was 10 years 
old, Hao Feng arrived in the United 
States from Shijiazhuang in northern 
China. Feng, who then knew fewer 
than a dozen words of English, started 
school on the following Monday. Today 
he speaks English with no trace of an 
accent, but the linguistic and cultural 
barriers of those early years have 
informed his approach to medicine. 
Feng, now taking a fifth year for 
research at the School of Medicine, 
was recently elected chair of the 
Council of Student Members (csm) of 
the American College of Physicians 
(acp). Flis role as a leader of the inter¬ 
nal medicine interest group during 
his second year of medical school 
led to an invitation to join the acp 
Connecticut chapter’s Governor’s 
Council. The organization’s support 
for medical students so impressed him 
that he applied for a position on the 
CSM, which represents the interests 
of approximately 28,000 students. As 
chair, Feng will become a voting mem¬ 
ber of the Board of Regents, the acp’s 
main policy-making body. He is the 
only medical student in the country 
to hold that privilege. “I will represent 
the opinions and interests of medical 
students across the nation,” he said. 
Those interests, he said, include fund¬ 
ing for graduate medical education, 
the huge debt burden faced by medical 
students, and changes in the health 
care system. 
Feng explored law, biotechnology, 
teaching, and engineering as an under¬ 
graduate at the University of California, 
Berkeley, and graduated with a 
degree in molecular and cell biology. 
Medicine—the only profession in 
which he felt he could make an impact 
on both individuals and on society— 
became his first choice for a career. 
Feng is well on his way to gaining 
experience in these areas. As a Doris 
Duke Clinical Research Fellow, he 
Hao Feng, a medical student taking a fifth year 
for research in photopheresis, was recently 
elected chair of the Council of Student Mem¬ 
bers of the American College of Physicians, 
where he will advocate on behalf of medical 
students across the country. 
is studying the mechanism behind 
photopheresis, an immunotherapy 
treatment that is effective for cuta¬ 
neous T cell lymphoma, transplant 
rejection, autoimmune disorders, and 
graft-versus-host disease. 
Feng also volunteers at haven, a 
free clinic staffed by Yale students 
under the supervision of faculty. His 
early struggles with English, he said, 
“gave me a respect and understand¬ 
ing of how important it is to accept 
diversity and keep in mind that other 
people have different beliefs.” Most 
patients at the clinic are Hispanic. 
When a patient told him that he felt 
“ice in his veins,” Eeng probed further. 
Although he and his colleagues were 
unable to make a definitive diagnosis, 
they asked the patient to return for 
another visit. “There are certain things 
patients offer because they feel it’s 
important, and if we ignore that aspect 
we may be missing a component of 
what they’re trying to tell us,” he said. 
Eeng is still trying to decide on a 
specialty. In addition to being both a 
physician and a researcher, he would 
like to advocate for better health care 
and influence health care legislation. 
He believes he will be able to fit it all 
in. “If you’re passionate about some¬ 
thing, you’ll make time for it,” he said. 
—Jill Max 
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Jeffrey Lowell, a pediatric transplant surgeon, 
has advised the Department of Homeland 
Security on medical affairs, and laid the 
groundwork for regional responses to natural 
disasters in St. Louis. 
Medicine, community, 
and justice intersect 
Jeffrey Lowell helps first responders, 
government officials, and health 
providers to prepare for disasters. 
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A few years after Jeffrey Lowell, m.d. ’85, 
joined the faculty at Washington 
University School of Medicine in St. 
Louis in 1994, the liver and kidney trans¬ 
plant surgeon transitioned from spend¬ 
ing his protected research time in a lab to 
spending it in support of the community. 
“Initially, I was interested in the 
intersection of medicine, commu¬ 
nity, and justice. Physicians and law 
enforcement are both involved in high- 
stakes, fast-tempo work, and I thought 
that medicine could contribute some¬ 
thing,” Lowell said. 
Completing coursework and training 
at the St. Louis Police Academy in 2001, 
Lowell rose through the ranks of com¬ 
munity and regional public service— 
receiving training in tactical medicine 
as a hostage negotiator and serving as 
the city’s police surgeon, then serving 
as the mayor’s regional medical critical 
incident director—until Tom Ridge, 
the first secretary of the Department 
of Homeland Security (dhs), invited 
Lowell to Washington to be his senior 
advisor for medical affairs. 
When Ridge came to St. Louis in 
October 2003 on a national tour of town 
hall meetings regarding the fledgling 
DHS, he had already heard of Lowell’s 
accomplishments in the mayor’s office 
and the St. Louis region. Lowell had 
spearheaded projects that coordinated 
the city’s hospitals and its first-response 
agencies—a need that St. Louis recog¬ 
nized during the 2001 anthrax attacks 
that followed 9/11. As in every major 
U.S. city, telephone lines at hospitals, 
post offices, and police, fire, and public 
health departments were jammed with 
calls about the dangers of unidentified 
white powders. 
“We were chasing our tail around 
and didn’t have any good program to 
deal with it, so Mayor [Francis] Slay 
asked if I would build a matrix organi¬ 
zation that integrated the region’s 
medical and health assets with all 
the other forms of local government, 
including first response,” he said. 
Lowell led the effort to devise and 
implement the St. Louis Hospital 
Mutual Aid Agreement, which binds 
the hospitals of the metropolitan 
area’s eight counties across two states 
(Missouri and Illinois) to share staff, 
beds, equipment, and supplies in the 
event of a disaster—natural, indus¬ 
trial, terrorist, or other. 
“It was a big deal. Hospitals are 
big business competitors. They would 
just as soon put a stake in each other’s 
heart as help one another. But we got 
every hospital in the region to say that 
in the event of a disaster, they’ll help 
one another,” Lowell said. 
The agreement laid the ground¬ 
work for the St. Louis Area Regional 
Alum promotes chronic 
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Response System (starrs), whioi--' 
Lowell led the effort to create. The net¬ 
work coordinates the fire departments, 
police departments, public health 
agencies, governments, and ngos of 
the two-state metro area for disaster 
preparation and response. Ridge was 
seeking just this type of multiagency 
coordination and integration for his 
new department that would bring 
together all or part of 22 federal agen¬ 
cies when he invited Lowell to meet 
with him in St. Louis. 
“When Congress built this depart¬ 
ment, they didn’t give him a top 
doctor, but almost everything that 
Secretary Ridge went to bed afraid of 
happening to America the next day 
had a medical or health implication,” 
Lowell said. 
Shortly after the meeting. Ridge 
asked Lowell to work for him in 
Washington, D.C., as his senior advi¬ 
sor for medical affairs. In Washington, 
Lowell defined the role of a permanent 
medical advisor. Later, he shared these 
recommendations in a 2005 House 
Subcommittee hearing. Largely based 
on these recommendations, dhs 
launched the Office of Health Affairs 
and the holder of Lowell’s former 
position is now known as the dhs 
Chief Medical Officer and Assistant 
Secretary for Health Affairs. 
Lowell’s recommendations also ap¬ 
peared in a report to Ridge that outlined 
a strategy to realign and strengthen the 
Federal Medical Response, which was 
released in January 2005 and later made 
national news. Eight months later, his 
assignment in Washington over, Lowell 
was back home in St. Louis, when 
Hurricane Katrina put his evaluation to 
the test, requiring the biggest National 
Disaster Medical System (ndms) 
deployment to date. The Washington 
Post quoted officials and ndms team 
leaders who strongly supported 
Lowell’s assessment. 
“I think a lot of my recommen¬ 
dations, if implemented, would 
have greatly improved our Katrina 
response,” Lowell said. 
Back at work in St. Louis, Lowell 
continues to serve his city as the 
mayor’s senior medical advisor and 
director of the health department. As 
chief of pediatric transplant surgery 
at St. Louis Children’s Hospital, he 
has performed a liver transplant on a 
lo-day-old patient, one of the youngest 
known organ recipients. He also served 
on one of the first teams to perform a 
transplant in which a piece of an adult 
liver from a living donor was trans¬ 
planted into an adult recipient. 
A commander in the U.S. Navy 
(reserve), Lowell was deployed to Central 
and South America on a humanitarian 
mission and in support of Operation 
Enduring Freedom to the U.S. Army 
hospital in Landstuhl, Germany. 
“It’s very rewarding, not only to 
be in health care and do something 
that people both need and otherwise 
wouldn’t be able to have, but to do it 
representing your country. Taking care 
of injured soldiers and marines has 
been my greatest honor. I am deeply 
grateful for having that privilege. ” 
—Sonya Collins 
Statins. Metformin. Glitazones. 
Fibrates. Familiar drugs to clinicians 
who treat patients with cardiovascu¬ 
lar diseases and diabetes. They tamp 
down infiammatory overreaction to 
the disease. Could they also work in 
acute illnesses, even infections.^ David 
Fedson, m.d. ’65, believes they could 
be useful against severe infiuenza, 
sepsis, trauma, and severe burn injury 
conditions that can also provoke a 
deadly inflammatory response. He 
believes this question is worth inves¬ 
tigating and is waging a campaign to 
persuade researchers to do so. 
Fedson, who is retired and lives in 
France near Geneva, Switzerland, where 
his wife works for the World Health 
Organization, is no stranger to public 
health. During medical school, he stud¬ 
ied an experimental smallpox drug, but 
it turned out to be ineffective. In 1968, 
as a resident at Johns Hopkins, he par¬ 
ticipated in a research project in Kolkata 
(Galcutta) with investigators who were 
instrumental in developing oral rehy¬ 
dration therapy (ort) to treat cholera. 
Later, he studied influenza vaccination 
at the nih; and in 1976, while on the 
faculty of the University of Chicago, 
he organized the university’s swine flu 
vaccination program. Six years later he 
published a recommendation that is 
now national policy: routinely offering 
influenza and pneumococcal vaccina¬ 
tion to patients being discharged from 
the hospital. After 13 years on the faculty 
of the University of Virginia, where he 
was head of the Division of General 
Medicine, he moved to France in 
1995 to become director of medical 
affairs at Sanofi Pasteur msd, a vaccine 
company. There he continued his 
work on the epidemiology and cost- 
effectiveness of influenza and pneumo¬ 
coccal vaccination. 
In the early 2000s, when H5N1 
avian influenza emerged as a global 
public health threat, Fedson recognized 
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David Fedson is campaigning to encourage 
physicians to use familiar drugs to treat acute 
illnesses, including infections. Fedson is retired 
and lives near Geneva, Switzerland. 
that vaccination alone would not save 
many lives—it would be difficult to 
produce and distribute in a short 
period of time. Like many researchers, 
he also wondered why the 1918 influ¬ 
enza pandemic had spared children 
but killed young adults. Clinicians 
and epidemiologists, he said, have 
noticed similar mortality differences in 
patients with other infectious diseases, 
in trauma victims, and in those with 
acute lung injury due to malaria and 
sickle cell disease. Children fare bet¬ 
ter than adults because their immune 
systems tend not to launch a damag¬ 
ing and sometimes fatal inflamma¬ 
tory response. No one knows why, but 
Fedson believes it makes evolutionary 
sense. “Children may be programmed 
to devote their energy to growth, not 
immune defense. Once they reach an 
age where they can reproduce, energy 
metabolism is redirected to immune 
defense,” he said. 
Fedson recalled a study in which 
adult mice reacted more severely to 
liver injury than juveniles. When 
researchers treated adult mice with 
the diabetes drug rosiglitazone, the 
adults had less severe inflammation 
and better survival. In effect, he said, 
the researchers “rolled back the host 
response of the young adult to that of a 
child.” Similar effects on acute inflam¬ 
mation have been seen in studies of 
statins for heart attack victims and 
in studies of other immunomodula¬ 
tory drugs in animal models of sepsis 
and influenza. In each instance, these 
drugs act to restore homeostasis. 
Equally important, they are produced 
as inexpensive generics and are avail¬ 
able in any country with a basic health 
care system. 
But much work needs to be done 
to determine whether these inexpen¬ 
sive drugs could be used routinely 
to treat patients with severe acute 
illness, including avian influenza. 
Unfortunately, said Fedson, research 
on the muted host response to disease 
in children, as well as on strategies 
to mimic this response in adults, has 
been neglected—especially by influ¬ 
enza scientists and immunologists. 
Fedson has lectured at conferences, 
published in medical journals and 
the lay press, and contacted dozens of 
prominent researchers, journalists, 
and policymakers. Responses to what 
he calls his “cry in the wilderness” 
have been few and mostly noncommit¬ 
tal. He blames narrow specialization 
and a driving desire among biomedi¬ 
cal scientists to explain mechanisms 
of disease rather than seek practical 
ways to manage it. 
It doesn’t help, he adds, that most 
experts are not m.d.s, but ph.d.s, who 
have a better understanding of the virus 
than the host response it can produce. 
ORT for cholera, Fedson pointed out, 
was introduced at a time when research¬ 
ers were trying and failing to develop an 
effective cholera vaccine, ort treated the 
host response—the diarrhea and subse¬ 
quent dehydration—without attacking 
the infectious organism. The strategy 
has saved tens of millions of lives world¬ 
wide. Might a physiologic treatment of 
the host response to pandemic influenza 
do the same? 
“Let’s see if we can use what 
we’ve already got,” Fedson said. “We 
don’t know whether these agents will 
work, but we can’t afford not to do the 
research to find out.” 
—Jenny Blair, M.D. ’04 
Familiar Faces 
Do you have a colleague who is making 
a difference in medicine or has followed 
an unusual path since leaving Yale? We’d i 
like to hear about alumni of the School off 
Medicine; Physician Associate Program; 
and the medical school’s doctoral, fellow¬ 
ship, and residency programs. Drop us a 
line at ymm@yale.edu or write to Faces, 
Yale Medicine, ^ Church Street, Suite 300, 
New Haven, CT 06510. 
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Sherwin Brian Kobilka 
Nuland 
1950s 
Herbert Kaplan, m.d., hs ’58, 
received the Presidential Cold 
Medal from the American College 
of Rheumatology In November. 
The award recognizes outstand¬ 
ing achievements in rheumatol¬ 
ogy over an entire career. 
Harry C. Miller Jr., m.d. ’54, 
received the William P. Didusch 
Art and History Award from the 
! American Urological Association 
I (aua) at its 2013 annual meeting 
in San Diego in May. Miller was an 
editor of the Centennial History of 
the AUA, published in 2003. 
Sherwin B. Nuland, M.D.’55, 
j HS’61, clinical professor of 
; surgery emeritus, received the 
Jonathan E. Rhoads Gold Medal 
“for distinguished service to 
medicine" from the American 
Philosophical Society at its No¬ 
vember 2011 meeting in Franklin 
Hall in Philadelphia. 
1970s 
i George J. Dohrmann, M.D., PH.D., 
HS ’78, received the 2012 Career 
Achievement Award from the 
Chicago Neurological Society. 
Dohrmann was honored for 
; expertise, knowledge, dedication, 
i and recognition in neurosur¬ 
gery and neurological research. 
Dohrmann is a member of the 
I neurosurgeryfaculty atthe Uni- 
! versity of Chicago Medical Center. 
j Richard Kayne, m.d. ’76, received 
I the Volunteerism and Community 
i Service Award in November from ij 
! the Connecticut Chapter of the 
American College of Physicians 
j (acp). Kayne’s son, a survivor of 
'I osteosarcoma,attended Paul 
j' Newman’s Hole in the Wall Gang 
y Camp in Ashford, Conn., in 1995. 
Steven Vishal Agrawal 
Rasmussen 
Rajesh Rao 
The next year Kayne volunteered 
as a counselorforthe camp, and 
he became a member of its board 
of directors in 2002. 
Barbara R. Pober, M.D. ’78, m.p.h., 
has joined the founding faculty of 
the Frank H. Netter m.d. School of 
Medicine at Quinnipiac Univer¬ 
sity in Hamden, Conn. Pober will 
teach genetics atthe medical 
school, which will open this fall. 
Pober, professor of pediatrics at 
Harvard Medical School, is recog¬ 
nized as an international expert 
on Williams syndrome, a genetic 
disorder marked by cardiovascular 
disease, developmental delays, 
and learning disabilities. 
Eddie Reed, m.d. ’76, was named 
clinical director of the Intramural 
Research Program at the National 
Institute on Minority Health and 
Health Disparities (nimhd) of the 
National Institutes of Health in 
January. Reed will oversee outpa¬ 
tient, inpatient, epidemiological, 
clinical, and laboratory-based 
investigations, and will build 
a multi-and interdisciplinary 
research program geared to trans¬ 
lating basic research into clinical 
trials and interventions. 
1980s 
Brian K. Kobilka, m.d. ’81, pro¬ 
fessor of molecular and cellular 
physiology and of medicine at 
Stanford University School of 
Medicine, won the 2012 Nobel 
Prize in Chemistry in October. 
He shares the prize with Robert 
J. Lefkowitz, m.d., of Duke Uni¬ 
versity Medical Center, for their 
work on sensors lodged in the 
cell membrane known as G- 
protein-coupled receptors (gpcrs) 
Their work has contributed to 
improved understanding of the 
ways cells sense and respond to 
their environment—almost half 
of all medications achieve their 
effects through gpcrs. 
Lefkowitz began using radio- 
actively labeled hormones to 
identify their receptors at Duke 
in 1968, and soon discovered the 
B-adrenergic receptor, which 
binds adrenaline on the cell sur¬ 
face and sets off a biochemical 
cascade inside the cell. Kobilka 
Joined Lefkowitz’s lab as a post¬ 
doctoral fellow in the 1980s. 
In 2011, Kobilka’s team 
captured an image of the R- 
adrenergic receptor at the 
moment that it is activated and 
sends a signal into its cell. In 
announcing the prize, the Nobel 
committee declared, "This image 
is a molecular masterpiece—^the 
result of decades of research.” 
Steven Rasmussen, m.d., hs ’83, 
known for his research in devel¬ 
oping circuit-based neuromodu- 
latory treatments for psychiatric 
disorders, has been named chair 
of the Department of Psychiatry 
and Human Behavior at the 
Warren Alpert Medical School of 
Brown University. 
1990s 
Brian Adams, m.d. ’95, m.p.h., 
has been named interim chair of 
dermatology at the University of 
Cincinnati College of Medi¬ 
cine, where he completed his 
internship and residency. Adams 
joined the faculty of the Depart¬ 
ment of Dermatology in 1999 
and serves as residency program 
director and director of medical 
student education. 
Keith von Eigen, m.d. ’90, m.p.h., 
PH.D., received a Laureate Award 
from the Connecticut Chapter of 
the American College of Physicians 
(acp) in November. The award 
is one of the chapter’s highest 
honors for distinguished service 
to patients and the profession. 
2000S 
Vishal Agrawal, M.D. ’02, FW ’96, 
has been named president of 
the Harris Corporation’s Health¬ 
care Solutions business. Agrawal 
has more than 15 years’ experi¬ 
ence developing strategies 
for and advising government 
and commercial health care 
organizations in North America. 
At the School of Medicine he 
was a Howard Hughes Medical 
Institute research fellow and in 
the Department of Molecular 
Biophysics and Biochemistry. 
Rockman Ferrigno, m.d. ’01, 
HS ’04, has been named the 
interim chair of the emergency 
department of Connecticut’s 
Bridgeport Hospital, where he has 
worked for seven years. 
Rajesh C. Rao, m.d. ’07, a vit- 
reoretinal surgery fellow in the 
Department of Ophthalmology 
and Visual Sciences at Washing¬ 
ton University School of Medi¬ 
cine in St. Louis, submitted one 
of 10 entries selected by the Na¬ 
tional Eye Institute, part of the 
National Institutes of Health, for 
its Audacious Goals challenge. 
Rao’s proposal involves restoring 
vision in patients whose retinas 
have deteriorated from dis¬ 
eases like age-related macular 
degeneration. 
SEND ALUMNI NEWS TO 
Claire M. Bessinger, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
VISIT US ON THE WEB 
yalemedicine.yale.edu 
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32 in Memoriam 
Margaret J.AIbrink, M.D. ’46, 
HS '47, FW '51, M.p.H. '51, died on 
December 23 in Morgantown, 
W. Va. She was 92. Albrink was 
one of the rare women of her 
generation to pursue a career in 
academic medicine and was the 
first researcher to establish the 
significance of serum triglycerides 
in coronary artery disease. Albrink 
joined the Yale faculty and served 
as instructor in medicine from 
1952 to 1958. She became assis¬ 
tant professor of medicine in 1958. 
She and her husband, Wilhelm S. 
Albrink, M.D., Joined the faculty 
ofthe West Virginia University 
School of Medicine in 1961. 
Robert S. Briggs, m.d. ’61, HS ’65, 
died of complications of Parkin¬ 
son disease in Litchfield, Conn., 
on November 25. He was 80. 
After residency and a fellowship 
in hematology at Yale, Briggs 
moved to Litchfield in 1965, 
where he joined an internal 
medicine practice. 
Peter R. Cunningham, m.d. ’49, 
HS ’50, a retired pediatrician, 
died on October n in Johnson, 
Vt. He was 86. After graduation, 
Cunningham worked at the Navy 
hospital in Newport, R.L, before 
completing his residency in pedi¬ 
atrics. He had pediatrics practices 
in Guilford and Westville, Conn., 
for over 30 years before retiring 
to Vermont in 1986. 
Herbert S. Harned Jr., m.d. ’45, 
a retired pediatric cardiologist, 
died on January 7 at University of 
North Carolina Hospitals in Cha¬ 
pel Hill. He was 91. During his ca¬ 
reer Harned saw the development 
of diagnostic and interventional 
cardiology as it involved children; 
the near-demise of rheumatic 
fever; the development of surgery 
for complex cardiac conditions; 
and the creation of intensive care 
units for newborns and children. 
Louis J. Kaplan, m.a., associ¬ 
ate dean for government and 
community affairs during a 
turbulent era in the history of 
the School of Medicine, died on 
January 8 in Springfield, Va. He 
was 96. Kaplan’s work helped 
to establish the Connecticut 
Mental Health Center (cmhc) 
and the Yale Comprehensive 
Cancer Center. 
Kaplan was hired as director 
of field services for the Connect¬ 
icut Mental Health Association 
in 1956, where he worked with 
community members, govern¬ 
ment agencies, and other insti¬ 
tutions. Kaplan also conducted a 
series of fundraising events with 
celebrities—including Vivian 
Vance, Lucille Ball’s best friend 
in the / Love Lucy series, and 
baseball great Jackie Robinson— 
to raise public awareness of 
mental health issues. 
Kaplan became the executive 
director ofthe association in 
1966 and was recruited to the 
planning team for the new cmhc. 
The following year he became as¬ 
sistant to Dean Frederick Redlich, 
M.D. Not long after, the city of 
New Haven was engulfed in 
racial riots similar to those that 
swept other cities at the time. 
Kaplan worked with community 
representatives and government 
officials to quell the violence and 
initiate new programs to address 
many ofthe local issues that had 
sparked the unrest. 
Leo D. Kellerman, m.d. ’42, of 
Douglaston, N.Y., died of natural 
causes at the home of his 
daughter in Avon, Conn., on No¬ 
vember 18. He was 95. The child 
of Russian immigrants, Keller¬ 
man practiced ophthalmology 
in Queens, N.Y., and volunteered 
his medical services in Kenya 
and the West Indies. 
Arthur E. Laidlaw, m.d. ’39, a 
retired pediatrician, died on No¬ 
vember 19 in Cooperstown, N.Y. 
He was 97. Laidlaw served in 
the Army Medical Corps during 
World War II, returning to prac¬ 
tice medicine in New Hampshire 
and upstate New York until his 
retirement in 1975. 
Jack LoveyM0).080H.D., di^ Q 
on November 19 in banta Bar 
bara, Calif. He was 82. After his 
second year of medical school. 
Love received a Rhodes Scholar¬ 
ship and studied experimental 
pathology at Oxford, where his 
thesis advisor was the Nobel 
laureate Sir Howard Florey, ph.d. 
Love served as a thoracic sur¬ 
geon in the U.S. Army Medical 
Corps and later was a member 
ofthe surgery faculty at Johns 
Hopkins School of Medicine and 
the UCLA School of Medicine. 
Ellen P. Mackenzie, m.d. ’44, 
died on December 14 in Gretna, 
La. She was 92. MacKenzie 
opened her private practice in 
pediatrics in Gretna in 1949 and 
received psychiatric training 
at Louisiana State University 
School of Medicine and the 
Charity Hospital of New Orleans. 
John H. Meyers, m.d. ’50, a 
retired dermatologist, died in 
Glen Cove, N.Y., on October 6. 
Meyers was a captain in the U.S. 
Army Medical Corps and chief of 
dermatology at Fort Belvoir, Va.; 
he later served as an adjunct 
professor of dermatology at 
New York Polyclinic Medical 
School and Hospital before 
becoming chief of dermatology 
at the Glen Cove Hospital. 
Richard A. Moore, m.d. ’6i, a 
retired pediatrician, died on 
November 26 in Cleveland, Ohio. 
He was 77. Moore was chief 
medical resident at Rainbow 
Babies and Children’s Hospital 
in Cleveland before moving to 
Elyria, Ohio, where he practiced 
for over 40 years. 
Edmund L. Piper, m.d. ’49, died 
on October 30 in Exeter, N.H. 
He was 87. Piper practiced 
dermatology in the Portsmouth 
area for most of his career. 
Giles Stevens Porter, m.d. ’43, a 
retired general practice physi¬ 
cian, died on November 23 in 
Eugene, Ore. He was 95. Porter 
served as a medical officer in 
the U.S. Navy in the Pacific The¬ 
ater during World War II. After 
the war, he moved to Eugene to 
open a general surgical practice. 
Porter also worked as a trauma 
specialist in the emergency 
department of Sacred Heart 
Hospital in Eugene. 
Frank H. Ruddle, ph.d., profes¬ 
sor emeritus of biology, died on 
March io at Yale-New Haven 
Hospital. He was 83. Ruddle re¬ 
ceived his doctorate in zoology 
from the University of California, 
Berkeley, in 1960, and completed 
postdoctoral work at Glasgow 
University. In 1961 he joined the 
Zoology Department (later Biol¬ 
ogy, and then Molecular, Cellular, 
and Developmental Biology) 
and had a joint appointment 
in the Department of Human 
Genetics until his retirement in 
2007. Ruddle served as chair of 
the Biology Department several 
times and held endowed chairs 
as the Ross G. Harrison Professor 
and the Sterling Professor of Biol¬ 
ogy. He was noted for his seminal 
studies on human gene mapping, 
his development ofthe transgenic 
mouse, and his work on homeo- 
box genes, important regulators 
of development. His achieve¬ 
ments were recognized by his 
election to the National Academy 
of Sciences, the Institute of Medi¬ 
cine, and the American Academy 
of Arts and Sciences. He was the 
recipient of many awards, includ¬ 
ing the Dickson Prize in Medicine, 
the William Allan Award ofthe 
American Society of Human Ge¬ 
netics, and the 2000 Connecticut 
Innovations Special Achievement 
Award. Ruddle served on numer¬ 
ous NIH review boards, was 
president ofthe American Society 
for Cell Biology, and was editor 
of such scientific journals as the 
Journal of Experimental Zoology 
and Cenomics. 
Arlene Sweedler, m.d. ’58, died 
on December 17 in Urbana, III. 
She was 80. After a residency at 
Bellevue Hospital in New York 
City, Sweedler spent several 
years working in Japan. Along 
with her husband, Daniel, 
whom she met at the School of 
Medicine, she started a medical 
practice in Livermore, Calif. 
SEND OBITUARY NOTICES TO 
Claire M. Bessinger, Yale Medicine, 
I Church Street, Suite 300, 
New Haven, CT 06510, or via e-mail 
to claire.bessinger@yale.edu 
A cliiTib for health and history 
'‘What do the Blumenfeld lab, 27 flights of stairs, and the 
have in common?” So read an invitation pictures 
from Haf Blumenfeld, m,d., ph.d,, to his lab. "We have a lab 
outing every year;” said Blumenfeld, professor of neurology, 
neurobiology, and neurosurgery, and director of the Yale 
Clinical Neuroscience Imaging Center. “This year I thought 
1 would combine historical tours and stair climbing. I walk 
the stairs regularly. It’s a good way to be fit and healthy.” 
The pictures In the invitation were of locations on 
the outing—dubbed cfanhy, Climb for Fitness And Neuro- 
science History at Yale—In which a dozen members 
of Blumenfeld’s lab joined him on March 20. Their stair- 
climbing tour took in the Cushing Cente*; the top of the 
Sterling Hall of Medicine, the Clinic Building, Smilow Cancer 
Hospital, and the helicopter landing pad at Yale-New Haven 
Hospital. At each high point Blumenfeld arranged for dis¬ 
cussions of history that covered neurosurgeon Harvey 
Cushing, New Haven's hospitals, and the era of Dean Milton 
Winternitz, aa.d. The tour ended with lunch at BAR. 
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